{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "06f102a9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import random as rnd\n",
    "from docx import Document\n",
    "from pathlib import Path\n",
    "\n",
    "rows = 100\n",
    "df = pd.read_csv(\"../Datasets/discharge.csv\", nrows=rows)\n",
    "df.to_json('../Datasets/test.json')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "60ec5b4e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "note_id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "subject_id",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "hadm_id",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "note_type",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "note_seq",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "charttime",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "storetime",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "text",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "38ea4526-3ca5-4c7d-8a13-cce99dd4f588",
       "rows": [
        [
         "0",
         "10000032-DS-21",
         "10000032",
         "22595853",
         "DS",
         "21",
         "2180-05-07 00:00:00",
         "2180-05-09 15:26:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nWorsening ABD distension and pain \n \nMajor Surgical or Invasive Procedure:\nParacentesis\n\n \nHistory of Present Illness:\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \nbioplar, PTSD, presented from OSH ED with worsening abd \ndistension over past week.  \nPt reports self-discontinuing lasix and spirnolactone ___ weeks \nago, because she feels like \"they don't do anything\" and that \nshe \"doesn't want to put more chemicals in her.\" She does not \nfollow Na-restricted diets. In the past week, she notes that she \nhas been having worsening abd distension and discomfort. She \ndenies ___ edema, or SOB, or orthopnea. She denies f/c/n/v, d/c, \ndysuria. She had food poisoning a week ago from eating stale \ncake (n/v 20 min after food ingestion), which resolved the same \nday. She denies other recent illness or sick contacts. She notes \nthat she has been noticing gum bleeding while brushing her teeth \nin recent weeks. she denies easy bruising, melena, BRBPR, \nhemetesis, hemoptysis, or hematuria.  \nBecause of her abd pain, she went to OSH ED and was transferred \nto ___ for further care. Per ED report, pt has brief period of \nconfusion - she did not recall the ultrasound or bloodwork at \nosh. She denies recent drug use or alcohol use. She denies \nfeeling confused, but reports that she is forgetful at times.  \nIn the ED, initial vitals were 98.4 70 106/63 16 97%RA  \nLabs notable for ALT/AST/AP ___ ___: ___, \nTbili1.6, WBC 5K, platelet 77, INR 1.6  \n\n \nPast Medical History:\n1. HCV Cirrhosis  \n2. No history of abnormal Pap smears.  \n3. She had calcification in her breast, which was removed  \npreviously and per patient not, it was benign.  \n4. For HIV disease, she is being followed by Dr. ___ Dr.  \n___.  \n5. COPD  \n6. Past history of smoking.  \n7. She also had a skin lesion, which was biopsied and showed  \nskin cancer per patient report and is scheduled for a complete  \nremoval of the skin lesion in ___ of this year.  \n8. She also had another lesion in her forehead with purple  \ndiscoloration. It was biopsied to exclude the possibility of  \n___'s sarcoma, the results is pending.  \n9. A 15 mm hypoechoic lesion on her ultrasound on ___  \nand is being monitored by an MRI.  \n10. History of dysplasia of anus in ___.  \n11. Bipolar affective disorder, currently manic, mild, and PTSD. \n \n12. History of cocaine and heroin use.  \n\n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  \ntalking to most of them. She only has one brother that she is in \n \ntouch with and lives in ___. She is not aware of any  \nknown GI or liver disease in her family.  \nHer last alcohol consumption was one drink two months ago. No  \nregular alcohol consumption. Last drug use ___ years ago. She  \nquit smoking a couple of years ago.  \n\n \nPhysical Exam:\nVS: 98.1 107/61 78 18 97RA  \nGeneral: in NAD  \nHEENT: CTAB, anicteric sclera, OP clear  \nNeck: supple, no LAD  \nCV: RRR,S1S2, no m/r/g  \nLungs: CTAb, prolonged expiratory phase, no w/r/r  \nAbdomen: distended, mild diffuse tenderness, +flank dullness, \ncannot percuss liver/spleen edge ___ distension  \nGU: no foley  \nExt: wwp, no c/e/e, + clubbing  \nNeuro: AAO3, converse normally, able to recall 3 times after 5 \nminutes, CN II-XII intact  \n\nDischarge:\n\nPHYSICAL EXAMINATION:  \nVS: 98 105/70 95\nGeneral: in NAD  \nHEENT: anicteric sclera, OP clear  \nNeck: supple, no LAD  \nCV: RRR,S1S2, no m/r/g  \nLungs: CTAb, prolonged expiratory phase, no w/r/r  \nAbdomen: distended but improved, TTP in RUQ, \nGU: no foley  \nExt: wwp, no c/e/e, + clubbing  \nNeuro: AAO3,  CN II-XII intact  \n\n \nPertinent Results:\n___ 10:25PM   GLUCOSE-109* UREA N-25* CREAT-0.3* SODIUM-138 \nPOTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-27 ANION GAP-9\n___ 10:25PM   estGFR-Using this\n___ 10:25PM   ALT(SGPT)-100* AST(SGOT)-114* ALK PHOS-114* \nTOT BILI-1.6*\n___ 10:25PM   LIPASE-77*\n___ 10:25PM   ALBUMIN-3.3*\n___ 10:25PM   WBC-5.0# RBC-4.29 HGB-14.3 HCT-42.6 MCV-99* \nMCH-33.3* MCHC-33.5 RDW-15.7*\n___ 10:25PM   NEUTS-70.3* LYMPHS-16.5* MONOS-8.1 EOS-4.2* \nBASOS-0.8\n___ 10:25PM   PLT COUNT-71*\n___ 10:25PM   ___ PTT-30.9 ___\n___ 10:25PM   ___\n.\n\nCXR: No acute cardiopulmonary process.  \nU/S:  \n1. Nodular appearance of the liver compatible with cirrhosis. \nSigns of portal  \nhypertension including small amount of ascites and splenomegaly. \n \n2. Cholelithiasis.  \n3. Patent portal veins with normal hepatopetal flow.  \nDiagnostic para attempted in the ED, unsuccessful.  \nOn the floor, pt c/o abd distension and discomfort.\n \nBrief Hospital Course:\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \nbioplar, PTSD, presented from OSH ED with worsening abd \ndistension over past week and confusion.  \n\n# Ascites - p/w worsening abd distension and discomfort for last \nweek. likely ___ portal HTN given underlying liver disease, \nthough no ascitic fluid available on night of admission. No \nsigns of heart failure noted on exam. This was ___ to med \nnon-compliance and lack of diet restriction. SBP negative\ndiuretics:  \n> Furosemide 40 mg PO DAILY  \n> Spironolactone 50 mg PO DAILY, chosen over the usual 100mg \ndose d/t K+ of 4.5.   \n CXR was wnl, UA negative, Urine culture blood culture negative. \n \nPt was losing excess fluid appropriately with stable lytes on \nthe above regimen. Pt was scheduled with current PCP for \n___ check upon discharge.   \nPt was scheduled for new PCP with Dr. ___ at ___ and \nfollow up in Liver clinic to schedule outpatient screening EGD \nand ___.   \n \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Furosemide 20 mg PO DAILY \n2. Spironolactone 50 mg PO DAILY \n3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n4. Raltegravir 400 mg PO BID \n5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n6. Nicotine Patch 14 mg TD DAILY \n7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n\n \nDischarge Medications:\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n3. Furosemide 40 mg PO DAILY \nRX *furosemide 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet \nRefills:*3\n4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n5. Nicotine Patch 14 mg TD DAILY \n6. Raltegravir 400 mg PO BID \n7. Spironolactone 50 mg PO DAILY \n8. Acetaminophen 500 mg PO Q6H:PRN pain \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAscites from Portal HTN\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\nIt was a pleasure taking care of you! You came to us with \nstomach pain and worsening distension. While you were here we \ndid a paracentesis to remove 1.5L of fluid from your belly. We \nalso placed you on you 40 mg of Lasix and 50 mg of Aldactone to \nhelp you urinate the excess fluid still in your belly. As we \ndiscussed, everyone has a different dose of lasix required to \nmake them urinate and it's likely that you weren't taking a high \nenough dose. Please take these medications daily to keep excess \nfluid off and eat a low salt diet. You will follow up with Dr. \n___ in liver clinic and from there have your colonoscopy \nand EGD scheduled. Of course, we are always here if you need us. \nWe wish you all the best!\nYour ___ Team.  \n \nFollowup Instructions:\n___\n"
        ],
        [
         "1",
         "10000032-DS-22",
         "10000032",
         "22841357",
         "DS",
         "22",
         "2180-06-27 00:00:00",
         "2180-07-01 10:15:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPercocet\n \nAttending: ___.\n \nChief Complaint:\nabdominal fullness and discomfort\n \nMajor Surgical or Invasive Procedure:\n___ diagnostic paracentesis\n___ therapeutic paracentesis\n\n \nHistory of Present Illness:\n___ with HIV on HAART, COPD, HCV cirrhosis complicated by \nascites and HE admitted with abdominal distention and pain. She \nwas admitted to ___ for the same symptoms \nrecently and had 3L fluid removed (no SBP) three days ago and \nfelt better. Since discharge, her abdomen has become \nincreasingly distended with pain. This feels similar to prior \nepisodes of ascites.  \nHer diuretics were recently decreased on ___ due to worsening \nhyponatremia 128 and hyperkalemia 5.1. Patient states she has \nbeen compliant with her HIV and diuretic medications but never \nfilled out the lactulose prescription. She states she has had \n___ BMs daily at home. She has had some visual hallucinations \nand forgetfulness. Her appetite has been poor.  \nIn the ED, initial vitals were 98.9 88 116/88 18 97% RA. CBC \nnear baseline, INR 1.4, Na 125, Cr 0.6. AST and ALT mildly above \nbaseline 182 and 126 and albumin 2.8. Diagnostic para with 225 \nWBC, 7% PMN, total protein 0.3. UA with few bact, 6 WBC, mod \nleuk, neg nitr, but contaminated with 6 epi. CXR clear. RUQ US \nwith no PV thrombus, moderate ascites. She was given ondansetron \n4mg IV and morphine 2.5mg IV x1 in the ED.  \nOn the floor, she is feeling improved but still has abdominal \ndistention and discomfort.  \nROS: +Abdominal distention and pain. No black/bloody stools. No \n___ pain or swelling. No fevers or chills. Denies chest pain, \nnausea, vomiting. No dysuria or frequency. \n \nPast Medical History:\n1. HCV Cirrhosis  \n2. No history of abnormal Pap smears.  \n3. She had calcification in her breast, which was removed  \npreviously and per patient not, it was benign.  \n4. For HIV disease, she is being followed by Dr. ___ Dr.  \n___.  \n5. COPD  \n6. Past history of smoking.  \n7. She also had a skin lesion, which was biopsied and showed  \nskin cancer per patient report and is scheduled for a complete  \nremoval of the skin lesion in ___ of this year.  \n8. She also had another lesion in her forehead with purple  \ndiscoloration. It was biopsied to exclude the possibility of  \n___'s sarcoma, the results is pending.  \n9. A 15 mm hypoechoic lesion on her ultrasound on ___  \nand is being monitored by an MRI.  \n10. History of dysplasia of anus in ___.  \n11. Bipolar affective disorder, currently manic, mild, and PTSD. \n \n12. History of cocaine and heroin use.  \n\n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  talking to most of \nthem. She only has one brother that she is in  touch with and \nlives in ___. She is not aware of any known GI or liver \ndisease in her family.  \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS: T98.1 105/57 79 20 97RA 44.6kg  \nGENERAL: Thin chronically ill appearing woman in no acute \ndistress  \nHEENT: Sclera anicteric, MMM, no oral lesions  \nHEART: RRR, normal S1 S2, no murmurs  \nLUNGS: Clear, no wheezes, rales, or rhonchi  \nABD: Significant distention with visible veins, bulging flanks, \nnontender to palpation, tympanitic on percussion, normal bowel \nsounds  \nEXT: no ___ edema, 2+ DP and ___ pulses  \nNEURO: alert and oriented, not confused, no asterixis\n\nDISCHARGE PE:\nVS: T 98.4 BP 95/55 (SBP ___ HR 80 RR 18 O2 95RA  \nI/O 240/150 this am  \nGENERAL: Thin chronically ill appearing woman in no acute \ndistress  \nHEENT: Sclera anicteric, MMM, no oral lesions  \nHEART: RRR, normal S1 S2, no murmurs  \nLUNGS: Clear, no wheezes, rales, or rhonchi  \nABD: Significant distention with visible veins, bulging flanks, \nnontender to palpation, tympanitic on percussion, normal bowel \nsounds  \nEXT: no ___ edema, 2+ DP and ___ pulses  \nNEURO: alert and oriented, not confused, no asterixis\n \nPertinent Results:\nLABS ON ADMISSION:\n___ 04:10PM BLOOD ___ \n___ Plt ___\n___ 04:10PM BLOOD ___ \n___\n___ 04:10PM BLOOD ___ \n___\n___ 04:10PM BLOOD ___ \n___\n___ 04:10PM BLOOD ___\n___ 04:39PM BLOOD ___\n\nLABS ON DISCHARGE:\n___ 05:10AM BLOOD ___ \n___ Plt ___\n___ 05:10AM BLOOD ___ ___\n___ 05:10AM BLOOD ___ \n___\n___ 05:10AM BLOOD ___ \n___\n___ 05:10AM BLOOD ___\n\nMICRO:\n___ 10:39 pm URINE      Source: ___. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n\n___ 7:00 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH.\n\n___ 7:00 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH. \n\nDiagnositc Para:\n___ 07:00PM ASCITES ___ \n___\n___ 07:00PM ASCITES ___\n\nIMAGING:\n___ CXR- No acute cardiopulmonary abnormality.  \n___ RUQ US-  \n1. Extremely coarse and nodular liver echotexture consistent \nwith a history of cirrhosis.  \n2. Moderate ascites.  \n3. Patent portal vein.\n \nBrief Hospital Course:\n___ with HIV on HAART, HCV cirrhosis with ascites and HE, h/o \nIVDU, COPD, bipolar disorder presents with abdominal discomfort \ndue to ___ ascites.  \n \n# ASCITES. Now diuretic refractory given last tap was three days \nago with 3L removed and she has already built up moderate \nascites. Infectious workup negative, with CXR clear, UA \ncontaminated but not grossly positive so will f/u culture, \ndiagnostic para with only 225 WBC, RUQ US with no PV thrombus. \nCompliant with diuretics but not following low sodium diet or \nfluid restriction. Dr. ___ discussed possible TIPS in \nthe office but due to lung disease, that was on hold pending \nfurther cardiac evaluation. Diuretics were recently decreased \ndue to hyponatremia and hyperkalemia. Held spironolactone for \nnow due to K 5.2 and increased lasix 20 -> 40. No evidence of \nsevere hyponatremia (Na<120) or renal failure Cr>2.0 to stop \ndiuretics at present. Diagnostic paracentesis negative for \ninfection. Ascitic total protein 0.3 so warrants SBP prophylaxis \n(<1.0) and fortunately already on Bactrim for PCP prophylaxis \nwhich would be appropriate for SBP ppx also. Patient did admit \nto eating pizza and some ___ food prior to \nadmission. She had therapeutic paracentesis with 4.3L removed \nand received 37.5G albumin IV post procedure. She felt much \nbetter with resolution of abdominal discomfort. Patient is \nscheduled for repeat paracentesis as outpatient on ___.  \n\n# HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. \nNow with mild encephalopathy (hallucinations and forgetfulness) \ndue to medication noncompliance, but not acutely encephalopathic \nand without asterixis on exam. Infectious workup negative thus \nfar. Continue lactulose 30mL TID and titrate to 3 BMs daily and \ncontinue rifaximin 550mg BID. \n \n# HYPONATREMIA. Na 125 on admission, 128 four days ago, and 135 \none month ago. Likely due to third spacing from worsening \nascites and fluid overload. 1.5L fluid restriction, low salt \ndiet. S/p therapeutic paracentesis with albumin replacement.\n\n# CIRRHOSIS, HEPATITIS C. MELD score of 10 and Child's ___ \nclass B on this admission. Now decompensated due to ascites. \nHepatitis C genotype IIIB. Dr. ___ starting \n___ and ___ with patient in clinic and the \ninsurance process was started by her office. No history of EGD, \nneeds this as outpatient for varices screening.  \n \n# NUTRITION. Unclear if truly compliant with low salt diet. Poor \noral intake. Low albumin 2.8 on admission. Met with nutrition. \n \n# COAGULOPATHY. INR 1.4 four days ago. No evidence of active \nbleeding. Very mild thrombocytopenia with plts 143.  \n \n# HIV. Most recent CD4 173. On HAART. No established ID \nprovider. Continue Truvada and Isentress, Bactrim DS daily for \nPCP ___. Needs outpatient ID appointment  \n\n# COPD. Stable. States she is on intermittent home O2 for \ncomfort at night and with abdominal distentiom. Continued home \nCOPD meds and home O2 as needed \n\n**Transitional Issues**\n- Discontinued spironolactone ___ elevated potassium\n- Increased furosemide to 40mg daily\n- Please recheck electrolytes at next visit\n- Had paracentesis ___ with 4.3 L removed, received 37.5G \nalbumin\n- Needs outpatient ID provider\n- ___ needs more frequent paracentesis\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, SOB \n2. ___ (Truvada) 1 TAB PO DAILY \n3. Furosemide 20 mg PO DAILY \n4. Raltegravir 400 mg PO BID \n5. Spironolactone 50 mg PO DAILY \n6. Acetaminophen 500 mg PO Q6H:PRN pain,fever \n7. Tiotropium Bromide 1 CAP IH DAILY \n8. Rifaximin 550 mg PO BID \n9. Calcium Carbonate 1250 mg PO BID \n10. Lactulose 15 mL PO TID \n11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 500 mg PO Q6H:PRN pain,fever \n2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, SOB \n3. Calcium Carbonate 1250 mg PO BID \n4. ___ (Truvada) 1 TAB PO DAILY \n5. Furosemide 40 mg PO DAILY \n6. Lactulose 15 mL PO TID \n7. Raltegravir 400 mg PO BID \n8. Rifaximin 550 mg PO BID \n9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY \n10. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:  diuretic refractory ascites\nSecondary: HCV cirrhosis, HIV, hyponatremia, COPD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\n___ was a pleasure to take care of you at ___ \n___. You were admitted with abdominal fullness and \npain from your ascites. You had a diagnostic and therapeutic \nparacentesis with 4.3 L removed. Your spironolactone was \ndiscontinued because your potassium was high. Your lasix was \nincreased to 40mg daily. You are scheduled for another \nparacentesis on ___ prior to your other appointments that day. \nPlease call tomorrow to find out the time of the paracentesis. \nPlease continue to follow a low sodium diet and fluid \nrestriction. You should call your liver doctor or return to the \nemergency room if you have abdominal pain, fever, chills, \nconfusion, or other concerning symptoms.\n\nSincerely,\nYour ___ medical team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "2",
         "10000032-DS-23",
         "10000032",
         "29079034",
         "DS",
         "23",
         "2180-07-25 00:00:00",
         "2180-07-25 21:42:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPercocet / Vicodin\n \nAttending: ___\n \nChief Complaint:\naltered mental status\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nMrs. ___ is a ___ female with HIV on HAART, COPD, HCV \ncirrhosis complicated by ascites and hepatic encephalopathy who \ninitially presented to the ED yesterday with hypotension after a \nparacentesis.  \nThe patient has had accelerated decompensation of her cirrhosis \nrecently with worsening ascites, and she is maintained on twice \nweekly paracentesis. She was at her regular session yesterday \nwhen she had hypotension to SBP ___ and felt lightheadedness. \nPer the patient, that's when her memory started to get fuzzy. \nShe does not have much recollection of what happened since then. \nHer outpatient hepatologist saw her and recommended that she go \nto the ED. In the ED, she was evaluated and deemed to have \nstable blood pressure. She was discharged home. At home, she had \nworsening mental status with her daughter getting concerned, and \nshe returned to the ED.  \nIn the ED, initial vitals were 98.7 77 96/50 16 98% RA. The \npatient was only oriented to person. Her labs were notable for \nNa 126, K 6.7, Cr 0.7 (baseline 0.4), ALT 153, AST 275, TBili \n1.9, Lip 66, INR 1.5. Initial EKG showed sinus rhythm with \npeaked T waves. Her head CT was negative for any acute \nprocesses. She received ceftriaxone 2gm x1, regular insulin 10U, \ncalcium gluconate 1g, lactulose 30 mL x2, and 25g 5% albumin.  \nOn transfer, vitals were 99.0 93 84/40 16 95% NC. On arrival to \nthe MICU, patient was more alert and conversant. She has no \nabdominal pain, nausea, vomiting, chest pain, or difficulty \nbreathing. She has a chronic cough that is not much changed. She \nhas not had any fever or chills. She reports taking all of her \nmedications except for lactulose, which she thinks taste \ndisgusting.  \n \nPast Medical History:\n- HCV Cirrhosis: genotype 3a  \n- HIV: on HAART, ___ CD4 count 173, ___ HIV viral load \nundetectable  \n- COPD: ___ PFT showed FVC 1.95 (65%), FEV1 0.88 (37%), \nFEFmax 2.00 (33%)  \n- Bipolar Affective Disorder  \n- PTSD  \n- Hx of cocaine and heroin abuse  \n- Hx of skin cancer per patient report  \n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  talking to most of \nthem. She only has one brother that she is in  touch with and \nlives in ___. She is not aware of any known GI or liver \ndisease in her family.  \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98% NC on 2L  \nGENERAL: Alert, oriented, no acute distress  \nLUNGS: Decreased air movement on both sides, scattered \nexpiratory wheezes  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, \ngallops  \nABD: Soft, non-tender, distended, flank dullness bilaterally, \nbowel sounds present  \nEXT: Warm, well perfused, 2+ pulses, no cyanosis or edema  \n\nDISCHARGE PHYSICAL EXAM:\nVitals- Tm 99.5, Tc 98.7, ___ 79-96/43-58 20 95% on 3L NC, \n7BM.  \nGeneral- Cachectic-appearing woman, alert, oriented, no acute \ndistress  \nHEENT- Sclera anicteric, MMM, oropharynx clear, poor dentition \nwith partial dentures  \nNeck- supple, JVP not elevated, no LAD  \nLungs- Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen- Mildly distended and firm, non-tender, bowel sounds \npresent, no rebound tenderness or guarding  \nGU- no foley  \nExt- warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNeuro- AOx3, No asterixis.  \n \nPertinent Results:\nADMISSION LABS:\n=================\n___ 06:39AM BLOOD WBC-6.9 RBC-3.98* Hgb-14.1 Hct-41.1 \nMCV-103* MCH-35.4* MCHC-34.3 RDW-15.8* Plt ___\n___ 06:39AM BLOOD Neuts-72.7* Lymphs-14.7* Monos-9.8 \nEos-2.5 Baso-0.3\n___ 06:39AM BLOOD ___ PTT-32.4 ___\n___ 06:39AM BLOOD Glucose-102* UreaN-49* Creat-0.7 Na-126* \nK-6.7* Cl-95* HCO3-25 AnGap-13\n___ 06:39AM BLOOD ALT-153* AST-275* AlkPhos-114* \nTotBili-1.9*\n___ 06:39AM BLOOD Albumin-3.6\n\nIMAGING/STUDIES:\n================\n___ CT HEAD:\nNo evidence of acute intracranial process.\nThe left zygomatic arch deformity is probably chronic as there \nis no\nassociated soft tissue swelling.\n\n___ CXR:\nNo acute intrathoracic process.\n\nDISCHARGE LABS:\n===============\n___ 04:45AM BLOOD WBC-4.8 RBC-3.15* Hgb-11.2* Hct-32.1* \nMCV-102* MCH-35.4* MCHC-34.8 RDW-15.8* Plt Ct-95*\n___ 04:45AM BLOOD ___ PTT-37.6* ___\n___ 04:45AM BLOOD Glucose-121* UreaN-35* Creat-0.4 Na-130* \nK-5.2* Cl-97 HCO3-27 AnGap-11\n___ 04:45AM BLOOD ALT-96* AST-168* AlkPhos-69 TotBili-1.7*\n___ 04:45AM BLOOD Calcium-8.6 Phos-2.4* Mg-2.___ w/ HIV on HAART, COPD on 3L home O2, HCV cirrhosis \ndecompensated (ascites requiring biweekly therapeutic \nparacenteses, hepatic encephalopathy; not on transplant list ___ \ncomorbidities) w/ AMS, hypotension, ___, and hyperkalemia. \nAltered mental status improved with lactulose. Hypotension was \nfelt to be due to fluid shifts from paracentesis on the day \nprior to admission as well as low PO intake in the setting of \nAMS. Hypotension and ___ resolved with IV albumin. Hyperkalemia \nresolved with insulin and kayexalate.\n\n# Hypotension: Patient presented with SBP in ___ and improved \nwith albumin in the ED to ___. It was felt to be due to \nfluid shifts from paracentesis on ___, as well as likely \nhypovolemia given AMS and decreased PO intake. No concern for \nbleeding or sepsis with baseline CBC and lack of fever. She \ncontinued to received IV albumin during her hospital course, \nwith which her SBP improved to ___ and patient remained \nasymptomatic.  \n\n# Hyperkalemia: Patient presented with K 6.7 with EKG changes. \nGiven low Na, likely the result of low effective arterial volume \nleading to poor K excretion, with likely exacerbation from ___. \nAM cortisol was normal. K improved with insulin and kayexalate \nand K was 5.2 on day of discharge. Bactrim was held during \nhospital course. \n\n# ___: Patient presented with Cr 0.7 from baseline Cr is \n0.3-0.4. It was felt to be likely due to volume shift from her \nparacentesis on the day prior to admission as well as now low \neffective arterial volume, likely ___ poor PO intake ___ AMS. Cr \nimproved to 0.4 with albumin administration. Furosemide and \nBactrim were held during hospital course.   \n\n#GOC: The ___ son (HCP) met with Dr. ___ \noutpatient hepatologist) during ___ hospital course. They \ndiscussed that the patient is not a transplant candidate \ngivenevere underlying lung disease (FEV1 ~0.8), hypoxia, RV \ndilation and very low BMI. A more conservative approach was \nrecommended and the patient was transitioned to DNR/DNI. The \npatient agreed with this plan. She was treated with the goal of \ntreating any any correctable issues. Social work met with the \npatient prior to discharge. The patient was interested in \nfollowing up with palliative care, for which an outpatient \nreferral was made. \n \n# Altered Mental Status: Patient presented with confusion that \nwas most likely secondary to hepatic encephalopathy. Based on \noutpatient records, patient has had steady decline in \ndecompensated cirrhosis and mental status. No signs of infection \nand head CT was negative as well. Mental status improved with \nlactulose in the ED and patient reports that she has not been \ntaking lactulose regularly at home. Patient was also continued \non rifaximin.   \n\n# HCV Cirrhosis: Genotype 3a. Patient is decompensated with \nincreasing ascites and worsening hepatic encephalopathy. She is \ndependent on twice weekly paracentesis. Spironolactone was \nrecently stopped due to hyperkalemia. Patient is not a \ntransplant candidate given her comorbidities COPD per outpatient \nhepatologist. The patient would like to continue biweekly \nparacenteses as an outpatient.\n\n# HIV: Most recent CD4 count 173 on ___. HIV viral load on \n___ was undetectable. She was continued on her home regimen \nof raltegravir, emtricitabine, and tenofovir. Bactrim \nprophylaxis was held during admission because of hyperkalemia.   \n\n\n# COPD: Patient on 3L NC at home. She was continued on her home \nregimen.\n\nTRANSITIONAL ISSUES:\n-Follow up with Palliative Care as outpatient\n-Bactrim prophylaxis (HIV+) was held during hospital course due \nto ___. Consider restarting as outpatient.\n-Furosemide was held due to ___, consider restarting as \noutpatient\n-Follow up with hepatology\n-Continue biweekly therapeurtic paracenteses\n-Code status: DNR/DNI\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lactulose 15 mL PO TID \n2. Tiotropium Bromide 1 CAP IH DAILY \n3. Raltegravir 400 mg PO BID \n4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n5. Furosemide 40 mg PO DAILY \n6. TraMADOL (Ultram) 50 mg PO Q8H:PRN Pain \n7. Fluticasone Propionate 110mcg 1 PUFF IH BID \n8. Calcium Carbonate 500 mg PO BID \n9. Rifaximin 550 mg PO BID \n10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY \n\n \nDischarge Medications:\n1. Calcium Carbonate 500 mg PO BID \n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n3. Fluticasone Propionate 110mcg 1 PUFF IH BID \n4. Lactulose 30 mL PO TID \n5. Raltegravir 400 mg PO BID \n6. Rifaximin 550 mg PO BID \n7. TraMADOL (Ultram) ___ mg PO Q6H:PRN pain \n8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n9. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\nHypotension\nHyperkalemia\nAcute Kidney Injury\n\nSecondary:\nHIV\nCirrhosis\nCOPD\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ because of confusion, low blood \npressure, and a high potassium value. Your confusion improved \nwith lactulose. Your blood pressure improved with extra fluids \nand your potassium improved as well. You also had small degree \nof kidney injury when you came to the hospital, and this also \nimproved with fluids. While you were here, you discussed \nchanging your goals of care to focusing on symptom management \nand treatment of reversible processes, such as an infection. \nWhile you were in the hospital, you were seen by one of our \nsocial workers. You will also follow up with Palliative Care in \ntheir clinic and will continue to have therapeutic paracenteses.\n\nIt has been a pleasure taking care of you and we wish you all \nthe best,\nYour ___ Care team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "3",
         "10000032-DS-24",
         "10000032",
         "25742920",
         "DS",
         "24",
         "2180-08-07 00:00:00",
         "2180-08-10 05:43:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPercocet / Vicodin\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\n___ Paracentesis\n\n \nHistory of Present Illness:\n___ w/ HIV on HAART, COPD on 3L home O2 (though sat'ing fine on \nRA on admission), HCV cirrhosis c/b ascites requiring biweekly \ntherapeutic paracenteses, hepatic encephalopathy; not on \ntransplant list ___ comorbidities) p/w worsening girth and abd \npain. She'd been having pain from her ascites, and felt overdue \nfor a paracentesis. She last had paracentesis on the ___. \nShe reported that she began feeling worsening abdominal pain \n(constant, epigastric and radiates to back, not a/w food) on \n___, which increased in severity throughout the course of the \nday. She was brought to the ED by her son because of this pain. \nShe had no confusion and was alert and oriented x3. The patient \nalso reported she recently ran out of most of her home \nmedications. She denied any fever, chills, shortness of breath, \ncough, dysuria. She reported loose stool a bit more than usual, \nbut attributed it to lactulose use. In the ED, vitals were: 99.4 \n105 106/57 18 96% ra. Labs were significant for Na 127 K 5.3 \nlactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. \nAscitic fluid showed 220 WBC. She was given Morphine Sulfate 5 \nmg IV ONCE MR1, and a GI cocktail.\n \nPast Medical History:\n- HCV Cirrhosis: genotype 3a  \n- HIV: on HAART, ___ CD4 count 173, ___ HIV viral load \nundetectable  \n- COPD: ___ PFT showed FVC 1.95 (65%), FEV1 0.88 (37%), \nFEFmax 2.00 (33%)  \n- Bipolar Affective Disorder  \n- PTSD  \n- Hx of cocaine and heroin abuse  \n- Hx of skin cancer per patient report  \n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  talking to most of \nthem. She only has one brother that she is in touch with and \nlives in ___. She is not aware of any known GI or liver \ndisease in her family.  \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\n=======================\nVitals - T 97, BP 98/65, HR 103, RR 18, O2 94RA, Glucose 128.  \nGENERAL: NAD, lying on her right side.\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, good dentition  \nNECK: nontender supple neck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: distended, + fluid wave, not tense. NABS, nontender  \nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose\nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact, AAO3, no asterxis  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n\nDISCHARGE PHYSICAL EXAM\n=======================\nVitals - Tm 98.6, Tc 98.2, BP 82-98/42-68, HR 80-95, RR ___, \nO2 91-99% RA.\nGENERAL: NAD, lying on her right side.\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, good dentition  \nNECK: nontender supple neck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: soft, decreased distension, not tense. NABS, nontender  \n\nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose\nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact, AAO3, no asterxis  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 09:20PM BLOOD WBC-8.2# RBC-3.48* Hgb-12.3 Hct-36.7 \nMCV-106* MCH-35.5* MCHC-33.6 RDW-16.5* Plt ___\n___ 09:28PM BLOOD ___ PTT-31.8 ___\n___ 09:20PM BLOOD Glucose-118* UreaN-33* Creat-0.6 Na-127* \nK-5.3* Cl-97 HCO3-24 AnGap-11\n___ 09:20PM BLOOD ALT-135* AST-244* AlkPhos-123* \nTotBili-1.3\n___ 09:20PM BLOOD Albumin-3.5 Calcium-8.3* Phos-3.3 Mg-2.3\n___ 09:27PM BLOOD Lactate-2.1*\n\nNOTABLE LABS\n============\n___ 12:30AM ASCITES WBC-220* ___ Polys-17* \nLymphs-48* Monos-19* Mesothe-2* Macroph-12* Other-2*\n___ 12:30AM ASCITES TotPro-0.7 Glucose-129\n\nMICROBIOLOGY\n============\n___ 12:30 am PERITONEAL FLUID\n\n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH.\n\n___ VRE screen: No VRE isolated.\n\nIMAGING/STUDIES\n===============\nCXR ___\nNo acute cardiopulmonary process.\n\nRUQUS ___\nCirrhotic, mild splenomegaly and ascites.  A solid 3cm nodule in \nthe left lobe of the liver is stable in size and appearance. \n\nDISCHARGE LABS\n==============\n___ 06:15AM BLOOD WBC-5.6 RBC-3.27* Hgb-11.6* Hct-33.5* \nMCV-103* MCH-35.5* MCHC-34.5 RDW-16.1* Plt ___\n___ 06:15AM BLOOD ___ PTT-36.0 ___\n___ 06:15AM BLOOD Glucose-87 UreaN-29* Creat-0.4 Na-123* \nK-5.4* Cl-93* HCO3-24 AnGap-11\n___ 06:15AM BLOOD ALT-112* AST-176* AlkPhos-101 \nTotBili-2.8*\n___ 06:15AM BLOOD Albumin-3.5 Calcium-8.8 Phos-3.4 Mg-2.___ w/ HIV on HAART, COPD on 3L home O2, HCV cirrhosis \ndecompensated (ascites requiring biweekly therapeutic \nparacenteses, hepatic encephalopathy; not on transplant list ___ \n \ncomorbidities) p/w worsening abd girth and pain.\n\n# Goals of care:  The patient expressed that her desire to \"let \ngo\" and be at peace. She is tired of \"fighting\" her end stage \nliver disease and does not feel that she has a good quality of \nlife. She wished to meet with a representative from hospice, \nwhich we were able to arrange, and she decided that she would \nlike to go home with hospice. A conversation was held with the \npatient regarding code status. She noted that she would probably \nbe DNR/DNI, but would like to discuss it with her son (HCP). \nTherefore, at this time, she remains full code. We also \ndiscussed the possibility of her getting a pleurex catheter \nplaced because of her repeated paracenteses. She was discharged \nto home with hospice on ___.\n\n# Decompensated HCV cirrhosis with ascites: The patient \npresented with worsening ascites. Her pain was initially managed \nwith tramadol and morphine. She underwent ___ paracentesis \non ___ with removal of 3.5L and she received albumin. Studies \non the fluid were negative, and she reported a significant \nimprovement in her pain.\n \n# Hyperkalemia: During her hospitalization, it was noted that \nshe had hyperkalemia 5.3 -> 5.9 -> 6.9 without EKG changes. \nAfter treatment with calcium gluconate 2gm x2, insulin and D50 x \n2, and kayexelate, her K downtrended to 5.4. Her K has been \npersistently elevated in the past and should continue to be \nmonitored.\n\n# Hepatic encephalopathy: The patient's mental status was A+Ox3 \non admission. She was continued on rifaximin and lactulose \nin-house and at discharge.\n\nCHRONIC ISSUES\n==============\n\n# Hyponatremia - The patient has a history of asymptomatic \nhyponatremia. It is most likely hypervolemic hyponatremia \nrelated to underlying liver disease as well as aldosterone axis \ndysfunction related to liver disease. She remained asymptomatic \nthrough her hospitalization. Because she was also started on \n10mg of furosemide to help prevent fluid re-accumulation, she \nwill require BMPs twice weekly in the outpatient setting.\n\n# HIV: Emtricitabine-Tenofovir (Truvada) and Raltegravir were \ncontinued in-house and at discharge.  \n\n# COPD: fluticasone, tiotropium and albuterol were continued \nin-house and at discharge.\n\nTRANSITIONAL ISSUES\n===================\n[ ] Follow-up peritoneal fluid culture\n[ ] New/changed medications: Furosemide 10mg daily (new)\n[ ] For hyperkalemia and hyponatremia, the patient should have \nbiweekly BMPs (script written). If K > 5.3, she should be given \nkayexelate once weekly. Lab results will be faxed/sent to Dr. \n___.\n[ ] Continue conversation regarding pleurex catheter placement \nand code status.\n[ ] She will continue to have twice weekly paracenteses\n\n# Code: full  \n# Emergency Contact: ___ ___ \n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Calcium Carbonate 500 mg PO BID \n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n3. Fluticasone Propionate 110mcg 1 PUFF IH BID \n4. Lactulose 30 mL PO TID \n5. Raltegravir 400 mg PO BID \n6. Rifaximin 550 mg PO BID \n7. TraMADOL (Ultram) ___ mg PO Q6H:PRN pain \n8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n9. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Medications:\n1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n2. Calcium Carbonate 500 mg PO BID \n3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n4. Fluticasone Propionate 110mcg 1 PUFF IH BID \n5. Lactulose 30 mL PO TID \n6. Raltegravir 400 mg PO BID \n7. Rifaximin 550 mg PO BID \n8. Tiotropium Bromide 1 CAP IH DAILY \n9. TraMADOL (Ultram) ___ mg PO Q6H:PRN pain \n10. Furosemide 10 mg PO DAILY \nRX *furosemide 20 mg 0.5 (One half) tablet(s) by mouth Please \ntake 1 tablet daily. Disp #*15 Tablet Refills:*0\n11. Outpatient Lab Work\nPlease obtain biweekly BMP to monitor K and Na. Please fax \nresults to Dr. ___ at the ___ at ___.\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\n=================\n-Decompensated HCV cirrhosis\n-Hyperkalemia\n\nSECONDARY DIAGNOSES\n===================\n-HIV\n-COPD\n-Hyponatremia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you during your stay at ___. You \nwere admitted because of worsening abdominal pain. It is likely \nthat this pain was due to increasing fluid in the abdomen from \nyour cirrhosis. After a paracentesis in which much of this fluid \nwas removed, your pain improved significantly. You were noted to \nhave a high potassium during your hospitalization, which came \ndown with treatment but this should continue to be followed as \nan outpatient. You also emphasized your desire to speak with a \nrepresentative from hospice. Because of your repeated \nparacenteses, we also discussed the possibility of a pleurex \ncatheter placement. We arranged for you to meet with hospice \ncoordinators, and you will be discharged home with hospice.\n\nWe wish you all the best!\n\nYour ___ care team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "4",
         "10000084-DS-17",
         "10000084",
         "23052089",
         "DS",
         "17",
         "2160-11-25 00:00:00",
         "2160-11-25 15:09:00",
         " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nVisual hallucinations\n \nMajor Surgical or Invasive Procedure:\nN/A\n\n \nHistory of Present Illness:\n___ male with ___ disease, dyslipidemia, and a\nhistory of prostate cancer (s/p prostatectomy) who was referred\nto the ED by his neurologist for worsening gait, falls, and\nvisual hallucinations. \n\nThe following history is taken from chart review: \n\nThe patient was seen by his neurologist on ___ at which time he\nwas noted to have visual hallucinations and worsening gait\nfreezing. For his gait freezing, his mirapex was increased by\n0.125 mg every week to a goal dose of 0.75 mg t.i.d. He\nsuccessfully up-titrated the medicine to 0.75/0.625/0.625 but\nbegan to have visual hallucinations and confusion so on ___ his\nneurologist recommended decreasing the dose to 0.625 TID. \nDespite\nthe changes to his Mirapex, the patient's daughter has noted\nprogressive gait stiffness and increased difficulty standing.\nThis has resulted in difficulty with simply getting to the\nbathroom leading to episodes of incontinence. A UA performed on\n___ was reassuring. \n\nOn the day of presentation to the hospital, the patient began to\nexperience visual hallucinations of a motor cross race in his\nbackyard. He subsequently had a fall while transferring from the\ncouch to a chair. His wife was unable to get him off the floor.\nThe fall was witnessed and there was no head strike. Per the\npatient's wife, his gait has acutely worsened over the past 24\nhours to the point where he has been unable to ambulate on his\nown. The patient's daughter called his neurologist who\nrecommended presentation to the ED. \n\nIn the ED, the patient was afebrile, HRs ___, normotensive, and\nSpO2 100% RA. On exam he was noted to have cogwheeling of upper\nextremities and decrease ___ strength. Labs were remarkable for a\nnegative urine and serum tox, Na 132, K 5.8 (hemolyzed and no \nEKG\nchanges), negative troponin, normal LFTs, unremarkable CBC. \nChest\nXray showed no acute process and CTH was reassuring. He was\nevaluated by neurology who recommended admission to medicine for\nfailure to thrive, to continue the patient's home medications,\nand complete a toxo-metabolic workup. The patient was given his\nhome pramipexole and pravastatin before he was admitted.  \n\nOn arrival to the floor, the patient is comfortable in bed. He \nis\nnot accompanied by family on my interview. He knows that he is \nin\nthe hospital and that it is ___. He is not sure why he is here\nand begins to tell me about a party in his house with a motor\ncross race in his backyard. When I asked him about his fall, he\nmentions that he has not had a fall for ___ years. He denies any\nfevers, chills, cough, chest pain, abdominal pain, nausea,\ndiarrhea, or dysuria. \n\nREVIEW OF SYSTEMS:\n==================\nPer HPI, otherwise, 10-point review of systems was within normal\nlimits.\n\n \nPast Medical History:\n___ disease\n___ Body Dementia \ndyslipidemia \nprostate cancer (s/p prostatectomy)\n \nSocial History:\n___\nFamily History:\nHis mother died at age ___ of \"old age.\"\nHis father died of prostate cancer at ___.  He has an older \nsister\n(age ___ and a younger sister (age ___.  He has a younger \nbrother\n(age ___.  As noted, he has 2 daughters.  There is no family\nhistory of neurologic illness or dementia.  There is no family\nhistory of neurodevelopmental mental disorders such as learning\ndisability or ADHD.  There is no family history of psychiatric\nproblems.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVITALS: reviewed in OMR \nGENERAL: Alert and interactive. In no acute distress.\nHEENT: PERRL, EOMI. Sclera anicteric and without injection. MMM.\nNECK: No cervical lymphadenopathy. No JVD.\nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No\nmurmurs/rubs/gallops.\nLUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or\nrales. No increased work of breathing.\nBACK: No CVA tenderness.\nABDOMEN: Normal bowels sounds, non distended, non-tender to deep\npalpation in all four quadrants. No organomegaly.\nEXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial \n2+\nbilaterally.\nSKIN: Warm. Cap refill <2s. No rashes.\nNEUROLOGIC: AOx3. CN2-12 intact. cogwheel UE b/l. Increased tone\nin LEs, ___ strength b/l ___. Normal sensation.\n\nDISCHARGE PHYSICAL EXAM\n======================\n24 HR Data (last updated ___ @ 2340)\n    Temp: 97.7 (Tm 98.4), BP: 130/80 (130-153/80-90), HR: 80\n(80-104), RR: 18 (___), O2 sat: 100% (95-100), O2 delivery: Ra \n\n\nGENERAL: In no acute distress. Talking very quietly.\nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No\nmurmurs/rubs/gallops.\nLUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or\nrales. No increased work of breathing.\nABDOMEN: Normal bowels sounds, non distended, non-tender to deep\npalpation in all four quadrants.\nEXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial \n2+\nbilaterally.\nSKIN: Warm.\nNEUROLOGIC: AOx3. CN2-12 intact. cogwheel UE b/l. Increased tone\nin LEs, ___ strength b/l ___. Normal sensation.\n\n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 10:30PM BLOOD WBC-8.6 RBC-4.03* Hgb-12.8* Hct-38.2* \nMCV-95 MCH-31.8 MCHC-33.5 RDW-13.0 RDWSD-45.2 Plt ___\n___ 10:30PM BLOOD Neuts-48.1 ___ Monos-15.9* \nEos-2.0 Baso-0.6 Im ___ AbsNeut-4.13 AbsLymp-2.86 \nAbsMono-1.36* AbsEos-0.17 AbsBaso-0.05\n___ 10:30PM BLOOD ___ PTT-23.4* ___\n___ 10:30PM BLOOD Glucose-100 UreaN-17 Creat-0.8 Na-132* \nK-5.8* Cl-98 HCO3-19* AnGap-15\n___ 10:30PM BLOOD ALT-18 AST-38 AlkPhos-39* TotBili-0.4\n___ 10:30PM BLOOD Lipase-47\n___ 10:30PM BLOOD cTropnT-<0.01\n___ 10:30PM BLOOD Albumin-4.0 Calcium-9.9 Phos-3.7 Mg-2.0\n___ 10:30PM BLOOD VitB12-570\n___ 10:30PM BLOOD TSH-1.4\n___ 07:00AM BLOOD Trep Ab-NEG\n___ 10:30PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nTricycl-NEG\n\nIMAGING:\n========\n___ Imaging CT HEAD W/O CONTRAST  \nFINDINGS:  \nThere is no evidence of infarction, hemorrhage, edema, or mass.  \nThere is \nprominence of the ventricles and sulci suggestive of \ninvolutional changes. \nThere is no evidence of fracture.  The visualized portion of the \nremaining \nparanasal sinuses and middle ear cavities are clear.  The \nvisualized portion of the orbits are unremarkable apart from \nbilateral lens replacements. \nIMPRESSION: \n1. No acute intracranial abnormality.  No hydrocephalus. \n\n___ Imaging CHEST (PA & LAT) \nIMPRESSION:  \nMild atelectasis in the lung bases without focal consolidation.  \n\nAge-indeterminate moderate to severe compression deformity of a \nlow thoracic vertebral body. \n\nDISCHARGE LABS:\n===============\n___ 06:21AM BLOOD WBC-7.0 RBC-4.02* Hgb-12.9* Hct-38.1* \nMCV-95 MCH-32.1* MCHC-33.9 RDW-12.8 RDWSD-44.4 Plt ___\n___ 06:21AM BLOOD Glucose-88 UreaN-10 Creat-0.7 Na-140 \nK-4.0 Cl-104 HCO3-24 AnGap-12\n___ 06:21AM BLOOD Calcium-9.5 Phos-3.2 Mg-1.___ male with ___ disease, dyslipidemia, and a\nhistory of prostate cancer (s/p prostatectomy) who was referred\nto the ED by his neurologist for worsening gait, falls, and\nvisual hallucinations concerning for progression of his\nneurologic disorder. \n\nACUTE/ACTIVE ISSUES:\n====================\n___ disease\n___ Body Dementia \n#Visual Hallucinations \nThe patient appears to have acute on chronic progression of his\n___ disease. Unclear if this is disease progression or\nunderlying medical cause. Continued mirapex, rasagiline, and \nrivastigmine. Neurology recommended started Seroquel for his \nhallucinations.\n\nHe was evaluated by physical therapy who recommended rehab. This \nrecommendation was discussed with the family who opted for \ndischarge to home with home physical therapy as this was in line \nwith the patient's goals of care.\n\nTRANSITIONAL ISSUES:\n[] f/u visual hallucination symptoms on Seroquel\n[] f/u physical therapy at home\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Rasagiline 1 mg PO DAILY \n2. Pramipexole 0.625 mg PO TID \n3. rivastigmine 9.5 mg/24 hr transdermal DAILY \n4. Pravastatin 40 mg PO QPM \n5. Cyanocobalamin Dose is Unknown  PO DAILY \n6. Loratadine 10 mg PO DAILY \n\n \nDischarge Medications:\n1.  QUEtiapine Fumarate 25 mg PO QHS \nRX *quetiapine 25 mg 1 tablet(s) by mouth AT NIGHT Disp #*30 \nTablet Refills:*0 \n2.  Loratadine 10 mg PO DAILY  \n3.  Pramipexole 0.625 mg PO TID  \n4.  Pravastatin 40 mg PO QPM  \n5.  Rasagiline 1 mg PO DAILY  \n6.  rivastigmine 9.5 mg/24 hr transdermal DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n___ Dementia\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\n\n \nDischarge Instructions:\nDear Mr. ___, \n\nIt was a privilege caring for you at ___. \n\nWHY WAS I IN THE HOSPITAL? \n- You were sent to the emergency room by your neurologist who \nwas concerned that you were having visual hallucinations.\n\nWHAT HAPPENED TO ME IN THE HOSPITAL? \n- You were started on a new medication to help treat your \nsymptoms.\n\nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? \n- Continue to take all your medicines and keep your \nappointments. \n\nWe wish you the best! \n\nSincerely, \nYour ___ Team \n \nFollowup Instructions:\n___\n"
        ],
        [
         "5",
         "10000117-DS-21",
         "10000117",
         "22927623",
         "DS",
         "21",
         "2181-11-15 00:00:00",
         "2181-11-15 15:04:00",
         " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nomeprazole\n \nAttending: ___.\n \nChief Complaint:\ndysphagia \n \nMajor Surgical or Invasive Procedure:\nUpper endoscopy ___\n\n \nHistory of Present Illness:\n ___ w/ anxiety and several years of dysphagia who p/w worsened \nforeign body sensation. \n\nShe describes feeling as though food gets stuck in her neck when \nshe eats. She put herself on a pureed diet to address this over \nthe last 10 days. When she has food stuck in the throat, she \nalmost feels as though she cannot breath, but she denies trouble \nbreathing at any other time. She does not have any history of \nfood allergies or skin rashes. \n \nIn the ED, initial vitals:  97.6  81  148/83  16  100% RA \nImaging showed: CXR showed a prominent esophagus\nConsults: GI was consulted.\n\nPt underwent EGD which showed a normal appearing esophagus. \nBiopsies were taken.\n\nCurrently, she endorses anxiety about eating. She would like to \ntry eating here prior to leaving the hospital. \n\n \nPast Medical History:\n- GERD  \n - Hypercholesterolemia  \n - Kidney stones  \n - Mitral valve prolapse  \n - Uterine fibroids  \n - Osteoporosis  \n - Migraine headaches \n \nSocial History:\n___\nFamily History:\n+ HTN - father  \n+ Dementia - father  \n \n \nPhysical Exam:\n=================\nADMISSION/DISCHARGE EXAM\n=================\nVS:  97.9  PO 109 / 71 70 16 97 ra \nGEN: Thin anxious woman, lying in bed, no acute distress  \nHEENT: Moist MM, anicteric sclerae, NCAT, PERRL, EOMI  \nNECK: Supple without LAD, no JVD  \nPULM: CTABL no w/c/r\nCOR: RRR (+)S1/S2 no m/r/g  \nABD: Soft, non-tender, non-distended, +BS, no HSM  \nEXTREM: Warm, well-perfused, no ___ edema  \nNEURO: CN II-XII grossly intact, motor function grossly normal, \nsensation grossly intact  \n \nPertinent Results:\n=============\nADMISSION LABS\n=============\n\n___ 08:27AM BLOOD WBC-5.0 RBC-4.82 Hgb-14.9 Hct-44.4 MCV-92 \nMCH-30.9 MCHC-33.6 RDW-12.1 RDWSD-41.3 Plt ___\n___ 08:27AM BLOOD ___ PTT-28.6 ___\n___ 08:27AM BLOOD Glucose-85 UreaN-8 Creat-0.9 Na-142 K-3.6 \nCl-104 HCO3-22 AnGap-20\n___ 08:27AM BLOOD ALT-11 AST-16 LD(LDH)-154 AlkPhos-63 \nTotBili-1.0\n___ 08:27AM BLOOD Albumin-4.8\n=============\nIMAGING\n=============\n\nCXR ___: \nIMPRESSION:  \n  \nProminent esophagus on lateral view, without air-fluid level. \nGiven the patient's history and radiographic appearance, barium \nswallow is indicated either now or electively. \n  \nNECK X-ray ___:\nIMPRESSION:  \n  \nWithin the limitation of plain radiography, no evidence of \nprevertebral soft tissue swelling or soft tissue mass in the \nneck. \n \n\nEGD: ___\n Impression: Hiatal hernia\nAngioectasia in the stomach\nAngioectasia in the duodenum\n (biopsy, biopsy)\nOtherwise normal EGD to third part of the duodenum \n\nRecommendations: - no obvious anatomic cause for the patient's \nsymptoms\n- follow-up biopsy results to rule out eosinophilic esophagitis\n- follow-up with Dr. ___ if biopsies show eosinophilic \nesophagitis \n\n \nBrief Hospital Course:\nMs. ___ is a ___ with history of GERD who presents with \nsubacute worsening of dysphagia and foreign body sensation. This \nhad worsened to the point where she placed herself on a pureed \ndiet for the last 10 days. She underwent CXR which showed a \nprominent esophagus but was otherwise normal. She was evaluated \nby Gastroenterology and underwent an upper endoscopy on ___. \nThis showed a normal appearing esophagus. Biopsies were taken. \n\nTRANSITIONAL ISSUES:\n-f/u biopsies from EGD\n-if results show eosinophilic esophagitis, follow-up with Dr. ___. \n___ for management\n-pt should undergo barium swallow as an outpatient for further \nworkup of her dysphagia\n-f/u with ENT as planned\n#Code: Full (presumed) \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Omeprazole 20 mg PO BID \n\n \nDischarge Medications:\n1.  Omeprazole 20 mg PO BID  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\n-dysphagia and foreign body sensation\n\nSECONDARY DIAGNOSIS:\n-GERD \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were hospitalized at ___.\n\nYou came in due to difficulty swallowing. You had an endoscopy \nto look for any abnormalities in the esophagus. Thankfully, this \nwas normal. They took biopsies, and you will be called with the \nresults. You should have a test called a barium swallow as an \noutpatient.\n\nWe wish you all the best!\n-Your ___ Team \n \nFollowup Instructions:\n___\n"
        ],
        [
         "6",
         "10000117-DS-22",
         "10000117",
         "27988844",
         "DS",
         "22",
         "2183-09-21 00:00:00",
         "2183-09-29 16:23:00",
         " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nomeprazole / Iodine and Iodide Containing Products / \nhallucinogens\n \nAttending: ___.\n \nChief Complaint:\nLeft hip pain \n \nMajor Surgical or Invasive Procedure:\nStatus post left CRPP ___, ___\n\n \nHistory of Present Illness:\nREASON FOR CONSULT: Femur fracture\n\nHPI: ___ female presents with the above fracture s/p mechanical\nfall. This morning, pt was walking ___, when dog\npulled on leash. Pt fell on L hip. Immediate pain. ___ ___ with movement. Denies Head strike, LOC or blood thinners.\nDenies numbness or weakness in the extremities. \n \nPast Medical History:\n- GERD  \n - Hypercholesterolemia  \n - Kidney stones  \n - Mitral valve prolapse  \n - Uterine fibroids  \n - Osteoporosis  \n - Migraine headaches \n \nSocial History:\n___\nFamily History:\n+ HTN - father  \n+ Dementia - father  \n \n \nPhysical Exam:\nGeneral: Well-appearing female in no acute distress.\n\nLeft Lower extremity:\n- Skin intact\n- No deformity, edema, ecchymosis, erythema, induration\n- Soft, non-tender thigh and leg\n- Full, painless ROM knee, and ankle\n- Fires ___\n- SILT S/S/SP/DP/T distributions\n- 1+ ___ pulses, WWP\n \nBrief Hospital Course:\nThe patient presented to the emergency department and was \nevaluated by the orthopedic surgery team. The patient was found \nto have a left valgus impacted femoral neck fracture and was \nadmitted to the orthopedic surgery service. The patient was \ntaken to the operating room on ___ for left closed reduction \nand percutaneous pinning of hip, which the patient tolerated \nwell. For full details of the procedure please see the \nseparately dictated operative report. The patient was taken from \nthe OR to the PACU in stable condition and after satisfactory \nrecovery from anesthesia was transferred to the floor. The \npatient was initially given IV fluids and IV pain medications, \nand progressed to a regular diet and oral medications by POD#1. \nThe patient was given ___ antibiotics and \nanticoagulation per routine. The patient's home medications were \ncontinued throughout this hospitalization. The patient worked \nwith ___ who determined that discharge to home with services was \nappropriate. The ___ hospital course was otherwise \nunremarkable.\n\nAt the time of discharge the patient's pain was well controlled \nwith oral medications, incisions were clean/dry/intact, and the \npatient was voiding/moving bowels spontaneously. The patient is  \nweightbearing as tolerated in the left lower extremity, and will \nbe discharged on Lovenox for DVT prophylaxis. The patient will \nfollow up with Dr. ___ routine. A thorough discussion \nwas had with the patient regarding the diagnosis and expected \npost-discharge course including reasons to call the office or \nreturn to the hospital, and all questions were answered. The \npatient was also given written instructions concerning \nprecautionary instructions and the appropriate follow-up care. \nThe patient expressed readiness for discharge.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lactaid (lactase) 3,000 unit oral DAILY:PRN \n2. Calcium Citrate + D (calcium citrate-vitamin D3) 315-200 \nmg-unit oral DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q6H:PRN Pain - Mild/Fever  \n2.  Bisacodyl 10 mg PO/PR DAILY:PRN Constipation  \n3.  Docusate Sodium 100 mg PO BID  \n4.  Enoxaparin Sodium 40 mg SC QHS \nRX *enoxaparin 40 mg/0.4 mL 40 mg Subcutaneously Nightly Disp \n#*30 Syringe Refills:*0 \n5.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nModerate \nRX *oxycodone 5 mg 1 tablet(s) by mouth q4 PRN Disp #*25 Tablet \nRefills:*0 \n6.  Senna 8.6 mg PO BID  \n7.  Calcium Citrate + D (calcium citrate-vitamin D3) 315-200 \nmg-unit oral DAILY  \n8.  Lactaid (lactase) 3,000 unit oral DAILY:PRN  \n9.  Multivitamins 1 TAB PO DAILY  \n10.  Vitamin D 400 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nLeft valgus impacted femoral neck fracture\n\n \nDischarge Condition:\nAVSS\nNAD, A&Ox3\nLLE: Incision well approximated. Dressing clean and dry. Fires \nFHL, ___, TA, GCS. SILT ___ n distributions. 1+ DP \npulse, wwp distally.\n\n \nDischarge Instructions:\nINSTRUCTIONS AFTER ORTHOPAEDIC SURGERY:\n\n- You were in the hospital for orthopedic surgery. It is normal \nto feel tired or \"washed out\" after surgery, and this feeling \nshould improve over the first few days to week. \n- Resume your regular activities as tolerated, but please follow \nyour weight bearing precautions strictly at all times.\n\nACTIVITY AND WEIGHT BEARING:\n- Weightbearing as tolerated left lower extremity\n\nMEDICATIONS:\n  1)  Take Tylenol ___ every 6 hours around the clock. This is \nan over the counter medication.\n  2)  Add oxycodone as needed for increased pain. Aim to wean \noff this medication in 1 week or sooner.  This is an example on \nhow to wean down:\nTake 1 tablet every 3 hours as needed x 1 day,\nthen 1 tablet every 4 hours as needed x 1 day,\nthen 1 tablet every 6 hours as needed x 1 day,\nthen 1 tablet every 8 hours as needed x 2 days, \nthen 1 tablet every 12 hours as needed x 1 day,\nthen 1 tablet every before bedtime as needed x 1 day.  \nThen continue with Tylenol for pain.\n  3)  Do not stop the Tylenol until you are off of the narcotic \nmedication.\n  4)  Per state regulations, we are limited in the amount of \nnarcotics we can prescribe. If you require more, you must \ncontact the office to set up an appointment because we cannot \nrefill this type of pain medication over the phone. \n  5)  Narcotic pain relievers can cause constipation, so you \nshould drink eight 8oz glasses of water daily and continue \nfollowing the bowel regimen as stated on your medication \nprescription list. These meds (senna, colace, miralax) are over \nthe counter and may be obtained at any pharmacy.\n  6)  Do not drink alcohol, drive a motor vehicle, or operate \nmachinery while taking narcotic pain relievers.\n  7)  Please take all medications as prescribed by your \nphysicians at discharge.\n  8)  Continue all home medications unless specifically \ninstructed to stop by your surgeon.\n      \nANTICOAGULATION:\n- Please take  Lovenox daily for 4 weeks\n \nFollowup Instructions:\n___\n"
        ],
        [
         "7",
         "10000248-DS-10",
         "10000248",
         "20600184",
         "DS",
         "10",
         "2192-11-30 00:00:00",
         "2192-11-30 19:49:00",
         " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nRight flank bruising and pain s/p fall\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMr. ___ is a ___ with history of factor VIII deficiency who \npresents with right neck swelling after snowboarding accident. \nThe patient reports that he fell while snowboarding with loss of \nconsciousness on ___. He was initially seen at \n___ where CT imaging of head/neck showed no \nintracranial hemorrhage. A CTA neck showed a thickened right \nplatysma muscle with surrounding hematoma and a focus of active \ncontrast extravasation within the right platysma muscle. He also \ndeveloped a right shoulder hematoma although shoulder plain \nfilms didn't show acute abnormality. He was seen by ___ \nHematology and gave him one dose of DDAVP IV. A factor VIII \nassay was 139 and vW level was >200 per report. Per report, his \nhemoglobin decreased from 13.2 on ___ to 11.6 on ___. \nRepeat imaging in the morning showed stable injuries. The \npatient saw his hematologist on ___ and was found to have a \nhemoglobin of 10.4. Because of the continued mild decrease, the \npatient followed up with his PCP ___ ___ at which time his \nhemoglobin was 9.9. He was found to have an enlarging flank \nhematoma, thus was referred given concern for retroperitoneal \nbleed. The patient has been using DDAVP intranasally \nintermittently since the accident. He denies lightheadedness or \npalpitations, any increase in neck swelling over the course of \nthe week. He does endorse pain in his right shoulder ___ \nresting, ___ moving), though this has improved over the course \nof the week.  \nIn the ED, initial vital signs were 99.2 87 124/75 18 100%/RA. \nInitial labs demonstrated hemoglobin 10.6, though repeat was \n9.7. Chemistries and coags were unremarkable. FVIII activity was \n103. A CTAP was performed which demonstrated muscular hemorrhage \nalong the flank, but no retroperitoneal bleed on preliminary \nread. The patient's outpatient hematologist, Dr. ___, was \ncontacted and it was decided to give the patient desmopressin \n0.3mg/kg IV. The patient was then admitted for futher \nmanagement.  \nPer review of records, the patient has a history of significant \nbleeding after his circumcision, requiring blood transfusion. \nThroughout childhood, he also had a tendency to bruise easily. \nHe was tested and found to have ___ disease. Later, \nafter wisdom tooth extraction, the patient experienced late \n(e.g. ___ days later) bleeding despite treatment with DDAVP. The \npatient was retested by a hematologist associated with the \n___ and was diagnosed \nwith hemophilia A. His FVIII activity has been checked on \nmultiple occasions, sometimes testing normal, though has been as \nlow as ~50.  \nUpon arrival to the floor, the patient is comfortable without \ncomplaint.  \nReview of Systems:  \n(+) per HPI  \n(-) fever, chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, cough, shortness of breath, \nchest pain, abdominal pain, nausea, vomiting, diarrhea, \nconstipation, BRBPR, melena, hematochezia, dysuria, hematuria.\n \nPast Medical History:\n-Factor VIII deficiency (mild)  \n\n \nSocial History:\n___\nFamily History:\nThe patient's mother had tendency to bleed.  \n\n \nPhysical Exam:\nON ADMISSION\nVS:98 120/40 64 20 100RA  \nGENERAL: lying flat in bed, no acute distress  \nHEENT: NCAT, MMM, OP clear  \nNECK: Supple  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: Generally CTA b/l  \nABDOMEN: Soft, non-tender, non-distended  \nEXTREMITIES: Warm, well-perfused  \nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact  \nSKIN: Hematomas on right aspect of neck and flank \n\nON DISCHARGE\nVitals: 98.0, 100-120/40-58, 66, 20, 99 on RA  \nGENERAL: lying flat in bed, no acute distress  \nHEENT: NCAT, MMM, OP clear  \nNECK: Supple  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: Generally CTA b/l  \nABDOMEN: Soft, non-tender, non-distended  \nEXTREMITIES: Warm, well-perfused  \nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact  \nSKIN: Hematomas on right aspect of neck and flank\n\n \nPertinent Results:\nADMISSION, DISCHARGE, PERTINENT LABS:\n\n___ 07:03PM BLOOD WBC-6.6 RBC-3.58* Hgb-10.6*# Hct-29.8*# \nMCV-83 MCH-29.6 MCHC-35.6* RDW-14.7 Plt ___\n___ 07:03PM BLOOD Neuts-69.7 ___ Monos-7.2 Eos-2.4 \nBaso-0.2\n___ 07:03PM BLOOD ___ PTT-35.2 ___\n___ 07:03PM BLOOD Plt ___\n___ 07:03PM BLOOD FacVIII-103\n___ 07:03PM BLOOD Glucose-93 UreaN-15 Creat-0.8 Na-139 \nK-4.1 Cl-101 HCO3-28 AnGap-14\n___ 11:00PM BLOOD WBC-6.6 RBC-3.30* Hgb-9.7* Hct-27.0* \nMCV-82 MCH-29.4 MCHC-36.0* RDW-14.7 Plt ___\n___ 07:25AM BLOOD WBC-5.2 RBC-3.14* Hgb-9.3* Hct-26.2* \nMCV-83 MCH-29.7 MCHC-35.7* RDW-14.6 Plt ___\n___ 03:25PM BLOOD WBC-6.3 RBC-3.27* Hgb-9.9* Hct-27.1* \nMCV-83 MCH-30.3 MCHC-36.5* RDW-14.7 Plt ___\n___ 07:50PM URINE Color-Yellow Appear-Clear Sp ___\n___ 07:50PM URINE Blood-NEG Nitrite-NEG Protein-30 \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\n___ 07:50PM URINE RBC-<1 WBC-1 Bacteri-FEW Yeast-NONE Epi-0\n___ 07:50PM URINE Mucous-RARE\n\nIMAGING/STUDIES:\n \n___ CT A/P\nAcute hemorrhage along right posterior flank musculature and \nprobably layering over it, only partly imaged and hard to \ndistinguish musculature from hemorrhage. No active extravasation \nseen. Probable old hematoma along posterior left flank. \n\n \nBrief Hospital Course:\nMr. ___ is a ___ with history of mild FVIII deficiency who \npresents after snowboarding accident with multiple hematomas and \nfalling hemoglobin concerning for ongoing bleeding.\n\n# FACTOR VIII DEFICIENCY, MULTIPLE HEMATOMAS: Patient presented \nafter recent snowboarding accident. At ___ \n___, imaging was notable for neck and shoulder hematomas. \nUpon reevaluation by his PCP, the patient was found to have a \nflank hematoma. Given falling hemoglobin, there was concern for \nretroperitoneal bleed. CTAP in the ED demonstrated hematoma over \nhis flank musculature, but no active extravasation. He was given \nIV DDAVP, but FVIII activity was 103 (wnl). CBC remained stable \nand patient declined further inpatient monitoring. Atrius \nhematology recommended continued outpatient hemoglobin \nmonitoring, but did not think further DDAVP was indicated given \nnormal FVIII level. \n  \n\n# TRANISTIONAL ISSUES:\n- PCP ___ ___\n- CBC ___ - ___ at ___\n- Caution to avoid dangerous activity\n- Code: presumed full  \n- Emergency Contact: ___ ___ - wife) \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Desmopressin Nasal ___ mcg NAS PRN bleeding \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H pain \n2. Desmopressin Nasal ___ mcg NAS PRN bleeding \n3. Outpatient Lab Work\nCBC on ___ or ___. Last hemoglobin 9.9 ___ ___.\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY:\n- Acute muscular hematoma, right flank\n- Hemophilia, factor VIII deficiency\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMr. ___,\n\nIt was our pleasure caring for you at ___ \n___. You were admitted with bruising on your right \nside and low blood counts after a snowboarding fall. With your \nhistory of hemophilia, it was important to evaluate internal \nbleeding which did show a right muscular flank blood collection. \nYour facotr VIII level was 103 and you received IV DDAVP under \nour care. Your blood counts were stable to improved on the day \nof admission. \n\nIt is important that you not participate in any dangerous \nactivities given your recent bleed and your hemophilia. Bleeding \nin hemophiliacs has more potential to be life-threatening.\n\nPlease get your blood counts checked at ___ site on either \n___ or ___. Follow up with your \nregular doctor early next week.\n\nBest wishes,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "8",
         "10000560-DS-15",
         "10000560",
         "28979390",
         "DS",
         "15",
         "2189-10-17 00:00:00",
         "2189-10-17 13:47:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: UROLOGY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nrenal mass\n \nMajor Surgical or Invasive Procedure:\nright laparascopic radical nephrectomy- Dr. ___, Dr. \n___ ___\n\n \nHistory of Present Illness:\n___ y/o healthy female with incidental finding of right renal \nmass suspicious for RCC following MRI on ___. \n \nPast Medical History:\nPMH: nonspecific right axis deviation  \n\nPSH- cesarean section\n\nALL-NKDA\n \nSocial History:\n___\nFamily History:\nno history of RCC\n \nPertinent Results:\n___ 07:15AM BLOOD WBC-7.6 RBC-3.82* Hgb-11.9* Hct-33.8* \nMCV-89 MCH-31.2 MCHC-35.2* RDW-12.8 Plt ___\n___ 07:15AM BLOOD Glucose-150* UreaN-10 Creat-0.9 Na-138 \nK-3.8 Cl-104 HCO3-27 AnGap-11\n \nBrief Hospital Course:\nPatient was admitted to Urology after undergoing laparoscopic \nright radical nephrectomy. No concerning intraoperative events \noccurred; please see dictated operative note for details. The \npatient received perioperative antibiotic prophylaxis. The \npatient was transferred to the floor from the PACU in stable \ncondition.  On POD0, pain was well controlled on PCA, hydrated \nfor urine output >30cc/hour, provided with pneumoboots and \nincentive spirometry for prophylaxis, and ambulated once. On \nPOD1,foley was removed without difficulty, basic metabolic panel \nand complete blood count were checked, pain control was \ntransitioned from PCA to oral analgesics, diet was advanced to a \nclears/toast and crackers diet. On POD2, diet was advanced as \ntolerated. The remainder of the hospital course was relatively \nunremarkable. The patient was discharged in stable condition, \neating well, ambulating independently, voiding without \ndifficulty, and with pain control on oral analgesics. On exam, \nincision was clean, dry, and intact, with no evidence of \nhematoma collection or infection. The patient was given explicit \ninstructions to follow-up in clinic with ___ in 3 weeks.\n\n \nMedications on Admission:\nnone\n \nDischarge Medications:\n1. Hydrocodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ6H (every 6 hours) as needed for break through pain only (score \n>4) .\nDisp:*60 Tablet(s)* Refills:*0*\n2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nrenal cell carcinoma\n\n \nDischarge Condition:\nstable\n\n \nDischarge Instructions:\n-You may shower but do not bathe, swim or immerse your incision.\n\n-Do not eat constipating foods for ___ weeks, drink plenty of \nfluids\n\n-Do not lift anything heavier than a phone book (10 pounds) or \ndrive until you are seen by your Urologist in follow-up\n\n-Tylenol should be used as your first line pain medication. If \nyour pain is not well controlled on Tylenol you have been \nprescribed a narcotic pain medication. Use in place of Tylenol. \nDo not exceed 4 gms of Tylenol in total daily\n\n-Do not drive or drink alcohol while taking narcotics\n\n-Resume all of your home medications, except hold NSAID \n(aspirin, advil, motrin, ibuprofen) until you see your urologist \nin follow-up\n\n-If you have fevers > 101.5 F, vomiting, or increased redness, \nswelling, or discharge from your incision, call your doctor or \ngo to the nearest ER\n\n-Call Dr. ___ to set up follow-up appointment and if \nyou have any urological questions. ___\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "9",
         "10000764-DS-11",
         "10000764",
         "27897940",
         "DS",
         "11",
         "2132-10-19 00:00:00",
         "2132-10-19 18:50:00",
         " \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nEpistaxis\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMr. ___ is an ___ with history of AAA s/p repair \ncomplicated by MI, hypertension, and hyperlipidemia who presents \nupon transfer from outside hospital with nasal fractures and \nepistaxis secondary to fall. The patient reports that he was at \nthe ___ earlier this afternoon. While coughing, he tripped \non the curb and suffered trauma to his face. He had no loss of \nconsciousness. However, he had a persistent nosebleed and \nappeared to have some trauma to his face, thus was transferred \nto ___ for further care. There, a CT scan of \nthe head, neck, and face were remarkable for a nasal bone and \nseptal fracture. Given persistent epistaxis, bilateral \nRhinoRockets were placed. He had a small abrasion to the bridge \nof his nose which was not closed. Bleeding was well controlled. \nWhile in the OSH ED, he had an episode of nausea and coughed up \nsome blood. At that time, he began to feel lightheaded and was \nnoted to be hypotensive and bradycardic. Per report, he had a \nbrief loss of consciousness, though quickly returned to his \nbaseline. His family noted that his eyes rolled back into his \nhead. The patient recalls the event and denies post-event \nconfusion. He had no further episodes of syncope or hemodynamic \nchanges.  Given the syncopal event and epistaxis, the patient \nwas transferred for further care.\n\nIn the ED, initial vital signs 98.9 92 140/77 18 100%/RA. Labs \nwere notable for WBC 11.3 (91%N), H/H 14.1/40.2, plt 147, BUN/Cr \n36/1.5. HCTs were repeated which were stable. A urinalysis was \nnegative. A CXR demonstrated a focal consolidation at the left \nlung base, possibly representing aspiration or developing \npneumonia. The patient was given Tdap, amoxicillin-clavulanate \nfor antibiotic prophylaxis, ondansetron, 500cc NS, and \nmetoprolol tartrate 50mg. Clopidogrel was held.\n \nPast Medical History:\nMI after AAA repair when he was ___ y/o\nHTN\nHypercholesterolemia\n \nSocial History:\n___\nFamily History:\nPatient is unaware of a family history of bleeding diathesis.\n\n \nPhysical Exam:\nADMISSION:\nVS: 98.5 142/65 95 18 98RA\nGENERAL: Alert, oriented, no acute distress  \nHEENT: Sclerae anicteric, MMM, oropharynx clear, bruising under \nboth eyes, swollen nose with mild tenderness, RhinoRockets in \nplace  \nNECK: Supple, without LAD  \nRESP: Generally CTA bilaterally  \nCV: RRR, (+)S1/S2 no m/r/g  \nABD: Soft, non-tender, non-distended\nGU: Deferred \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNEURO: CN II-XII grossly intact, motor function grossly normal\nSKIN: No excoriations or rash.\n\nDISCHARGE:\nVS: 98.4 125/55 73 18 94RA\nGENERAL: Alert, oriented, no acute distress  \nHEENT: Sclerae anicteric, MMM, oropharynx clear, bruising under \nboth eyes, swollen nose with mild tenderness, RhinoRockets in \nplace  \nNECK: Supple, without LAD  \nRESP: Generally CTA bilaterally  \nCV: RRR, (+)S1/S2 no m/r/g  \nABD: Soft, non-tender, non-distended\nGU: Deferred \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNEURO: CN II-XII grossly intact, motor function grossly normal\nSKIN: No excoriations or rash.\n \nPertinent Results:\nADMISSION:\n___ 08:15PM BLOOD WBC-11.3* RBC-4.30* Hgb-14.1 Hct-40.2 \nMCV-93 MCH-32.8* MCHC-35.1* RDW-12.8 Plt ___\n___ 08:15PM BLOOD Neuts-91.1* Lymphs-4.7* Monos-3.8 Eos-0.3 \nBaso-0.1\n___ 08:15PM BLOOD ___ PTT-26.8 ___\n___ 08:15PM BLOOD Glucose-159* UreaN-36* Creat-1.5* Na-141 \nK-4.1 Cl-106 HCO3-21* AnGap-18\n___ 06:03AM BLOOD CK(CPK)-594*\n\nCARDIAC MARKER TREND:\n___ 07:45AM BLOOD cTropnT-0.04*\n___ 06:03AM BLOOD CK-MB-36* MB Indx-6.1* cTropnT-0.57*\n___ 03:03PM BLOOD CK-MB-23* MB Indx-4.2 cTropnT-0.89*\n___ 05:59AM BLOOD CK-MB-8 cTropnT-1.28*\n___ 01:16PM BLOOD CK-MB-5 cTropnT-1.29*\n___ 06:10AM BLOOD CK-MB-4 cTropnT-1.48*\n___ 07:28AM BLOOD CK-MB-2 cTropnT-1.50*\n\nDISCHARGE LABS:\n___ 07:28AM BLOOD WBC-4.2 RBC-3.85* Hgb-12.5* Hct-36.0* \nMCV-94 MCH-32.5* MCHC-34.7 RDW-12.9 Plt ___\n___ 07:28AM BLOOD Glucose-104* UreaN-30* Creat-1.6* Na-142 \nK-4.3 Cl-106 HCO3-26 AnGap-14\n\nIMAGING:\n___ CXR\nPA and lateral views of the chest provided. The lungs are \nadequately \naerated. There is a focal consolidation at the left lung base \nadjacent to the lateral hemidiaphragm. There is mild vascular \nengorgement. There is bilateral apical pleural thickening. The \ncardiomediastinal silhouette is remarkable for aortic arch \ncalcifications. The heart is top normal in size. \n\n___ ECHO\nThe left atrium is mildly dilated. Left ventricular wall \nthicknesses and cavity size are normal. There is mild regional \nleft ventricular systolic dysfunction with focal apical \nhypokinesis. The remaining segments contract normally (LVEF = 55 \n%). No masses or thrombi are seen in the left ventricle. Right \nventricular chamber size and free wall motion are normal. There \nare three aortic valve leaflets. There is mild aortic valve \nstenosis (valve area 1.7cm2). Mild (1+) aortic regurgitation is \nseen. The mitral valve leaflets are mildly thickened. Trivial \nmitral regurgitation is seen. The pulmonary artery systolic \npressure could not be determined. There is a trivial/physiologic \npericardial effusion. \n\nIMPRESSION: Normal left ventricular cavity size with mild \nregional systolic dysfunction most c/w CAD (distal LAD \ndistribution). Mild aortic valve stenosis. Mild aortic \nregurgitation. \n \nBrief Hospital Course:\nMr. ___ is an ___ with history of AAA s/p repair \ncomplicated by MI, hypertension, and hyperlipidemia who \npresented with nasal fractures and epistaxis after mechanical \nfall with hospital course complicated by NSTEMI.\n\n#Epistaxis, nasal fractures\nPatient presenting after mechanical fall with Rhinorockets \nplaced at outside hospital for ongoing epistaxis. CT scan from \nthat hospital demonstrated nasal bone and septal fractures. The \nRhinorockets were maintained while inpatient and discontinued \nprior to discharge. He was encouraged to use oxymetolazone nasal \nspray and hold pressure should bleeding reoccur. \n\n#NSTEMI\nPatient found to have mild elevation of troponin in the ED. This \nwas trended and eventually rose to 1.5, though MB component \ndowntrended during course of admission. The patient was without \nchest pain or other cardiac symptoms. Cardiology was consulted \nwho thought that this was most likely secondary to demand \nischemia (type II MI) secondary to his fall. An echocardiogram \ndemonstrated aortic stenosis and likely distal LAD disease based \non wall motion abnormalities. The patient's metoprolol was \nuptitrated, his pravastatin was converted to atorvastatin, his \nclopidogrel was maintained, and he was started on aspirin.\n\n#Hypoxemia/L basilar consolidation\nPatient reported to be mildly hypoxic in the ED, though he \nmaintained normal oxygen saturations on room air. He denied \nshortness of breath or cough, fevers, or other infectious \nsymptoms and had no leukocytosis. A CXR revealed consolidation \nin left lung, thought to be possibly related to aspirated blood. \n-monitor O2 saturation, temperature, trend WBC. He was convered \nwith antibiotics while inpatient as he required prophylaxis for \nthe Rhinorockets, but this was discontinued upon discharge.\n\n#Acute kidney injury\nPatient presented with creatinine of 1.5 with last creatinine at \nPCP 1.8. Patient was unaware of a history of kidney disease. The \npatient was discharged with a stable creatinine.\n\n#Peripheral vascular disease\nPatient had a history of AAA repair in ___ without history of \nMI per PCP. Patient denied history of CABG or cardiac/peripheral \nstents. A cardiac regimen was continued, as above.\n\nTRANSITIONAL ISSUES\n-Outpatient stress echo for futher evaluation distal LAD disease \n(possibly a large myocardial territory at risk). \n-Repeat echocardiogram in ___ years to monitor mild AS/AR.\n-If epistaxis returns, can use oxymetolazone nasal spray.\n-Repeat chest x-ray in ___ weeks to ensure resolution of the LLL \ninfiltrative process.\n-Consider follow-up with ENT or Plastic Surgery for later \nevaluation of nasal fractures.\n-Repeat CBC in one week to ensure stability of HCT and \nplatelets.\n-Consider conversion of metoprolol tartrate to succinate for \nease-of-administration.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Clopidogrel 75 mg PO DAILY \n2. Metoprolol Tartrate 50 mg PO TID \n3. Pravastatin 80 mg PO QPM \n\n \nDischarge Medications:\n1. Clopidogrel 75 mg PO DAILY \n2. Acetaminophen 650 mg PO Q8H:PRN pain \nPlease avoid NSAID medications like ibuprofen given your \nbleeding. \n3. Aspirin 81 mg PO DAILY Duration: 30 Days \n4. Metoprolol Tartrate 75 mg PO TID \nRX *metoprolol tartrate 25 mg 3 tablet(s) by mouth three times \ndaily Disp #*270 Tablet Refills:*0\n5. Atorvastatin 40 mg PO QPM \nRX *atorvastatin 40 mg 1 tablet(s) by mouth every evening Disp \n#*30 Tablet Refills:*0\n6. Oxymetazoline 1 SPRY NU BID:PRN nosebleed \nThis can be purchased over-the-counter, the brand name is ___. \n\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nNasal fracture\nEpistaxis\nNSTEMI\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMr. ___,\nYou were admitted after you fell and broke your nose. You had \nnose bleeds that were difficult to control, thus plugs were \nplaced in your nose to stop the bleeding. During your hospital \ncourse, you were found to have high troponins, a blood test for \nthe heart. A ultrasound of your heart was performed. You should \nfollow-up with your PCP to discuss stress test.\n\nIt was a pleasure participating in your care, thank you for \nchoosing ___.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "10",
         "10000826-DS-17",
         "10000826",
         "20032235",
         "DS",
         "17",
         "2146-12-12 00:00:00",
         "2146-12-12 18:22:00",
         " \nName:  ___.          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___\n \nChief Complaint:\nAbdominal distention.\n \nMajor Surgical or Invasive Procedure:\nParacentesis.\n \nHistory of Present Illness:\nThis is a very nice ___ woman with ETOH abuse who \npresents with constipation, abdominal distention x 10 days.  \nPatient drinks about ___ glasses of wine per night and went on a \n2 month binge drinking ~10/day, which ended about 1 month ago.  \nShe noted abdominal distension progressive over the past week \nand has also not had a solid stool x 7 days.  She denies any \nf/C/NS, CP/SOB/DOE or decrease in her excercise tolerance.  No \nrecent travel but has traveled to ___ and ___ \npreviously.  No NSAIDs, Tylenol or OTC medications other than \noccasional peptobismol.  She notes that she has missed her past \ntwo periods.  \n\nIn ED, bedside US with ascites.  CT with fatty liver, good \nportal flow.  Patient with HR 110 in ED, for IV 5mg valium.  Got \nNS IVF at 100cc/hr and thiamine 100mg IV.\n \nPast Medical History:\n--Alcohol abuse\n--Chronic back pain\n \nSocial History:\n___\nFamily History:\nBreast Ca in mother age ___, No IBD, liver failure.  Multiple \nrelatives with alcoholism.\n \nPhysical Exam:\nVS: 97.9, 103/73, 86, 18, 96% RA  \nGEN: A/Ox3, pleasant, appropriate, well appearing  \nHEENT: No temporal wasting, JVD not elevated, neck veins fill \nfrom above.  \nCV: RRR, No MRG  \nPULM: CTAB but decreased BS in R base.  \nABD: Distended and tight, diffusely tender to palpation, BS+, + \npassing flatulence.  \nLIMBS: 2+ edema of the LEs to knee bilaterally ___ pulses 2+ \nbilaterally  \nNEURO: No asterixis, very mild general tremor.  \n\n \nPertinent Results:\n___ 04:50AM BLOOD WBC-12.2* RBC-3.37* Hgb-12.0 Hct-37.2 \nMCV-110* MCH-35.5* MCHC-32.2 RDW-13.9 Plt ___\n___ 04:50AM BLOOD WBC-11.5* RBC-3.52* Hgb-12.2 Hct-37.7 \nMCV-107* MCH-34.6* MCHC-32.3 RDW-13.3 Plt ___\n___ 04:55AM BLOOD WBC-11.6* RBC-3.67* Hgb-12.8 Hct-39.0 \nMCV-106* MCH-34.8* MCHC-32.7 RDW-13.2 Plt ___\n___ 06:35AM BLOOD WBC-12.2* RBC-3.37* Hgb-12.0 Hct-36.4 \nMCV-108* MCH-35.7* MCHC-33.1 RDW-13.3 Plt ___\n___ 09:00AM BLOOD WBC-13.7* RBC-3.35* Hgb-11.6* Hct-35.6* \nMCV-106* MCH-34.5* MCHC-32.5 RDW-13.1 Plt ___\n___ 11:30AM BLOOD WBC-14.4* RBC-3.80* Hgb-13.2 Hct-40.3 \nMCV-106* MCH-34.8* MCHC-32.8 RDW-13.6 Plt ___\n___ 11:30AM BLOOD Neuts-80.6* Lymphs-11.7* Monos-5.5 \nEos-0.5 Baso-1.7\n___ 04:50AM BLOOD Plt ___\n___ 04:50AM BLOOD ___ PTT-35.0 ___\n___:50AM BLOOD Plt ___\n___ 04:50AM BLOOD ___ PTT-36.3* ___\n___ 04:55AM BLOOD Plt ___\n___ 04:55AM BLOOD ___ PTT-32.4 ___\n___ 06:35AM BLOOD Plt ___\n___ 06:35AM BLOOD ___ PTT-32.5 ___\n___ 09:00AM BLOOD Plt ___\n___ 11:30AM BLOOD ___ PTT-26.0 ___\n___ 11:30AM BLOOD Plt ___\n___ 04:50AM BLOOD Glucose-156* UreaN-5* Creat-0.3* Na-129* \nK-3.6 Cl-95* HCO3-25 AnGap-13\n___ 04:50AM BLOOD Glucose-113* UreaN-4* Creat-0.3* Na-131* \nK-3.2* Cl-96 HCO3-27 AnGap-11\n___ 04:55AM BLOOD Glucose-105* UreaN-5* Creat-0.4 Na-134 \nK-3.3 Cl-96 HCO3-30 AnGap-11\n___ 06:35AM BLOOD Glucose-101* UreaN-4* Creat-0.4 Na-132* \nK-3.6 Cl-94* HCO3-30 AnGap-12\n___ 04:24AM BLOOD Glucose-100 UreaN-3* Creat-0.4 Na-135 \nK-3.4 Cl-95* HCO3-30 AnGap-13\n___ 11:30AM BLOOD Glucose-141* UreaN-4* Creat-0.4 Na-138 \nK-3.6 Cl-98 HCO3-26 AnGap-18\n___ 04:50AM BLOOD ALT-45* AST-144* AlkPhos-275* \nTotBili-1.6*\n___ 04:50AM BLOOD ALT-41* AST-158* LD(___)-260* \nAlkPhos-277* TotBili-2.3*\n___ 04:55AM BLOOD ALT-46* AST-187* AlkPhos-299* \nTotBili-2.1*\n___ 06:35AM BLOOD ALT-46* AST-223* AlkPhos-297* \nTotBili-2.1*\n___ 04:24AM BLOOD ALT-56* AST-335* LD(LDH)-370* \nAlkPhos-313* TotBili-1.7*\n___ 11:30AM BLOOD ALT-71* AST-401* LD(___)-470* CK(CPK)-87 \nAlkPhos-325* TotBili-1.5\n___ 04:24AM BLOOD Lipase-33\n___ 11:30AM BLOOD Lipase-40 GGT-2266*\n___ 04:50AM BLOOD Calcium-7.5* Phos-2.6* Mg-1.7\n___ 04:50AM BLOOD Calcium-7.3* Phos-2.4* Mg-1.6\n___ 04:55AM BLOOD Albumin-2.7* Calcium-7.7* Phos-2.1* \nMg-1.7 Iron-47\n___ 06:35AM BLOOD Calcium-7.4* Phos-2.6* Mg-1.9\n___ 04:24AM BLOOD Albumin-3.0* Calcium-7.1* Phos-3.3 \nMg-1.5* Iron-65\n___ 11:30AM BLOOD Albumin-3.2*\n___ 04:24AM BLOOD calTIBC-151* VitB12-1059* Folate-11.1 \nFerritn-GREATER TH TRF-116*\n___ 06:35AM BLOOD TSH-5.6*\n___ 04:55AM BLOOD Free T4-1.2\n___ 11:30AM BLOOD HBsAg-NEGATIVE HBsAb-POSITIVE \nHBcAb-NEGATIVE HAV Ab-POSITIVE IgM HAV-NEGATIVE\n___ 11:30AM BLOOD HCG-<5\n___ 04:24AM BLOOD AMA-NEGATIVE Smooth-NEGATIVE\n___ 04:24AM BLOOD ___\n___ 04:24AM BLOOD HIV Ab-NEGATIVE\n___ 11:30AM BLOOD ASA-NEG ___ Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 11:30AM BLOOD HoldBLu-HOLD\n___ 11:30AM BLOOD LtGrnHD-HOLD\n___ 11:30AM BLOOD HCV Ab-NEGATIVE\n___ 11:49AM BLOOD Glucose-125* Lactate-2.3*\n___ 04:55AM BLOOD CERULOPLASMIN-PND\n___ 04:55AM BLOOD ALPHA-1-ANTITRYPSIN-PND\n\nImaging\n___ US abd/pelvis\nIMPRESSION: \n1. Diffusely echogenic liver, suggestive of fatty infiltration. \nOther forms of liver disease and more advanced liver disease \nincluding fibrosis and cirrhosis cannot be excluded. \n2. Layering sludge within the gallbladder, with mild gallbladder \nwall \nthickening, which may relate to underlying liver disease.  \n3. Patent portal venous system. \n4. Moderate ascites. \nThe study and the report were reviewed by the staff radiologist. \n\n\nCT abd/pelvis ___\nIMPRESSION: \n1. Large volume ascites and enlarged edematous liver. The \nfindings are \nsuggestive of acute hepatitis.  \n2. Small bilateral pleural effusions.\n\nECHO ___:\nThe left atrium and right atrium are normal in cavity size. Left \nventricular wall thickness, cavity size and regional/global \nsystolic function are normal (LVEF >55%). Transmitral and tissue \nDoppler imaging suggests normal diastolic function, and a normal \nleft ventricular filling pressure (PCWP<12mmHg). There is no \nventricular septal defect. Right ventricular chamber size and \nfree wall motion are normal. The diameters of aorta at the \nsinus, ascending and arch levels are normal. The aortic valve \nleaflets (3) appear structurally normal with good leaflet \nexcursion and no aortic regurgitation. The mitral valve appears \nstructurally normal with trivial mitral regurgitation. There is \nno mitral valve prolapse. There is no pericardial effusion. \n\nIMPRESSION: Normal global and regional biventricular systolic \nfunction. No diastolic dysfunction, pulmonary hypertension or \npathologic valvular disease seen.\n \nBrief Hospital Course:\nThis is a ___ woman with history of EtOH ___ years, \nheavy at times, with new onset liver failure and ascites.  \n  \n#  ASCITES/LFTs:  New onset ascites with SAAG supportive of \nportal hypertension.  Likely alcoholic hepatitis with ascites \nand possibility of cirrhosis.  Steroids and pentoxyphyline were \ndeferred given her low discriminate factor.  In terms of other \netiologies of liver disease, iron panel was not consistent with \nhemochromatosis, and ___, AMA, ___ were negative, making \nautoimmune causes unlikely.  Alpha 1 antitrypsin and \nceruloplasmin were normal.  Viral studies show immunity to Hep B \nand A.  HIV was negative.  U/S and CT abd/pelvis were not \nsuggestive of mass or obstructive lesions.  Patient received a \n2.5L paracentesis on ___, day prior to discharge.  Low-dose \nspironolactone was started.  Ms. ___ will follow-up with \nDr. ___ in 1 week.\n  \n#  ALCOHOLISM:  On admission, alcohol level was 336 though \npatient was clinically sober.  Patient was monitored on a CIWA \nscale and treated with MVI, thiamine, and folate.  She was seen \nby social work and given the contact information for rehab \nfacilities.  Although patient was encouraged to enter ___ \nrehab, she refused.  She will seek outpatient treatment for her \naddiction.  Ms. ___ was warned on multiple occasions that \nif she continues to drink she will irreperably destroy her liver \nand could even die.\n\n#  BACK PAIN:  Patient was started on a lidocaine patch and \ngiven oxycodone for breakthrough pain while in the hospital.\n  \n#  LEUKOCYTOSIS:  Likely a combination of alcoholic hepatitis \nand UTI; patient was started on ciprofloxacin.  Other infectious \nwork-up was unrevealing.  On day prior to discharge, patient \nspiked a fever to 101 and was pan cultured.  CXR was unrevealing \nand urine was negative for infection after the Cipro.  Ms. \n___ was discharged on levofloxacin for a 5 day course.\n  \n#  MACROCYTIC ANEMIA:  Likely from folate and nutritional \ndeficiency in setting of alcoholism.  Patient was started on MV, \nthiamine, and folate supplementation.  HCT was monitored \nthroughout admission.\n\n#  ANXIETY:  Patient with marked anxiety.  She would likely \nbenefit from outpatient therapy and/or SSRI treatment.\n\n#  SINUS TACHYCARDIA:  Likely in context of decompensated liver \ndisease.  ECHO was within normal limits.  Patient was monitred \non telemetry throughout hospitalization.\n\n#  CONSTIPATION:  Patient was maintained on senna and colace.\n \nMedications on Admission:\nNone.\n \nDischarge Medications:\n1. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n2. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n3. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n4. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily): Apply \nto affected area once daily as directed.\nDisp:*30 Adhesive Patch, Medicated(s)* Refills:*2*\n5. Nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \nTransdermal DAILY (Daily): Apply once daily as directed.\nDisp:*30 Patch 24 hr(s)* Refills:*2*\n6. Spironolactone 25 mg Tablet Sig: One (1) Tablet PO once a \nday.\nDisp:*30 Tablet(s)* Refills:*0*\n7. Levofloxacin 750 mg Tablet Sig: One (1) Tablet PO once a day \nfor 5 days.\nDisp:*5 Tablet(s)* Refills:*0*\n8. Outpatient Lab Work\nPlease draw blood samples for CBC with differential, AST/ALT, \ntotal bilirubin, alkaline phosphatase, albumin, LDH, INR/PTT, \nand chem10 (K, Na, P, Ca, Mg, Cl, CO3, renal function, glucose)\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnoses:\n- alcohol-related hepatitis\n- ascites\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou were admitted to the hospital for inflammation in the liver \nthat was likely due to alcohol consumption. You were treated \nsupportively with nutrition and also treated with medicines for \nalcohol withdrawal. We monitored your liver function daily with \nblood tests and found that the liver function was improving at \ntime of discharge. During this admission, you were also found to \nhave a urinary tract infection and a pneumonia. Please complete \nfive more days of antibiotics (levofloxacin) to treat these \ninfections.\n\nWe have started a new medicine that will help remove fluid from \nthe abdomen and legs. This medicine is called spironolactone. \nSince this medicine can raise potassium levels in the blood, we \nwould like you to have your blood-work checked next ___. \nYou can have this done at ___ in the Atrium Suite on the first floor or on \nthe sixth floor, anytime from 8am to 6pm.\n\nWe made the following changes to your medicines:\n- we ADDED folate, thiamine, and multivitamin (for general \nnutrition)\n- we ADDED lidocaine patch (for pain)\n- we ADDED nicotine patch\n- we ADDED levofloxacin (antibiotic for pneumonia)\n- we ADDED spironolactone (diuretic to prevent fluid \naccumulation)\nThere were no other changes to your medicines.\n\nPlease see the appointments that we have scheduled for you \nbelow.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "11",
         "10000826-DS-18",
         "10000826",
         "21086876",
         "DS",
         "18",
         "2146-12-24 00:00:00",
         "2146-12-24 19:31:00",
         " \nName:  ___.          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nTramadol\n \nAttending: ___.\n \nChief Complaint:\nAbdominal distention, back pain, fever; leukocytosis.\n \nMajor Surgical or Invasive Procedure:\nParacentesis x 3.\n\n \nHistory of Present Illness:\nThis is a ___ woman with a history of ETOH abuse who \npresents with abdominal distention, back pain, fever, and \nelevated white count from Liver Clinic.  Ms. ___ was \nrecently admitted to this hospital about 1 week ago for \ntreatment of ascites and work-up of alcoholic hepatitis.  At \nthat time she had a diagnostic and therapeutic paracentesis and \nwas treated for a UTI.  She was discharged home and instructed \nto follow-up in Liver Clinic in 1 week.  On day of presentation \nto liver clinic, patient complained of worsening abdominal pain \nand low-grade fevers at home.  Her labwork was also significant \nfor an elevated white count.  As such, Ms. ___ was \nadmitted for work-up of fever and white count, and for treatment \nof recurrent ascites.\n \nPast Medical History:\n--Alcohol abuse\n--Chronic back pain\n \nSocial History:\n___\nFamily History:\nBreast cancer in mother age ___, No IBD, liver failure.  Multiple \nrelatives with alcoholism.\n \nPhysical Exam:\nVS: 97.9, 103/73, 86, 18, 96% RA  \nGEN: A/Ox3, pleasant, appropriate, well appearing  \nHEENT: No temporal wasting, JVD not elevated, neck veins fill \nfrom above.  \nCV: RRR, No MRG  \nPULM: CTAB but decreased BS in R base.  \nABD: Distended and tight, diffusely tender to palpation, BS+, + \npassing flatulence.  \nLIMBS: 2+ edema of the LEs to knee bilaterally ___ pulses 2+ \nbilaterally  \nNEURO: No asterixis, very mild general tremor.\n \nPertinent Results:\nLabs at Admission:\n\n___ 09:47AM BLOOD WBC-26.2*# RBC-3.86* Hgb-13.0 Hct-43.3 \nMCV-112* MCH-33.7* MCHC-30.0* RDW-12.7 Plt ___\n___ 09:47AM BLOOD Neuts-88* Bands-1 Lymphs-2* Monos-7 Eos-1 \nBaso-1 ___ Myelos-0\n___ 09:20PM BLOOD ___\n___ 09:47AM BLOOD UreaN-8 Creat-0.5 Na-133 K-5.1 Cl-92* \nHCO3-26 AnGap-20\n___ 09:47AM BLOOD ALT-45* AST-165* LD(LDH)-345* \nAlkPhos-200* TotBili-2.0*\n___ 09:47AM BLOOD Albumin-2.9* Calcium-8.1* Phos-4.0 Mg-2.2\n___ 09:20PM BLOOD Ethanol-NEG Bnzodzp-NEG\n\nLabs at Discharge:\n\n___ 07:20AM BLOOD WBC-20.7* RBC-3.03* Hgb-10.3* Hct-32.0* \nMCV-106* MCH-33.9* MCHC-32.1 RDW-13.7 Plt ___\n___ 07:20AM BLOOD ___ PTT-42.0* ___\n___ 07:20AM BLOOD Glucose-96 UreaN-7 Creat-0.4 Na-125* \nK-4.4 Cl-90* HCO3-30 AnGap-9\n___ 07:20AM BLOOD ALT-35 AST-131* LD(___)-265* AlkPhos-184* \nTotBili-1.9*\n___ 07:20AM BLOOD Albumin-2.5* Calcium-7.2* Phos-2.6* \nMg-2.0\n\nMicro Data:\n\n___ PERITONEAL FLUID GRAM STAIN- negative; FLUID \nCULTURE-PENDING; ANAEROBIC CULTURE- negative\n___ STOOL CLOSTRIDIUM DIFFICILE TOXIN A & B \nTEST- negative\n___ URINE URINE CULTURE- negative\n___ SWAB R/O VANCOMYCIN RESISTANT ENTEROCOCCUS- \nnegative\n___ STOOL CLOSTRIDIUM DIFFICILE TOXIN A & B \nTEST- negative\n___ FLUID RECEIVED IN BLOOD CULTURE BOTTLES \nFluid Culture in Bottles- negative\n___ PERITONEAL FLUID GRAM STAIN-FINAL; FLUID \nCULTURE-FINAL; ANAEROBIC CULTURE- negative\n___ BLOOD CULTURE Blood Culture, Routine- \nnegative \n___ BLOOD CULTURE Blood Culture, \nRoutine-negative \n___ URINE URINE CULTURE-FINAL {GRAM POSITIVE \nBACTERIA} INPATIENT \n___ FLUID RECEIVED IN BLOOD CULTURE BOTTLES \nnegative\n\nImaging Results:\n\nCTA (___):\n1. No evidence of pulmonary embolism. \n2. Stable atelectasis at the right lung base. \n3. Moderate right and small left pleural effusions, unchanged. \n\nCTAP (___):\n1. Hepatomegaly and large ascites consistent with stated history \nof liver \ndisease. No evidence of portal venous thrombosis suggesting that \nthe findings on the prior ultrasound may have resulted from \nextremely slow / undetectable flow.  \n2. Moderate right and small left pleural effusions, increased on \nthe right \nwith right basilar atelectasis. \n3. Replaced right hepatic artery arising from the SMA, otherwise \nconventional arterial and venous anatomy.\n \nBrief Hospital Course:\nThis is a ___ woman with likely alcoholic hepatitis and \nrecurrent ascites who is admitted with low-grade fevers, high \nwhite count, and abdominal pain.\n \n# ASCITES/ALC HEPATITIS/LEUKOCYTOSIS: Patient with fatty liver \nand ascites in setting of extensive drinking history and AST/ALT \nelevation >2. Discriminant function on admission was ~30.  \nPatient had a paracentesis on ___ and 4L was removed; \nperitoneal fluid was negative for SBP. Diuretics were initially \nheld in the setting of hyponatremia. She was treated \nsupportively with nutrition, brief antibiotics for urinary tract \ninfection (3-days of ceftriaxone), and therapeutic paracenteses \nx3. Her symptoms, white cell count, and total bilirubin were \nimproving at time of discharge. She will follow-up with Dr. \n___ in liver clinic and with her primary care provider, Dr. \n___, in two weeks. \n\n# HYPONATREMIA: Likely hypovolemic hyponatremia with some \ncomponent of euvolemic hyponatremia from liver disease. Her \nspironlactone was held and can be restarted at the discretion of \nher outpatient liver team, if necessary. Sodium at time of \ndischarge was 125. She has been advised to continue a low sodium \ndiet and free water restriction to ___ liters daily.\n \n# ALCOHOLISM: Patient has been trying to cut back recently, but \nreports daily heavy alcohol intake for the past ___ years; she has \nhad withdrawal symptoms before but no seizures. Shakes and \nhallucinations.  Reports sobriety since prior admission. She \nwill continue outpatient rehab.\n  \n# URINARY TRACT INFECTION: she was treated with a three-day \ncourse of empiric ceftriaxone for concern of UTI.\n\n# BACK PAIN/ABDOMINAL PAIN: this was treated in house with \nlidocaine patches as needed and oxycodone as needed. She has \nbeen provided with a short course of Tramadol to take as needed \nuntil follow-up with her primary care provider. She understands \nthat this is only a temporary medication and will be \ndiscontinued when her acute hepatitis resolves.\n\n# Prophylaxis:  \n-DVT ppx with SC heparin  \n-Bowel regimen with lactulose, no PPI  \n-Pain management with oxycodone and lidocaine patch  \n# Communication: Patient  \n# Code: presumed full\n \nMedications on Admission:\nMultivitamin, thiamine, folate, spironolactone 25mg daily, \nlidocaine patch prn, nicotine patch.\n \nDischarge Medications:\n1. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n2. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n3. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n4. Nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \nTransdermal DAILY (Daily).  \n5. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily).  \n6. Tramadol 50 mg Tablet Sig: One (1) Tablet PO every eight (8) \nhours as needed for pain.\nDisp:*30 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary diagnosis: Alcoholic hepatitis.\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou were admitted to the hospital for alcoholic hepatitis. This \nis a condition in which your liver becomes inflamed due to \nexcessive alcohol intake. You were also noted to have an \nelevated white cell count which can sometimes indicate \ninfection. You were treated with a brief course of antibiotics \nfor a urinary tract infection. Otherwise your blood and \nperitoneal fluid cultures remain negative.\n\nWe made the following changes to your medications: \nWe stopped your spironolactone because your blood sodium levels \nwere too low.\nWe added Tramadol to take as needed for back pain. \n \nFollowup Instructions:\n___\n"
        ],
        [
         "12",
         "10000826-DS-19",
         "10000826",
         "28289260",
         "DS",
         "19",
         "2147-01-02 00:00:00",
         "2147-01-05 14:58:00",
         " \nName:  ___.          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nAbdominal distention/pain and fever\n \nMajor Surgical or Invasive Procedure:\nParacentesis ___ (diagnostic) and ___ (therapeutic)\n\n \nHistory of Present Illness:\n___ with recently diagnosed alcoholic hepatitis, persistent \nascites, and persistent fevers and leukocytosis which have been \natributed to her hepatitis who presented to ___ today with \nworsening abdominal distention, pain, and persistent fever. She \ndenies chills but did have sweats the night prior to admission. \nShe has tried to be strictly compliant with her low socium diet \nand fluid restriction, and denies any increased fluid or sodium \nintake. She reports sobriety from alcohol since ___. At ___ \nshe was febrile and tender to palpation, so she was referred to \nthe ED.  \n.  \nIn the ED initial vital signs were 99.0 113/72 132 16 99% on RA. \nHer temp increased to 100.4 and her pulse came down to the 100s \nwith Ativan. She received morphine 4mg IV x 4 for pain, tylenol \n___ PO x1 for fever, ondansetron 4mg IV x2 for nausea, and \nlorazeman 0.5mg IV x1 for anxiety. She underwent a diagnostic \nparacentesis but the samples were initially lost. She was \ntreated with ceftriaxone 2g IV x1 for possible SBP. She was \nadmitted to Medicine for further management. Fortunately, her \nsamples were found after she arrived on the floor.  \n.  \nOn the floor her mood is labile. She is at times tearful and at \ntimes pleasant. She does seem uncomfortable. She is not confused \nor obviously encephalopathic. She denies cough, dysuria, \ndiarrhea, or rash. She does endorse decreased UOP for the past \nfew days.  \n.\nReview of Systems:  \n(+) Per HPI  \n(-) Denies chills. Denies headache, sinus tenderness, rhinorrhea \nor congestion. Denies chest pain or tightness, palpitations. \nDenies cough, shortness of breath, or wheezes. Denied nausea, \nvomiting, diarrhea, constipation. No recent change in bowel or \nbladder habits. No dysuria. Denies arthralgias or myalgias. \nDenies rashes or skin breakdown. No numbness/tingling in \nextremities. No feelings of depression or anxiety. All other \nreview of systems negative.  \n\n \nPast Medical History:\n- Alcohol abuse  \n- Alcoholic hepatitis, with persistent fever and leukocytosis\n- Ascites \n- Chronic back pain \n \nSocial History:\n___\nFamily History:\n- Mother: ___ cancer, age ___  \n- No family history of liver disease  \n- Multiple relatives with alcoholism  \n \nPhysical Exam:\nPhysical Exam on Admission:  \nGEN: NAD, labile affect between pleasant and tearful  \nVS: 101.0 104/69 125 18 95% on RA  \nHEENT: Dry MM, no OP lesions, mild scleral icterus  \nCV: RR, tachy, no MRG  \nPULM: Bibasilar crackles R > L  \nABD: BS+, soft, distended, diffusely tender with mild rebound, \nobvious collateral veins, some mild angiomata  \nLIMBS: Trace ___ edema, no tremors or asterixis  \nSKIN: No rashes or skin breakdown, scattered ecchymoses at \npuncture sites  \nNEURO: A and O x 3, no pronator drift, reflexes are 1+ of the \nupper and lower extremities  \n \nPertinent Results:\nLABS:\n\nBlood ___:\nWBC-17.9* RBC-3.25* HGB-11.0* HCT-34.1* MCV-105* MCH-33.9* \nMCHC-32.3 RDW-14.0 PLT COUNT-198 ___ PTT-39.3* ___\nALBUMIN-2.7* ALT(SGPT)-33 AST(SGOT)-124* ALK PHOS-186* TOT \nBILI-2.4\n\nAscitic Fluid ___:  \nWBC-52* RBC-98* POLYS-13* LYMPHS-20* MONOS-0 EOS-1* \nMESOTHELI-16* MACROPHAG-50*\nTOT PROT-1.1 LD(LDH)-42 ALBUMIN-<1.0\n\nAscitic Fluid ___:\nWBC-104* RBB-290* POLYS-14* LYMPHS-17* MONOS-3* EOS-21* \nMESOTHELI-45* \n\nBlood ___:\nWBC-11.1 HCT 30.7\n \nRADIOLOGY:\nLumbo-sacral XR: Normal, no evidence of osteomyelitis/vertebral \ncompression fracture.\n\n \nBrief Hospital Course:\n#Abdominal distention/pain:\nShe was treated empirically due to concern for spontaneous \nbacterial peritonitis with ceftriaxone 2g x 1.  A diagnostic \nparacentesis was performed in the ED.  Ascitic fluid analysis \nwas performed.  Spontaneous bacterial peritonitis was ruled out \ngiven that the fluid cell count showed only 52 WBC; antibiotics \nwere discontinued in this setting.  Subsequently, a large volume \nparacentesis was performed on ___ with 4.5L of fluids \nremoved. After the procedure, her abdomen was less distended and \nless painful.  Fluid analysis again did not reveal SBP.  \n.\n#Alcoholic hepatitis:\nPatient's liver synthetic function was monitored while \nhospitalized. She was maintained on her home regimen of \nlactulose. She also had 24-hr urine collection for copper to \nevaluate for ___ disease. \n.\n#Leukocytosis and mild fever:\nShe had a temparature of 101 upon presentation in the ED.  She \nhad no signs or symptoms of any infection.  Urine culture showed \nonly GU flora, consistent with contamination. After arrival to \nthe floor her temperature was stable, ranging from 99 to 101.  \nHer WBC trended down throughout the hospitalization and was 11 \nat the time of discharge.    \n.\n#Tachycardia:\nHer heart rate was elevated in the 100-120s throughout the \nhospitalization. She had good oxygenation and had no complaints \nof SOB, dyspnea, chest pain, palpitations. The most likely \netiology of this is pain, anxiety, and her low intravascular \nvolume.  She was tachycardic in the 100s upon discharge.  \n.\n#Back pain:\nLumbosacral spine film revealed no skeletal abnormalities \n(vertebral compression fracture and osteomyelitis).  Her pain \nwas present but well-controlled throughout the hospitalization \nwith oxycodone ___ Q6H PRN pain.  Recommended follow up with \nher primary care provider to address management of her chronic \npain. \n.\n#Diet:\nLow sodium (2g/day), fluid restriction (1500mL/day)\n.\n#Code: Full\n\n \nMedications on Admission:\n- AMITRIPTYLINE - 10 mg PO HS  \n- OXYCODONE - 5 mg PO Q8H PRN pain  \n- Thiamine 100mg PO daily  \n- Folic acid 1mg PO daily  \n- MVI PO daily  \n \nDischarge Medications:\n1. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\n2. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n3. Amitriptyline 10 mg Tablet Sig: One (1) Tablet PO HS (at \nbedtime).  \n4. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n5. Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO DAILY \n(Daily).  \n6. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every eight (8) \nhours as needed for pain.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\nAscites\nPortal hypertension\nAlcoholic hepatitis\n.\nSecondary:\nChronic back pain\n\n \nDischarge Condition:\nAlert and Oriented.  Ambulating without help.  Hemodynamically \nstable, afebrile, tachycardic.  \n\n \nDischarge Instructions:\nYou were seen in the ___ Associates with \ncomplaints of increasing abdominal distention and pain. In the \nclinic, you also had a mild fever, fast heart rate, and \nincreased white blood count.  You were sent to the emergency \ndepartment and admitted to the hospital for further workup.  \nDuring the hospitalization your ascitic fluid was tapped and \nanalyzed.  The result showed that you did not have an infection \nof the ascitic fluid.  Subsequently, fluid was removed from your \nabdomen via paracentesis. We also started a 24-hr urine \ncollection for copper to work up for other potential causes of \nyour liver disease.  The liver clinic will follow up with you \nregarding the results of these tests.  \n.\nYour back pain persisted during your hospitalization.  You \nunderwent x-rays which showed no evidence of fracture or bone \ninfection.  Please continue your home pain regimen and readdress \nwith your primary care provider.\n.\nNo changes were made to your home medications.  You should \ncontinue to use lactulose for constipation while using pain \nmedications.  \n.\nPlease stop using all herbal or tonic remedies until your liver \nfunction has recovered. Some of these therapies may interact \nwith your current medications or make it difficult to interpret \nyour laboratory results.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "13",
         "10000883-DS-4",
         "10000883",
         "25221576",
         "DS",
         "4",
         "2124-05-22 00:00:00",
         "2124-05-23 16:31:00",
         " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: PSYCHIATRY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___\n \nChief Complaint:\nI have been overwhelmed and I felt suicidal.\"\n\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nHPI:  Mr. ___ is a ___ yo ___ freshman at ___ (___) c h/o depressed mood and anxiety symptoms\n(panic) who was sent to ___ at recommendation of ___, his\ntherapist of 4 months at ___ for evaluation of 3 weeks of\nworsening depression with anhedonia, social isolation &\nwithdrawal, escalating feelings of guilt, poor sleep secondary \nto\nruminations of guilt.  Patient is also having trouble\nconcentrating and going to his other classes because of his\ndepression and anxiety.  He has been eating fine and taking care\nof himself w/r/t hygiene.  Mr. ___ reported that what seems\nhave caused his recent bout of anxiety is the culmination of\nstress in a professional relationship with one of his teachers \nat\nhis program.  For reasons that are not completely clear, patient\nwas removed from a studio class with a particular instructor. \nPatient referred me to speak with ___ to explain the \nspecifics,\nbut ___ was not available and patient felt too\noverwhelmed to give me the story in detail--in fact had a panic\nattack during our talk.  For the past weeks, since being removed\nfrom the class, Mr. ___ has written letters, called (did \nnot\nleave messages) and emailed this instructor w/o getting any\nresponse.  The lack of response has caused an escalating pattern\nof guilt that Mr. ___ has been dealing with by cutting\nhimself with a knife (cut left wrist, no stitches).  Last night,\nin the context of this guilt, not sleeping and having more\nanxiety, Mr. ___ began feeling suicidal and developed a \nplan\nto kill himself by cutting himself with a knife.  He decided \nthat\nthe only way he could deal with his overwhelming feelings would\nbe suicide.  Mr. ___ told his counselor about these \nthoughts\nand his counselor recommended that he come to the ED.  \n\nMr. ___ reported that he has felt \"highs,\" but never for\nmore than a day and never impacting sleep or resulting in\ndramatically impaired decision-making (e.g., spending too much,\nindiscriminate sexual relationships, etc).  Mr. ___ has no\nh/o ___ psychotic symptoms, although his level of guilt has\nreached a near psychotic proportion.  Mr. ___ denied ever\nbeing asked by the instructor never to contact him, but he feels\nthe instructor not answering his calls or responding to emails\nmeans that the instructor does not like him.  He denied any\nthoughts of trying to harm the instructor.  \n\nMr. ___ reported feeling anxious a great deal, having a \nrare\npanic attack. \n\n \nPast Medical History:\nPAST PSYCH HX:  No previous medication trials or psychiatric\nhospitalizations.  One previous episode of being kept in a\npsychiatric ED in ___ in the context of having chest\npain which turned out to be a panic attack.  Gets occasional\npanic attacks (although not frequently enough to make a \ndiagnosis\nof panic d/o).  Has been seeing a counselor ___ at ___ x 4\nmonths.  Prior to 3 weeks ago, no h/o self-injurious behaviors,\nalthough has had suicidal ideation in the past (once or twice\nprior to last night, but never with intent like now).  Saw a\ncounselor in high school to help with \"coping\" with feeling\ndifferent in school.\n\nMr. ___ reported that he had thoughts of fighting with a\nfellow student a few months ago, which is why he started in\ncounseling (he said he did not want to get into details re. that\nsituation). He said that ultimately he was able to come to terms\nwith this person w/o fighting.  He denied any h/o violent\nbehavior.\n\nPMH:  Essentially healthy young man.  Had repair of meniscus of\nleft knee several months ago secondary to injury while running. \nNo other surgeries.\n\n \nSocial History:\n___\nSOCIAL/FAMILY HX:  Only child born to now divorced parents. \nParents separated when patient was ___.  Raised by mother in\n___, but also has a relationship with father.  Father\nstruggled with active alcohol dependence for many years, but is\nnow sober.  Patient denied any h/o physical or sexual abuse \nwhile\ngrowing up.  Described feeling \"different\" and having trouble\nfitting in, but could not give more details.  Had some \nbehavioral\ntroubles in school as a child, was suspended at least 3 times in\nhigh school, struggled academically, but did graduate.  \nCurrently\na freshman at ___ with an area of concentration in the clarinet,\nbut having a difficult time as above.  Mr. ___ lives alone\nin student housing.  No current romantic relationships, has \ndated\na girl in the past, but the relationship ended because the girl\ndid not feel ready to continue.  Mr. ___ denied any legal\nproblems and denied having access to any guns.  \n\n \nFamily History:\nFamily history remarkable for father with alcohol problems (in\nremission) and mother with h/o hypothyroidism.  No other family\nmedical or psychiatric problems known by patient.\n\n \nPhysical Exam:\nMSE- Mr. ___ is a\n___ white male, dressed in hospital ___.  Appears\nanxious, had a panic attack during the interview.  Speech normal\nrate, tone & volume.  Normal language.  Mood is \"depressed\" with\na constricted affective range in anxious realm.  Thoughts\norganized, but themes of guilt.  Endorsed suicidal ideation with\nplan to commit suicide using a knife to cut himself, vacillating\nintent.  Denied thoughts of harming others.  Insight into need\nfor help is good, judgment fair.\n\n \nPertinent Results:\n___ 03:58PM   GLUCOSE-96 UREA N-17 CREAT-0.9 SODIUM-140 \nPOTASSIUM-4.2 CHLORIDE-103 TOTAL CO2-29 ANION GAP-12\n___ 03:58PM   estGFR-Using this\n___ 03:58PM   TSH-1.4\n___ 03:58PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 03:58PM URINE  HOURS-RANDOM\n___ 03:58PM URINE  HOURS-RANDOM\n___ 03:58PM URINE  GR HOLD-HOLD\n___ 03:58PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 03:58PM   WBC-7.6 RBC-5.09 HGB-14.5 HCT-42.6 MCV-84 \nMCH-28.5 MCHC-34.0 RDW-12.7\n___ 03:58PM   NEUTS-55.6 ___ MONOS-3.7 EOS-1.4 \nBASOS-0.5\n___ 03:58PM   PLT COUNT-287\n___ 03:58PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 03:58PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n \nBrief Hospital Course:\n1) Psychiatric:\nPt arrived on floor denying passive abd active SI, intent, plan \nbut admitted to still feeling depressed, anxious. he was eager \nto start treatment and meds. Consequently, celexa 10 mg and \nklonopin 0.5 QHS and 0.5 BID prns anxiety were started. No side \neffects, pt reported significant anxiety reduction and \nresolution of depressive symptoms (slept throughout the night) \nand all SI/SIB urges within days of arrival. He stated he \nrealized he had overreacted in his dealings with the teacher and \nwanted to be discharged so that he could return to school. \nHowever, in speaking with ___ (counselor at ___) \n___ and the Academic ___ @___, ___ \n___, both expressed concerns over pt's \"repeated\nacts of impulsivity (apparently in ___ he got in a fight \nwith another student who he thought was talking about him. He \nthen ran back to his roomatte's dorm and asked the roommate to \nkill hm by cutting his throat). They both stated the pt had \n\"burned a lot more bridges\" than just the one teacher he had a \nfalling out\nwith, that other teachers at ___ are still \"unwilling or \nconcerned to take him on as a student given his growing \nreputation as impulsive\". They stated the NEC may\nrecommend pt take the rest of the semester off on medical leave. \n\n\nWe had a meeting with team, the academic ___ of ___, and the \npatient where all parties agreed that the pt should take the \nrest of the semester off on medical leave of absence with the \npossibility of returning next year. The patient stated, after \nspeaking with his family, that he would return to ___ \n___ immediately to be close to his family, \"for extra support\" \nduring his time of medical leave. he strongly agreed that he \nneeded to continue taking his medications and would followup \nwith psychiatric care arranged in ___ for him. The school \nwas satisfied with his mental status at this joint meeting and \nfelt he was safe to be discharged. Pt continued to deny \ndepression, SI, SIB, was future oriented and goal oriented and \nwas deemed safe for discharge on ___.\n\n2) Medical:\nNo active issues during hospital stay.\n\n3) Groups/Behavioral:\nPt attended groups, remained visible and  calm in unit milieu.  \nno disruptive or threatening behavior.  no quiet room, 1:1 \nsitter, physical or chemical restraints needed at any time.\n\n4) Legal:\n___\nMedications on Admission:\nnone\n \nDischarge Medications:\n1. Citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*0*\n2. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO QAM and QHS.\nDisp:*12 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAxis I:\nMajor depressive disorder, severe, without psychotic features\nAnxiety disorder not otherwise specified\nII- deferred\nIII- status post meniscus repair (knee)\nIV- moderately severe psychosocial stressors identified\nV- GAF upon discharge: 45\n\n \nDischarge Condition:\nMSE:general- thin caucasian man,seated, NAD\nbehavior= calm, no tremors, no PMA\nspeech- normal, not pressured \naffect:  more emotionally reactive than\nprior, smiles appropriately, even and euthymic\nTC: no delusions, no AVH\nTP: linear and goal-directed;\nsafety- denies SI, SIB, intent, plan \ncog: AOx3\nI/J; fair/fair\n\n \nDischarge Instructions:\nPlease take medications as prescribed.\nPlease attend outpatient appointments as scheduled.\nIf you are feeling unsafe or that your condition is worsening, \ncall ___ or go to your nearest ED\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "14",
         "10000935-DS-18",
         "10000935",
         "29541074",
         "DS",
         "18",
         "2183-11-04 00:00:00",
         "2183-11-10 15:59:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nSulfonamides / Codeine / Bactrim\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain and vomiting\n \nMajor Surgical or Invasive Procedure:\n___ Exploratory laparotomy, lysis of adhesions, small\nbowel resection with enteroenterostomy.\n\n \nHistory of Present Illness:\nThe patient is a ___ year old woman s/p hysterectomy for uterine \nfibroids and s/p R lung resection for carcinoid tumor who is \nseen in surgical consultation for abdominal pain, nausea, and \nvomiting. The patient was feeling well until early this morning \nat approximately 1:00am, when she developed cramping abdominal \npain associated with nausea and bilious emesis without blood.  \nShe\nvomited approximately ___ times which prompted her presentation \nto the ED.  At the time of her emesis, she had diarrhea and \nmoved her bowels > 3 times.  She has never had this or similar \npain in the past, and she states that she has never before had a \nsmall bowel obstruction.  She has never had a colonoscopy. \n\n \n\n \n\n \nPast Medical History:\nPMH: \ncarcinoid tumor as above\nVitamin B12 deficiency\ndepression\nhyperlipidemia\n\nPSH: \ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nnon contributory\n \nPhysical Exam:\nTemp 96.9  HR 105  BP 108/92 100%RA\nNAD, appears non-toxic but uncomfortable\nheart tachycardic but regular, no murmurs appreciated\nlungs clear to auscultation; decreased breath sounds on R;\nwell-healed R thoracotomy scar present\nabdomen soft, very obese, minimally distended, somewhat tender \nto\npalpation diffusely across abdomen; no guarding; no rebound\ntenderness, low midline abdominal wound c/d/i, no drainage, no \nerythema\n\n \nPertinent Results:\n___ 04:40AM   WBC-12.5*# RBC-4.46 HGB-13.6 HCT-39.7 MCV-89 \nMCH-30.5 MCHC-34.2 RDW-13.0\n___ 04:40AM   NEUTS-91.1* LYMPHS-7.4* MONOS-0.8* EOS-0.3 \nBASOS-0.2\n___ 04:40AM   PLT COUNT-329\n___ 04:40AM   GLUCOSE-151* UREA N-10 CREAT-0.8 SODIUM-142 \nPOTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-28 ANION GAP-13\n___ 04:40AM   ALT(SGPT)-12 AST(SGOT)-16 LD(LDH)-180 ALK \nPHOS-62 \n\n___ CT of abdomen and pelvis :1. Slightly dilated loops of \nsmall bowel with fecalization of small bowel contents and distal \ncollapsed loops, together indicating early complete or partial \nsmall-bowel obstruction. \n2. Post-surgical changes noted at the right ribs as detailed \nabove.\n\n___ CT of abdoman and pelvis :  \n1. Interval worsening of small bowel obstruction. Transition \npoint in the \nleft mid abdomen. (The patient went to the OR on the evening of \nthe study). \n2. Trace free fluid in the pelvis is likely physiologic.  \n\n  \n\n___ 10:57PM URINE  COLOR-Yellow APPEAR-Hazy SP ___\n___ 10:57PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-15 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 10:57PM URINE  RBC->50 ___ BACTERIA-MOD YEAST-NONE \nEPI-0\n___ 10:57PM URINE  MUCOUS-OCC\n___ 04:40AM   GLUCOSE-151* UREA N-10 CREAT-0.8 SODIUM-142 \nPOTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-28 ANION GAP-13\n___ 04:40AM   estGFR-Using this\n___ 04:40AM   ALT(SGPT)-12 AST(SGOT)-16 LD(LDH)-180 ALK \nPHOS-62 TOT BILI-0.2\n___ 04:40AM   LIPASE-17\n___ 04:40AM   WBC-12.5*# RBC-4.46 HGB-13.6 HCT-39.7 MCV-89 \nMCH-30.5 MCHC-34.2 RDW-13.0\n___ 04:40AM   NEUTS-91.1* LYMPHS-7.4* MONOS-0.8* EOS-0.3 \nBASOS-0.2\n___ 04:40AM   PLT COUNT-329\n \nBrief Hospital Course:\nThis ___ year old female was admitted to the hospital and was \nmade NPO, IV fluids were started and she had a nasogastric tube \nplaced.  She was pan cultured for a temperature of 101 and was \nfollowed with serial KUB's and physical exam. Her nasogastric \ntube was clamped on hospital day 2 and she soon developed \nincreased abdominal pain prompting repeat CT of abdomen and \npelvis.  This demonstrated an increase in the degree of \nobstruction and she was subsequently taken to the operating room \nfor the aforementioned procedure.\n\nShe tolerated the procedure well, remained NPO  with nasogastric \ntube in place and treated with IV fluids.  Her pain was \ninitially controlled with a morphine PCA .  Her nasogastric tube \nwas removed on post op day #2 and she began a clear liquid diet \nwhich she tolerated well.  This was gradually advanced over 36 \nhours to a regular diet and was tolerated well.  She was having \nbowel movements and tolerated oral pain medication.  Her \nincision was healing well and staples were intact.  After an \nuncomplicated course she was discharged home on ___\n \nMedications on Admission:\nAlbuteral MDI prn wheezes\nFlovent inhaler prn wheezes\nSrtraline 200 mg oral daily\nSimvastatin 20 mg oral daily\nTrazadone 100 mg oral daily at bedtime\nWellbutrin 75 mg oral twice a day\n \nDischarge Medications:\n1. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for \nwheezing, shortness of breath.  \n2. Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff \nInhalation BID (2 times a day).  \n3. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ4H (every 4 hours) as needed for pain.\nDisp:*40 Tablet(s)* Refills:*0*\n4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n5. Simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n6. Trazodone 100 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n7. Wellbutrin 75 mg Tablet Sig: One (1) Tablet PO twice a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nHigh grade small bowel obstruction\n\n \nDischarge Condition:\nHenodynamically stable, tolerating a regular diet, having bowel \nmovements, adequate pain control\n\n \nDischarge Instructions:\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n\n*You experience new chest pain, pressure, squeezing or \ntightness.\n\n*New or worsening cough, shortness of breath, or wheeze.\n\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications , unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\n\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\nIncision Care:\n\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \nsite.\n\n*Avoid swimming and baths until your follow-up appointment.\n\n*You may shower, and wash surgical incisions with a mild soap \nand warm water. Gently pat the area dry.\n\n*If you have staples, they will be removed at your follow-up \nappointment.\n\n*If you have steri-strips, they will fall off on their own. \nPlease remove any remaining strips ___ days after surgery.\n\n*Please look at the site every day for signs of infection \n(increased redness or pain, swelling, odor, yellow or bloody \n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "15",
         "10000935-DS-19",
         "10000935",
         "21738619",
         "DS",
         "19",
         "2187-07-12 00:00:00",
         "2187-07-12 14:01:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Codeine / Bactrim\n \nAttending: ___\n \nChief Complaint:\nnausea, vomiting, cough\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ female, with past medical history significant for \ndepression, hyperlipidemia, Hysterectomy, B12 deficiency, back \npain, carcinoid, cervical DJD, depression, hyperlipidemia, \nosteoarthritis, and history of Exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy for \na high grade SBO ___ who presents with nausea, vomiting, \nweakness x 2 weeks. She has been uable to tolerate PO liquids, \nand solids. Had similar presentation ___ for high grade SBO. \nDenies passing flatus today. However reports having last normal \nbowel movement this AM, without hematochezia, melena. Also \nreporting subjective fever (100.0), non productive cough. Denies \nHA, myalgias. Takes NSAIDS sparingly. Denies alcohol use. Denies \nsick contacs/ travel or recent consumption of raw foods. Has \nnever had a colonoscopy.  \n.  \nIn ED VS were 97.8 120 121/77 20 98% RA  \nLabs were remarkable for lactate 2.8, alk phos 293, HCT 33, WBC \n13.9  \nImaging: CT abdomen showed mult masses in the liver, consistent \nwith malignancy. CXR also showed multiple nodules  \nEKG: sinus, 112, NA, NI, TWI in III, but largely unchanged from \nprior  \nInterventions: zofran, tylenol, 2L NS, GI was contacted and they \nare planning on upper / lower endoscopy for cancer work-up.  \n.  \nVitals on transfer were 99.2 113 119/47 26 98%  \n\n \nPast Medical History:\nPMH: \n# high grade SBO ___ s/p exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy \n# carcinoid\n# hyperlipidemia\n# vitamin B12 deficiency\n# cervical DJD\n# osteoarthritis \n\nPSH: \ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nnon contributory\n \nPhysical Exam:\nOn admission\n\nVS: 98.9 137/95 117 20 100 RA  \nGENERAL: AOx3, NAD  \nHEENT: MMM. no JVD. neck supple.  \nHEART: Regular tachycardic, S1/S2 heard. no \nmurmurs/gallops/rubs.  \nLUNGS: CTAB, non labored  \nABDOMEN: soft, tender to palpation in epigastrium.  \nEXT: wwp, no edema. DPs, PTs 2+.  \nSKIN: dry, no rash  \nNEURO/PSYCH: CNs II-XII intact. strength and sensation in U/L \nextremities grossly intact. gait not assessed.  \n\nOn Discharge: \nVS: 98.7   118/78   97  20 99RA\nGENERAL: Patient is sitting in a chair, appears comfortable, \nA+Ox3, cooperative.   \nHEENT: EOMI, PERRLA, No Pallor or Jaundice, MMM, no JVD, neck \nsupple.  \nHEART: RRR, no m/r/g.  \nLUNGS: CTAB  \nABDOMEN: obese, soft, mild tenderness on mid +right epigastrium \nw/o peritoneal signs, no shifting dullness, difficult to \nappreciate organomegaly.  \nEXT: wwp, no edema, no signs of DVT  \nSKIN: no rash, normal turgor  \nNEURO: no gross deficits \nPSYCH: appropriate affect, no preceptual disturbances, no SI, \nnormal judgment.   \n\n \nPertinent Results:\n___ 03:14PM   ___\n___ 12:50PM URINE  HOURS-RANDOM\n___ 12:50PM URINE  UHOLD-HOLD\n___ 12:50PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 12:50PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 \nLEUK-TR\n___ 12:50PM URINE  RBC-2 WBC-2 BACTERIA-NONE YEAST-NONE \nEPI-2\n___ 09:54AM   LACTATE-2.8*\n___ 09:45AM   GLUCOSE-96 UREA N-7 CREAT-0.5 SODIUM-138 \nPOTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-27 ANION GAP-15\n___ 09:45AM   estGFR-Using this\n___ 09:45AM   ALT(SGPT)-17 AST(SGOT)-46* ALK PHOS-293* TOT \nBILI-0.5\n___ 09:45AM   LIPASE-14\n___ 09:45AM   ALBUMIN-3.0*\n___ 09:45AM   ___ AFP-1.7\n___ 09:45AM   WBC-13.9* RBC-3.94* HGB-9.8* HCT-33.0* \nMCV-84# MCH-25.0*# MCHC-29.9* RDW-16.1*\n___ 09:45AM   NEUTS-75.2* LYMPHS-17.9* MONOS-5.9 EOS-0.7 \nBASOS-0.3\n___ 09:45AM   PLT COUNT-657*#\n\nCT abdomen/pelvis\n1. Innumerable hepatic and pulmonary metastases.  No obvious \nprimary \nmalignancy is identified on this study. \n  \n2. No evidence of small bowel obstruction, ischemic colitis, \nfluid collection, \nor perforation. \n\nCXR: \n \nNew nodular opacities within both upper lobes, left greater than \nright. \nFindings are compatible with metastases, as was noted in the \nlung bases on the \nsubsequent CT of the abdomen and pelvis performed later the same \nday. \n\n \nBrief Hospital Course:\n___ Female with PMH significant for depression, \nhyperlipidemia, Hysterectomy, B12 deficiency, OA, carcinoid, \ncervical DJD, depression, SBO who presented with nausea, \nvomiting, weakness x 2 weeks and was found to have multiple \nliver and lung masses per CT consistent with metastatic cancer \nof unknown primary. \n\nPatient was treated with IV fluids overnight for dehydration. \nShe refused to stay in the hospital for any further work-up or \ntreatment and stated she would rather go home to to think and \nsee to her affairs over the weekend and consider pursuing \nfurther work-up as an outpatient. She tolerated oral fluids well \nw/o vomiting. She remained hemodynamically stable and afebrile \nthroughout her stay. \n\nOf note patient has psychiatric history of depressive symptoms \nand isolation tendencies. She denied any SI/SA or any risk to \nherself.  She has little social supports but does have a good \nrelationship with her driver and friend who came in and was \nupdated by the medical team on the morning of discharge and will \nbe taking her home. She sees a mental health provider at ___ \nonce a month and has a good relationship with her primary care \nphysician. Patient was dischaerged home at her request. Home \nmedications were continued to which we added some symptomatic \ntreatment for her cough with benzonatate and Guaifenesin. We \nheld off on anti-emetics for now as she did not want to stay \ninhouse to make sure these would be well tolerated (would need \nto monitor for drug interactions given multiple QTc prolonging \nand serotonergic medications on her home meds).  She was \ninstructed to maintain good hydration and try a soft diet at \nhome if she can not tolerate regular diet. The patient met with \nSW who provided her with resources for community councelling. \nOutpatient appointments with oncology, GI and her PCP were set \nup and her PCP and mental health provider were updated. Her PCP \n___ also ___ with her later today by telephone. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN wheezing/SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO TID \n4. Ibuprofen 800 mg PO Q8H:PRN pain \n5. Sertraline 200 mg PO DAILY \n6. Simvastatin 40 mg PO DAILY \n7. Tizanidine 4 mg PO BID:PRN muscle spasms/pain \n8. traZODONE 100 mg PO HS:PRN sleep \n9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP TID \n\n \nDischarge Medications:\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO TID \n4. Sertraline 200 mg PO DAILY \n5. Simvastatin 40 mg PO DAILY \n6. Tizanidine 4 mg PO BID:PRN muscle spasms/pain \n7. traZODONE 100 mg PO HS:PRN sleep \n8. Ibuprofen 800 mg PO Q8H:PRN pain \n9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP TID \n10. Benzonatate 100 mg PO TID:PRN cough \nRX *benzonatate 100 mg 1 capsule(s) by mouth TID: PRN cough Disp \n#*60 Capsule Refills:*0\n11. Guaifenesin ___ mL PO Q6H:PRN cough \nRX *guaifenesin 100 mg/5 mL ___ ml by mouth Q6H:PRN cough Disp \n#*1 Bottle Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nLiver and Lung Mets of unkown primary\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___, \n\n___ were seen in the ED for ongoing cough, nausea and vomiting \nand had imaging studies which unfortunately showed spots in your \nliver and lungs which are likely due to wide-spread cancer. ___ \nwere admitted for further work-up and treatment of your \nsymptoms. ___ chose to not have any more work-up in the hospital \nand wanted to be discharged home as soon as possible. \nPlease make sure ___ keep well hydrated by taking water sips \nthroughout the day. I also prescribed some symptomatic treatment \nfor your nausea and cough. \nI updated your PCP and ___ and have set up ___ \nappointments as below.  \n \nFollowup Instructions:\n___\n"
        ],
        [
         "16",
         "10000935-DS-20",
         "10000935",
         "26381316",
         "DS",
         "20",
         "2187-08-27 00:00:00",
         "2187-08-27 16:59:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Codeine / Bactrim\n \nAttending: ___.\n \nChief Complaint:\n Weakness, nausea/vomiting  \n\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nThis is a ___ yo f with h/o recently diagnosed metastatic cancer \nof unknown prior presenting with nausea, vomiting, and fever to \n101 today. Patient has been vomiting over the past 6 - 8 weeks, \nsince before she was diagnosed with metastatic cancer. She also \nreports pain over her upper abdomen and has very poor PO intake. \nShe has been feeling progressively weak over this time period. \nHer vomiting and abdominal pain has not increased from the past \nweeks, but she just feels more fatigued. She has a chronic \nnon-productive cough as well. No URI symptoms, no urinary \ncomplaints. She has been constipated, which improves when she \nstops her anti-emetics. Last bowel movement was yesterday. She \nis passing gas. She has lower extremity edema, which has been \npresent for the past several weeks.  \nOf note, she was supposed to have one of her liver mets biopsied \nin the past several weeks, but she was taking ibuprofen so the \nbiopsy had to be postponed.  \n \nIn the ED, initial VS were: 97.6 117 128/74 18 95% RA. Labs were \nsignificant for WBC of 18.7, with 77% polys. UA was significant \nfor ketones. Patient received zofran, NS. She had a CXR that \nshowed new left sided opacity that may reflect PNA superimposed \non metastatic diseae vs. lymphangiitic spread of cancer. She \nreceived vanc and cefepime for pneumonia. Vitals on transfer \nare: 99.6 110 118/78 20 99%.  \nCurrently, she continues to feel weak and nauseous. She is \ntrying to take her pants off, but feels too weak and tired to do \nso.  \nREVIEW OF SYSTEMS:  \n(+) per HPI  \n(-) night sweats, headache, vision changes, rhinorrhea, \ncongestion, sore throat, BRBPR, melena, hematochezia, dysuria, \nhematuria.  \n \n\n \nPast Medical History:\nPMH: \n# high grade SBO ___ s/p exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy \n# carcinoid\n# hyperlipidemia\n# vitamin B12 deficiency\n# cervical DJD\n# osteoarthritis \n\nPSH: \ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nMother - ___ cancer d. at ___  \nYoungest of ___ - not in touch with siblings  \nFather - ___ d. at ___  \n\n \nPhysical Exam:\nAdmission Physical Exam: \nVS: 98.6, 130/80, 111, 24, 98% on RA  \nGENERAL: Obese woman, appears comfortable, in no acute distress  \n\nHEENT: PERRLA, EOMI, sclerae anicteric, slightly dry mucus \nmembranes  \nNECK: supple, obese  \nLUNGS: Distant breath sounds, decreased on the right, few \ncrackles b/l  \nHEART: RRR, no MRG, nl S1-S2  \nABDOMEN: + bowel sounds, soft, epigastric and RUQ tenderness to \npalpation, markedly enlarged liver, with liver edge palpable 5 \ncm below rib cage. No rebound/guarding.  \nEXTREMITIES: 2+ lower extremity edema, 2+ pulses radial and dp  \nNEURO: awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout  \n\nDischarge Physical Exam:\nVitals-  Tm 99.8 BP 125/76 HR 105 RR 20 99RA\nGeneral- Alert, oriented, no acute distress, obese appearing \nwoman  \nHEENT- Sclera anicteric, MMM, oropharynx clear  \nNeck- supple, JVP not elevated, no LAD  \nLungs- Clear to auscultation bilaterally with decreased breath \nsound on left posterior basilar lung field, no wheezes, rales, \nronchi  \nCV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen- soft, obese, diffusely tender, non-distended, bowel \nsounds present, no rebound tenderness or guarding, no \norganomegaly  \nGU- no foley  \nExt- warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ \npitting edema  \nNeuro- CNs2-12 intact, motor function grossly normal  \nLabs: Reviewed, please see below.  \n\n \nPertinent Results:\nADMIT LABS:\n\n___ 04:35PM BLOOD WBC-18.7*# RBC-3.49* Hgb-9.2* Hct-31.2* \nMCV-90 MCH-26.5* MCHC-29.6* RDW-18.6* Plt ___\n___ 04:35PM BLOOD Neuts-77.4* Lymphs-14.9* Monos-6.8 \nEos-0.5 Baso-0.4\n___ 04:35PM BLOOD Plt ___\n___ 04:35PM BLOOD Glucose-90 UreaN-8 Creat-0.5 Na-139 K-3.5 \nCl-99 HCO3-29 AnGap-15\n___ 04:35PM BLOOD ALT-12 AST-48* AlkPhos-328* TotBili-0.9\n___ 07:45AM BLOOD Calcium-8.4 Phos-2.5*# Mg-2.0\n___ 04:35PM BLOOD Albumin-2.8*\n___ 06:42PM BLOOD Lactate-2.0\n\nDISCHARGE  LABS:\n\n___ 06:05AM BLOOD WBC-16.8* RBC-3.20* Hgb-8.3* Hct-28.7* \nMCV-90 MCH-25.9* MCHC-28.9* RDW-18.1* Plt ___\n___ 06:05AM BLOOD Glucose-87 UreaN-10 Creat-0.4 Na-136 \nK-3.7 Cl-99 HCO3-27 AnGap-14\n___ 06:05AM BLOOD ALT-11 AST-45* LD(LDH)-517* AlkPhos-282* \nTotBili-0.8\n___ 06:05AM BLOOD Calcium-8.4 Phos-2.7 Mg-2.2\n\nIMAGING: ___\nFinal Report \nHISTORY:  New diagnosis of metastatic cancer with unknown \nprimary.  Assess for extent of lesions.   \nCOMPARISON:  CT abdomen and pelvis dated ___.  \nTECHNIQUE:  Multidetector CT of the torso was performed with \nintravenous and oral contrast.  Coronal and sagittal \nreformations were provided.  Images are substantially degraded \ndue to the patient's body habitus.   \nFINDINGS: \nCHEST:  \nThere are innumerable pulmonary nodules, which have an upper \nlobe \npredilection, particularly in the left upper lobe.  The largest \nnodule \nmeasures 6 mm in diameter (sequence 3 image 8).  Calcification \nis noted within  the right pleural cavity (sequence 3 image 24), \nwhich is likely related to the patient's history of previous \nright lung surgery.  No pleural effusion.  No pneumothorax.  \nNo significant mediastinal, axillary or hilar adenopathy.  \nCardiac size is \nnormal.  No pericardial effusion.  \nABDOMEN:  \nThe liver is enlarged and there are innumerable ___ density \nlesions throughout both lobes of the liver which are replacing \nthe vast majority of the hepatic parenchyma.  The portal vein is \npatent.  No intra or extrahepatic duct dilatation.  The \ngallbladder is unremarkable.  There is a small amount of ascites \nadjacent to the right lobe of the liver.   \n  \nThe right kidney is mildly compressed anteriorly due to the \nenlarged liver. There is a subcentimeter ___ density lesion in \nthe upper pole of the right kidney, likely representing a \nsubcentimeter cyst (sequence 5 image 31).  The right kidney is \notherwise unremarkable.  The left kidney is within normal \nlimits.  The adrenals and spleen are unremarkable.  The pancreas \nis within normal limits.  The small and large bowel are \nunremarkable.  No retroperitoneal or mesenteric adenopathy.  \n  \nPELVIS:  \nThe images of the pelvis are substantially degraded secondary to \nthe patient's body habitus.  No pelvic masses are identified.  \nThe bladder is unremarkable.  The patient is status post \nsupracervical hysterectomy.  No pelvic adenopathy. No free fluid \nwithin the pelvis.  \n  \nOSSEOUS STRUCTURES:  \nBilateral symmetrical sclerosis is identified on the iliac side \nof the \nsacroiliac joints, consistent with osteitis condensans ilii.  \nThere is severe degenerative change within the right hip joint \nwith joint space loss and osteophyte formation.  No destructive \nosseous lesions.   \n  \nIMPRESSION: \nMultiple pulmonary and hepatic metastases.  No separate primary \nlesion \nidentified.   \n\n \nBrief Hospital Course:\n___ yo f with h/o recently diagnosed metastatic cancer of unknown \nprimary presenting with nausea, vomiting, and fever to 101 on \nday of admission.  \n.\n# Fever/leukocytosis: Patient presented with fever and \nleukocytosis, which was initially concerning for post \nobstructive PNA. Patient was treated with vanc-cefepime-azithro \nfor a day and a half, however CT torso was concerning for \nongoing malignancy without evidence of primary tumor. There was \nno concern for a pneumonia. Consequently, abx were stopped on \n___. Patient felt weak and unable to go home, as she lives \nalone and so was screened by physical therapy and discharged to \nrehab facility. \n.\n# Failure to thrive: Patient presents with 6 weeks of nausea, \nvomiting and poor PO intake likely from her enlarged liver. She \ncontinues to have bowel movements and pass gas. Patient now with \nalbumin of 2.8, ketones in her urine, weight loss and new \nperipheral edema, concerning for poor nutrition/starvation \nketosis. Nutrition consult followed the patient throughout her \nhospital stay and recommended ___ fat Carnation Instant \nBreakfast with Beneprotein.\n.\n# Chronic back pain:  Patient was continued on her home \ngabapentin. \n.\n# Depression:  Patient was continued on home bupropion, \nsertraline  \n.\n# HCTZ: Patient's hctz was discontinued during her \nhospitalization due to poor PO intake and concern for \ndehydration. Blood pressures were well-controlled such that HCTZ \nwas not deemed necessary. This issue should be readdressed by \nPCP.\n.\n# Hyperlipidemia: Given patient's metastatic process, statin was \ndiscontinued during hospitalization to simplify her medical \nregimen.  \n.\n# Insomnia: Continued home trazodone  \n.\nTRANSITION ISSUES\n# CODE: FULL (Confirmed)  \n# CONTACT: ___ (friend) ___  \n# HCTZ discontinued on admission- consider restarting if \nconsidered medically necessary by PCP \n# ___ fat Carnation Instant Breakfast with Beneprotein with \nmeals\n# Follow up with oncology for further diagnosis and management \nof malignancy\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO HS \n4. Sertraline 200 mg PO DAILY \n5. Simvastatin 40 mg PO DAILY \n6. traZODONE 100 mg PO HS:PRN sleep \n7. Ibuprofen 800 mg PO Q12H:PRN pain \n8. Hydrochlorothiazide 12.5 mg PO DAILY \n9. Ondansetron 4 mg PO Q8H:PRN nausea \n\n \nDischarge Medications:\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO HS \n4. Sertraline 200 mg PO DAILY \n5. traZODONE 100 mg PO HS:PRN sleep \n6. Ondansetron 4 mg PO Q8H:PRN nausea \n7. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n8. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \nplease hold for sedation, RR<10 \nRX *oxycodone 5 mg 1 tablet(s) by mouth every 6 hours Disp #*30 \nTablet Refills:*0\n9. Enoxaparin Sodium 40 mg SC DAILY \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nMetastatic disease of unknown primary: Weakness and nausea \nlikely from tumor burden\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ for evaluation of several weeks of \nweakness and nausea. You had some markers of infection, so you \nwere initially given antibiotics. However, a scan of your torso \nshowed metastatic disease from a cancer of unknown origin in \nyour liver and lungs. Your weakness and nausea are most likely \ndue to your enlarged liver. \n\nYou are scheduled to see your oncologist this week, so please \nfollow-up with them so that they may proceed with the further \ndiagnosis and treatment of your malignancy.\n\nYou are being discharged to a rehabilitation facility to help \nyou regain some strength before going home. Your anticipated \nlength of stay is LESS THAN 30 DAYS. \n\nPlease see the attached sheet for your updated medication list. \n\nIt was a pleasure taking care of you in the hospital. We wish \nyou all the best.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "17",
         "10000935-DS-21",
         "10000935",
         "25849114",
         "DS",
         "21",
         "2187-10-26 00:00:00",
         "2187-10-27 15:36:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Codeine / Bactrim\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nPercutaneous liver biopsy\n \nHistory of Present Illness:\nMs. ___ is a ___ with metastatic cancer of unknown primary \n(known lesions in lungs and liver) presenting with shortness of \nbreath. She initially presented to ___ in ___ with abdominal \npain and failure to thrive. Evaluation at that time included an \nabdominal CT scan that showed multiple lung and liver \nmetastases. She has yet to undergo definite diagnosis with \nbiopsy, and per recent oncology documentation seems disengaged \nwith care.  \nShe was reportedly in her usual state of health until the \nevening prior to admission, when she developed acute on chronic \nshortness of breath while at rest. She reported midsternal chest \nache associated with this shortness of breath. Pain is \nexacerbated by direct pressure; nothing seems to alleviate pain. \nShe denied any pleuritic or exertional component to the chest \npain or shortness of breath. She feels that symptoms are \nsecondary to her \"cancer\" and \"feels as if the cancer has \nspread\". She reports stable, chronic nonproductive cough, which \nhas been present over the preceding months.  \nShe was seen recently in the ED for evaluation of left greater \nthan right lower extremity edema with lower extremity venous \nultrasounds negative, without change in edema since since that \nvisit. She denies associated fever, chills, sweats, PND, \northopnea, or positional component to pain. \nIn the ED, initial vital signs were: 98.0 116 100/49 24 99% RA. \nLabs notable for leukocytosis to 17.9, hematocrit of 32, and \nlactate of 2.8. Urinalysis was positive, but with 19 epithelial \ncells. CTA was negative for central pulmonary embolus, focal \nconsolidation, or pleural effusion, though did reveal \ninnumerable pulmonary nodules, as well as enlarged liver with \nstable metastases. EKG was interpreted as sinus tachycardia and \nwas overall consistent with prior. Ceftriaxone/azithromycin were \ninitiated for possible pneumonia. Vital signs on  transfer were \nas follows: 97.9 107 100/60 22 100% RA. On arrival to the floor, \nshe reports that shortness of breath has improved and that she \nis chest pain free.\n \nPast Medical History:\nPer OMR:\n# metastatic cancer of unknown primary\n# high grade SBO ___ s/p exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy \n# carcinoid\n# hyperlipidemia\n# vitamin B12 deficiency\n# cervical DJD\n# osteoarthritis \n\ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nPer OMR:\nMother - Died of pancreatic cancer at age ___.  \nFather - Died of ___ disease at age ___. \n \nPhysical Exam:\nOn admission:\nVS: 97.9 114/71 105 sinus 18 95%2L  \nGENERAL: non-toxic appearing, speaking in full sentences  \nHEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM  \nNECK: supple, no LAD, no JVD  \nCHEST: mild reproducible pain on palp of midsternum; no palpable \nmass  \nLUNGS: poor aeration but relatively CTA bilat, no r/rh/wh, resp \nunlabored, no accessory muscle use  \nHEART: clear and audible heart sounds, tachycardiac but regular \nrhythm, sofy SEM, nl S1-S2  \nABDOMEN: normal bowel sounds, soft, mild tenderness to palp \nthroughout and more pronounced in the RUQ, non-distended, no \nrebound or guarding, palpable liver edge  \nEXTREMITIES: left > right 1+ pitting edema to mid shin, 2+ \npulses radial and dp  \nNEURO: awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact\n\nAt discharge:\nVS - Tc 99.7, 116/59, 131, 18, 99% RA\nGENERAL: obese, NAD, lying in bed comfortably, flat affect and \npoor eye contact\nHEENT: NCAT, EOMI, mild scleral icterus, pink conjunctiva, MMM, \npoor dentition, mild palor of conjunctiva \nNECK: supple, no LAD  \nCARDIAC: tachycardic but regular, S1/S2, no m/r/g\nLUNG: CTAB in anterior fields, decreased breath sounds at right \nbase, exam limited secondary to body habitus and mobility, no \nw/r/r, no accessory muscle use\nABDOMEN: obese, ND, +BS, no rebound/guarding, localized area of \nfirmness in mid-upper abdomen and tender to palpation over this \narea \nEXTREMITIES: WWP, 2+ DP pulses bilaterally, 1+ pitting edema to \ntorso bilateraly \nNEURO: no asterixis, moving all four extremities, minimal \nmovement ___ to gravity but distal muscles 4+/5, good hand \ngrip strength today\n \nPertinent Results:\nOn admission:\n___ 12:50PM BLOOD WBC-17.9* RBC-3.69* Hgb-9.5* Hct-32.1* \nMCV-87 MCH-25.8* MCHC-29.7* RDW-19.1* Plt ___\n___ 12:50PM BLOOD Neuts-82.8* Lymphs-11.7* Monos-4.4 \nEos-0.7 Baso-0.3\n___ 12:50PM BLOOD ___ PTT-31.2 ___\n___ 12:50PM BLOOD Glucose-97 UreaN-12 Creat-0.6 Na-140 \nK-2.7* Cl-92* HCO3-31 AnGap-20\n___ 12:50PM BLOOD ALT-17 AST-73* LD(___)-586* CK(CPK)-218* \nAlkPhos-340* TotBili-2.6* DirBili-1.8* IndBili-0.8\n___ 12:50PM BLOOD CK-MB-1 cTropnT-<0.01\n___ 12:50PM BLOOD Albumin-2.5* Mg-2.2\n___ 12:50PM BLOOD Hapto-307*\n___ 05:12PM BLOOD Lactate-2.8*\n\n___ 06:00PM URINE Color-YELLOW Appear-Cloudy Sp ___\n___ 06:00PM URINE Blood-NEG Nitrite-NEG Protein-30 \nGlucose-NEG Ketone-10 Bilirub-SM  Urobiln-8* pH-6.0 Leuks-MOD\n___ 06:00PM URINE RBC-0 WBC-66* Bacteri-FEW Yeast-NONE \nEpi-14\n___ 06:00PM URINE CastHy-6*\n\nAt discharge:\n___ 08:30AM BLOOD WBC-16.1* RBC-3.06* Hgb-8.3* Hct-29.2* \nMCV-95 MCH-27.1 MCHC-28.5* RDW-22.5* Plt ___\n___ 08:30AM BLOOD Glucose-95 UreaN-7 Creat-0.3* Na-143 \nK-3.5 Cl-110* HCO3-20* AnGap-17\n___ 08:30AM BLOOD Calcium-8.3* Phos-2.4* Mg-1.9\n\nMicrobiology:\nBlood x2 (___): No growth\nUrine (___): No growth\nBlood x2 (___): No growth\n\nPathology:\nLiver biopsy (___):\nLiver, core needle biopsy (A):\nAdenocarcinoma, involving the liver (see note).\nNote: Immunohistochemical stains are performed.  The tumor cells \nare positive for CK20 and CDX-2, and negative for CK7 and TTF-1. \n These results are consistent with metastasis from a colorectal \nprimary.\n\nImaging:\nEKG (___):\nSinus tachycardia. Low voltage. Diffuse non-specific \nrepolarization\nabnormalities. Compared to the previous tracing of ___ \nrepolarization\nabnormalities are slightly more prominent.\n___\n___\n\nPortable CXR (___):\nInnumerable pulmonary metastases.  Possible mild pulmonary \nvascular\ncongestion.  Low lung volumes.\n\nCTA (___):\n1.  No central or segmental filling defect in the pulmonary \narteries.\nEvaluation is slightly limited due to suboptimal IV bolus. \n2.  Innumerable bilateral pulmonary nodules, simas seen on the \nprior CT study on ___, slightly increased.  No focal \nconsolidation or pleural effusion.  \n3.  Enlarged liver with multiple hypodense lesions, with \nsuggestion of\nincreased burden of disease.\n\nRight upper quadrant ultrasound (___):\nExtensive diffuse hepatic metastatic disease.  No evidence of \nbiliary duct\nobstruction.\n\nPortable CXR (___):\n1. Low lung volumes and mild pulmonary vascular congestion is \nunchanged. \n2. New small right fissural pleural effusion.\n3. No new focal opacities to suggest pneumonia.  \n\nNoncontrast head CT (___):\nNo acute intracranial process.  No mass is identified.  MRI is \nmore sensitive for evaluation of metastases.\n\nLeft hip XR (___):\nNo definite lytic lesion; however, an MRI can be performed to \nevaluate for an osseous lesion if indicated.\n\nPortable abdomen (___):\nRadiographs of the abdomen and pelvis demonstrate a \nnonobstructed\nbowel gas pattern.  A relative paucity of bowel gas is present \nin the upper and mid abdomen, likely due to marked enlargement \nof the liver, displacing bowel loops.  Note that the upright \nview is technically suboptimal, and limits evaluation for free \nintraperitoneal air.  If free intraperitoneal air is suspected \nclinically, a left lateral decubitus view of the abdomen would \nbe recommended.\n \nBrief Hospital Course:\nMs. ___ is a ___ with metastatic cancer of unknown primary, \nincluding lesions in the liver and lungs, who initially \npresented with shortness of breath, likely due to worsening \nintrapulmonary tumor burden, and later underwent percutaneous \nliver biopsy with pathology consistent with metastatic colon \ncancer, prompting transfer to the oncology service and \neventually discharged home with hospice.\n\nActive Issues:\n(1) Metastatic colon adenocarcinoma: CTA to exclude pulmonary \nembolus and right upper quadrant ultrasound on admission \ndemonstrated progression of previously recognized metastatic \ncancer of unknown primary involving the liver and lungs, which \nhad evaded diagnosis in the outpatient setting due to patient \nreluctance to engage with care. Percutaneous liver biopsy \nultimately revealed primary colonic adenocarcinoma. Following \ndiscussion with her outpatient oncology providers, she was \ntransferred to the inpatient oncology service for potential \ntrial of FLOX. However, given the patient's very poor functional \nand nutritional status a goals of care discussion was held with \nthe patient's HCP, ___ and it was decided to focus \ngoals of care of comfort and symptom management and the patient \nwas discharged home with home hospice. \n\n(2) Left thigh weakness/spinous tenderness: She was found to \nhave focal left thigh weakness in association with diffuse \nspinous tenderness of unclear chronicity in the setting of \npreserved rectal tone without saddle anesthesia. She was noted \nto be incontinent of urine, but not feces. Given underlying \nmalignancy, there was concern for bony metastases or cord \ninvolvement, with alternative consideration given to epidural \nabscess, prompting transient initiation of empiric antibiotic \ncoverage with vancomycin/cefepim ___ to ___. Despite \nfrequent persuasive efforts, she declined multiple attempts at \nlumbosacral MRI, including with lorazepam premedication, citing \nclaustrophobia. Neuro exam was monitored and remained stable.\n\n(3) Abdominal pain: She experienced intermittent abdominal pain \nand tenderness without peritoneal signs, concerning for \nobstruction in the setting of intraabdominal malignancy, \nparticularly given episodes of emesis/hematemesis as below. \nWhile multiple KUBs were negative for obstruction, CT abdomen \nwas planned to evaluate for alternative sources of \nintraabdominal pathology, but she declined on multiple \noccasions. Pain was controlled with acetaminophen and tramadol \nas needed.\n\n(4) ? Hematemesis: She experienced a single episode of small \nvolume emesis, reportedly approximately 100cc, streaked with \nblood and found to be guiac positive. Vital signs and hematocrit \nremained stable. IV pantoprazole was initiated for \ngastrointestinal prophylaxis, with subsequent discontinuation of \nPPI given no recurrence and questionable if first episode was \ntrue blood vs. red popsicle was eating at time. \nEsophagogastroduodenoscopy was deferred in the absence of \nrecurrent hematemesis; no prior EGDs were available in OMR. \n\n(5) Altered mental status: She was intermittently altered \nthroughout admission, never oriented to more than person and \nplace, with occasional difficulty following simple commands as \ncompared to an uncertain baseline. Infectious work up, including \nblood and urine cultures and CTA on admission with subsequent \nCXRs, was unrevealing. Noncontrast head CT was negative for \nacute intracranial process. Brain MRI for definitive exclusion \nof metastases could not be obtained due to claustrophobia/MRI \naversion as above.  ABG on ___ without signs of CO2 retention. \nHistory of opiates making patient sleepy per HCP as possible \ncontributing factor and therefore these were discontinued. \nHepatic encephalopathy also on differential given metastatic \nlesions to liver and asterixis on exam.  AMS could also be ___ \nto severe depression. Mental status monitored and remained \nstable and patient at baseline per HCP on discharge.\n\n(6) Shortness of breath: She presented with acute onset \nshortness of breath without frank hypoxia. CTA on admission was \nnegative for pulmonary embolus, though (subsegmental clot could \nnot be excluded definitively), pleural effusion, or focal \ninfiltrate. EKG and cardiac enzymes were reassuring against \nacute coronary syndrome.  Low voltages on EKG were consistent \nwith prior, hence limited suspicion for pericardial effusion. \nShortness of breath resolved over the course of admission \nwithout dedicated treatment, with the exception of nebulizers \nand expectorants as needed.\n\n(7) Leukocytosis: White blood cell count was elevated and peaked \nat 20.6, consistent with recent baseline, likely reflecting \nunderlying malignancy. As noted above, infectious work up \nincluding CTA, urine and blood cultures, and CXRs, was \nunrevealing. She remained afebrile, with the exception of \nisolated transient fever to 100, with stable vital signs. \n\n(8 )Liver function test abnormalities: AST remained elevated ___ \nto ___, alkaline phosphatase 260s to 380s, and total bilirubin \n2.1 to 2.6, likely due to hepatic infiltration of malignancy. \nRight upper quadrant ultrasound was negative for cholecystitis \nor obstructive process. The possibility of superimposed \nintraabdominal process, such as infection, could not be excluded \nin the setting of abdominal pain with emesis as above, but she \ndeclined CT for further evaluation.\n\n(9) Elevated lactate: Lactate was found to be 2.7-3.8 throughout \nadmission despite copious IV fluids, likely reflecting \ncompromised hepatic clearance in the setting of malignant \ninfiltration. \n\n(10) Sinus tachycardia: She remained persistently tachycardic \n100s to 115s throughout admission in the setting of poor PO \nintake, but incompletely responsive to copious IV fluids. \nTachycardia has been present since at least ___. Despite \nconcurrent leukocytosis and elevated lactate, there was no clear \ninfectious source, hence low suspicion for sepsis. Subsegmental \npulmonary embolus could not be excluded on the basis of \nadmission CTA, but shortness of breath was short lived, and she \nwas never hypoxic. Hematocrit remained stable without signs of \nactive bleeding, with the exception of transient hematemesis as \nabove.\n\n(11) Depression: She appeared depressed with flat affect and \nseeming anhedonia throughout admission, with underlying \ndepression likely affecting motivation to seek diagnosis and \ntreatment of known malignancy. She denied active suicidal \nideation and frequently declined home sertraline, particularly \nprior to liver biopsy, believing that it was supposed to be held \npreprocedurally despite explanation to the contrary. She was \nseen by social work throughout admission.\n\n(12) Normocytic anemia: Hematocrit remained stable and \nconsistent with recent baseline at 27 to 33 throughout \nadmission, seemingly due to anemia of chronic disease on the \nbasis of preadmission labs. Vital signs remained stable, with \nthe exception of persistent tachycardia, without signs of active \nbleeding apart from isolated blood streaked emesis as above.\n\n(13) Coagulopathy: INR of 1.2 to 1.8 was felt to reflect \nsynthetic dysfunction in the setting of hepatic infiltration of \nmalignancy, as well as poor oral intake. There were no signs of \nactive bleeding, with the exception of transient hematemesis as \nabove.\n\nTransitional Issues:\n-Patient discharge home with home hospice\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO HS \n4. Sertraline 200 mg PO DAILY \n5. traZODONE 100 mg PO HS:PRN sleep \n6. Ondansetron 4 mg PO Q8H:PRN nausea \n7. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n8. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \nplease hold for sedation, RR<10 \n9. Enoxaparin Sodium 40 mg SC DAILY \n\n \nDischarge Medications:\n1. BuPROPion 150 mg PO DAILY \n2. Ondansetron 4 mg PO Q8H:PRN nausea \n3. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain \nRX *tramadol 50 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*60 Tablet Refills:*0\n4. Senna 1 TAB PO BID:PRN constipation \nRX *sennosides [___] 8.6 mg 1 tablet by mouth twice a \nday Disp #*60 Tablet Refills:*0\n5. Omeprazole 20 mg PO DAILY \nRX *omeprazole 20 mg 1 capsule,delayed ___ by \nmouth Daily Disp #*30 Capsule Refills:*0\n6. Hospital Bed\nBariatric Hospital Bed and\nTherapeutic Mattress: BariMaxxII\n\n7. Hospice Order\nPlease Screen and Admit to Hospice.\n8. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n9. Docusate Sodium 100 mg PO BID \n10. Sertraline 200 mg PO DAILY \n11. traZODONE 100 mg PO HS:PRN sleep \n12. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nMetastatic colon adenocarcinoma\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Bedbound.\n\n \nDischarge Instructions:\nDear Ms. ___,\nIt was a pleasure taking part in your care during your admission \nto ___. As you know, you were \nadmitted for shortness of breath, likely due to your underlying \ncancer, and there was no evidence of pneumonia or blood clot in \nthe blood vessels of your lungs. Your shortness of breath \nresolved, but you were found to have weakness in your left thigh \nand abdominal pain. You declined imaging studies for further \ninvestigation of these findings. You underwent biopsy of your \nliver that revealed that the cancer known to affect your liver \nand lungs originated in your colon (large bowel). You were \ntransferred to the oncology service, but unfortunately \nchemotherapy would do more harm for you than good.  After a long \ndiscussion with you and your health care proxy, it was decided \nthat you will go home to be with your family and loved ones.  We \nwill also set up hospice services for you so that they can help \nwith any issues that arise while you are at home.  \n \nFollowup Instructions:\n___\n"
        ],
        [
         "18",
         "10000980-DS-20",
         "10000980",
         "29654838",
         "DS",
         "20",
         "2188-01-05 00:00:00",
         "2188-01-06 20:49:00",
         " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ yo woman with h/o hypertension, hyperlipidemia, diabetes \nmellitus on insulin therapy, h/o cerebellar-medullary stroke in \n___, CKD stage III-IV presenting with fatigue and dyspnea on \nexertion (DOE) for a few weeks, markedly worse this morning. \nOver the past few weeks, the patient noted DOE and shortness of \nbreath (SOB) even at rest. She has also felt more tired than \nusual. She notes no respiratory issues like this before. She \ncannot walk up stair due to DOE, and feels SOB after only a \nshort distance. She is unsure how long the episodes last, but \nstates that her breathing improves with albuterol which she gets \nfrom her husband. She had a bad cough around a month ago, but \ndenies any recent fevers, chills, or night sweats. No chest \npain, nausea, or dizziness.\n \nPast Medical History:\n1. CAD RISK FACTORS: +Diabetes, +Dyslipidemia, +Hypertension\n2. CARDIAC HISTORY: \nMI in ___\n3. OTHER PAST MEDICAL HISTORY:  \nHypertension\nHyperlipidemia\nDiabetes mellitus on insulin therapy\nh/o cerebellar-medullary stroke in ___\nCKD stage III-IV\nPVD\n \nSocial History:\n___\nFamily History:\nDenies cardiac family history. Family hx of DM and HTN; \notherwise non-contributory.\n \nPhysical Exam:\nAdmission exam:\nGENERAL- Oriented x3. Mood, affect appropriate.\nVS- T= 98.1 BP= 200/103 HR= 65 RR= 26 O2 sat= 100% on RA\nHEENT- NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were \npink, no pallor or cyanosis of the oral mucosa. No xanthalesma.\nNECK- JVD to angle of mandible\nCARDIAC- RR, normal S1, S2. No murmurs, rubs or gallops. No \nthrills, lifts.\nLUNGS- Kyphosis. Resp were labored, mild exp wheezes \nbilaterally.\nABDOMEN- Soft, non-tender, not distended. Abd aorta not enlarged \nby palpation. No abdominal bruits.\nEXTREMITIES- No clubbing, cyanosis or edema. No femoral bruits.\nSKIN- No stasis dermatitis, ulcers, scars, or xanthomas.\nNEURO- CNII-XII grossly intact. Strength ___ in LEs and UEs. \nDiminished sensation along lateral aspect of left leg to light \ntouch\n\nDischarge exam:\nLungs: CTAB\nOtherwise unchanged\n \nPertinent Results:\nAdmission Labs\n___ 01:18PM BLOOD WBC-6.4# RBC-3.15* Hgb-9.5* Hct-30.1* \nMCV-96 MCH-30.1 MCHC-31.5 RDW-14.1 Plt ___\n___ 01:18PM BLOOD Glucose-150* UreaN-33* Creat-1.6* Na-144 \nK-4.8 Cl-111* HCO3-18* AnGap-20\n___ 01:18PM BLOOD CK(CPK)-245*\n___ 01:18PM BLOOD cTropnT-0.05*\n___ 01:18PM BLOOD CK-MB-6 proBNP-4571*\n___ 03:56AM BLOOD Calcium-9.4 Phos-4.9* Mg-2.0 Cholest-230*\n\nPertinent Labs\n___ 06:09AM BLOOD WBC-4.3 RBC-3.27* Hgb-9.9* Hct-31.4* \nMCV-96 MCH-30.4 MCHC-31.6 RDW-14.5 Plt ___\n___ 06:09AM BLOOD Glucose-138* UreaN-31* Creat-1.4* Na-144 \nK-4.3 Cl-107 HCO3-26 AnGap-15\n\n___ 06:09AM BLOOD ALT-20 AST-17\n___ 03:56AM BLOOD Triglyc-97 HDL-65 CHOL/HD-3.5 \nLDLcalc-146*\n___ 03:56AM BLOOD %HbA1c-8.1* eAG-186*\n\n___ 01:18PM BLOOD CK(CPK)-245* CK-MB-6 cTropnT-0.05*\n___ 08:43PM BLOOD CK(CPK)-198  CK-MB-5 cTropnT-0.03*\n___ 03:56AM BLOOD CK(CPK)-173  CK-MB-5 cTropnT-0.04*\n___ 06:09AM BLOOD                      cTropnT-0.01\n\n___ 01:18PM proBNP-4571*\n\nECG ___  7:56:06 ___  \nBaseline artifact. Sinus rhythm. The Q-T interval is 400 \nmilliseconds. Q waves in leads V1-V2 with ST-T wave \nabnormalities extending to lead V6. Consider prior anterior \nmyocardial infarction. Since the previous tracing of ___ \natrial premature beats are not seen. The Q-T interval is \nshorter. ST-T wave abnormalities are less prominent.  \n \nCXR ___:\nPA and lateral views of the chest demonstrate low lung volumes. \nTiny bilateral pleural effusions are new since ___. No \nsigns of pneumonia or pulmonary vascular congestion. Heart is \ntop normal in size though this is stable. Aorta is markedly \ntortuous, unchanged. Aortic arch calcifications are seen. There \nis no pneumothorax. No focal consolidation. Partially imaged \nupper abdomen is unremarkable.\nIMPRESSION: Tiny pleural effusions, new. Otherwise unremarkable.\n\nECHO ___:\nThe left atrium is mildly dilated. The estimated right atrial \npressure is ___ mmHg. Left ventricular wall thickness, cavity \nsize and regional/global systolic function are normal (LVEF \n>55%). Right ventricular chamber size and free wall motion are \nnormal. The diameters of aorta at the sinus, ascending and arch \nlevels are normal. The aortic valve leaflets (3) are mildly \nthickened but aortic stenosis is not present. No masses or \nvegetations are seen on the aortic valve, but cannot be fully \nexcluded due to suboptimal image quality. Trace aortic \nregurgitation is seen. The mitral valve leaflets are \nstructurally normal. An eccentric, anteriorly directed jet of \nmild to moderate (___) mitral regurgitation is seen. Moderate \n[2+] tricuspid regurgitation is seen. There is moderate \npulmonary artery systolic hypertension. The end-diastolic \npulmonic regurgitation velocity is increased suggesting \npulmonary artery diastolic hypertension. There is an anterior \nspace which most likely represents a prominent fat pad.\nIMPRESSION: Suboptimal image quality. Normal biventricular \ncavity sizes with preserved global and regional biventricular \nsystolic function. Pulmonary artery hypertension. Mild-moderate \nmitral regurgitation. Moderate tricuspid regurgitation. \nCompared with the prior study (images reviewed) of ___, the \nseverity of mitral and tricuspid regurgitation are increased and \nmoderate PA hypertension is now identified.\n \nBrief Hospital Course:\n___ woman with h/o hypertension, hypelipidemia, diabetes \nmellitus on insulin, cerebellar-medullary stroke in ___, \nstage ___ CKD followed by Dr ___ presenting with fatigue and \nDOE for a few weeks, markedly worse the morning of admission. \nThe patient has known diastolic dysfunction. Of note, she has \nbeen noncompliant with her medications at home. On arrival to \nthe floor, she required hydralazine 20 mg to bring down her BP. \nShe has likely had elevated BPs at home for a while, which is \ncontributing to her SOB, CHF exacerbation, and secondary demand \nmyonecrosis (hypertensive urgency) with mildly elevated \ntroponin.\n\n# CAD: Although she did not have a classic anginal presentation, \npatient has several risk factors for acute coronary syndrome. \nHer only symptom was SOB in the setting of elevated BPs \nattributed to medication noncompliance at home. Her troponin \nfell from 0.05 at admission to 0.01 at discharge in the setting \nof renal dysfunction, but there was not a clear rise and fall to \nsuggest an acute infarction from plaque rupture and thrombosis. \nShe was scheduled for an outpatient stress test to evaluate for \nevidence of ischemia from flow-limiting CAD. We decreased ASA to \n81 mg from 325 mg daily to decrease the risk of bleeding. Her \nLDL was found to be 146. We wanted to change her from \nsimvastatin to the more potent atorvastatin (and avoid issues \nwith drug-drug interactions), but her insurance would not cover \natorvastatin. She was therefore switched to pravastatin 80 mg at \ndischarge. From a cardiac standpoint, we did not feel that \nPlavix was necessary for CAD, but her neurologist was contacted \nand wanted Plavix continued. We had to stop metoprolol due to HR \nin the ___ during admission even off metoprolol.\n  \n# Pump: Last echo in ___ showed low normal LVEF. Her current \npresentation was consistent with CHF exacerbation with bilateral \npleural effusions, dyspnea, and elevated NT-Pro-BNP. Her TTE \nshowed mild-moderate mitral and moderate tricuspid \nregurgitation, LVEF 50-55%, and pulmonary hypertension. We \nchanged her HCTZ to Lasix 40 mg PO at discharge. This medication \ncan be uptitrated as needed.\n\n# Hypertension: The patient's nephrologist, Dr. ___, agreed \nwith our proposed medication adjustments, but recommended \nstaying away from clonidine. There has been a H/O medication \nnon-adherence. Social work was involved in discharge planning, \nand ___ will be assisting the patient at home. We added \nlisinopril 20 mg daily, Lasix 40 mg daily and continued \nnifedipine 120 mg daily. Her atenolol was stopped due to her \nrenal dysfunction, but her metoprolol had to be stopped due to \nbradycardia. She should continue on once a day medication dosing \nto help with compliance.\n\n# ? COPD: The patient may have a component of COPD as she was \nwheezing on admission and responded to albuterol. She was given \na prescription for albuterol prn.\n\nTransitional Issues:\n- She will be scheduled for outpt stress stress test\n- She has follow-up appointments with Dr. ___ and Dr. \n___ and both can work on uptitrating her BP \nmeds as needed.\n- ___ will need to work with patient on medication compliance.\n \nMedications on Admission:\nATENOLOL - 100 mg Tablet - 1.5 Tablet(s) by mouth once a day \nCLONIDINE - 0.1 mg/24 hour Patch Weekly - place on shoulder once \na week\nCLOPIDOGREL [PLAVIX] - 75 mg Tablet - 1 Tablet(s) by mouth once \na day generic is available preferable, please call Dr ___ \nan appointment  \nFENOFIBRATE MICRONIZED - 134 mg Capsule - 1 Capsule(s) by mouth \nonce a day\nHYDROCHLOROTHIAZIDE - 25 mg Tablet - 1 (One) Tablet(s) by mouth \nonce a day\nNIFEDIPINE [NIFEDIAC CC] - 60 mg Tablet Extended Release - 2 \nTablet(s) by mouth once a day\nNITROGLYCERIN [NITROSTAT] - 0.3 mg Tablet, Sublingual - 1 \nTablet(s) sublingually sl as needed for prn chest pain may use 3 \ndoses, 5 minutes apart; if no relief, ED visit \nRANITIDINE HCL - 300 mg Tablet - 1 Tablet(s) by mouth once a day\nSIMVASTATIN - 80 mg Tablet - 1 Tablet(s) by mouth at bedtime\n\nMedications - OTC  \nASPIRIN [ENTERIC COATED ASPIRIN] - 325 mg Tablet, Delayed \nRelease (E.C.) - 1 (One) Tablet(s) by mouth once a day\nINSULIN NPH & REGULAR HUMAN [HUMULIN 70/30] - 100 unit/mL \n(70-30) Suspension - 30 units at dinner at dinner\nMULTIVITAMIN - (OTC) - Tablet - 1 Tablet(s) by mouth once a day\n \nDischarge Medications:\n1. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily). Disp:*30 Tablet(s)* Refills:*2*\n2. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Tablet, \nSublingual Sublingual PRN (as needed) as needed for chest pain: \nmay take up to 3 over 15 minutes. Disp:*30 Tablet, \nSublingual(s)* Refills:*0*\n3. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \nDisp:*30 Tablet(s)* Refills:*2*\n4. ranitidine HCl 150 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily). Disp:*60 Tablet(s)* Refills:*2*\n5. pravastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily). Disp:*30 Tablet(s)* Refills:*2*\n6. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily). Disp:*30 Tablet, Chewable(s)* Refills:*2*\n7. lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \nDisp:*30 Tablet(s)* Refills:*2*\n8. nifedipine 60 mg Tablet Extended Release Sig: Two (2) Tablet \nExtended Release PO DAILY (Daily). Disp:*30 Tablet Extended \nRelease(s)* Refills:*2*\n9. furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \nDisp:*30 Tablet(s)* Refills:*2*\n10. insulin NPH & regular human 100 unit/mL (70-30) Insulin Pen \nSig: Thirty (30) units Subcutaneous at dinner. Disp:*900 units* \nRefills:*2*\n11. albuterol sulfate 90 mcg/actuation HFA Aerosol Inhaler Sig: \n___ puffs Inhalation every ___ hours as needed for shortness of \nbreath or wheezing. Disp:*1 inhaler* Refills:*1*\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n-Hypertension with hypertensive urgency\n-Myocardial infarction attributed to demand myonecrosis\n-Acute on chronic left ventricular diastolic heart failure\n-Chronic kidney disease, stage ___\n-Chronic obstructive pulmonary disease\n-Prior cerebellar-medullary stroke\n-Hyperlipidemia\n-Diabetes mellitus requiring insulin therapy\n-Medication non-adherence\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear Ms. ___, \n\nYou were admitted for shortness of breath. You were found to \nhave elevated blood pressure on admission in the setting of not \ntaking all of your medications regularly. We obtained an \nechocargiogram of your heart which showed some strain on your \nheart possibly related to your elevated blood pressures.\n\nYou will be contacted about an outpatient stress test. This will \nbe completed within the next month.\n\nYou will be prescribed several new medications as shown below. A \nvisiting nurse ___ come to your home to help with managing your \nmedications. You should dispose of all your home medications and \nonly take the medications shown on this discharge paperwork.\n\nMedications:\nSTOP Hydrochlorothiazide\nSTOP Simvastatin\nSTOP Clonidine\nSTOP Atenolol due to low heart rate\nCHANGE 325mg to 81mg once daily\nSTART Lisinopril 20mg once daily\nSTART Lasix 40mg once daily\nSTART Pravastin 80mg once daily\n\nIf you experience any chest pain, excessive shortness of breath, \nor any other symptoms concerning to you, please call or come \ninto the emergency department for further evaluation.\n\nThank you for allowing us at the ___ to participate in your care.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "19",
         "10000980-DS-21",
         "10000980",
         "26913865",
         "DS",
         "21",
         "2189-07-03 00:00:00",
         "2189-07-03 19:50:00",
         " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\ndyspnea\n \nMajor Surgical or Invasive Procedure:\nCardiac catheterization ___\n\n \nHistory of Present Illness:\nThis is a ___ M with history of diabetes, diastolic CHF, \nhypertension, ?CAD, peripheral vascular disease, CKD presenting \nwith ___ days of increasing dyspnea and non-productive cough. \nShe denies fevers, chills, chest pain, nausea, vomiting. Did \nreport feeling somewhat wheezy. Denies leg swelling, has \npossibly had a 2 lb weight gain. Denies missed medication doses. \nDoes report 2 pillow orthopnea last night. Her husband has also \nbeen sick with a cough for the past day or so. She is a \nnon-smoker. She lives at home and has had no recent \nhospitalizations or courses of antibiotics.\n\nIn the ED, initial vitals:  97.8 80 132/83 25 97% ra. CXR showed \nprobable RUL PNA. Normal WBC and lactate, Cr at baseline.  \nTroponin 0.09 with normal CK-MB. BNP 2826. She was started on \nbipap due to tachypnea and increased work of breathing. She was \ngiven 40mg IV lasix and started on vancomycin, cefepime and \nlevofloxacin.\n \nOn transfer, vitals were:  69 141/82 28 100% bipap \n\nOn arrival to the MICU, patient reports improved breathing on \nbipap.  \n\nReview of systems:  \n(+) Per HPI  \n \nPast Medical History:\n- hypertension\n- diabetes\n- hx CVA (cerebellar-medullary stroke in ___\n- CAD (has never been cathed, hx of MI in ___\n- peripheral arterial disease- claudication, followed by \nvascular, managed conservatively\n- stage IV CKD (baseline 2.5-2.8)\n- GERD/esophageal rings\n \nSocial History:\n___\nFamily History:\nNiece had some sort of cancer. Otherwise, no family history of \ncancer or early heart disease.\n \nPhysical Exam:\nADMISSION EXAM:\nGeneral-  appears comfortable on BiPap\nHEENT- PERRL, EOMI \nNeck- difficult to assess JVP due to habitus and presence of \nBiPap strap \nCV-  RRR, no gallops\nLungs-  good air entry. diffuse crackles R>L, rhonchi in RUL. \nscattered inspiratory wheezing\nAbdomen-  soft, NTND\nExt-  trace edema, faint peripheral pulses\nNeuro-  A and O x 3, moving all 4 extremities. mildly decreased \nstrength in LLL\n\nDISCHARGE EXAM:\nVS: T98.9 BP144/83 P66 RR18 99RA 76.1kg\nGENERAL: Laying in bed, sleeping. No acute distress.  \nHEENT: Moist mucous membranes. \nNECK: Supple, unable to visualize JVP.\nCARDIAC: Regular rate and rhythm. Normal S1, S2. No S3, S4. ___ \nsystolic murmur.\nLUNGS: Clear to auscultation bilaterally. No crackles, wheezes, \nrhonchi.  \nABDOMEN: +BS, soft, nondistended, nontender to palpation.   \nEXTREMITIES: Warm and well perfused. Pulses 2+. Trace peripheral \nedema. \n \nPertinent Results:\nON ADMISSION:\n\n___ 06:48AM BLOOD WBC-5.3 RBC-2.94* Hgb-9.5* Hct-27.3* \nMCV-93 MCH-32.4* MCHC-34.9 RDW-13.5 Plt ___\n___ 06:48AM BLOOD Neuts-65.6 ___ Monos-5.2 Eos-2.7 \nBaso-0.4\n___ 08:03PM BLOOD ___ PTT-69.6* ___\n___ 06:48AM BLOOD Glucose-89 UreaN-37* Creat-2.3* Na-144 \nK-3.9 Cl-109* HCO3-21* AnGap-18\n___ 06:48AM BLOOD CK-MB-6 proBNP-2826*\n___ 06:48AM BLOOD cTropnT-0.09*\n___ 12:58PM BLOOD CK-MB-9 cTropnT-0.11*\n___ 07:52AM BLOOD Lactate-1.7\n___ 07:40AM URINE Color-Straw Appear-Clear Sp ___\n___ 07:40AM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\n\nON DISCHARGE:\n\n___ 09:00AM BLOOD WBC-4.8 RBC-2.53* Hgb-8.0* Hct-23.6* \nMCV-94 MCH-31.5 MCHC-33.7 RDW-12.9 Plt ___\n___ 09:26AM BLOOD Glucose-121* UreaN-52* Creat-2.2* Na-142 \nK-4.5 Cl-108 HCO3-24 AnGap-15\n___ 09:26AM BLOOD Calcium-9.9 Phos-4.8* Mg-2.5\n\nCXR: ___\nRight upper lobe pneumonia or mass.  However, given right hilar \nfullness, a mass resulting in post-obstructive pneumonia is \nwithin the \ndifferential.  Recommend chest CT with intravenous contrast for \nfurther \nassessment. \n\nTTE: ___\nThe left atrium is elongated. There is mild symmetric left \nventricular hypertrophy with normal cavity size. There is mild \nto moderate regional left ventricular systolic dysfunction with \nnear-akinesis of the inferior, inferolateral and basal lateral \nsegments. The remaining segments contract normally (LVEF = \n35-40%). Right ventricular chamber size and free wall motion are \nnormal. The aortic valve leaflets (3) are mildly thickened but \naortic stenosis is not present. No aortic regurgitation is seen. \nThe mitral valve leaflets are mildly thickened. An eccentric jet \nof moderate to severe (3+) mitral regurgitation is seen. There \nis moderate pulmonary artery systolic hypertension. There is no \npericardial effusion.\n\nIMPRESSION: Mild to moderate regional left ventricular systolic \ndysfunction, c/w CAD. Moderate to severe mitral regurgitation. \nModerate pulmonary hypertension.\n\nCompared with the prior study (images reviewed) of ___, \nregional LV wall motion abnormalities are new. Severity of \nmitral regurgitation has increased.\n\nCARDIAC CATH: ___\n1. Selective coronary angiography of this right dominant system \nrevealed three vessel coronary artery disease.  The LMCA had no \nobstructive disease.  The LAD had a moderate disease in the mid \nartery and a diagonal branch had an 80% proximal lesion.  The \nLcx had a 70% proximal lesion.  The RCA was totally occluded \nmid-vessel. \n  \nFINAL DIAGNOSIS:     \n1. Three vessel coronary artery disease. \n2. Recommend CABG evaluation\n\nCT CHEST: ___\n1.  Diffuse confluent ground-glass opacities predominantly in \nthe right upper lobe and right lower lobe most likely represent \nresidual pulmonary edema, localized to the right lung because of \ndirection of jet in mitral \nregurgitation.  \n2.  Possible pulmonary hypertension. \n3.  Moderate coronary artery disease. \n\nCAROTID US: ___\nNo evidence of hemodynamically significant internal carotid \nstenosis on either side. \n\nECHO ___- PCI)\nThere is mild symmetric left ventricular hypertrophy with normal \ncavity size. There is mild regional left ventricular systolic \ndysfunction with inferior and infero-lateral hypokinesis. No \nmasses or thrombi are seen in the left ventricle. There is no \nventricular septal defect. Right ventricular chamber size and \nfree wall motion are normal. The mitral valve leaflets are \nmildly thickened. An eccentric jet of mild (1+) mitral \nregurgitation is seen. There is no pericardial effusion. \n\nCompared with the prior study (images reviewed) of ___, \nthe LVEF has increased. The degree of MR seen has decreased. \n\n \nBrief Hospital Course:\n___ female with ___, HTN, diabetes, CKD presented with \nincreased dyspnea and non-productive cough without fevers or \nelevated white count, initially admitted to ___ with concern \nfor pneumonia. However, was found to have ST-changes, enzyme \nleak, new wall motion abnormality consistent with a recent \ncardiac event and had no evidence of pneumonia (no fevers, wbc, \nlactate, normal vitals, CXR with likely one sided pulmonary \nedema from mitral regurgitation). She was seen by cardiology who \ntransferred the patient to cardiology floor.\n\n# Acute systolic CHF exacerbation/mitral regurgitation: \nLikely secondary to ischemic valvular disease resulting in \nworsening mitral regurgitation. ECHO also with akinetic inferior \nwall segments, which also supports an ischemic event. Cardiac \ncath revealed 3 vessel disease. Patient was managed medically \nwith lasix, lisinopril, and metoprolol. Cardiac surgery was \nconsulted for possible CABG and mitral valve repair/replacement. \nHowever, given her multiple comorbidities, she is extremely high \nrisk and surgery was deferred. Therefore, the decision was made \nto revascularize the patient with PCI to see if the patient \nwould regain function of her mitral valve. Patient received a \nbare metal stent in the LCx and plain old balloon angioplasty in \nthe diagonal artery. Repeat echo showed improvement of her \nmitral regurgitation. \n\n# NSTEMI/CAD:\nAs evidenced by EKG changes and troponin leak. Patient was \nbriefly started on a heparin drip prior to her first cardiac \ncatheterization. As above, cardiac catheterization revealed \n3-vessel disease. Patient was initially medically managed with \naspirin, plavix, metoprolol, lisinopril, and atorvastatin. As \nthe patient would be too high risk for CABG, patient returned to \nthe cath lab and had a bare metal stent and POBA. She will \nrequire plavix for at least 1 month.\n\n# Hypertension: Patient remained normotensive. Continued \nnifedipine at half of her home dose. Continued on lisinopril. \nShe was also started on metoprolol as above for CHF.\n\n# Diabetes: Continued home insulin regime. \n \n# CKD stage IV: Baseline Cr 2.5-2.8 per renal notes. Currently \nat baseline. \n\n# History of CVA: Continued home aspirin and clopidogrel. \n\n# GERD: Continued home ranitidine.\n\nTRANSITIONAL ISSUES: \n* Will need follow up with a cardiologist. Patient will be \nscheduled to follow up with the first available CMED \ncardiologist. \n* Will need plavix for at least one month (day of bare metal \nstent placement = ___.\n* Atorvastatin dose increased to 80mg (per pharmacy, her \ninsurance will cover. Her co-pay will be $10/month).\n* Consider titrating nifedipine dose back to 120mg if still \nhypertensive. \n* Please recheck Chem7 at next appointment to evaluate for ___ \nsecondary to dye received during cardiac catheterization.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lisinopril 30 mg PO DAILY \n2. NIFEdipine CR 60 mg PO DAILY \n3. Ranitidine 300 mg PO DAILY \n4. Pravastatin 80 mg PO DAILY \n5. HumuLIN 70/30 (insulin NPH and regular human) 30 units \nsubcutaneous daily \n6. Ferrous Sulfate 325 mg PO BID \n7. Furosemide 40 mg PO DAILY \n8. Multivitamins 1 TAB PO DAILY \n9. Nitroglycerin SL 0.3 mg SL PRN chest pain \n10. DiphenhydrAMINE 25 mg PO HS:PRN insomnia \n11. sevelamer CARBONATE 800 mg PO TID W/MEALS \n12. Clopidogrel 75 mg PO DAILY (was not taking regularly)\n13. Aspirin 81 mg PO DAILY \n14. Vitamin D ___ UNIT PO DAILY \n\n \nDischarge Medications:\n1. Aspirin 81 mg PO DAILY \n2. Clopidogrel 75 mg PO DAILY \n3. Furosemide 40 mg PO DAILY \n4. Lisinopril 30 mg PO DAILY \n5. Multivitamins 1 TAB PO DAILY \n6. Ranitidine 300 mg PO DAILY \n7. sevelamer CARBONATE 800 mg PO TID W/MEALS \n8. Atorvastatin 80 mg PO DAILY \nRX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0\n9. Metoprolol Succinate XL 25 mg PO DAILY \nRX *metoprolol succinate 25 mg 1 tablet extended release 24 \nhr(s) by mouth daily Disp #*30 Tablet Refills:*0\n10. DiphenhydrAMINE 25 mg PO HS:PRN insomnia \n11. HumuLIN 70/30 (insulin NPH and regular human) 30 units \nsubcutaneous daily \n12. Nitroglycerin SL 0.3 mg SL PRN chest pain \n13. Vitamin D ___ UNIT PO DAILY \n14. NIFEdipine CR 60 mg PO DAILY \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\nSevere mitral regurgitation\nCoronary artery disease\n\nSECONDARY DIAGNOSIS:\nHypertension\nDiabetes\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you at ___ \n___. As you recall, you were admitted for shortness \nof breath. This was because one of your heart valves was weak, \nwhich caused fluid to build up in your lungs. Your heart valve \nwas weak because there was a blockage in one of your heart \narteries. You underwent a procedure, called cardiac \ncatheterization, which opened up the blocked arteries. Your \nvalve and heart are pumping much more efficiently now. We are \nglad you are feeling better. Please weigh yourself every \nmorning, and call your MD if your weight goes up more than 3 lbs \nover 24 hours.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "20",
         "10000980-DS-22",
         "10000980",
         "24947999",
         "DS",
         "22",
         "2190-11-08 00:00:00",
         "2190-11-09 13:57:00",
         " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nDyspnea and chest tightness\n \nMajor Surgical or Invasive Procedure:\n___ Pharmacologic nuclear stress test\n \nHistory of Present Illness:\n___ year old female with history of HTN, HLD, hx of CVA, CAD s/p \nBMS to circumflex and POBA (___), on Aspirin and Plavix, CHF \n(EF 45% in ___, diabetes, presenting with acute onset \nshortness of breath and substernal chest tightness since ___ \nevening. \n\nPatient notes that ___ evening had a large seafood dinner \nwhich is not usual for her, and then later around 10pm had acute \nonset of SOB feeling like she could not take deep breaths with \nchest tightness (patient notes this is her \"angina\"). Denies \npleuritic component to CP, described as central and across lower \nrib cage, persistent since onset, no radiation to the \nshoulders/jaw/back, no diaphoreses. Worsens with activity, \nimproves somewhat with rest. Patient does not it feels like \nother episodes when she then required her stent placement. Took \na SLNx1, which improved her symptoms though these persisted, but \nalmost immediately led to abdominal discomfort with vomiting x1, \nnonbloody with dinner pieces. ___, 1 day prior to admission, \ndecided to see if her pain improved on its own, then when it \npersisted on ___, husband arranged for UC appt at ___ \n___. At PCP, ___, SBP up to 200s, EKG with ST \ndepressions in the precordial leads, specifically V3, V4 and V5, \ngiven full dose ASA and SLNx1, and sent to the ED given concern \nfor ACS versus HTN emergency. \n\nPatient reporting baseline sleeps with 2 pillows, unchanged \nrecently, no cough, PND, orthopnea with 2 pillows. Worsening DOE \nsince onset of symptoms, now unable to complete a block where \nshe used to be able to walk a few blocks at a time without \nstopping ___ SOB/CP. Denies new ___ edema (baseline says L leg > \nR).\n\nAlso had emesis last night x 1; no diaphoresis, no chest pain, \nno radiation of symptoms anywhere. No diarrhea or constipation, \nno dysuria, no focal weakness/numbness. On ROS, also with some L \nleg tingling intermittently, stable and chronic. Had diarrhea x1 \non ___ following ___ seafood dinner, normal BMs since \nthen. \n \nIn the ED initial vital signs; T 98 P 88 BP 190/120 R 18 O2 Sat \n98% 3L nasal cannula. Labs notable for Cr 2.1 (baseline \n2.1-2.7), BUN 29. wbc 4.3, H/H 8.6/26.0, Plt 147. Initial and \nrpt Tn <0.01. BNP 4279. CXR showed no pulmonary edema, pleural \neffusions, or consolidation, borderline cardiomegaly. The \npatient received carvedilol, nebulizers, and IV lasix. It is \nunclear how much UOP the patient has as it was not documented in \nthe ED. \n\nThe patient was seen by cardiology in the ED who felt that in \nthe setting of systolic heart failure, her dyspnea was likely \ndue to a CHF exacerbation in the setting of dietary \nindiscretion. Diuresis was recommended in addition to increasing \ncarvedilol to 12.5mg BID, as well as a nuclear stress test this \nmorning.\n\nOn the floor, the patient c/o of some improved dyspnea/chest \ntightness as well as wheezing (no COPD/asthma history, no \nsignificant smoking history), but otherwise has no acute \ncomplaints. Given her continued SOB and wheezing, she was \nwritten for nebulizers and steroids for reactive airway disease \novernight.\n \nPast Medical History:\n- hypertension  \n- diabetes  \n- hx CVA (cerebellar-medullary stroke in ___  \n- CAD (hx of MI in ___ BMS to circumflex and POBA ___  \n- peripheral arterial disease- claudication, followed by \nvascular, managed conservatively\n- stage IV CKD (baseline 2.1-2.6)  \n- GERD/esophageal rings\n \nSocial History:\n___\nFamily History:\nNiece had some sort of cancer. Father died in his ___ due to \nlung disease.  Mother died in her ___ due to an unknown cause.  \nNo early CAD or sudden cardiac death. No other known history of \ncancer.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n===========================\nVitals: Tm 98, Tc 98, HR 68 (68-78), BP 191/103 \n(163-191/86-103), RR 18 (24 on my check), O2 Sat 94-100%RA\nFSBS 250s\nGeneral: Obese woman lying in bed in NAD, audible wheezing with \nsome tachypnea. Speaking in ___ word sentences with slow speech.\nHEENT: PERRL, EOMI with ___ beats of nystagmus on rightward gaze \nin both eyes, no other nystagmus, sclera anicteris, some \nconjunctibal pallor, MMM, clear posterior OP, no lesions, \nsymmetric palate elevation, tongue midline.\nNeck: No cervical/supraclavicular LAD, no notable JVD (difficult \nto assess ___ body habitus)\nCV: RRR, soft S1, normal S2, no murmurs noted.\nLungs: Diffuse expiratory rhonchi this morning, no wheezing on \nlung exam, with crackles in bilateral bases up ___ of back. Poor \nair movement overall.\nAbdomen: soft, obese, nontender, nondistended, +BS. Unable to \nadequately assess organomegaly.\nGU: No foley\nExt: wwp, 2+ peripheral pulses, 3+ pitting edema to knee on L, \n2+ pitting edema in R leg.\nNeuro: CN2-12 notable for rightward gaze nystagmus ___ beats), \notheriwse intact. A+O to person, hospital, month, year (date was \nwrong on calendar so did not know date). No pronator drift, some \npositional tremor in bilateral hands. FNF with hesitancy at \nend-action. No asterixis. Sensation to light touch grossly \nintact in all extremities. No truncal ataxia sitting upright in \nbed during exam. Gait testing deferred. Noted to have repetitive \nmovements at rest with L hand (wringing sheets, tapping, etc. \nseemingly patient unaware).\nSkin: No obvious rashes/excoriations on extremities and \nabdomen/back.\n\nDISCHARGE PHYSICAL EXAM:\n===========================\nVitals: Tm 98.1, 146/64 (SBP 110-146), 70-76, 18, 98%RA\nWeight: 75.9 kg\nGeneral: Obese woman in NAD. \nHEENT: PERRL, EOMI with ___ beats of nystagmus on rightward gaze \nin both eyes, no other nystagmus, sclera anicteris, some \nconjunctibal pallor, MMM, clear posterior OP, no lesions, \nsymmetric palate elevation, tongue midline.  \nNeck: No notable JVD (difficult to assess ___ body habitus)\nCV: RRR, soft S1, normal S2, no murmurs noted.\nLungs: CTAB \nAbdomen: soft, obese, nontender, nondistended, +BS. Unable to \nadequately assess organomegaly.\nExt: wwp, 2+ peripheral pulses, no pitting edema\n \nPertinent Results:\n==== ADMISSION LABS ====\n___ 04:00PM BLOOD WBC-4.3 RBC-2.84* Hgb-8.6* Hct-26.0* \nMCV-92 MCH-30.4 MCHC-33.2 RDW-14.2 Plt ___\n___ 04:00PM BLOOD Neuts-71.5* ___ Monos-4.5 Eos-2.6 \nBaso-0.1\n___ 04:00PM BLOOD ___ PTT-24.5* ___\n___ 04:00PM BLOOD Glucose-325* UreaN-29* Creat-2.1* Na-141 \nK-4.0 Cl-106 HCO3-24 AnGap-15\n___ 07:55AM BLOOD Calcium-9.5 Phos-3.5# Mg-1.5*\n\n___ 07:00PM URINE Color-Yellow Appear-Clear Sp ___\n___ 07:00PM URINE Blood-NEG Nitrite-NEG Protein-100 \nGlucose-300 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-SM \n___ 07:00PM URINE RBC-2 WBC-4 Bacteri-FEW Yeast-NONE Epi-1\n___ 07:00PM URINE CastHy-6*\n\n___ 04:00PM BLOOD cTropnT-<0.01 proBNP-4279*\n___ 09:30PM BLOOD cTropnT-<0.01\n\n==== IMAGING ====\n\n___ CHEST (PA AND LAT):\nThe lungs are clear of consolidation, effusion, or edema. \nCardiac silhouette is top normal. Descending thoracic aorta is \ntortuous with atherosclerotic calcification seen at the arch. No \nacute osseous abnormalities identified. \nIMPRESSION:  \nNo acute cardiopulmonary process.\n\n___ P-MIBI:\nClinical Indication: SS CHEST TIGHTNESS ASSESS FOR EVIDENCE OF \nISCHEMIA  \nHISTORY: ___ yo woman with a history of CAD and CHF referred for \nevaluation of chest pain and dyspnea.\n\nSUMMARY FROM THE EXERCISE LAB: \nFor pharmacologic coronary vasodilatation dipyridamole was \ninfused intravenously for 4 minutes at a dose of 0.142 \nmilligram/kilogram/min. She had no anginal symptoms or ischemic \nECG changes.\n\nTECHNIQUE: \nISOTOPE DATA: (___) 11.0 mCi Tc-99m Sestamibi Rest; \n(___) 29.6 mCi Tc-99m Sestamibi Stress; DRUG DATA: (Non-NM \nadmin) Dipyridamole;\n\nIMAGING METHOD:\nResting perfusion images were obtained with Tc-99m sestamibi. \nTracer was injected approximately 45 minutes prior to obtaining \nthe resting images. \nFollowing resting images and following intravenous infusion, \napproximately three times the resting dose of Tc-99m sestamibi \nwas administered intravenously. Stress images were obtained \napproximately 30 minutes following tracer injection. \nImaging protocol: Gated SPECT. \nThis study was interpreted using the 17-segment myocardial \nperfusion model. \n\nFINDINGS: \nThe image quality is adequate but limited due to soft tissue and \nbreast attenuation.\nLeft ventricular cavity size is increased.\nRest and stress perfusion images reveal uniform tracer uptake \nthroughout the left ventricular myocardium. \nGated images reveal normal wall motion. \nThe calculated left ventricular ejection fraction is 59% with an \nEDV of 117 ml.\n\nIMPRESSION:\n1. Normal myocardial perfusion. \n2. Increased left ventricular cavity size with normal systolic \nfunction.\nCompared with prior study of ___, the cavity size is \nlarger.\n \n \nBrief Hospital Course:\n___ year old female with history of HTN, CVA, CAD (s/p BMS to \ncircumflex in ___, CHF (EF 45% in ___ who presented \nwith acute onset shortness of breath and substernal chest \ntightness.\n\n# Shortness of breath:\nPatient with acute onset SOB following seafood meal with \nassociated chest tightness (see below). Patient with crackles \nand expiratory rhonchi on lung exam. CXR did not show \nsignificant pulmonary edema, pleural effusions, or consolidation \nalthough her BNP was elevated. Per pharmacy records, patient had \nnot refilled lasix prescription since ___. Overall, \npresentation was most consistent with a mild CHF exacerbation. \nShe received treatment with IV lasix and her shortness of breath \nsubsequently improved quickly. She was able to be transitioned \nto a PO regimen of lasix 40mg qday on ___ (day of discharge). \nDry weight on day of discharge was 75.9kg.\n\n# Chest Tightness:\nPatient reported chest tightness associated with her shortness \nof breath. Was given aspirin and SL nitroglycerin in her PCP's \noffice prior to being directed to the ED. Troponin was negative \nx2. EKG without evidence of acute ischemia. Due to her \nsignificant CAD history, she underwent a P-MIBI on ___ which \nwas unremarkable. Her chest tightness was thought to be of \nnon-cardiac etiology.\n\n# HTN:\nPatient presented with SBP of 190-200. Cardiology was consulted \nand recommended increasing her carvedilol from 6.25mg BID to \n12.5mg BID. With this change, and continuation of her other home \nmedications, her blood pressure decreased to systolics in range \nof 110-146 on day of discharge. It is unclear whether her very \nelevated BP on admission was occurring in the setting of \nmedication non-compliance. Nifedipine was decreased from BID to \ndaily given increased carvedilol and addition of Lasix (which \npatient was believed to have been non-compliant with prior to \nthis admission).\n\n==== TRANSITIONAL ISSUES ====\n\n# CHF:\n- ___ services for medication teaching and pill-box, as well as \nweights\n- Follow up with her cardiologist Dr. ___ on ___\n- Please check repeat Chem-10 and CBC on ___\n- Continue furosemide 40mg qday\n\n# Hct Drop: Patient with chronic anemia and Hgb drop on day of \ndischarge from 9.3 to 8.5.\n- Repeat CBC check on ___\n\n# HTN:\n- Increased carvedilol to 12.5mg BID\n- Nifedipine was decreased from BID to daily given increased \ncarvedilol and addition of lasix (with which patient was likely \nnon-compliant prior to this admission).\n\n# Health Screening\n- Patient is due for colonoscopy this year.\n- PCP follow up with Dr. ___ on ___\n\n# Weight at discharge: 75.9 kg\n\n# Code: Full (confirmed with patient)\n# Emergency Contacts:\n- ___, ___ (___)\n- Alternate HCP ______)\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Clopidogrel 75 mg PO DAILY \n3. Furosemide 40 mg PO DAILY \n4. Multivitamins 1 TAB PO DAILY \n5. Ranitidine 300 mg PO DAILY \n6. Atorvastatin 80 mg PO DAILY \n7. HumuLIN 70/30 (insulin NPH and regular human) 30 units \nsubcutaneous daily \n8. Nitroglycerin SL 0.3 mg SL PRN chest pain \n9. Vitamin D ___ UNIT PO DAILY \n10. NIFEdipine CR 60 mg PO BID \n11. Lisinopril 40 mg PO DAILY \n12. Allopurinol ___ mg PO DAILY \n13. Ferrous Sulfate 325 mg PO DAILY \n14. Carvedilol 6.25 mg PO BID \n\n \nDischarge Medications:\n1. Outpatient Lab Work\nPlease draw Chem-10 and CBC on ___.\nIndication: 428.0 (CHF) and anemia (280.1)\nSend results to Dr. ___ (fax: ___\n2. Nitroglycerin SL 0.3 mg SL PRN chest pain \n3. Vitamin D ___ UNIT PO DAILY \n4. Ranitidine 300 mg PO DAILY \n5. NIFEdipine CR 60 mg PO DAILY \n6. Multivitamins 1 TAB PO DAILY \n7. Allopurinol ___ mg PO DAILY \n8. Aspirin 81 mg PO DAILY \n9. Atorvastatin 80 mg PO DAILY \n10. Clopidogrel 75 mg PO DAILY \n11. Ferrous Sulfate 325 mg PO DAILY \n12. Furosemide 40 mg PO DAILY \nRX *furosemide 40 mg 1 tablet(s) by mouth qday Disp #*30 Tablet \nRefills:*0\n13. HumuLIN 70/30 (insulin NPH and regular human) 30 units \nsubcutaneous daily \n14. Lisinopril 40 mg PO DAILY \n15. Carvedilol 12.5 mg PO BID \nRX *carvedilol 12.5 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n- Acute on chronic decompensated systolic heart failure\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\n___ were admitted to ___ on ___ with shortness of breath. \n___ were diagnosed with an exacerbation of your heart failure, a \nresult of retaining too much fluid. ___ were treated with \ndiuretics and removal of this fluid with subsequent improvement \nin your symptoms. We also increased your carvedilol dose for \nbetter blood pressure control.\n\nIt is very important that ___ weigh yourself every morning, call \nMD if weight goes up more than 3 lbs. Taking your furosemide \nwill keep ___ from retaining fluid.\n\nSincerely,\nYour ___ Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "21",
         "10000980-DS-23",
         "10000980",
         "25242409",
         "DS",
         "23",
         "2191-04-11 00:00:00",
         "2191-04-11 17:48:00",
         " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nDVT\n \nMajor Surgical or Invasive Procedure:\nEGD\n\n \nHistory of Present Illness:\nThis is a ___ y/o female with PMHx significant for CAD, HTN, HLD, \nT2DM, CKD stage IV, PVD (s/p in ___, left superficial femoral \nartery), presents with lower Left leg numbness and pain since \nyesterday evening. The numbness started last night in bed. The \nonset was gradual, and it was associated with pain/cramping over \nher lateral calf, radiating down into her foot. She has had sx \nlike this before, usually when resting or lying in bed, not with \nexertion. She denies leg weakness at this time, and is able to \nwalk without assistance. Today the pain and numbness is \nimproved; residual numbness in her lateral calf. Denies hx DVT. \nDenies spine sx: no trauma, no back pain, no incontinence, no \nfevers/chills. No numbness elsewhere. Additionally, she denies \nheadache, visual changes, chest pain, chest pressure, chest \npalpitations, shortness of breath abdominal pain, dysuria, or \ndiarrhea. \n \nPast Medical History:\n- hypertension  \n- diabetes  \n- hx CVA (cerebellar-medullary stroke in ___  \n- CAD (hx of MI in ___ BMS to circumflex and POBA ___  \n- peripheral arterial disease- claudication, followed by \nvascular, managed conservatively\n- stage IV CKD (baseline 2.1-2.6)  \n- GERD/esophageal rings\n \nSocial History:\n___\nFamily History:\nNiece had some sort of cancer. Father died in his ___ due to \nlung disease.  Mother died in her ___ due to an unknown cause.  \nNo early CAD or sudden cardiac death. No other known history of \ncancer.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n\nVitals: 97.7, 166/85, 59, 16, 100% on RA.  \nGeneral: Pleasant affect, laying in bed, resting comfortably in \nNAD.  \nHEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  \nNeck: Supple, JVP not elevated.  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nLungs: Minimal bibasilar crackles improved with cough.  \nAbdomen: obese abdomen, soft, non-tender, non-distended, no \nrebound or guarding.  \nExt: Warm, well perfused, 1+ pulses, right calf swelling greater \nthan left calf swelling. No calf tenderness to palpation. Thick \ntoenails, dry skin along toes. Hallux valgus.  \nNeuro: CNII-XII intact, ___ strength upper/lower extremities, \ngrossly normal sensation. \n\nDISCHARGE PHYSICAL EXAM\nVitals:  Tmax 99.1 HR ___ BP 97-168/50s-70s RR 18 SpO2 \n97-100%RA\nFSG 90-307\nGeneral: Pleasant affect, laying in bed, resting comfortably in \nNAD.  \nHEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  \nNeck: Supple, JVP not elevated.  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nLungs: clear to auscultation in all fields without wheezes or \nronchi\nAbdomen: obese abdomen, soft, non-tender, non-distended, no \nrebound or guarding.  \nExt: Warm, well perfused, dopplerable pulses ___ on RLE, \ndopplerable ___ pulse on LLE, dopplerable DP pulse on LLE, R \nradial pulse 2+, L radial pulse 1+, mild right calf swelling \ngreater than left calf swelling. No calf tenderness to \npalpation. No pain to palpation on left dorsal and lateral foot \n- callous present on left lateral foot. Thick toenails, dry skin \nalong toes. Non-tender indurated cord in left antecubital fossa.\nNeuro: alert and oriented x 3, CNII-XII intact, ___ RUE, ___ \nstrength LUE, ___ hip flexor strength, ___ dorsi and plantar \nflexion of bilateral lower extremities (4+/5 on right lower \nextremity, 4- on LLE), fine touch sensation on extremities \nbilaterally \n\n \nPertinent Results:\nADMISSION LABS:\n\n___ 02:45PM BLOOD WBC-5.1 RBC-2.50* Hgb-7.7* Hct-23.4* \nMCV-94 MCH-30.8 MCHC-32.9 RDW-14.7 RDWSD-50.0* Plt ___\n___ 02:45PM BLOOD Neuts-74.4* Lymphs-15.1* Monos-7.7 \nEos-2.4 Baso-0.2 Im ___ AbsNeut-3.79 AbsLymp-0.77* \nAbsMono-0.39 AbsEos-0.12 AbsBaso-0.01\n___ 02:45PM BLOOD ___ PTT-26.1 ___\n___ 02:45PM BLOOD Glucose-107* UreaN-72* Creat-2.9* Na-141 \nK-4.3 Cl-108 HCO3-21* AnGap-16\n___ 02:45PM BLOOD calTIBC-303 Ferritn-153* TRF-233\n\nPERTINENT LABS/IMAGING:\n\n-She received 1U pRBCs on admission on ___ 07:00AM BLOOD WBC-6.0 RBC-2.83* Hgb-8.7* Hct-26.3* \nMCV-93 MCH-30.7 MCHC-33.1 RDW-14.7 RDWSD-50.2* Plt ___\n-She had one large episode of coffee ground emesis-\n___ 05:10PM BLOOD WBC-5.6 RBC-2.44* Hgb-7.4* Hct-22.7* \nMCV-93 MCH-30.3 MCHC-32.6 RDW-14.7 RDWSD-49.8* Plt ___\n-She received 500cc NS and 2UpRBCs-\n___ 07:45AM BLOOD WBC-5.7 RBC-3.49*# Hgb-10.7*# Hct-32.3* \nMCV-93 MCH-30.7 MCHC-33.1 RDW-14.9 RDWSD-49.1* Plt ___\n\n___ bilateral lower extremity doppler U/S\nIMPRESSION:  \n1.  Deep venous thrombosis in the bilateral posterior tibial \nveins. \n2.  2.0 x 1.3 x 1.8 cm right-sided ___ cyst. \n\nEGD ___\nSmall amount of hematin without evidence of ulceration or active \nbleeding seen at the GE junction.\nThe stomach is significantly deformed. Diffuse erythema and \nsuperficial ulcerations in the stomach consistent with severe \ngastritis. No active bleeding identified.\nMedium hiatal hernia\nErythema and superficial ulcerations in the duodenal bulb \nconsistent with duodenitis.\nOtherwise normal EGD to third part of the duodenum\n\n___ Left upper extremity ultrasound\nIMPRESSION:  \n1.  No evidence of deep vein thrombosis in the left upper \nextremity. \n2.  Likely evolving hematoma in the left antecubital fossa. \n\n___ CT head non contrast\nIMPRESSION: 1. No evidence of acute infarction, hemorrhage, \nfractures. \n\nDISCHARGE LABS:\n___ 07:30AM BLOOD WBC-5.8 RBC-2.44* Hgb-7.4* Hct-22.9* \nMCV-94 MCH-30.3 MCHC-32.3 RDW-14.6 RDWSD-50.2* Plt ___\n___ 07:30AM BLOOD Plt ___\n___ 07:30AM BLOOD Glucose-78 UreaN-45* Creat-1.7* Na-142 \nK-4.7 Cl-109* HCO3-20* AnGap-18\n___:30AM BLOOD Calcium-9.4 Phos-4.5 Mg-2.0\n___ 07:30AM BLOOD EDTA ___\n \nBrief Hospital Course:\nOutpatient Providers: ___ with PMHx significant for CAD, HTN, \nHLD, T2DM, CKD stage IV, PVD (s/p in ___, left superficial \nfemoral artery), presents with lower left leg numbness and pain, \nfound to have bilateral unprovoked DVT. She was treated with a \nheparin drip and had many bleeding events during her stay: she \ndeveloped an upper GIB, had an EGD, and was followed by GI \nduring her admission. The heparin drip was stopped and then \nre-started once her coffee-ground emesis resolved. Her stools \nwere guiac positive, however no active blood was found on rectal \nexam. GI felt that colonoscopy could be deferred to out patient. \nAdditionally she developed a left arm hematoma. The heparin drip \nwas stopped and then re-started once her hematoma was felt to be \nstable. She had left radial as well as bilateral lower extremity \n___ dopplerable pulses throughout admission. Hematology was \nconsulted after the patient developed a left arm hematoma and \nthe drip was slowly uptitrated as per their recommendations. She \nwas successfully bridged to coumadin with an INR on discharge of \n2.0. She was discharged to rehab as per ___ recs. \n\nPlease see below for a more problem based/detailed summary and \ntransitional issues.\n\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\n\n___ y/o female with PMHx significant for CAD, HTN, HLD, T2DM, CKD \nstage IV, PVD (s/p in ___, left superficial femoral artery), \npresented with lower Left leg numbness and pain since yesterday \nevening, with ultrasound bilateral lower extremities showing \nbilateral posterior tibial veins DVT's.\n\n# Unprovoked Bilateral DVTs: No clinical signs of PE on \nadmission or during stay, positive bilateral DVTs on LENIs. Pain \nand swelling improved on anticoagulation. Patient was bridged \nwith heparin drip to therapeutic warfarin with INR goal ___. Due \nto continually supratherapeutic PTT > 150 on heparin drip, \nhematology was consulted and no further workup was deemed \nnecessary. Heparin drip was carefully uptitrated as needed. \nClopidogrel was stopped per outpatient cardiologist. Patient \nwill need age-appropriate cancer screening including colonoscopy \nand mammogram. Patient will follow-up in ___ clinic for \nanticoagulation management and should continue on warfarin for \nat least 3 months. \n\n# Upper GI bleed: Patient developed 1 episode large coffee \nground emesis while on heparin drip with PTT > 150. Received 2U \npRBCs. GI consulted and EGD showed gastritis and superficial \nerosions but no active bleeding. Incidental finding of medium \nsized hiatal hernia. Stool h. pylori antigen was negative. GI \nrecommended 8 weeks of high dose PPI.\n\n# Left antecubital hematoma: Patient developed large left \nantecubital hematoma in setting of phlebotomy and PTT > 150 on \nheparin gtt. Heparin gtt held while hematoma improved. Repeat \nh/h were stable. \n\n# Acute on CKD Stage IV: Patient with creatinine of 2.9 on \nadmission with baseline 2.0-2.5. Improved with hydration. Home \nlasix and lisinopril were initially held. Home lasix restarted \non discharge at 20mg daily. \n\n# Normocytic Anemia: Patient has normocytic anemia. Rectal exam \nin ED was guaiac negative. In past treated with aransep as well \nas EPO. Etiology likely related to underlying CKD, however also \nmust consider slow GI bleed (patient has gastritis/duodenitis on \nEGD but no evidence of active bleeding. Iron studies were \nnormal. \n\n# HFpEF: Home furosemide and Lisinopril were held on admission \nfor ___ followed by GI bleed. Carvedilol and nifedine were held \nin setting of GIB (see above). Nifedipine was restarted at 30mg \nbid and lasix was decreased from 40mg to 20mg daily.\n\n# CAD: hx of MI in ___ BMS to circumflex and POBA ___. Per \ndiscussions with Dr. ___, patient's cardiologist, \nclopidogrel was held given GI bleed and initiation of warfarin. \nLasix initially held as above, but restarted on discharge at \n20mg daily. Home ASA, statin, and carvedilol were continued. \n\n# HTN: Nifedipine was decreased to 30mg BID from 60mg BID given \nmultiple bleeding episodes and normal blood pressures. Home \ncarvedilol continued. Patient's nifedipine was decreased to 30mg \ndaily given acute bleed and SBPs in the ___\nLasix was decreased from 40 daily to 20 daily.\n \n# Diabetes Mellitus: Stable on home 30 units 70/30 insulin at \nbedtime.  \n\nTRANSITIONAL ISSUES:\n- Out patient hypercoaguability work up including screening \ncolonoscopy (last in ___ and mammogram\n- Patient will need to complete an 8 week course of high dose \nPPI (started 40mg pantoprazole PO twice daily on ___ with \nprojected end date ___ for upper GI bleed likely from \ngastritis.\n- Patient's hypertension medications (Lisinopril and nifedipine) \nwere held due to upper GI bleed.\n- Patient's furosemide was decreased to 20mg daily\n- Patient's nifedipine was decreased to 30mg daily given acute \nbleed and SBPs in the ___\n- Patient was started on Coumadin. Clopidogrel was stopped per \ncardiology. ASA 81mg was continued.\n- Please address patient's home environment for fall risk given \nrecent \"trip\" at home and new anticoagulation.\n- please ensure patient has outpatient anticoagulation follow-up \nand management upon discharge from rehab\n \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lisinopril 40 mg PO DAILY \n2. Allopurinol ___ mg PO DAILY \n3. Atorvastatin 80 mg PO QPM \n4. Carvedilol 12.5 mg PO BID \n5. Clopidogrel 75 mg PO DAILY \n6. Furosemide 40 mg PO DAILY \n7. Ranitidine 150 mg PO DAILY:PRN reflux \n8. Aspirin 81 mg PO DAILY \n9. Multivitamins 1 TAB PO DAILY \n10. Vitamin D ___ UNIT PO DAILY \n11. NIFEdipine CR 60 mg PO BID \n12. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n13. 70/30 30 Units Dinner\n\n \nDischarge Medications:\n1. Allopurinol ___ mg PO EVERY OTHER DAY \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 80 mg PO QPM \n4. Carvedilol 12.5 mg PO BID \n5. 70/30 30 Units Dinner\n6. Lisinopril 40 mg PO DAILY \n7. Multivitamins 1 TAB PO DAILY \n8. NIFEdipine CR 30 mg PO BID \n9. Vitamin D ___ UNIT PO DAILY \n10. Docusate Sodium 100 mg PO BID \n11. Gabapentin 100 mg PO QHS neuropathic pain \n12. Pantoprazole 40 mg PO Q12H \n13. Senna 8.6 mg PO BID constipation \n14. Warfarin 5 mg PO DAILY16 \nplease dose and adjust for INR \n15. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n16. Furosemide 20 mg PO DAILY \n17. Polyethylene Glycol 17 g PO DAILY \n18. Acetaminophen 325-650 mg PO Q6H:PRN pain or fever \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nDeep vein thrombosis (DVT)\n\nSecondary:\nUpper GI bleed\nL arm hematoma\nSuperficial thrombophlebitis, L antecubital fossa\nChronic kidney disease (Stage IV)\nPeripheral vascular disease\nDiabetes mellitus type II\nCoronary artery disease\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\n\n \nDischarge Instructions:\nDear ___,\n\nIt was a pleasure caring for you at ___. You were admitted for \nleg swelling and pain. Diagnostic tests were performed and you \nwere diagnosed with deep vein thrombosis, blood clots in your \nlegs. You were treated with blood thinning medications that you \nwill continue at home. You had an episode of upper GI bleeding \nduring your stay for which you are being treated with medication \nand you underwent an EGD. You developed a left arm hematoma as \nwell during your stay which will resolve on its own over time.\n\nFor your blood clots, you were started on a new drug called \nwarfarin. You will need to have your blood checked to adjust the \ndosing. For your upper GI bleed, you were started on \nPantoprazole 40mg twice daily. You will continue this drug as an \noutpatient for at least 8 weeks. Additionally, you will no \nlonger be taking Clopidogrel (Plavix), until you speak with your \ncardiologist.\n\nIt was a pleasure taking care you during your hospital stay.\n\nBest wishes,\n\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "22",
         "10000980-DS-24",
         "10000980",
         "25911675",
         "DS",
         "24",
         "2191-05-24 00:00:00",
         "2191-05-24 17:29:00",
         " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nfatigue, anemia\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ year old woman with a past medical \nhistory of type-2 DM, hypertension, stage IV CKD, CAD s/p \ndistant MI and bare metal stent, stroke, recent unprovoked DVTs \non Coumadin, and recent upper GI bleeding, who was sent to ___ \nby her physician for anemia (Hgb 6.5).\n\nThe patient was admitted to ___ in ___ with unprovoked \nbilateral lower extremity DVTs. She was started on heparin as an \ninpatient, but anticoagulation was complicated by severely \nelevated PTT (>150) and upper GI bleed. Endoscopy was notable \nfor significant erythema, superficial ulceration, and gastritis \nwithout active bleeding. She was placed on BID PPI prophylaxis. \nShe was eventually bridged to Coumadin for a planned 6 month \ncourse. Her INR is managed by her rehab facility, and she is \nfollowed by Dr. ___ in ___ clinic. \n\nFor the last two weeks she has noted increasing fatigue along \nwith shortness of breath, exertional sub-sternal chest pain \nrelieved with rest, and symmetrical lower extremity swelling. \nDuring this period she reports that her appetite remained good, \nand he bowel function was normal. She denies bloody stools or \ndark stool. On ___ she presented to her PCP office from rehab \nreporting increasing shortness of breath and fatigue. She was \nfound to have a Hgb of 6.5, with an unconcerning CXR. She was \nsent to the ___ ED.\n\nIn the ED, her initial vitals were T: 97.5 P: 60 BP: 156/76 RR: \n16 SPO2: 100% RA. Exam was notable for guiac negative stool. \nImaging was notable for:\n \"1. Nonocclusive deep vein thrombosis of one of the paired \nposterior tibial veins bilaterally. The extent of thrombus \nbilaterally has decreased. No new deep venous thrombosis in \neither lower extremity. \n 2. Right complex ___ cyst.\"\n\nThe patient was transfused with 2 units of pRBCs, with \nappropriate increase in Hgb to 9.0. Following transfusion, a \nrepeat CXR was notable for pulmonary edema with bilateral \npleural effusions. She was given 20mg PO Lasix and 40mg IV Lasix \nin the ED. The decision was made to admit the patient for anemia \nand flash pulmonary edema. \n\nOn the floor, vitals notable for T: 97.9 BP: 154/75 P: 65 R: 20 \nO2: 99RA FSBG: 76. She reports no acute complaints, and that her \nshortness of breath has resolved. She denies chest pain, \ndizziness, lightheadedness.\n \nPast Medical History:\n- hypertension  \n- diabetes  \n- hx CVA (cerebellar-medullary stroke in ___  \n- CAD (hx of MI in ___ BMS to circumflex and POBA ___  \n- peripheral arterial disease- claudication, followed by \nvascular, managed conservatively\n- stage IV CKD (baseline 2.1-2.6)  \n- GERD/esophageal rings\n \nSocial History:\n___\nFamily History:\nNiece had some sort of cancer. Father died in his ___ due to \nlung disease.  Mother died in her ___ due to an unknown cause.  \nNo early CAD or sudden cardiac death. No other known history of \ncancer.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVitals: T: 97.9 BP: 154/75 P: 65 R: 20 O2: 99RA FSBG: ___ \nGeneral: Overweight woman, alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated  \nLungs: Crackles to the mid-lungs bilaterally  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs or \ngallops  \nAbdomen: soft, non-tender, non-distended, bowel sounds present, \nno rebound tenderness or guarding, no organomegaly  \nExt: Warm, well perfused, 2+ pulses, no clubbing or cyanosis. 2+ \npitting edema in dependent areas to the buttocks  \nSkin: no rashes noted\nNeuro: ___ strength in deltoids, biceps, triceps, wrist \nextensors, finger extensors, hip flexors, hamstrings, \nquadriceps, gastrocs, tibialis anterior, bilaterally. Sensation \nintact bilaterally. \nPSYCH: Alert and fully oriented; normal mood and affect.\nsometimes slow to respond and responding with repetitive answers\nbut otherwise appropriate\n\nDISCHARGE PHYSICAL EXAM:\nVS: T: 97.6 BP: 150s-160s/70s-80s P: 60s-70s RR: 18 SPO2: 100RA\nGeneral: Overweight woman, alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated  \nLungs: Clear to auscultation bilaterally\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs or \ngallops  \nAbdomen: soft, non-tender, non-distended, bowel sounds present, \nno rebound tenderness or guarding, no organomegaly  \nExt: Warm, well perfused, 2+ pulses, no clubbing or cyanosis. 1+ \npitting edema in shins bilaterally\nSkin: no rashes noted\n\n \nPertinent Results:\nLABORATORY STUDIES ON ADMISSION\n=============================================\n___ 12:30PM   WBC-4.4 RBC-2.03* HGB-6.5* HCT-20.6* \nMCV-102*# MCH-32.0 MCHC-31.6* RDW-16.3* RDWSD-59.6*\n___ 12:30PM   ___\n___ 12:30PM   ALBUMIN-4.1 CALCIUM-9.2 PHOSPHATE-4.7* \nIRON-61\n___ 12:30PM   calTIBC-303 FERRITIN-155* TRF-233\n___ 12:30PM   UREA N-42* CREAT-2.3* SODIUM-142 \nPOTASSIUM-4.7 CHLORIDE-109* TOTAL CO2-23 ANION GAP-15\n___ 04:50PM   LD(___)-247 TOT BILI-0.2\n___ 04:50PM   HAPTOGLOB-188\n\nIMAGING:  \n==============================================\nLENIs (___)\n1. Nonocclusive deep vein thrombosis of one of the paired \nposterior tibial veins bilaterally.  The extent of thrombus \nbilaterally has decreased.  No new deep venous thrombosis in \neither lower extremity. \n2. Right complex ___ cyst. \n\nCXR (___): \n1. New mild pulmonary edema with persistent small bilateral \npleural effusions. \n2. Severe cardiomegaly is likely accentuated due to low lung \nvolumes and patient positioning. \n\nCXR (___):\nAs compared to ___, the lung volumes have slightly \ndecreased.  Signs of mild overinflation and moderate pleural \neffusions persist.  Moderate cardiomegaly.  Elongation of the \ndescending aorta.  No pneumonia. \n\nLABORAROTY STUDIES ON DISCHARGE\n==============================================\n___ 05:45AM BLOOD WBC-3.4* RBC-2.93* Hgb-8.9* Hct-28.0* \nMCV-96 MCH-30.4 MCHC-31.8* RDW-17.5* RDWSD-59.7* Plt ___\n___ 05:45AM BLOOD ___ PTT-30.6 ___\n___ 05:45AM BLOOD Glucose-116* UreaN-41* Creat-2.1* Na-144 \nK-4.0 Cl-108 HCO3-25 AnGap-15\n___ 04:50PM BLOOD LD(LDH)-247 TotBili-0.2\n___ 05:45AM BLOOD Calcium-9.4 Phos-4.7* Mg-1.7\n \nBrief Hospital Course:\nMs. ___ is a ___ year old woman with a past medical \nhistory of type-2 DM, hypertension, stage IV CKD, CAD s/p \ndistant MI and bare metal stent, stroke, recent unprovoked DVTs \non Coumadin, and recent upper GI bleed, who was sent to ___ by \nher physician for anemia. \n\n# Anemia: \nPatient presented with Hgb of 6.5, down from her recent baseline \nof ~7.5 since her ___ hospitalization. Upon presentation she \nhad a new macrocytic anemia. Hemolysis labs were negative. She \nreceived two units of packed red cells with an appropriate rise \nin her Hgb to 9.0. Stool was guiac negative, with no reports of \ndark stool or blood in stool. Her hemoglobin remained stable at \nthis level, there was no overt bleeding, and her stool was guiac \nnegative. After transfusion the patient reported significant \nimprovement in her shortness of breath and fatigue. Given her \nhistory of gastritis and diverticulosis, a GI bleed was believed \nresponsible for her anemia. Patient should receive an \nEGD/colonoscopy as an outpatient. \n\n# Acute exacerbation of heart failure with preserved ejection \nfraction: \nThe patient was also found to be slightly volume overloaded, and \nwas treated with 2x40mg IV Lasix, with good urine output and \nsymptomatic improvement. Her pulmonary edema and peripheral \nedema resolved with diuresis.\n\nCHRONIC ISSUES:\n# Gastic ulceration: \nContinued on home pantoprazole BID\n\n# Hypertension:\nContinued on home nifedipine, carvadilol, lisinopril.\n\n# Stage IV Chronic Kidney Disease: \nCreatinine remained at baseline (b/l Cr 2.1-2.6) during \nadmission.\n\nTRANSITIONAL ISSUES\n======================\n--Patient's Anemia is thought to be due to slow GI bleed given \nhistory of gastritis and diverticulosis. Please schedule \nEGD/colonoscopy within the next month\n--Patient continued on Coumadin for bilateral DVTs; please \ncontinue to weigh the risks and benefits of anticoagulation \ngiven history of bleed.\n--Discharge weight: 167.7\n\n# CONTACT: ___ ___\n# CODE: full, confirmed\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Allopurinol ___ mg PO EVERY OTHER DAY \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 80 mg PO QPM \n4. Carvedilol 12.5 mg PO BID \n5. Lisinopril 40 mg PO DAILY \n6. Multivitamins 1 TAB PO DAILY \n7. NIFEdipine CR 30 mg PO BID \n8. Vitamin D ___ UNIT PO DAILY \n9. Docusate Sodium 100 mg PO BID \n10. Gabapentin 100 mg PO QHS neuropathic pain \n11. Pantoprazole 40 mg PO Q12H \n12. Senna 8.6 mg PO BID constipation \n13. Warfarin 4 mg PO 3X/WEEK (___) \n14. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n15. Furosemide 20 mg PO DAILY \n16. Polyethylene Glycol 17 g PO DAILY \n17. Acetaminophen 325-650 mg PO Q6H:PRN pain or fever \n18. Warfarin 3 mg PO 4X/WEEK (___) \n19. 70/30 30 Units Dinner\n\n \nDischarge Medications:\n1. Acetaminophen 325-650 mg PO Q6H:PRN pain or fever \nRX *acetaminophen 325 mg ___ tablet(s) by mouth Q6H:PRN Disp \n#*120 Tablet Refills:*0\n2. Aspirin 81 mg PO DAILY \nRX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0\n3. Atorvastatin 80 mg PO QPM \nRX *atorvastatin 80 mg 1 tablet(s) by mouth QPM Disp #*30 Tablet \nRefills:*0\n4. Carvedilol 12.5 mg PO BID \nRX *carvedilol 12.5 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0\n5. Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*0\n6. Gabapentin 100 mg PO QHS neuropathic pain \nRX *gabapentin 100 mg 1 capsule(s) by mouth at bedtime Disp #*30 \nCapsule Refills:*0\n7. Lisinopril 40 mg PO DAILY \nRX *lisinopril 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0\n8. Multivitamins 1 TAB PO DAILY \nRX *multivitamin  1 capsule(s) by mouth daily Disp #*30 Capsule \nRefills:*0\n9. NIFEdipine CR 30 mg PO BID \nRX *nifedipine 30 mg 1 tablet(s) by mouth twice a day Disp #*60 \nTablet Refills:*0\n10. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \nRX *nitroglycerin [Nitrostat] 0.3 mg 1 tablet(s) sublingually \nQ5MIN:PRN Disp #*10 Tablet Refills:*0\n11. Pantoprazole 40 mg PO Q12H \nRX *pantoprazole 40 mg 1 tablet(s) by mouth every twelve (12) \nhours Disp #*60 Tablet Refills:*0\n12. Polyethylene Glycol 17 g PO DAILY \nRX *polyethylene glycol 3350 17 gram/dose 1 powder(s) by mouth \ndaily Refills:*0\n13. Senna 8.6 mg PO BID constipation \nRX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day \nDisp #*60 Capsule Refills:*0\n14. Vitamin D ___ UNIT PO DAILY \nRX *ergocalciferol (vitamin D2) 2,000 unit 1 tablet(s) by mouth \ndaily Disp #*30 Tablet Refills:*0\n15. Warfarin 4 mg PO 3X/WEEK (___) \nRX *warfarin 4 mg 1 tablet(s) by mouth 3X/WEEK Disp #*30 Tablet \nRefills:*0\n16. Warfarin 3 mg PO 4X/WEEK (___) \nRX *warfarin 3 mg 1 tablet(s) by mouth 4X/WEEK Disp #*30 Tablet \nRefills:*0\n17. Furosemide 20 mg PO DAILY \nRX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0\n18. Allopurinol ___ mg PO EVERY OTHER DAY \nRX *allopurinol ___ mg 1 tablet(s) by mouth EVERY OTHER DAY Disp \n#*30 Tablet Refills:*0\n19. 70/30 30 Units Dinner\nRX *insulin NPH and regular human [Humulin 70/30 KwikPen] 100 \nunit/mL (70-30) 30 units SC Take 30 Units before DINER Disp #*2 \nPackage Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis:\nAnemia\nCongestive heart failure exacerbation\n\nSecondary diagnosis:\nHypertension \nDMII on insulin \nCoronary artery disease \nStage IV chronic kidney disease\nDeep vein thrombosis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear ___,\n\nIt was a pleasure caring for you. You were admitted to the \nhospital with fatigue, chest pain, and shortness of breath. You \nwere found to have too few red blood cells (anemia). We gave you \nblood, and your symptoms improved. Additionally, you were found \nto have too much fluid in your legs and lungs. We treated you \nwith a diuretic, which helped eliminate the fluid. \n\nWeigh yourself every morning, call MD if weight goes up more \nthan 3 lbs.\n\nSincerely,\nYour ___ Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "23",
         "10000980-DS-25",
         "10000980",
         "29659838",
         "DS",
         "25",
         "2191-07-19 00:00:00",
         "2191-07-22 09:37:00",
         " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\ndyspnea on exertion\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ with a history of of HTN, CAD s/p DES with ischemic MR and \nsystolic dysfunction, ___ on torsemide, hx of DVT, who presents \nwith 4 days of dyspnea on exertion, leg swelling, and 10 weight \ngain.\n\nOf note, patient was seen in the Heart Failure Clinic with Dr. \n___ on ___ where she noted that she has had \npersistent dyspnea on exertion and PND after a lengthy prior \nhospitalization for DVT/GIB. At that time she was started on \n40mg po torsemide which initially improved her symptoms. \n\nOver the holiday she indulged in a high salt diet and developed \nslow-onset dyspnea on exertion. Denies any medication \nnoncompliance, chest pain, palpitations, palpitations. Describes \nPND, worsening exercise tolerance (unable to walk >50 feet) and \northopnea. \n\nIn the ED, patient was found to have 1+ bilateral lower \nextremity edema, and have bibasilar crackles on exam. Patient \nunderwent CXR, BNP, and was given one dose of IV 40mg Lasix. In \nthe ED initial vitals were: 97.8 73 199/100 18 95% RA. Prior to \ntransfer, vitals were 74 188/95 18 100% RA. Patient's labs were \nremarkable for sodium 146, Chloride 115, K 5.4, Bicarb 19, BUN \n39, Creatinine 2.3. Patient had CK 229, with MB 6, Trop < 0.01. \nPatient had BNP of 10,180. Patient also had Hgb 8.1, Hct 26.8, \nPlatelet 168, WBC 5.4. Urinalysis still pending upon discharge. \n\nEKG: notable for SR 76, with LAD, TWI in the inferior leads \nwhich appears unchanged from prior on ___\n\nOn the floor she is symptomatically improved since coming to the \nED. \n \nPast Medical History:\n- hypertension  \n- diabetes  \n- hx CVA (cerebellar-medullary stroke in ___  \n- CAD (hx of MI in ___ BMS to circumflex and POBA ___  \n- peripheral arterial disease- claudication, followed by \nvascular, managed conservatively\n- stage IV CKD (baseline 2.1-2.6)  \n- GERD/esophageal rings\n \nSocial History:\n___\nFamily History:\nFather died in his ___ due to lung disease.  Mother died in her \n___ due to an unknown cause.  No early CAD or sudden cardiac \ndeath. No other known history of cancer.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAMINATION:  \nVS: T=98.0 BP: 168/96 HR=67 RR=16 O2 sat=100% on 2L NC  \nAdmission weight 178lbs\nGENERAL: WDWN, obese, sitting upright in bed, in NAD. AOx3. \nMood, affect appropriate.  \nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were \npink, no pallor or cyanosis of the oral mucosa.\nNECK: Supple with JVP of 8cm.  \nCARDIAC: PMI located in ___ intercostal space, midclavicular \nline. RR, normal S1, S2, +S3. No murmurs/rubs/gallops. No \nthrills, lifts. \nLUNGS: Resp were unlabored, no accessory muscle use, dyspneic at \nthe end of a long sentence. Bibasilar crackles ___ up thorax, \ndiffuse wheezing.  \nABDOMEN: Soft, NTND. No HSM or tenderness.  \nEXTREMITIES: 2+ edema to shins. No femoral bruits.  \nPULSES:  Distal pulses palpable and symmetric\n\nDISCHARGE PHYSICAL EXAMINATION:  \nVS: T=98.0 BP: 135/72 HR=67 RR=16 O2 sat=100% on RA\nweight: 74kg\nGENERAL: WDWN, obese, sitting upright in bed, in NAD. AOx3. \nMood, affect appropriate.  \nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were \npink, no pallor or cyanosis of the oral mucosa.\nNECK: Supple with JVP of 7cm.  \nCARDIAC: PMI located in ___ intercostal space, midclavicular \nline. RR, normal S1, S2, +S3. No murmurs/rubs/gallops. No \nthrills, lifts. \nLUNGS: Resp were unlabored, no accessory muscle use. Bibasilar \ncrackles trace, diffuse wheezing.  \nABDOMEN: Soft, NTND. No HSM or tenderness.  \nEXTREMITIES: dry. No femoral bruits.  \nPULSES:  Distal pulses palpable and symmetric\n \nPertinent Results:\nADMISSION LABS\n___ 11:55AM BLOOD WBC-5.4 RBC-2.63* Hgb-8.1* Hct-26.8* \nMCV-102*# MCH-30.8 MCHC-30.2* RDW-17.2* RDWSD-64.7* Plt ___\n___ 11:55AM BLOOD Neuts-80.6* Lymphs-11.2* Monos-5.0 \nEos-2.4 Baso-0.2 Im ___ AbsNeut-4.38 AbsLymp-0.61* \nAbsMono-0.27 AbsEos-0.13 AbsBaso-0.01\n___ 12:45PM BLOOD ___ PTT-32.9 ___\n___ 07:30AM BLOOD Ret Aut-2.4* Abs Ret-0.06\n___ 11:55AM BLOOD Glucose-153* UreaN-39* Creat-2.3* Na-146* \nK-5.4* Cl-115* HCO3-19* AnGap-17\n___ 11:55AM BLOOD CK-MB-6 cTropnT-<0.01 ___\n___ 07:38PM BLOOD CK-MB-6 cTropnT-<0.01\n___ 11:55AM BLOOD Calcium-9.0 Phos-3.9 Mg-1.8\n\nDISCHARGE LABS\n=====\n___ 07:10AM BLOOD WBC-3.9* RBC-2.81* Hgb-8.6* Hct-26.7* \nMCV-95 MCH-30.6 MCHC-32.2 RDW-16.0* RDWSD-56.4* Plt ___\n___ 07:10AM BLOOD ___\n___ 07:10AM BLOOD Glucose-100 UreaN-37* Creat-1.9* Na-144 \nK-3.9 Cl-105 HCO3-29 AnGap-14\n___ 07:10AM BLOOD Calcium-9.5 Phos-4.4 Mg-1.8\n\nIMAGING\n=====\n___ CXR\nFINDINGS: \nThere is mild pulmonary edema with superimposed region of more \nconfluent consolidation in the left upper lung.  There are \npossible small bilateral pleural effusions.  Moderate \ncardiomegaly is again seen as well as tortuosity of the \ndescending thoracic aorta.  No acute osseous abnormalities.\n \nIMPRESSION: \nMild pulmonary edema with superimposed left upper lung \nconsolidation, potentially more confluent edema versus \nsuperimposed infection.\n\n \nBrief Hospital Course:\n___ year-old female with history of hypertension, CAD s/p DES \nwith ischemic MR and systolic dysfunction, ___, hx of DVT, who \nadmitted for CHF exacerbation.\n\n# Acute on chronic decompensated heart failure: presented in the \nsetting of high salt diet with dyspnea on exertion, decreased \nexercise tolerance, ___ edema, crackles on exam, elevated BNP to \n10K, 8lbs above dry weight and pulmonary congestion on CXR. \nLater discovered on pharmacy review that patient had not filled \ntorsemide after last outpatient Cardiology appointment where she \nwas instructed to start taking it. Troponins cycled and \nnegative. On admission, she was placed on a salt and fluid \nrestricted diet. She was diuresed with IV Lasix 80mg for 2 days \nand then transitioned to po torsemide 40mg with steady weight \ndecline and net negative fluid balance of goal -___ and \nstable renal function. Electrolytes repleted for goal Mg>2 and \nK>4. She was continued on home carvedilol 12.5mg BID, \natorvastatin 80mg daily and lisinopril 40mg daily for blood \npressure control and increased home nifedipine CR from 30 to \n60mg BID to achieve goal SBP <140. Discharged with close PCP and \n___ to monitor weights and blood pressure \ncontrol.\n\n# Hypertension: She was continued on home carvedilol 12.5mg BID, \natorvastatin 80mg daily and lisinopril 40mg daily for blood \npressure control and increased home nifedipine CR from 30 to \n60mg BID to achieve goal SBP <140. \n\n# Positive U/A: patient asymptomatic but with 32WBCs, ___, \n+bacteria (although 3 epis). Asymptomatic with no \nfevers/dysuria/malaise. Urine culture negative.\n\n# Left upper lung consolidation: infiltrate per Radiology read \non admission CXR. No cough, fevers, leukocytosis. Rereviewed \nwith on-call radiologist who favored pulmonary edema with no \nneed for repeat imaging or PNA treatment unless clinically \nindicated. Monitored without any significant clinical findings.\n\n# DVT: anticoagulated on Coumadin goal 2.0-3.0, no signs of \nthrombus on exam. Daily INR trended and continued on home \nCoumadin 5mg daily. \n\n# Anemia: no signs of external loss, specifically denying any \nmelena. Chronically anemic with baseline ___, presented with Hgb \n8. Likely ___ renal disease and ACD however elevated MCV \nindicates possible reticulocytosis. Altogether low suspicion for \nGIB so Coumadin was continued. Reticulocytes 2.4 which is \ninappropriate arguing against acute loss. Trended daily CBC with \nnoted uprising by discharge.\n\n# Chronic kidney disease, stage IV- baseline ___, likely ___ \nHTN and DM. Renally dosed medications and trended Cr with no \nsignificant change. \n# HLD: continued home atorvastatin\n# DM: held home 25U 70/30.  Patient maintained on aspart ISS and \nglargine qHS with good glycemic control.\n\nTRANSITIONAL ISSUES\n==================\nCHF: diuresed with IV lasix, transitioned to po diuretics, \ndischarged home on 40mg po torsemide, to take in the AM and take \na banana. Pt complained of unilateral R-sided incomplete hearing \nloss on day of discharge- was not felt to be related to \ndiuretics but would ___.\nHTN: increased nifedipine CR to 60mg BID given elevated SBPs. \nPlease f/u at next appointments.\nAnemia: multiple prior workups showing ACD. Hgb 8s during \nadmission\nPrior DVT/PE: continued on warfarin, will need continued \nmonitoring\nDM: stopped home 70/30 while in-house and put on \naspart/glargine, discharged on home regimen\n\nDischarge weight: 74kg\nDischarge Cr: 1.9\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 325-650 mg PO Q6H:PRN pain or fever \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 80 mg PO QPM \n4. Carvedilol 12.5 mg PO BID \n5. Docusate Sodium 100 mg PO BID \n6. Gabapentin 100 mg PO QHS neuropathic pain \n7. Lisinopril 40 mg PO DAILY \n8. Multivitamins 1 TAB PO DAILY \n9. NIFEdipine CR 30 mg PO BID \n10. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n11. Pantoprazole 40 mg PO Q12H \n12. Polyethylene Glycol 17 g PO DAILY \n13. Senna 8.6 mg PO BID constipation \n14. Vitamin D ___ UNIT PO DAILY \n15. Warfarin 5 mg PO DAILY16 \n16. Allopurinol ___ mg PO EVERY OTHER DAY \n17. Torsemide 40 mg PO DAILY \n18. HumuLIN 70/30 (insulin NPH and regular human) 100 unit/mL \n(70-30) subcutaneous 25 units with dinner \n\n \nDischarge Medications:\n1. HumuLIN 70/30 (insulin NPH and regular human) 100 unit/mL \n(70-30) subcutaneous 25 units with dinner \n2. Warfarin 5 mg PO DAILY16 \n3. Vitamin D ___ UNIT PO DAILY \n4. Acetaminophen 325-650 mg PO Q6H:PRN pain or fever \n5. Allopurinol ___ mg PO EVERY OTHER DAY \n6. Aspirin 81 mg PO DAILY \n7. Atorvastatin 80 mg PO QPM \n8. Docusate Sodium 100 mg PO BID \n9. Gabapentin 100 mg PO QHS neuropathic pain \n10. Lisinopril 40 mg PO DAILY \n11. Multivitamins 1 TAB PO DAILY \n12. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n13. Polyethylene Glycol 17 g PO DAILY \n14. Senna 8.6 mg PO BID constipation \n15. Torsemide 40 mg PO DAILY \nRX *torsemide 20 mg 2 tablet(s) by mouth once daily Disp #*60 \nTablet Refills:*0\n16. Pantoprazole 20 mg PO Q12H \n17. Carvedilol 25 mg PO BID \n18. NIFEdipine CR 60 mg PO BID \nRX *nifedipine 20 mg 3 capsule(s) by mouth twice daily Disp \n#*180 Capsule Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnoses:\nAcute on chronic decompensated congestive Heart Failure\nHypertension\n\nSecondary Diagnoses:\nAnemia\nDiabetes mellitus\nPrior deep vein thrombosis\nChronic Kidney Disease\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMrs. ___, \n\n___ were admitted to ___ for treatment of your congestive \nheart failure and hypertension. ___ were given IV diuretics with \nimprovement in your symptoms, labs and exam. We increased one of \nyour blood pressure medications and continued your other home \nmedicines. \n\nIt was a pleasure taking care of ___ during your stay- we wish \n___ all the best!\n\n- Your ___ Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "24",
         "10000980-DS-26",
         "10000980",
         "20897796",
         "DS",
         "26",
         "2193-08-17 00:00:00",
         "2193-08-17 16:05:00",
         " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nshortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPatient is a ___ with history of coronary artery disease c/b\nischemic MR ___ DES to LCX ___, TTE ___ with mild regional LV\nsystolic dysfunction), heart failure with preserved ejection\nfraction (LVEF 50% ___, peripheral vascular disease, chronic\nkidney disease (stage IV), prior unprovoked DVT c/b severe UGIB\nwhile on AC, HTN, dyslipidemia, and T2DM who presents with\nseveral days of shortness of breath.     \n\nPatients says that she first noticed rather acute onset dyspnea\nstarting ___ when trying to walk up the stairs in her home. \n\nShe had to sit down and catch her breath, whereas just days \nprior\nshe was able to mount ___ of stairs without difficulty. \nPatient denies any associated chest pain or palpitations.  No\ndizziness or lightheadedness.  Patient further denies any cough,\nfevers/chills, or pleuritic chest discomfort.  She has not\nexperienced any symptoms consistent with orthopnea or PND.  No\nincreased ___ swelling, patient notes that she has experienced\nthis in the past.  \n\nPatient takes her weight nearly every day, 7lbs reported weight\ngain over the past week (154lbs -> 161lbs), which she attributes\nto eating more over the ___.  She is currently\ntaking torsemide 40mg qd, no missed doses.  No issues with\nabdominal bloating or constipation.  No recent travel.  \nPatient's\nhusband just recovered from a viral URI.       \n\nIn the ED, initial VS were: 97.2 90 186/87 22 100% RA   \n\nExam notable for:\nObvious bilateral wheezing.\nNo overt volume overload.  \n\nEKG: NSR (92bpm), normal axis, normal PR/QRS intervals, QTc 479,\nq-waves III/aVF, TWIs III/aVF/V3/V6, submm lateral STDs, no \nSTEs.\n\nLabs showed:  \nCBC 6.0>9.0/27.8<176 (PMNs 75.2%, MCV 97)\nBMP 142/4.8/105/___/2.4/189\nTrop <.01\nproBNP 4512\nVBG 7.33/40\nUA: 1.010 SG, pH 6.0, urobilinogen NEG, bilirubin NEG, leuk NEG,\nblood NEG, nitrite NEG, protein 100, glucose NEG, ketones NEG,\nRBC 1, WBC 1, few bacteria\n\nImaging showed: \nCXR ___\nFINDINGS:  \nLungs are moderately well-expanded. There is an asymmetric right\nlower lung opacity, new from ___. The heart appears mildly\nenlarged and there is mild pulmonary vascular congestion. No\npleural effusion or pneumothorax. \nIMPRESSION:  \nRight lower lobe opacity could represent pneumonia in the right\nclinical setting, although atelectasis or asymmetric pulmonary\nedema could account for this finding. Dedicated PA and lateral\nviews could be helpful for further assessment. \n \nConsults: NONE  \n\nPatient received:  \n___ 21:45 IH Albuterol 0.083% Neb Soln 1 NEB  \n___ 22:08 IH Albuterol 0.083% Neb Soln 1 NEB  \n___ 22:08 IH Ipratropium Bromide Neb 1 NEB  \n___ 22:47 IH Albuterol 0.083% Neb Soln 1 NEB \n___ 22:47 IH Ipratropium Bromide Neb 1 NEB \n___ 22:51 IV Azithromycin \n___ 22:51 IV CefTRIAXone\n___ 22:51 PO PredniSONE 60 mg\n___ 22:51 IV Furosemide 80 mg \n___ 23:01 IV CefTRIAXone 1 gm  \n___ 00:13 IV Azithromycin 500 mg\n___ 00:23 PO/NG Atorvastatin 80 mg\n___ 00:23 PO/NG Carvedilol 25 mg\n___ 00:23 PO NIFEdipine (Extended Release) 60 mg \n___ 00:23 IH Albuterol 0.083% Neb Soln 1 NEB \n___ 00:23 IH Ipratropium Bromide Neb 1 NEB\n___ 00:26 PO/NG Gabapentin 100 mg\n___ 00:44 SC Insulin 4 Units\n\nTransfer VS were: 98.2 77 141/76 18 100% 2L NC \n   \nOn arrival to the floor, patient recounts the history as above. \nShe says that she feels improved after treatment in the ED, no\nongoing SOB. \n \n10-point ROS is otherwise NEGATIVE.\n\n \nPast Medical History:\nCoronary artery disease\nPeripheral vascular disease\nType II Diabetes Mellitus c/b diabetic retinopathy\nObesity\nEsophageal ring\nHypertension\nDyslipidemia\nBilateral unprovoked posterior tibial DVTs (___) off AC given\nsevere UGIB\nCKD Stage IV iso DM/HTN, secondary hyperparathyroidism\nAnemia\nGout\n \nSocial History:\n___\nFamily History:\nNiece had some sort of cancer. Father died in his ___ due to \nlung disease. Mother died in her ___ due to an unknown cause. \nNo early CAD or sudden cardiac death. No other known history of \ncancer. \n \nPhysical Exam:\n==============================\n ADMISSION PHYSICAL EXAM\n==============================\nVS: 97.5 162/93 78 16 100RA   \nGENERAL: Pleasant female appearing younger than her stated age,\ntaking deep breaths while speaking  \nHEENT: EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM.  \nNECK: JVD 10 CM. \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs.  \nLUNGS: CTAB, no wheezes. \nABDOMEN: Obese abdomen, normoactive BS throughout, nondistended,\nnontender in all quadrants, no rebound/guarding, no\nhepatosplenomegaly.  \nEXTREMITIES: No cyanosis, clubbing, or edema.  \nPULSES: 2+ radial pulses bilaterally.  \nNEURO: A&Ox3, moving all 4 extremities with purpose.  \nSKIN: Warm and well perfused, no excoriations or lesions, no\nrashes.  \n \n==============================\nDISCHARGE PHYSICAL EXAM\n==============================\nVS: Afeb, 144/78, HR 57, 97% RA, RR 12\nGEN: Well appearing in NAD\nNeck:  No JVD appreciated\nCV: RRR no m/r/g, no carotid bruits appreciated\nPULM: CTAB no wheezes, rales, or crackles.  Symmetric expansion\nEXT: warm well perfused, no pitting edema \n \nPertinent Results:\n==============================\n ADMISSION LABS\n==============================\n___ 09:37PM BLOOD WBC-6.0 RBC-2.88* Hgb-9.0* Hct-27.8* \nMCV-97 MCH-31.3 MCHC-32.4 RDW-15.1 RDWSD-52.0* Plt ___\n___ 09:37PM BLOOD Neuts-75.2* Lymphs-17.6* Monos-4.4* \nEos-1.8 Baso-0.3 Im ___ AbsNeut-4.49 AbsLymp-1.05* \nAbsMono-0.26 AbsEos-0.11 AbsBaso-0.02\n___ 06:40AM BLOOD ___ PTT-25.9 ___\n___ 09:37PM BLOOD Glucose-189* UreaN-38* Creat-2.4* Na-142 \nK-4.8 Cl-105 HCO3-20* AnGap-17\n___ 09:37PM BLOOD proBNP-4512*\n___ 09:37PM BLOOD cTropnT-<0.01\n___ 06:40AM BLOOD CK-MB-6 cTropnT-0.05*\n___ 02:01PM BLOOD CK-MB-5 cTropnT-0.04*\n___ 09:37PM BLOOD Calcium-9.4 Phos-4.1 Mg-2.3\n___ 09:41PM BLOOD ___ pO2-30* pCO2-40 pH-7.33* \ncalTCO2-22 Base XS--5\n \n==============================\n IMAGING\n==============================\nTTE ___: The left atrial volume index is mildly increased. \nThe estimated right atrial pressure is ___ mmHg. Left \nventricular wall thicknesses and cavity size are normal. There \nis mild regional left ventricular systolic dysfunction with \nbasal inferoseptal, inferior, inferolateral as well as mid \ninferior/inferoseptal wall motion abnormalities. Doppler \nparameters are most consistent with Grade II (moderate) left \nventricular diastolic dysfunction. Right ventricular chamber \nsize and free wall motion are normal. The diameters of aorta at \nthe sinus, ascending and arch levels are normal. The aortic \nvalve leaflets (3) are mildly thickened but aortic stenosis is \nnot present. There is no aortic valve stenosis. Trace aortic \nregurgitation is seen. The mitral valve leaflets are moderately \nthickened. Mild (1+) mitral regurgitation is seen. The tricuspid \nvalve leaflets are mildly thickened. There is mild pulmonary \nartery systolic hypertension. There is no pericardial effusion. \n\n IMPRESSION:   1) Mild regional LV systolic dysfunction c/w \nprior myocardial infarction in the RCA territory.   2) Grade II \nLV diastolic dysfunction.\n Compared with the prior study (images reviewed) of ___, LV \nsytolic function appears mildly less vigorous. Regional wall \nmotion abnormalities encompassess slightly greater territory.  \n\nCXR PA & LAT ___: No focal consolidation or pulmonary \nedema.\n\nBILATERAL LOWER EXTREMITY DOPPLER ULTRASOUND ___:   \n1. Nonocclusive thrombosis of one of the paired posterior tibial \nveins in the bilateral lower extremities which appears grossly \nunchanged compared to bilateral lower extremity ultrasound ___.  No new deep venous thrombosis in either \nextremity. \n2. Right ___ cyst measuring up to 1.8 cm across maximal \ndiameter is \nunchanged in size compared to ___. \n  \n==============================\n MICROBIOLOGY\n==============================\n URINE CULTURE ___: ENTEROCOCCUS SP..    >100,000 CFU/mL.\n BLOOD CULTURE ___: Blood Culture: PENDING \n BLOOD CULTURE ___: Blood Culture: PENDING \n\n==============================\n DISCHARGE LABS\n==============================\n___ 05:45AM BLOOD WBC-5.1 RBC-2.57* Hgb-7.9* Hct-24.5* \nMCV-95 MCH-30.7 MCHC-32.2 RDW-15.0 RDWSD-51.8* Plt ___\n___ 05:45AM BLOOD Glucose-144* UreaN-49* Creat-2.6* Na-147 \nK-4.0 Cl-105 HCO3-24 AnGap-___ yo F  PMH CAD c/b ischemic MR ___ DES to ___ ___, TTE ___ \nwith mild regional LV systolic dysfunction), HFpEF (LVEF 50% \n___, PAD, CKD (stage IV), prior DVT c/b severe UGIV on AC, \nT2DM presents with subacute SOB, weight gain, c/f acute heart \nfailure exacerbation.  She underwent diuresis with IV Lasix 80 \nmg, 120mg IV x2 with rapid improvement in subjective dyspnea.  \n___ showed no acute DVT, CXR without sign of consolidation.  \nGiven her improvement in dyspnea, no supplemental O2 \nrequirement, the patient was discharged w/o medication changes.\n\n# Shortness of breath\n# Hypoxia\n# acute exacerbation of chronic diastolic heart failure with \npreserved LVEF (50%)\nDry weight per pt 154 lbs.  Admission weight above baseline, BNP \nelevated.  Regarding trigger, suspect dietary vs uncontrolled \nBP. No EKG changes for ACS, trop negative, repeat TTE showed \nmild regional LV systolic dysfunction c/w prior myocardial \ninfarction in the RCA territory, as well as Grade II LV \ndiastolic dysfunction and similar to prior ___ TTE. Doubt PNA \ngiven CXR and lack of cough/fever, doubt PE given low Wells' \nscore 1.5, and stable repeat ___. Underwent diuresis with IV \nLasix 80 mg, 120mg IV x2 with rapid improvement in subjective \ndyspnea.  Resumed home torsemide 40mg, nifedipine 60mg BID and \ncarvedilol 25mg BID.  Was stable on RA prior to discharge.\n\n# Hypertension - Patient missed her antiHTN medications earlier \nday of admission. Continued home carvedilol 25mg BID and \nnifedipine 60mg BID with holding parameters. Appears that a \ntrial of ___ or spironolactone would be limited by \nhyperkalemia, so this was deferred.\n     \n# Urinary frequency/urge incontinence: occurred in setting of \ndiuresis, however UCx ordered in ED did grow enterococci, likely \ncolonization. If symptoms persists would revaluate/treat.\n         \nCHRONIC STABLE ISSUES\n\n# Normocytic anemia (recent baseline Hb 9.4 ___ - Hb was at \nbaseline, no signs of active bleeding.  Likely multifactorial, \nanemia of chronic disease as well as decreased erythropoiten \nproduction iso CKD.\n \n# Non anion gap metabolic acidosis - Patient has intermittently \nhad a NAGMA in the past.  No recent diarrhea.  ___ suspect Type \nIV RTA given advanced age and history of T2DM (both of which can \ncause hyporeninemia).\n\n# Stage IV Chronic Kidney Disease (baseline Cr 2.3-2.8) - CKD \niso HTN and T2DM, Cr is currently at baseline. Low K/Phos/Na \ndiet. Continued home calcitriol, avoided nephrotoxins and \nrenally dosed all medications.\n\n# Coronary artery disease ___ DES to LCX ___: troponins were \ntrended from < 0.01 to 0.05 to 0.04 then stopped. CK-MB was \nflat.  Patient deneied any chest pain. A TTE showed mild \nregional LV systolic dysfunction c/w prior myocardial infarction \nin the RCA territory and similar to prior ___ TTE. Continued \nhome aspirin 81mg qd, home carvedilol 25mg BID with holding \nparameters, home atorvastatin 80mg qHS.\n \n# Type II Diabetes Mellitus (last HbA1C 6.4% ___ - Under \nexcellent control, most recently in the pre-diabetic range.\n- Continue home 70/30 sliding scale (___t dinner if \nblood sugar over 130, 10 units 90-130, none if blood sugar under \n90) \n\n# Dyslipidemia: continued home atorvastatin\n\n# Insomnia: continued home gabapentin\n\n# Gout: continued home allopurinol\n \n==============================\n TRANSITIONAL ISSUES\n==============================\n- Discharge weight: 69.2kg\n- Discharge creatinine: 2.6\n- Discharge oral diuretic: torsemide 40mg daily\n- Transitional issue: consider outpatient epo with renal \n- Transitional issue: BP goal of 140/90 per accord or even \n130/80 per ACC/AHA ___ guidelines however anticipate difficulty \nin adding additional agents iso CKD (limits use of clonidine) \nand baseline potassium (would likely limit ___ or \nspironolactone) \n- TTE showed prior LV hypokinesis, could consider MIBI or \noutpatient pharmacological stress test\n- had some urinary retention/incontinence while undergoing IV \ndiuresis would assess for recurrent symptoms at routine \noutpatient visits\n\n#CODE: Full (confirmed)  \n#CONTACT: ___ (husband) ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Allopurinol ___ mg PO EVERY OTHER DAY \n2. Atorvastatin 80 mg PO QPM \n3. Calcitriol 0.5 mcg PO DAILY \n4. Carvedilol 25 mg PO BID \n5. Gabapentin 100 mg PO QHS \n6. NIFEdipine (Extended Release) 60 mg PO BID \n7. Torsemide 40 mg PO DAILY \n8. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n9. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild \n10. Aspirin 81 mg PO DAILY \n11. Insulin SC \n      Sliding Scale\nInsulin SC Sliding Scale using 70/30 Insulin\n\n \nDischarge Medications:\n1.  Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild  \n2.  Allopurinol ___ mg PO EVERY OTHER DAY  \n3.  Aspirin 81 mg PO DAILY  \n4.  Atorvastatin 80 mg PO QPM  \n5.  Calcitriol 0.5 mcg PO DAILY  \n6.  Carvedilol 25 mg PO BID  \n7.  Gabapentin 100 mg PO QHS  \n8.  Insulin SC \n      Sliding Scale\nInsulin SC Sliding Scale using 70/30 Insulin \n9.  NIFEdipine (Extended Release) 60 mg PO BID  \n10.  Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain  \n11.  Torsemide 40 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\n- Acute on chronic diastolic congestive heart failure\n\nSECONDARY DIAGNOSES\n- Hypertension\n- History of prior DVT\n- Anemia, NOS\n- Chronic Kidney Disease stage IV\n- Coronary Artery Disease ___ drug eluting stent\n- Diabetes Mellitus Type 2 controlled\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\nYou were admitted to the hospital with shortness of breath and \nweight gain.  This was likely caused by an exacerbation of your \nheart failure possibly from salty foods over the holiday. \n\nWhile you were in the hospital:\n- we gave you IV diuretics to help remove extra fluid\n- we checked for pneumonia with a chest x-ray, there was no sign \nof a pneumonia\n- we checked for signs on new clots in your legs, there was no \nnew clot\n\nNow that you are going home:\n- continue to take all of your medications as prescribed\n- monitor your salt intake, this should be no more than 2 grams \nevery day, ask your doctors for help with this if you do not \nknow how to keep track of your salt\n- continue to weigh yourself every morning, call your doctor if \nweight goes up more than 3 lbs.\n- follow-up with your primary care doctor regarding your blood \npressure and blood sugar control\n\nIt was a pleasure taking care of you!\n\nYour ___ Inpatient Care Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "25",
         "10001176-DS-17",
         "10001176",
         "23334588",
         "DS",
         "17",
         "2186-12-02 00:00:00",
         "2186-12-02 16:38:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nfever\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ with history of morbid obesity, coronary artery disease, \npresenting today with cough productive of brown sputum and \nfevers up to 103.2 for last 2 days. Also endorses chills. \nHusband with similar symptoms 2d prior, now improving without \nantibiotics. Denies any chest pain but states that he she has \nbeen more short of breath.  \n \nIn the ED, initial VS: 101.3 97 168/58 18 93% ra. CXR showed b/l \nperihilar prominence but no evidence of CHF or pneumonia. CT A/P \nshowed no acute abdominal process. Labs notable for WBC 7.2 with \n81%N, TroT <.01 x1, lactate 2, UA with trace leuks. Given \nclinical picture and fever, patient was treated for presumptive \nPNA with Levofloxacin 750mg IV. She was also given Ativan 2mg \nPO, Tylenol 2g, Zofran 4mg. SpO2 dropped to 91& with ambulation. \nPt. initially wanted to leave, but was convinced to stay. VS at \ntransfer: 100.3 98 18 127/71 95%ra.  \n.  \nCurrently, she is tired but denies F/C/SOB.  \n.  \nROS: As per HPI  \n\n \nPast Medical History:\nMYOCARDIAL INFARCT - INFEROPOSTERIOR  \nHYPERCHOLESTEROLEMIA  \nDM (diabetes mellitus), type 2, uncontrolled  \nHYPERTENSION - ESSENTIAL, UNSPEC  \nAnemia  \nThyroid nodule  \nAsymptomatic carotid artery stenosis  \nOBESITY - MORBID  \nESOPHAGEAL REFLUX  \nHYPOTHYROIDISM, UNSPEC  \nANXIETY STATES, UNSPEC  \nDERMATITIS - ECZEMATOUS  \nHEADACHE  \nCOLONIC ADENOMA  \nDISC DISEASE - LUMBAR  \nOvarian Retention Cyst  \n.  \n\n \nSocial History:\n___\nFamily History:\nNon contributory \n \nPhysical Exam:\nPhysical Exam on Admission:\nVS - Temp 98.3F, BP 141/61, HR 101, R 20, O2-sat 93% RA  \nGENERAL - morbidly obese female in NAD, comfortable, appropriate \n \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MM slightly dry, \nOP clear  \nNECK - supple, no thyromegaly, no JVD, no carotid bruits  \nLUNGS - very distant breath sounds, scattered exp wheezes, no \ncrackles, resp unlabored, no accessory muscle use  \nHEART - RRR, no MRG, nl S1-S2  \nABDOMEN - NABS, obese, soft/NT/ND, no masses or HSM, no \nrebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nSKIN - no rashes or lesions  \nNEURO - awake, A&Ox3 \n.\nPhysical Exam on Discharge:\nVS - Tm 100.3 Tc 98.6 BP 137/46 HR  R 20 O2-sat 94% RA  \nGENERAL - morbidly obese female in NAD, comfortable, appropriate \n \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MM slightly dry, \nOP clear  \nNECK - supple, no thyromegaly, no JVD, no carotid bruits  \nLUNGS - very distant breath sounds, few scattered exp wheezes, \nno crackles, resp unlabored, no accessory muscle use  \nHEART - RRR, no MRG, nl S1-S2  \nABDOMEN - NABS, obese, soft/NT/ND, no masses or HSM, no \nrebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nSKIN - no rashes or lesions  \nNEURO - awake, A&Ox3  \n\n \nPertinent Results:\nLabs on Admission:\n\n___ 10:00PM   WBC-7.2 RBC-4.11* HGB-11.5* HCT-35.4* MCV-86 \nMCH-27.8 MCHC-32.3 RDW-15.5\n___ 10:00PM   NEUTS-81.1* LYMPHS-10.8* MONOS-6.9 EOS-0.8 \nBASOS-0.4\n___ 10:00PM   cTropnT-<0.01\n___ 10:00PM   LIPASE-21\n___ 10:00PM   ALT(SGPT)-54* AST(SGOT)-50* ALK PHOS-64 TOT \nBILI-0.4\n___ 10:00PM   GLUCOSE-119* UREA N-14 CREAT-0.7 SODIUM-136 \nPOTASSIUM-3.9 CHLORIDE-98 TOTAL CO2-28 ANION GAP-14\n___ 10:11PM   LACTATE-2.0\n___ 10:47PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 10:47PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 \nLEUK-TR\n___ 10:47PM URINE  RBC-<1 WBC-4 BACTERIA-NONE YEAST-NONE \nEPI-1\n___ 10:47PM URINE  MUCOUS-RARE\n\nImaging:\n\nCXR ___:\nIMPRESSION:  Mild perihilar prominence, suspected to represent \nmildly prominent pulmonary vessels without definite pneumonia.  \nStreaky left basilar opacification seen only on the frontal view \nis probably due to minor atelectasis or scarring. \n.  \nCT A/P ___: \n1.  No acute intra-abdominal pathology. There is diverticulosis \nand sequelae of prior inflammation, but no active \ndiverticulitis. \n2.  3-mm nodule seen along the right major fissure and right \nlower lobe.  According to ___ guidelines, in the absence \nof risk factors, no further followup is needed.  If patient has \nrisk factors such as smoking, followup chest CT at 12 months is \nrecommended to document stability. \n\nCXR ___:\nThere are low lung volumes with an appearance of bronchovascular \ncrowding.  Despite this, there is likely mild vascular \ncongestion and edema.  No focal consolidation is seen with \nlinear bibasilar atelectasis.  The heart is top normal in size \nwith aortic totuosity.  \n  \nIMPRESSION:  Mild pulmonary edema  \n.\nUrine legionella-negative\n.\nLabs on Discharge:\n.\n___ 05:25AM BLOOD WBC-11.6* RBC-3.34* Hgb-9.3* Hct-28.5* \nMCV-86 MCH-27.9 MCHC-32.6 RDW-15.9* Plt ___\n___ 05:25AM BLOOD ___ PTT-33.8 ___\n___ 05:25AM BLOOD Glucose-106* UreaN-15 Creat-0.6 Na-134 \nK-3.8 Cl-96 HCO3-28 AnGap-14\n___ 06:15AM BLOOD ALT-68* AST-50* AlkPhos-66 TotBili-0.5\n___ 05:25AM BLOOD Calcium-8.7 Phos-2.4* Mg-1.8\n___ 10:47PM URINE Color-Yellow Appear-Clear Sp ___\n___ 10:47PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-TR\n___ 10:47PM URINE RBC-<1 WBC-4 Bacteri-NONE Yeast-NONE \nEpi-___ with diabetes, morbid obesity, s/p MI, HTN who presents with \n2 days of fevers and cough productive of rust colored sputum \nwith associated SOB.  \n.  \n# Fevers: Likely secondary to pneumonia, but possibly a viral \nillness. Most likely not bacterial process but no leukocytosis, \njust PMN predominance. Urine legionella neg. CXR underwhelming \nfor pnuemonia but given poor PO intake and overall constellation \nof symptoms without other localizing source and neg CT, so \npatient was treated presumptively for CAP.  O2 sats stable on \nroom air during the day, but at night de-satted.  On exam, lungs \nwith improved wheezing since yesterday. With ambulation, O2 87, \non ___, repeat cxr with pulm edema likely due to IV fluid bolus \nday prior. She was given lasix 40mg POx1.  On day of d/c, sats \nmid ___ on RA, down to 88% with prolonged ambulation.  Pt not \nsubjectively SOB, likely this is baseline given pt's habitus.  \nTreated with albuterol nebs and Levofloxacin 750mg PO daily.  On \nd/c, will complete 5 day course of levofloxacin.  \n.  \n# Hypotnatremia: Na 134 on am of discharge, improved from lowest \nof 129 .  Based on urine lytes/osm and serum osm, most likely \nSIADH secondary to pulmonary process.\n.\n# Diabetes: Stable.  Continued home Lantus 100U qhs and ISS.  \nHeld metformin in house.  Was on diabetic diet.  \n.  \n# HTN: Continued home lisinopril, metoprolol.  Held lasix \ninitially in setting of dehydration initially.  Re-started on \nd/c.  \n.  \n# CAD: No CP now, ECG shows <1mm STD laterally, c/w prior. \nContinued home asa, metoprolol. Heart healthy diet. \n.  \n# HL: Stable.  Continued home simvastatin pending med rec given \n80mg.  \n.  \n# Anxiety: Stable.  Continued home lorazepam, escitalopram.  \n.  \n# Anemia: Hct now at baseline 35.   \n.  \n# GERD: Stable.  Substituted omeprazole for home esomeprazole.\n.\n#incidental radiographic findings-pulmonary nodule. Will require \nfollow up.  \n.  \nTRANSITIONS OF CARE:\n- will complete day 5 of levofloxacin course on ___\n- will have labs checked (particularly Na) and faxed to PCP ___ \n___\n- will f/u with PCP next week\n- 3mm lung nodule seen on CXR; can be followed as outpt\n- CODE: Confirmed full  \n- CONTACT: Husband ___ ___  \n\n \n___ on Admission:\nHumalog SSI  \nLasix 40mg daily  \nDicyclomine 10mg Q4-6H:PRN  \nLevothyroxine 25mcg daily  \nEscitalopram 20mg daily  \nMetoprolol succinate 50mg daily  \nLantus 92 units QHS  \nVicodin 1 tab Q4-6H:PRN  \nLorazepam 2mg QHS:PRN  \nEsomeprazole 40mg BID  \nLisinopril 20mg daily  \nSimvastatin 80mg QHS  \nMetformin 1000mg BID  \nFerrous sulfate 325mg TID  \n\n \nDischarge Medications:\n1. Escitalopram Oxalate 20 mg PO DAILY \n2. Lisinopril 20 mg PO DAILY \nhold for sbp<100 \n3. esomeprazole magnesium *NF* 40 mg Oral BID \n4. Ferrous Sulfate 325 mg PO TID \n5. DiCYCLOmine 10 mg PO QID:PRN pain \n6. Levothyroxine Sodium 25 mcg PO DAILY \n7. Metoprolol Succinate XL 50 mg PO DAILY \n8. Lorazepam 2 mg PO HS:PRN insomnia \n9. Glargine 100 Units Bedtime\nInsulin SC Sliding Scale using HUM InsulinMax Dose Override \nReason: home dosing\n\n10. Levofloxacin 750 mg PO DAILY Start: In am \nlast day is ___ \nRX *levofloxacin 750 mg once a day Disp #*1 Tablet Refills:*0\n11. Hydrocodone-Acetaminophen (5mg-500mg 1 TAB PO Q6H:PRN pain \nhold for sedation, RR<10 \n12. Simvastatin 80 mg PO DAILY \n13. MetFORMIN (Glucophage) 1000 mg PO BID \n14. Furosemide 40 mg PO DAILY \n15. Outpatient Lab Work\nPlease check chem7 and CBC on ___ and fax results to:\nName: ___ \nFax: ___ \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCommunity Acquired Pneumonia\nDiabetes Mellitus Type 2\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nYou were admitted to the hospital for a pneumonia.  You were \nstarted on antibiotics which you will need to continue for one \nmore day (as listed below).  You were also a little bit \ndehydrated when you came in, so you received some IV fluids to \nhelp hydrate you. \n\nYou sodium levels in your blood were a bit low.  This was most \nlikely due to the infection in your lungs.  As we treated your \npneumonia, your sodium levels improved.\n\nThe following changes were made to your medications: \n- Please START levofloxacin 750mg daily for 1 more day\n\nIf you begin to feel more short of breath or more sick, please \ndon't hesitate to call your primary care physician.\n\nPlease follow up with your primary care doctor on discharge as \nscheduled below.\n\nPlease have your labs checked before your appointment with Dr. \n___ included below.\n\nIt was a pleasure taking care of you, we wish you all the best!\n \nFollowup Instructions:\n___\n"
        ],
        [
         "26",
         "10001186-DS-10",
         "10001186",
         "21334040",
         "DS",
         "10",
         "2190-07-21 00:00:00",
         "2190-07-21 09:41:00",
         " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nPenicillins / Paxil / Wellbutrin\n \nAttending: ___.\n \nChief Complaint:\nExposed hardware\n \nMajor Surgical or Invasive Procedure:\nExposed hardware removal \n\n \nHistory of Present Illness:\nThe is a ___ year old female who had prior surgery for a possible \nright parietal\nanaplastic astrocytoma with craniotomy for resection on ___ \nby Dr. ___ in ___ followed by involved-field \nirradiation to 6,120 cGy ___ in ___, 3 cycles of \nTemodar ended ___ and a second craniotomy for tumor recurrence \non ___ by Dr. ___ at ___ with PCV(comb chemo) ___ -\n___.  \n\nIn ___ she presented with exposed hardware to the office and \nshe needed admission an complex revision for a plate that had \neroded through the skin; Plastics and I reconstructed the scalp \nat that time.\n\nThe patient presents today again with some history of pruritus \non the top of her head and newly diagnosed exposed hardware. She \nreports that she had her husband look at the top of her head \" a \nfew ago\" and saw that metal hardware from her prior surgery was \npresent.\n \nPast Medical History:\nright parietal anaplastic astrocytoma, Craniotomy ___ by  \nDr. ___ in ___ irradiation to 6,120 \n \ncGy ___ in ___,3 cycles of Temodar ended ___  \ncraniotomy on ___ by Dr. ___ at ___ ___ -  \n___ wound revision and removal of the exposed craniotx \nhardware, Accutane for 2 weeks only ___ disease since \n___,  \ntubal ligation,tonsillectomy, bronchitis, depression.  \nseizures  \n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nAF VSS\nobese\nGen: WD/WN, comfortable, NAD.\nHEENT: ___ bilat EOMs: intact\nNeck: Supple.\nno LNN\nRRR\nno SOB\nobese\nExtrem: Warm and well-perfused, \n\nNeuro:\nMental status: Awake and alert, cooperative with exam, normal\naffect but VERY simple construct.\nOrientation: Oriented to person, place, and date.\nRecall: ___ objects at 5 minutes.\nLanguage: Speech fluent with good comprehension and repetition.\nNaming intact. No dysarthria or paraphasic errors.\n\nCranial Nerves:\nI: Not tested\nII: Pupils equally round and reactive to light,  3 to 2\nmm bilaterally. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Facial strength and sensation intact and symmetric.\nVIII: Hearing intact to voice.\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\n\nMotor: Normal bulk and tone bilaterally. No abnormal movements\n\nW: there is an area over the R hemiconvexity that shows a \nchronic\nskin defect where the underlying harware has eroded through the\nskin.\nDifferent from previous repaired portion and represents piece of \nthe implanted miniplates; No discharge; no reythemal no \nswelling;  surprisingly benign aspect.\n\nPHYSICAL EXAM PRIOR TO DISCHARGE: \nAF VSS\nobese\nGen: WD/WN, comfortable, NAD.\nHEENT: ___ bilat EOMs: intact\nNeck: Supple.\nIncision: clean, dry, intact. No redness, swelling, erythema or \ndischarge. Sutures in place. \n \nPertinent Results:\n___:\nHematology \nCOMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct \n___ 06:25    4.8 3.49* 11.2* 34.4* 98 31.9 32.5 16.3* 245 \n\nBASIC COAGULATION ___, PTT, PLT, INR) Plt Ct \n___ 06:25    245 \n \nChemistry \nRENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap \n___ 06:25    ___ 142 3.4 110* 23 12 \n\n \n\n \nBrief Hospital Course:\nThe patient presented to the ___ neurosurgical service on \n___ for treatment of exposed hardware from a previous \nsurgery on her head. She went to the OR on ___, where a  \nwas performed removal of exposed hardware by Dr. ___. \nPostoperatively, the patient was stable. Infectious disease \nconsulted the patient and recommended fluconazole 200 mg PO for \n5 days for yeast infection and Keflex ___ mg PO BID for 7 days.\n\nFor DVT prophylaxis, the patient received subcutaneous heparin \nand SCD's during her stay.\n\nAt the time of discharge, the patient was able to tolerate PO, \nwas ambulatoryand able to void independently. She was able to \nverbalize agreement and understanding of the discharge plan.\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. ALPRAZolam 0.5 mg PO TID \n2. Azathioprine 100 mg PO BID \n3. DiCYCLOmine 10 mg PO Q6H:PRN abdominal pain \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. Hydrocodone-Acetaminophen (5mg-500mg) 1 TAB PO Q4H:PRN pain \n6. Infliximab 100 mg IV Q6 WEEKS \n7. Levothyroxine Sodium 50 mcg PO DAILY \n8. Mesalamine 500 mg PO QID \n9. Omeprazole 20 mg PO DAILY \n10. Promethazine 25 mg PO Q6H:PRN n/v \n11. Topiramate (Topamax) 200 mg PO BID \n12. Venlafaxine XR 150 mg PO DAILY \n13. Zolpidem Tartrate 15 mg PO HS \n\n \nDischarge Medications:\n1. ALPRAZolam 0.5 mg PO TID \n2. Azathioprine 100 mg PO BID \n3. DiCYCLOmine 10 mg PO Q6H:PRN abdominal pain \n4. Levothyroxine Sodium 50 mcg PO DAILY \n5. Mesalamine 500 mg PO QID \n6. Omeprazole 20 mg PO DAILY \n7. Topiramate (Topamax) 200 mg PO BID \n8. Venlafaxine XR 150 mg PO DAILY \n9. Zolpidem Tartrate 15 mg PO HS \n10. Hydrocodone-Acetaminophen (5mg-500mg) 1 TAB PO Q4H:PRN pain \n11. Acetaminophen 325-650 mg PO Q6H:PRN temperature; pain \n12. Docusate Sodium 100 mg PO BID:PRN constipation \nRX *docusate sodium 100 mg 100 capsule(s) by mouth twice a day \nDisp #*30 Capsule Refills:*0\n13. Fluconazole 200 mg PO Q24H Duration: 4 Days \nRX *fluconazole 200 mg 1 tablet(s) by mouth daily Disp #*4 \nTablet Refills:*0\n14. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN for moderate \npain \nRX *oxycodone 5 mg ___ tablet(s) by mouth every six (6) hours \nDisp #*40 Tablet Refills:*0\n15. Cephalexin 500 mg PO Q12H Duration: 7 Days \nRX *cephalexin 500 mg 1 tablet(s) by mouth twice a day Disp #*14 \nTablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nHardware removal\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n Please take Fluconazole 200mg once daily for 4 days. Please \ntake Keflex for 7 days for wound infection. \n\nClearance to drive and return to work will be addressed at your \npost-operative office visit.\nCALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE \nFOLLOWING\n\nNew onset of tremors or seizures.\nAny confusion or change in mental status. \nAny numbness, tingling, weakness in your extremities.\nPain or headache that is continually increasing, or not \nrelieved by pain medication.\nAny signs of infection at the wound site: increasing redness, \nincreased swelling, increased tenderness, or drainage.\nFever greater than or equal to 101.5 F.\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "27",
         "10001186-DS-8",
         "10001186",
         "24906418",
         "DS",
         "8",
         "2188-09-26 00:00:00",
         "2188-09-26 13:06:00",
         " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nPenicillins / Paxil / Wellbutrin\n \nAttending: ___.\n \nChief Complaint:\nexposed craniotomy hardware\n \nMajor Surgical or Invasive Procedure:\nwound revision and hardware removal\n\n \nHistory of Present Illness:\nThis is a ___ year old female with prior surgery which\nincludes right parietal anaplastic astrocytoma with Craniotomy\nfor resection on ___ by Dr. ___ in ___ \nfollowed\nby involved-field irradiation to 6,120 cGy ___ in ___,\n3 cycles of Temodar ended ___ and a second craniotomy for tumor\nrecurrence on ___ by Dr. ___ at ___ with PCV(comb chemo)\n___ - ___.  \n\nThe patient presents today with ___ month history of pruritus on\nthe top of her head.  She reports that she had her husband look\nat the top of her head ___ days ago and saw that metal hardware\nfrom her prior surgery was present.  The patient and her husband\npresented to their local Emergency and was told to follow up\nhere.  The patient denies fever, chills, nausea vomiting, nuchal\nrigidity, numbness or tingling sensation, vision or hearing\nchanges, bowel or bladder incontinence.  She denies new onset\nweakness.  She reports baseline tremors in arms due to her\nhyperthyroid disease and baseline left sided weakness since her\ninitial surgery.  She does not ambulate with a walker \n\n \nPast Medical History:\nright parietal anaplastic astrocytoma,Craniotomy ___ by\nDr. ___ in ___ irradiation to 6,120\ncGy ___ in ___,3 cycles of Temodar ended ___\ncraniotomy on ___ by Dr. ___ at ___ ___ -\n___ for 2 weeks only ___ disease since ___,\ntubal ligation,tonsillectomy, bronchitis, depression.\nseizures\n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nO: T:96.7  BP: 139/73  HR:114    R:20    O2Sats: 100% ra\nGen: WD/WN, comfortable, NAD.\nHEENT: Pupils:3-2mm bilat         EOMs: intact\nNeck: Supple.\nExtrem: Warm and well-perfused, arms hands tremulous- (patient\nstates this is her baseline due to hyperthyroid disease)\nNeuro:\nMental status: Awake and alert, cooperative with exam, normal\naffect.\nOrientation: Oriented to person, place, and date.\nRecall: ___ objects at 5 minutes.\nLanguage: Speech fluent with good comprehension and repetition.\nNaming intact. No dysarthria or paraphasic errors.\n\nCranial Nerves:\nI: Not tested\nII: Pupils equally round and reactive to light,  3 to 2\nmm bilaterally. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Facial strength and sensation intact and symmetric.\nVIII: Hearing intact to voice.\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\n\nMotor: Normal bulk and tone bilaterally. No abnormal movements,\ntremors. Strength full power ___ on right 4+/5 on left. No\npronator drift\n\nSensation: Intact to light touch bilaterally.\n\nToes downgoing bilaterally\n\nCoordination: normal on finger-nose-finger, rapid alternating\nmovements, heel to shin\n\n \nPertinent Results:\nCT Head\n1. No evidence of abscess formation. \n2. Stable appearance of postoperative changes related to right \nfrontal mass resection with residual encephalomalacia and edema \nin a similar distribution as ___ MR exam. \n\n \nBrief Hospital Course:\npatient presented to the ED at ___ on ___ with complaints of \nitchy head and exposed hardware.  She was admitted to the floor \nfor observation and pre-operative planning.  On 3.5 she was \ntaken to the OR for wound revision and removal of the exposed \nhardware.  She tolerated the procedure well and was transferred \nto the ___ post-operatively.  She was transferred to the floor \nfor further management and remained stable.  On the morning of \n___ she was deemed fit for discharge and was given instructions \nfor close follow-up of her incision.  \n \nMedications on Admission:\nazathioprine, Pentasa, topiramate,\nalprazolam, omeprazole, zolpidem, venlafaxine hcl er 30,\npopylthiouracil, promethazine- patient does not have doses at \nthe\ntime of the exam.\n\n \nDischarge Medications:\n1. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain.  \n2. azathioprine 50 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n3. alprazolam 1 mg Tablet Sig: 0.5 Tablet PO TID (3 times a day) \nas needed for anxiety.  \n4. promethazine 25 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 \nhours) as needed for nausea.  \n5. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n6. cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q6H (every \n6 hours) for 13 days.\nDisp:*52 Capsule(s)* Refills:*0*\n7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).  \n8. zolpidem 5 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime) \nas needed for for sleep.  \n9. mesalamine 250 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO QID (4 times a day).  \n10. topiramate 100 mg Tablet Sig: Two (2) Tablet PO BID (2 times \na day).  \n11. fluticasone-salmeterol 250-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n12. propylthiouracil 50 mg Tablet Sig: Two (2) Tablet PO Q8H \n(every 8 hours).  \n13. venlafaxine 75 mg Capsule, Ext Release 24 hr Sig: One (1) \nCapsule, Ext Release 24 hr PO DAILY (Daily).  \n14. venlafaxine 75 mg Capsule, Ext Release 24 hr Sig: Two (2) \nCapsule, Ext Release 24 hr PO DAILY (Daily).  \n15. hydrocodone-acetaminophen ___ mg Tablet Sig: ___ Tablets \nPO Q8H (every 8 hours) as needed for back pain.\nDisp:*45 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nexposure of craniotomy hardware and infection\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nHave a friend/family member check your incision daily for \nsigns of infection.\nTake your pain medicine as prescribed.\nExercise should be limited to walking; no lifting, straining, \nor excessive bending.\nYou may wash your hair only after sutures and/or staples have \nbeen removed. \nIncrease your intake of fluids and fiber, as narcotic pain \nmedicine can cause constipation. We generally recommend taking \nan over the counter stool softener, such as Docusate (Colace) \nwhile taking narcotic pain medication.\nUnless directed by your doctor, do not take any \nanti-inflammatory medicines such as Motrin, Aspirin, Advil, and \nIbuprofen etc. \nClearance to drive and return to work will be addressed at \nyour post-operative office visit.\nMake sure to continue to use your incentive spirometer while \nat home, unless you have been instructed not to. \n\nCALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE \nFOLLOWING\n\nNew onset of tremors or seizures.\nAny confusion or change in mental status. \nAny numbness, tingling, weakness in your extremities.\nPain or headache that is continually increasing, or not \nrelieved by pain medication.\nAny signs of infection at the wound site: redness, swelling, \ntenderness, or drainage.\nFever greater than or equal to 101 F.\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "28",
         "10001186-DS-9",
         "10001186",
         "24016413",
         "DS",
         "9",
         "2188-10-21 00:00:00",
         "2188-10-21 15:32:00",
         " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: PLASTIC\n \nAllergies: \nPenicillins / Paxil / Wellbutrin\n \nAttending: ___.\n \nChief Complaint:\nexposed craniotomy hardware \n \nMajor Surgical or Invasive Procedure:\nRight scalp flap with split thickness skin graft and wound VAC \nplacement\n\n \nHistory of Present Illness:\n___ year old female with multiple prior surgeries for right \nparietal anaplastic astrocytoma diagnosed in ___. She has also \nundergone chemo and radiation. She presented to ___ in \n___ with ___ month history of pruritus on the top of her head. \nShe reports that she had her husband look at the top of her head \nand her found her metal hardware from her prior surgery was \npresent. On ___ Dr. ___ metal hardware (removal of \nharware but not the bone flap). She presented today for a \nrotational flap and skin graft for proper coverage of wound. \n \nPast Medical History:\nright parietal anaplastic astrocytoma,Craniotomy ___ by  \nDr. ___ in ___ irradiation to 6,120 \n \ncGy ___ in ___,3 cycles of Temodar ended ___  \ncraniotomy on ___ by Dr. ___ at ___ ___ -  \n___ wound revision and removal of the exposed craniotx \nhardware, Accutane for 2 weeks only ___ disease since \n___,  \ntubal ligation,tonsillectomy, bronchitis, depression.  \nseizures  \n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nAfebrile. vital signs stable. Right scalp incision clean, dry \nand intact with xeroform dressing in place. Right STSG site with \nbolstered xeroform dressing in place. No drainage or bleeding.\n \nPertinent Results:\nNone this admission.\n \nBrief Hospital Course:\nThe patient was admitted to the plastic surgery service on \n___ and had a flap and skin graft to your scalp defect.  \nThe patient tolerated the procedure well. \n.\nNeuro: Post-operatively, the patient received vicodin with good \npain relief noted.\n.\nCV: The patient was stable from a cardiovascular standpoint; \nvital signs were routinely monitored.\n.\nPulmonary: The patient was stable from a pulmonary standpoint; \nvital signs were routinely monitored.\n.\nGI/GU: Post-operatively, the patient was given IV fluids until \ntolerating oral intake. Her diet was advanced when appropriate, \nwhich was tolerated well. She was also started on a bowel \nregimen to encourage bowel movement. Intake and output were \nclosely monitored. \n.\nID: Post-operatively, the patient was started on IV cefazolin, \nthen switched to PO cefadroxil for discharge home. The patient's \ntemperature was closely watched for signs of infection. \n.\nProphylaxis: The patient received subcutaneous heparin during \nthis stay, and was encouraged to get up and ambulate as early as \npossible. \n.\nAt the time of discharge on POD#1, the patient was doing well, \nafebrile with stable vital signs, tolerating a regular diet, \nambulating, voiding without assistance, and pain was well \ncontrolled. Her scalp graft site was clean and pink and she had \nxeroform dressing intact.  Her right thing graft donor site had \noriginal xeroform dressing in place to left open to air to dry \nout.\n\n \nMedications on Admission:\n___: azathioprine, Pentasa, topiramate, alprazolam, omeprazole, \nzolpidem, venlafaxine hcl er 30, popylthiouracil, promethazine, \nkeflex \n \nDischarge Medications:\n1. azathioprine 75 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n2. dicyclomine 10 mg Capsule Sig: One (1) Capsule PO Q8H (every \n8 hours) as needed for abdominal pain.  \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n4. mesalamine 250 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO QID (4 times a day).  \n5. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n6. topiramate 100 mg Tablet Sig: Two (2) Tablet PO BID (2 times \na day).  \n7. venlafaxine 75 mg Capsule, Ext Release 24 hr Sig: Three (3) \nCapsule, Ext Release 24 hr PO DAILY (Daily).  \n8. propylthiouracil 50 mg Tablet Sig: Two (2) Tablet PO Q8H \n(every 8 hours).  \n9. bacitracin zinc 500 unit/g Ointment Sig: One (1) Appl Topical \nBID (2 times a day).\nDisp:*1 tube* Refills:*2*\n10. cefadroxil 500 mg Capsule Sig: One (1) Capsule PO twice a \nday for 7 days.\nDisp:*14 Capsule(s)* Refills:*0*\n11. hydrocodone-acetaminophen ___ mg Tablet Sig: ___ Tablets \nPO every six (6) hours as needed for pain: Max 8/day. .\nDisp:*40 Tablet(s)* Refills:*0*\n12. alprazolam 0.25 mg Tablet Sig: Two (2) Tablet PO TID (3 \ntimes a day) as needed for anxiety.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___ \n \nDischarge Diagnosis:\nexposed craniotomy wound Status post hardware removal, split \nthickness skin graft application to scalp, donor site from leg\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n-The hemovac drain should always be collapsed so as to apply \nconstant suction to the wound. Does not need to be emptied \nunless not collapsed and does not have suction.\n-Your skin graft site on your scalp should be covered with a \nXeroform dressing and you should apply bacitracin ointment with \nQtips UNDER the xeroform dressing twice a day.  WARNING: do NOT \nchange the xeroform that is sewn/sutured in place \nalready...leave that in place.\n-Please keep your skin graft site free of any pressure or \nextreme temperatures (cover with loose hat that does not sit on \nyour graft site).\n-You may shower 48 hours after surgery but do not let water run \non your head/scalp area.  You may shower from the neck down \nonly.\n-your thigh 'donor site' should be left 'open to air' and left \nto dry out.  The old xeroform dressing will peel back/fall off \non its own.  When you shower you must cover your thigh 'donor \nsite' with Plastic wrap to keep it free of water while you \nshower.  You may remove plastic wrap when you are done and leave \nthe donor site open to air again to dry out.\n.\nDiet/Activity: \n1. You may resume your regular diet. \n2. DO NOT bend over, avoid heavy lifting and do not engage in \nstrenuous activity until instructed by Dr. ___. \n. \nMedications: \n1. Resume your regular medications unless instructed otherwise \nand take any new meds as ordered. \n2. You may take your prescribed pain medication for moderate to \nsevere pain. You may switch to Tylenol or Extra Strength Tylenol \n\nfor mild pain as directed on the packaging. Please note that \nPercocet and Vicodin have Tylenol as an active ingredient so do \nnot take these meds with additional Tylenol. \n4. Take prescription pain medications for pain not relieved by \ntylenol. \n5. Take your antibiotic as prescribed. \n6. Take Colace, 100 mg by mouth 2 times per day, while taking \nthe prescription pain medication. You may use a different \nover-the-counter stool softener if you wish. \n7. Do not drive or operate heavy machinery while taking any \nnarcotic pain medication. You may have constipation when taking \nnarcotic pain medications (oxycodone, percocet, vicodin, \nhydrocodone, dilaudid, etc.); you should continue drinking \nfluids, you may take stool softeners, and should eat foods that \nare high in fiber. \n8. do not take any medicines such as Motrin, Aspirin, Advil or \nIbuprofen etc\n. \nCall the office IMMEDIATELY if you have any of the following: \n1. Signs of infection: fever with chills, increased redness, \nwelling, warmth or tenderness at the surgical site, or unusual \ndrainage from the incision(s). \n2. A large amount of bleeding from the incision(s) or drain(s). \n3. Fever greater than 101.5 oF \n4. Severe pain NOT relieved by your medication. \n. \nReturn to the ER if: \n* If you are vomiting and cannot keep in fluids or your \nmedications. \n* If you have shaking chills, fever greater than 101.5 (F) \ndegrees or 38 (C) degrees, increased redness, swelling or \ndischarge from incision, chest pain, shortness of breath, or \nanything else that is troubling you. \n* Any serious change in your symptoms, or any new symptoms that \nconcern you. \n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "29",
         "10001217-DS-4",
         "10001217",
         "24597018",
         "DS",
         "4",
         "2157-11-25 00:00:00",
         "2157-11-25 17:26:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nPenicillins\n \nAttending: ___\n \nChief Complaint:\nLeft hand and face numbness, left hand weakness and clumsiness, \nfever, and headache.\n \nMajor Surgical or Invasive Procedure:\nRight parietal craniotomy for abscess incision and drainage.\n \nHistory of Present Illness:\nMrs. ___ is a ___ y/o F from ___ with history of MS \npresents with headaches and left hand clumsiness. Patient states \nthat her headaches first presented on ___ of this week in \nwhich she did not think much of, but on ___, developed left \nhand clumsiness. She states that she had difficulty with \ngrasping objects and using her fingers. She also reported some \nnumbness in the hand. Today, she presented to the ED because she \nwas found to have a temperature of 101.7 in which she took \nTylenol and was normothermic after. Once in the ED, patient was \nseen by neurology who recommended an MRI head. MRI head revealed \na R parietal lesion concerning for MS, metastatic disease, or \nabscess. Neurosurgery was consulted for further evaluation.\n\nShe reports a mild headache, numbness on the left side of face \nand difficulty using her left hand. She denies any recent travel \noutside of ___ and the ___. or ingesting any raw or uncooked \nmeats. She also denies any changes in vision, dysarthria, \nweakness, nausea, vomitting, diarrhea, cough, or chills.\n\n \nPast Medical History:\nMultiple sclerosis\n \nSocial History:\n___\nFamily History:\nMother with pancreatic cancer, brother-lung cancer, two sisters \nwith brain cancer.\n\n \nPhysical Exam:\nPHYSICAL EXAM ON ADMISSION:\nO: T:99  BP:160/102  HR: 81    R: 16    O2Sats: 97% RA\nGen: WD/WN, comfortable, NAD.\nHEENT: atraumatic, normocephalic\nPupils: 4-3mm bilaterally         EOMs: intact\n\nNeuro:\nMental status: Awake and alert, cooperative with exam, normal\naffect.\nOrientation: Oriented to person, place, and date.\nRecall: ___ objects at 5 minutes.\nLanguage: Speech fluent with good comprehension and repetition.\nNaming intact. No dysarthria or paraphasic errors.\n\nCranial Nerves:\nI: Not tested\nII: Pupils equally round and reactive to light, 4 to 3\nmm bilaterally. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Facial strength and sensation intact and symmetric.\nVIII: Hearing intact to voice.\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\n\nMotor: Normal bulk and tone bilaterally. No abnormal movements,\ntremors. Strength L FI ___, otherwise full power ___ \nthroughout.\nNo pronator drift\n\nSensation: Intact to light touch\n\nPHYSICAL EXAM ON DISCHARGE:\n\nT:98.1  BP:133/95  HR: 95 RR: 18 O2Sats: 98% RA\nGen: WD/WN, comfortable, NAD.\nHEENT: atraumatic, normocephalic, with right craniotomy \nincision.\nPupils: 4-3mm bilaterally, EOMs: intact\n\nNeuro:\nMental status: Awake and alert, cooperative with exam, normal\naffect.\nOrientation: Oriented to person, place, and date.\nRecall: ___ objects at 5 minutes.\nLanguage: Speech fluent with good comprehension and repetition.\nNaming intact. No dysarthria or paraphasic errors.\n\nCranial Nerves:\nI: Not tested\nII: Pupils equally round and reactive to light, 4 to 3 mm \nbilaterally. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Facial strength and sensation intact and symmetric.\nVIII: Hearing intact to voice.\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\n\nMotor: Normal bulk and tone bilaterally. No abnormal \nmovements,tremors. Strength L FI ___, otherwise full power ___ \nthroughout.\nNo pronator drift\n\nSensation: Intact to light touch\n\n \nPertinent Results:\n___ MRI HEAD W/WO CONTRAST \nIMPRESSION: \n  \n1.  Ring-enhancing lesion identified in the area of the right \nprecentral \nsulcus frontal lobe, with associated vasogenic edema, restricted \ndiffusion, possibly consistent with an abscess, other entities \ncannot be completely ruled out such as metastases or primary \nbrain neoplasm. \n  \n2.  Multiple FLAIR and T2 hyperintense lesions in the \nsubcortical white matter along the callososeptal region, \nconsistent with known multiple sclerosis disease. \n\n___ MRI HEAD W/ CONTRAST \nIMPRESSION:  Unchanged ring-enhancing lesion identified in the \narea of the \nright precentral sulcus of the frontal lobe, with associated \nvasogenic edema.  The differential diagnosis again includes \npossible abscess, other entities, however, cannot be completely \nexcluded. \n\n___ NON CONTRAST HEAD CT \nIMPRESSION: \n  \n1.  Status post right parietal craniotomy with mixed density \nlesion in the \nright precentral sulcus and surrounding edema not significantly \nchanged from prior MR of ___ allowing for \ndifference in technique.  \n  \n2.  No acute intracranial hemorrhage or major vascular \nterritorial infarct.  \n  \n3.  Bifrontal subcortical white matter hypodensities compatible \nwith \nunderlying multiple sclerosis.  \n\n___ 2:37 am CSF;SPINAL FLUID      TUBE #1. \n\n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Preliminary):    NO GROWTH.\n\n \nBrief Hospital Course:\nMrs. ___ presented to the ___ Emergency Department on \n___ with left-sided numbness of her hand and face and left \nhand clumsiness.  She was evaluated in the ED and initially \nbelieved to have an MS flare and she was evaluted by Neurology \nservice which resulted in the recommendation for an MRI brain.  \nThe MRI was read to demonstrate a right parietal lesion \nconcerning for MS, metastatic disease or abscess. She was \nadmitted to Neurosurgery for further evaluation and treatment.  \n\nOn ___, Mrs. ___ was taken to the OR for a right \nparietal craniotomy with cordisectomy, drainage and irrigation \nof brain abscess. She tolerated the procedure well. She was \ntaken to PACU to recover then to the ICU. ID recommmend \nVancomycin and Meropenem. Gram stain PRELIM: gram negative rods \nand gram positive cocci in pairs and chains. Post operative head \nCT showed post operative changes. On post operative exam she had \nleft arm weakness. \n\nOn ___ the patient continued on vancomycin and Meropenem. \nWBC was elevated to 19.0 from 15.7 on ___. She was \ntransferred to the floor. Left arm weakness was slightly \nimproved. the patient reported lethargy and left leg weakness. \non exam the patient was sleepy but awake.  she was oriented to \nperson place and time.  right sided strength was ___ and left \nupper extremity was ___ and left lower extremity was full except \nfor IP which was 5-. A stat NCHCT was performed which was \nstable.\n\nOn ___, consent for picc line placement obtained, picc line \nplaced by IV nurse. She will continue with vanco and meropenum \nIV. Final abcess culture result is still pending. Exam remains \nstable. \n\nOn ___ ___ evaluated the patient and found that she continues \nto have an unsteady gait and would not be safe to go home.  They \nplanned to visit her again on ___ for re-evaluation and to \nperform stair maneuvers with her. The final results on the \nabcess culture was streptococcus Milleri. New ID recommendations \nwere to discontiniu Vanco and Meropenum, she was started on \nCeftriaxone 2 grams and and Flagyl Tid. \n\nOn ___, patient was re-evaluated by ___ and OT and cleared to be \ndischarged home with the assistance of a cane. They also \nrecommend services while patient is at home. She remained stable \non examination.\n\nOn ___, Mrs. ___ was seen and evaluated, she \ncomplained of headache and a non-contrast head CT was ordered. \nThis showed the stable post-operative changes.  Home services \nwere established and the patient was discharged.\n\n \nMedications on Admission:\nIbuprofen\n \nDischarge Medications:\n1. Acetaminophen 325-650 mg PO Q6H:PRN pain \nRX *acetaminophen 325 mg ___ tablet(s) by mouth every six (6) \nhours Disp #*112 Tablet Refills:*0\n2. CeftriaXONE 2 gm IV Q12H \nRX *ceftriaxone 2 gram 2 gm IV every twelve (12) hours Disp #*84 \nVial Refills:*0\n3. Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice \na day Disp #*45 Capsule Refills:*0\n4. LeVETiracetam 1000 mg PO BID \nRX *levetiracetam [Keppra] 1,000 mg 1 tablet(s) by mouth twice a \nday Disp #*56 Tablet Refills:*0\n5. MetRONIDAZOLE (FLagyl) 500 mg PO TID \nRX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth three \ntimes a day Disp #*126 Tablet Refills:*0\n6. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \nRX *oxycodone [Oxecta] 5 mg 1 tablet, oral only(s) by mouth \nevery six (6) hours Disp #*168 Tablet Refills:*0\n7. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush \n\nRX *heparin lock flush (porcine) [heparin lock flush] 10 unit/mL \n1 ml IV every eight (8) hours Disp #*126 Vial Refills:*0\n8. Sodium Chloride 0.9%  Flush 10 mL IV Q8H and PRN, line flush \nFlush before and after each infusion of antibiotics. \nRX *sodium chloride 0.9 % [Normal Saline Flush] 0.9 % 10 ml IV \nq12 Disp #*168 Syringe Refills:*1\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nBrain abscess\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nHave a friend/family member check your incision daily for \nsigns of infection.\nTake your pain medicine as prescribed.\nExercise should be limited to walking; no lifting, straining, \nor excessive bending.\n**Your wound was closed with sutures. You may wash your hair \nonly after sutures and/or staples have been removed. \nYou may shower before this time using a shower cap to cover \nyour head.\nIncrease your intake of fluids and fiber, as narcotic pain \nmedicine can cause constipation. We generally recommend taking \nan over the counter stool softener, such as Docusate (Colace) \nwhile taking narcotic pain medication.\nUnless directed by your doctor, do not take any \nanti-inflammatory medicines such as Motrin, Aspirin, Advil, and \nIbuprofen etc. \nYou have been discharged on Keppra (Levetiracetam), you will \nnot require blood work monitoring.\nClearance to drive and return to work will be addressed at \nyour post-operative office visit.\nMake sure to continue to use your incentive spirometer while \nat home, unless you have been instructed not to. \n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "30",
         "10001217-DS-5",
         "10001217",
         "27703517",
         "DS",
         "5",
         "2157-12-24 00:00:00",
         "2157-12-24 15:57:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nPenicillins\n \nAttending: ___\n \nChief Complaint:\nWound Infection\n \nMajor Surgical or Invasive Procedure:\nRight Craniotomy and Evacuation of Abscess on ___\n \nHistory of Present Illness:\nMs. ___ is a ___ y/o woman with a past medical history\nof MS, and a right parietal brain abscess which was discovered\napproxiamtely one month ago, when she presented with left arm \nand\nface numbness. The abscess was drained in the OR on ___, and she\nwas initially started on broad spectrum antibiotics until \nculture\ndata returned with S. anginosus and fusobacterium, she was then\ntransitioned to Ceftriaxone 2g IV q12h, and flagyl 500mg TID,\nwhich she has been on since through her PICC line. On ___, she\nwas seen in ___ clinic and a repeat MRI was performed\nwhich revealed increased edema with persistent ring enhancing\nabnormality at the right parietal surgical site, concerning for\nongoing abscess. She was therefore scheduled for repeat drainage\non ___. She was seen as an outpatient in the infectious disease\noffice today, ___, and it was recommended that she be admitted\nto the hospital one day early for broadening of her antibiotic\nregimen prior to drainage.\n\nShe states that over the past month, her symptoms, including \nleft\nupper extremity weakness and numbness, have come and gone,\nalthough she thinks that overall they have worsened slightly. \nShe\ndenies any fevers/chills, or headaches. No changes in vision, \nleg\nweakness or trouble with coordination or balance.\n\nShe denies shortness of breath, chest pain, abdominal pain.\n\n \nPast Medical History:\nMultiple sclerosis\n \nSocial History:\n___\nFamily History:\nMother with pancreatic cancer, brother-lung cancer, two sisters \nwith brain cancer.\n\n \nPhysical Exam:\nPHYSICAL EXAMINATION ON ADMISSION:\nGeneral Physical Exam:\nGeneral - Appears comfortable\nHEENT - MMM, no scleral icterus, no proptosis, sclera and\nconjunctiva with no edema/injection. Neck is supple.\nCV - RRR, no murmurs, rubs, or gallops. No carotid bruits\nPulm - CTA b/l\nAbd - soft, non-tender, normal bowel sounds\nExtremities - no cyanosis, no edema\nSkin - warm and pink with no rashes\nNeurologic Exam:\nMENTAL STATUS: Awake and alert, oriented x 3, responds to\nmulti-step commands which cross the midline. Knows recent and\ndistant events. No hemisensory or visual neglect.\n\nPHYSICAL EXAMINATION ON DISCHARGE:\nXXXXXX\n \nPertinent Results:\nMRI Brain for Operative Planning: ___\nDecrease in size of known right frontal vertex rim-enhancing \nlesion, but unchanged vasogenic edema and mass effect.\n\nNon-Contrast Head CT: ___\nPOST-OP SCAN \nIMPRESSION:  \nStatus post redo right parietal vertex craniotomy with no \nevidence of hemorrhage.  Stable vasogenic edema extending in the \nright frontal and parietal lobes. \n\n \nBrief Hospital Course:\nMs. ___ is a ___ y/o F who was admitted to the neurosurgery \nservice on the day of admission, ___ from the Infectious \nDisease Clinic in anticipation for evacuation of the brain \nabscess. She underwent a MRI prior surgery for operative \nplanning. She underwent a right craniotomy and evacuation of \nabscess on ___. She tolerated the procedure well and was \nextubated in the operating room. She was then transferred to the \nICU for recovery. She underwent a post-operative non-contrasat \nhead CT which revealed normal post operative changes and no new \nhemorrahge. \n\nOn ___, she was sitting in the chair, hemodynamically and \nneurologically intact. She transfered to the floor in stable \nconditions. \n\nMrs. ___ was followed by Infectious Disease.  They \nrecommended that the patient be started on vancomycin and \nmeropenem until culture data from her head wound was obtained.  \n\nOn ___, cultures revealed no growth. The patient was continued \non Vancomycin, meropenem was changed to ertapenum.\n\nThe patient continued to progress well, although she had some \nresidual left-sided weakness.  She also complained of some \nleft-handed numbness and pain.  \n\nOn ___, the patient had a MR head with and without contrast \nincluding DWI, which showed slight improvement. She was \ndischarged home on ___ with appropriate follow-up, and all \nquestions were answered before discharge.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. CeftriaXONE 1 gm IV Q12H \n2. MetRONIDAZOLE (FLagyl) 500 mg PO TID \n3. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \n4. Acetaminophen 325-650 mg PO Q6H:PRN pain \n5. LeVETiracetam 1000 mg PO BID \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nBrain Abscess\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYour staples should stay clean and dry until they are removed. \n\nHave a friend or family member check the wound for signs of \ninfection such as redness or drainage daily. \nTake your pain medicine as prescribed if needed. You do not \nneed to take it if you do not have pain.\nExercise should be limited to walking; no lifting >10lbs, \nstraining, or excessive bending.\nIncrease your intake of fluids and fiber, as narcotic pain \nmedicine can cause constipation. We generally recommend taking \nan over the counter stool softener, such as Docusate (Colace) \nwhile taking narcotic pain medication.\nDO not take any anti-inflammatory medicines such as Motrin, \nAspirin, Advil, or Ibuprofen etc. until follow up.\n You have been discharged on Keppra (Levetiracetam) for \nanti-seizure medicine; you will not require blood work \nmonitoring.\nDo not drive until your follow up appointment.\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "31",
         "10001338-DS-6",
         "10001338",
         "22119639",
         "DS",
         "6",
         "2138-05-27 00:00:00",
         "2138-05-27 14:21:00",
         " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\ndiverticulitis\n \nMajor Surgical or Invasive Procedure:\ns/p laparoscopic sigmoid colectomy \n\n \nHistory of Present Illness:\nMrs. ___ is a ___ F with history of recurrent diverticulitis, \noriginally\ndiagnosed ___ ___. Pt reports a one month history of \nLLQ\npain varying ___ intensity. Pt was prescribed a 10 day course of\nCipro/Flagyl PO which she completed on ___. Pt was doing \nwell\nuntil abdominal pain returned ___, one week after finishing\nantibiotic course. Pt reports no nausea or vomiting, pt has been\nable to maintain hydration with regular PO intake although\nappetite has been somewhat decreased. Pt has been having \nregular,\nnon-bloody bowel movements, pt reports several small, soft-brown\nbowel movements today. No diarrhea. Pt presents to ___ today \nas\na direct admission for refractory LLQ pain.\n\n \nPast Medical History:\ndiverticulitis\nMigraines\nLeft finger cellulitis\n \nSocial History:\n___\nFamily History:\nfather with h/o colitis\n \nPhysical Exam:\nCrimson Admission\nTemp 98.6, HR 70, BP 110/70, RR 18, 96% RA\nGen: well, NAD, A&O\nCV: RRR, No R/G/M\nRESP: CTAB\nABD: Focal tenderness LLQ inferolateral to umbilicus, otherwise\nNT, ND, no guarding or rebound\nEXT: No edema\n\n \nPertinent Results:\nRADIOLOGY  Final Report\nCT PELVIS W/CONTRAST  ___ 2:58 AM\nUNDERLYING MEDICAL CONDITION:\n___ year old woman with diverticulitis, increasing RLQ pain \nIMPRESSION: Moderate uncomplicated diverticulitis at the \njunction of the descending colon and sigmoid colon. Stable \nmildly enlarged retroperitoneal lymph nodes may be reactive ___ \nnature. If surgery has not been contemplated, a followup is \nrecommended ___ six weeks, to assess for complete resolution of \nthese findings.\n.\n___ 06:05AM BLOOD WBC-9.9 RBC-2.85* Hgb-8.9* Hct-25.9* \nMCV-91 MCH-31.3 MCHC-34.4 RDW-13.0 Plt ___\n___ 09:10AM BLOOD WBC-23.2*# RBC-3.73* Hgb-11.6* Hct-33.5* \nMCV-90 MCH-31.0 MCHC-34.5 RDW-13.0 Plt ___\n___ 05:25AM BLOOD WBC-10.5 RBC-3.98* Hgb-12.7 Hct-34.4* \nMCV-87 MCH-32.0 MCHC-37.0* RDW-12.8 Plt ___\n___ 06:05AM BLOOD Plt ___\n___ 05:15AM BLOOD ___ PTT-28.3 ___\n___ 05:25AM BLOOD ___ PTT-28.4 ___\n___ 06:05AM BLOOD Glucose-109* UreaN-9 Creat-1.9* Na-138 \nK-3.2* Cl-100 HCO3-30 AnGap-11\n___ 05:25AM BLOOD Glucose-127* UreaN-5* Creat-0.6 Na-138 \nK-4.0 Cl-102 HCO3-27 AnGap-13\n___ 06:05AM BLOOD ALT-85* AST-49* LD(LDH)-204 AlkPhos-208* \nTotBili-0.7\n___ 05:25AM BLOOD ALT-15 AST-14 LD(LDH)-149 AlkPhos-47 \nAmylase-42 TotBili-1.7*\n___ 06:05AM BLOOD Albumin-2.8* Calcium-8.2* Phos-2.8 Mg-2.4\n___ 05:25AM BLOOD Albumin-4.0 Calcium-8.9 Phos-3.5 Mg-2.0\n___ 05:15AM BLOOD Vanco-25.0*\n.\n___ 12:23 pm SWAB     Site: ABDOMEN\n      Fluid should not be sent ___ swab transport media.  Submit \nfluids ___ a\n      capped syringe (no needle), red top tube, or sterile cup. \n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      4+   (>10 per 1000X FIELD):   GRAM POSITIVE COCCI. \n                                  ___ PAIRS, CHAINS, AND CLUSTERS\n   FLUID CULTURE (Final ___: \n      STAPH AUREUS COAG +.    MODERATE GROWTH.  CLINDAMYCIN PER \nID.. \n         This isolate is presumed to be resistant to clindamycin \nbased on\n         the detection of inducible resistance .\n   ANAEROBIC CULTURE (Preliminary):    NO ANAEROBES ISOLATED. \n   ACID FAST SMEAR (Final ___: \n      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. \n   ACID FAST CULTURE (Preliminary): \n      A swab is not the optimal specimen for recovery of \nmycobacteria or\n      filamentous fungi.  A negative result should be \ninterpreted with\n      caution.  Whenever possible tissue biopsy or aspirated \nfluid should\n      be submitted. \n   FUNGAL CULTURE (Preliminary): \n      NO FUNGUS ISOLATED. \n      A swab is not the optimal specimen for recovery of \nmycobacteria or\n      filamentous fungi.  A negative result should be \ninterpreted with\n      caution.  Whenever possible tissue biopsy or aspirated \nfluid should\n      be submitted. \n.\nPathology Examination \nSPECIMEN SUBMITTED: sigmoid colon.\nProcedure date     ___ \nDIAGNOSIS:  \nSigmoid colon, segmental resection: \nColonic segment with organizing pericolic abscess, consistent \nwith ruptured diverticulum. \nUnremarkable regional lymph nodes. \nNo intrinsic mucosal abnormalities seen.\nClinical: Diverticulitis.\n.\nRADIOLOGY  Final Report\nCT ABDOMEN W/CONTRAST  ___ 10:22 AM\nReason: Rule out subcutaneous air or fluid. IV contrast ONLY. \nHISTORY: ___ female with recurrent diverticulitis, \nstatus post laparoscopic sigmoid colectomy, now with incisional \nerythema. Rule out subcutaneous air or fluid.\nIMPRESSION:\n1. Status post sigmoid colectomy with a small amount of \npost-operative free intraperitoneal air and fluid within the \npelvis.\n2. Small amount of scattered subcutaneous air ___ the mid and \nlower anterior abdominal wall consistent with postsurgical \nchange, without evidence of discrete fluid collection.\n\n \nBrief Hospital Course:\nMrs. ___ was directly admitted to ___ from Dr. ___ \noffice with persistent abdominal pain likely related to \ndiverticulitis flare. Her vitals signs and labwork remained \nstable excluding a slightly decreased hematocrit. She was \nstarted on IV Cipro & Flagyl, made NPO with IVF hydration, pain \nmanagment, and serial abdominal exams. \n.\nHD2-HD7-She underwent a abd CT scan which revealed uncomplicated \ndiverticulitis. She continued with the above mentioned treatment \nregimen. Her abdominal pain responded well to IV Dilaudid. She \nhad multiple non-bloody stools. She continued to ambulate \nwithout difficulty, and refused SC Heparing injections. Surgical \noptions were discussed b/w patient and Dr. ___. Surgery \nplanned for ___. TPN & PICC was not indicated. She was \nstarted on Ensure supplements. Operative consent, labwork, CXR, \n& EKG were collected.\n.\nHD8-She was made NPO overnight for surgery. Continue with IVF. \nSurgery was performed on ___. Her operative course was \nuncomplicated. Routinely observed ___ PACU, and transferred to \n___. \n.\nPOD1-Continued with IVF, NPO, and foley. PCA for pain management \nwith adequate relief. \n.\nPOD2-3-Reported flatus and had a small BM. Abdomen appropriately \nTTP/ND with active bowel sounds. Ffanesstial incision with \nincreased erythema extending to right. IV Vancomycin started. No \nimprovement ___ wound x 24 hrs. Zosyn added to regimen. Pain \nmedication switched to PO medication. ___ pump removed.\n.\nPOD4-5-Temp spike to 102.5, IV antibiotics started. WBC spike to \n23 from 8 with 10% bands. Reports of persistent nausea-zofran \nmildly effective. Compazine added to regimen with improved \neffects. IVF continued. ID team consulted regarding antibiotic \nregimen. Underwent CT scan of abd with no significatn intra-abd \nfindings. Wound opened at bedside on ___. Cultures of serous \nfluid sent to ___. Site packed with w-d dressing. Infectious \nreaction likely r/t GAS or staphylococcus aureus. Nasal swab for \nstaphy collected & sent to Micro. Clindamycin IV added to \nregimen. Cultures were followed, and wound checked serially. \nT-max 100.7. Bump ___ creatinine noted 0.6 to 1.7.\n.\nPOD6-wound culture positive for MSSA. IV Nafcillin added with \ncontinued Clinda. IV Vanco & Zosyn discontinued. CDIFF cultures \nnegative x 3. Nasal swab for Staph cultured collected. Patient \nreports nausea still present, but better. Has been eating small \namount of regular food with continued flatus and liquid stool \nproduction. Continues with IVF due to elevated Creatinine to \n1.9. Adequate urine output. Ambulating independently. LFT's \nslightly elevated as well.\n.\nPOD7-IV Clindamycin discontinued due to culture resistance. \nNafcillin continued. Patient's status contiues to improve. \nRemains afebrile, decreased WBC, and improved appearance of \nwound including erythema. IVF switched to maintenance.\n.\nPOD8-Nasal swab-no growth. Continues IVF & Nafcillin. Improved \nPO intake. Continues with complaints of intermittent nausea, \nimproving slowly, & responsive to Compazine. Ambulating \nindependently. Remains afebrile.\n\nPOD9-Discharge day: Creatinine continued to decrease. Currently \n1.4. Creatinine level will be collected per Home ___ on ___ \n___, and called into PCP/Dr. ___. Continued to \ntolerate food with intermittent nausea, improved with eating. \nAll PO narcotics discontinued, and Keflex switched to suspension \nwhich patient was better able to tolerate. ___ was set up for \nwound care. \n \nMedications on Admission:\nLexapro 10, nasonex \n \nDischarge Medications:\n1. Escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n2. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n3. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as \nneeded for constipation for 1 months.\nDisp:*60 Capsule(s)* Refills:*0*\n4. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 \nhours) as needed for anxiety.  \n5. Hydrocortisone 2.5 % Cream Sig: One (1) Appl Rectal TID (3 \ntimes a day) as needed for hemorrhoids.  \n6. Cephalexin 250 mg/5 mL Suspension for Reconstitution Sig: Two \n(2)  PO q12hrs () for 5 days.\nDisp:*qs * Refills:*0*\n7. Tylenol ___ mg Tablet Sig: Two (2) Tablet PO every ___ hours \nas needed for fever or pain.  \n8. Outpatient Lab Work\nPlease check serum Creatinine on ___.\n\n**Call result to PCP and Dr. ___\n\n \n___ Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nRecurrent Diverticulitis\nPost-op wound cellulitis\nPost-op hypovolemia\nPost-op fever\n.\nSecondary:\nAnxiety\ndiverticulosis\n\n \nDischarge Condition:\nStable\nTolerating a regular, low-residue diet\nAdequate pain control with oral medication\n\n \nDischarge Instructions:\nPlease call your doctor or return to the ER for any of the \nfollowing:\n* You experience new chest pain, pressure, squeezing or \ntightness.\n* New or worsening cough or wheezing.\n* If you are vomiting and cannot keep ___ fluids or your \nmedications.\n* You are getting dehydrated due to continued vomiting, \ndiarrhea or other reasons. Signs of dehydration include dry \nmouth, rapid heartbeat or feeling dizzy or faint when standing.\n* You see blood or dark/black material when you vomit or have a \nbowel movement.\n* Your pain is not improving within ___ hours or not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or is changing location or moving to your chest or \n\nback.\n*Avoid driving or operating heavy machinery while taking pain \nmedications.\n* You have shaking chills, or a fever greater than 101.5 (F) \ndegrees or 38(C) degrees.\n* Any serious change ___ your symptoms, or any new symptoms that \nconcern you. \n* Please resume all regular home medications and take any new \nmeds \nas ordered. \n* Continue to ambulate several times per day.\n.\nWOUND CARE:\n*Assess surgical wound site daily.\n*Change packing at least once per day, and as needed.\n*Pack with moistened gauze (Normal Saline) into incisional \ncavity. Apply dry gauze on top, and adhere with paper tape.\n**Changed top (dry gauze) if saturated to prevent irritation to \nsurrounding skin.\n**If wound continues to weep, pack with  Aquacel or DSD.\n-You may shower briefly, and wash around surgical incisions.\n-Avoid swimming and tub baths until wound completely healed\n-Please call the doctor if you have increased pain, swelling, \nredness, or drainage from the incision sites.\n.\nCREATININE:\n*Please have the ___ check your creatinine on ___. Please \ncall Dr. ___ and/or your PCP's office with the \nresult.\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "32",
         "10001338-DS-7",
         "10001338",
         "28835314",
         "DS",
         "7",
         "2138-06-05 00:00:00",
         "2138-06-06 11:33:00",
         " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nIV Dye, Iodine Containing\n \nAttending: ___.\n \nChief Complaint:\nnausea, vomiting x 1 day\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ s/p sigmoid colectomy for recurrent diverticulitis on ___ \ndischarged home on ___ after tolerating a low residue diet \nand po antibiotics for a wound infection.  She returned one week \nafter discharge with 1 day of intense nausea and emesis \n(non-bloody, non-biliary).  The nausea is associated with a \nslight increase in epigastric abdominal pain without any \nsignificant tenderness on exam. \n \nPast Medical History:\ndiverticulitis s/p lap sigmoid colectomy c/b wound infection \nMigraines\nLeft finger cellulitis\n \nSocial History:\n___\nFamily History:\nfather with h/o colitis\n \nPhysical Exam:\nafebrile, vital signs within normal limits\nNAD, talkative\nEOM full, PERRL, anicteric sclera\nChest clear\nRRR, no murmurs\nAbdomen soft, round, non-tender, non-distended with 6cm of open \ntransverse incision through the subcutis with intact deep \nfascia; no erythema or induration; minimal serous output.  \n___ without edema, 2+ DP pulses\n \nPertinent Results:\nCT ABDOMEN W/O CONTRAST  ___ 6:___BDOMEN W/O CONTRAST; CT PELVIS W/O CONTRAST\n\nReason: r/o abscess-NO IV contrast, PO only \nField of view: 40\n\nUNDERLYING MEDICAL CONDITION:\n___ year old woman with h/o divertic s/p colectomy here with \nelevated WBC and nausea \nREASON FOR THIS EXAMINATION:\nr/o abscess-NO IV contrast, PO only \nCONTRAINDICATIONS for IV CONTRAST: RF\n\nINDICATION: ___ woman with elevated white blood cell \ncount and nausea, history of recent colectomy for recurrent \ndiverticulitis.\n\nCOMPARISON: CT abdomen and pelvis of ___.\n\nTECHNIQUE: MDCT acquired axial images were obtained through the \nabdomen and pelvis after the administration of oral contrast. No \nintravenous contrast was administered. Multiplanar reformatted \nimages were also obtained.\n\nFINDINGS: \n\nThe lung bases are clear. A 4-mm calcified granuloma in the \nright lung base is unchanged. Limited images of the heart are \nunremarkable. There is no pericardial effusion.\n\nIn the abdomen, the liver, gallbladder, spleen, kidneys, adrenal \nglands, pancreas, stomach, and intra-abdominal loops of small \nand large bowel are unremarkable. There is no mesenteric \nlymphadenopathy. There is no free fluid or free air in the \nabdomen. Immediately adjacent to the left common iliac artery, \nis a linear focus of hyper-attenuating material, with the \nappearance of suture material, largely unchanged from the prior \nexamination.\n\nIn the pelvis, suture material is seen in the distal sigmoid \ncolon, unchanged in appearance from prior examination and \nconsistent with colonic anastomosis. There is no evidence of \nstricture or obstruction at this site. There is no local fluid \ncollection to indicate abscess. There are no signs of \ninflammation. The intrapelvic loops of small and large bowel are \nunremarkable, containing air and stool in a normal pattern \nwithout bowel dilatation. The appendix is visualized and is \nnormal. The urinary bladder, uterus, and adnexa are \nunremarkable. There are no abnormally enlarged lymph nodes in \nthe pelvis. A fat-containing left inguinal hernia is unchanged.\n\nExamination of soft tissues reveals stranding and subcutaneous \nair of the soft tissues along the midline lower anterior \nabdominal wall, slightly larger in size than on the prior \nexamination of approximately 2 weeks ago. Additionally, a small \nfocus of fluid attenuating material now extends from the \nabdominal wall musculature through the subcutaneous tissues, and \nappears to drain into an external collecting device. No discrete \nfluid collection is identified to indicate abscess formation, or \nthat would be amenable to drainage. However, this appearance \nsuggests continued cellulitis.\n\nExamination of osseous structures reveals mild degenerative \ndisease at L5-S1 and are otherwise unremarkable.\n\nIMPRESSION:\n1. Stable appearance of sigmoid colon anastomosis without \nobstruction or abscess formation.\n2. Stranding and subcutaneous air along the lower abdominal wall \nin the midline, indicating cellulitis, but without discrete or \ndrainable fluid collection\n\nThe study and the report were reviewed by the staff radiologist.\n___. ___\n___. ___\n___. ___: SUN ___ 9:36 AM\n____________________________________________\n\n___ 03:45AM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 03:45AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 \nLEUK-NEG\n___ 02:20AM   GLUCOSE-124* UREA N-20 CREAT-1.4* SODIUM-138 \nPOTASSIUM-4.8 CHLORIDE-98 TOTAL CO2-30 ANION GAP-15\n___ 02:20AM   estGFR-Using this\n___ 02:20AM   ALT(SGPT)-38 AST(SGOT)-20 ALK PHOS-107 TOT \nBILI-0.6\n___ 02:20AM   LIPASE-62*\n___ 02:20AM   WBC-15.4*# RBC-3.17* HGB-9.4* HCT-28.2* \nMCV-89 MCH-29.7 MCHC-33.4 RDW-13.7\n___ 02:20AM   NEUTS-85.8* LYMPHS-10.0* MONOS-2.5 EOS-1.2 \nBASOS-0.5\n___ 02:20AM   PLT COUNT-730*#\n \nBrief Hospital Course:\nGI: Admitted in early morning on ___ the pt was made NPO with \nIVF resuscitation.  A abdominal/pelvic CT was done and \ndemonstrated a stable sigmoid anastomosis without any fluid \ncollections or free air.  Over the first night her urine output \nincreased and a foley was not placed.  Due to her constant loose \nstools, toxin screens of C.diff were sent and returned negative. \n By HD2, the nausea persisted an a GI consult was obtained.  The \nGI service believed the nausea to be related to baseline reflux \nexacerbated by her postop course, including a wound infection.  \nPer their recommendations, she was started on an antacid and \nupon discharge she will follow up with a gastroenterologist to \ndetermine her H.pylori status.   Prior to discharge, she was \ntolerating a low residue diet and able to hydrate herself.  \n \nDischarge Medications:\n1. Escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*0 Tablet(s)* Refills:*0*\n2. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours).\nDisp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*2*\n3. Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO HS (at \nbedtime).\nDisp:*30 Tablet(s)* Refills:*2*\n4. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).\nDisp:*0 * Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nnausea and vomiting\n\n \nDischarge Condition:\nFollowup Instructions:\n___\n"
        ],
        [
         "33",
         "10001338-DS-8",
         "10001338",
         "27987619",
         "DS",
         "8",
         "2142-03-02 00:00:00",
         "2142-03-02 16:02:00",
         " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \n___\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain \n \nMajor Surgical or Invasive Procedure:\nColonoscopy with biopsy ___\n\n \nHistory of Present Illness:\nThis patient is a ___ year old female with Hx of sigmoid \ndiverticulitis s/p resection in ___, who complains of RLQ \nabdominal pain. The patient states that her pain began yesterday \nafternoon, worsened overnight and causing her to present to the \nED around 3AM. She describes it as a \"gnawing\" pain, \nnonradiating, constant and ___ intensity. She states this \nfeels similar to her episode of diverticulitis several years \nago, only is present on the other side of her abdomen. She \ndenies any fever, nausea, vomiting, SOB, Chest pain, BRBPR. She \ndoes endorse subjective feeling of chills.  \n.  \nPrior to the current episode, the patient reports having a \n\"sinus infection\" about 3 weeks ago that resolved over one week \nago. About 2 weeks ago she also began taking a low dose OCP in \norder to treate perimenopausal cramping. On the second week she \nstarted to have spotting, with intermittent bleeding and LH this \npast week. She had an episode of diarrhea one week ago ___ \nmorning), that was nonbloody and resolved on its own. Starting \non ___ she has had a feeling of \"lightheadedness\" \nassociated with diaphoresis and nausea.  \n.  \nIn the ED, initial VS were: 8 97.2 88 117/64 18 100%. Patient \nwas given morphine 4 mg IV, dilaudid 0.5 mg IV x 6, zofran 4 mg \nIV, and 3 L NS. She underwent bimanual exam that was reportedly \nwithout signs of mass, CMT, or adnexal tenderness. Labs were \nnotable for a leukocytosis of 11, but were otherwise \nunremarkable. CT abdomen showed normal appendix but thick-walled \ncecum with appearance of possible mass. Pelvic ultrasound did \nnot show any source of her pain. As she did not have adequate \nrelief with pain medications, she was admitted to the medical \nservice for pain control.  \n.  \nVitals on transfer were 97.2 68 98/55 18 100%RA  \n.  \nOn the floor, patient reported continued ___ pain in the RLQ, \nalong with some mild nausea.  \n.  \nReview of systems:  \n(+) Per HPI  \n(-) Denies fever, chills, night sweats, recent weight loss or \ngain. Denies headache, sinus tenderness, rhinorrhea or \ncongestion. Denied cough, shortness of breath. Denied chest pain \nor tightness, palpitations. Denied vomiting, diarrhea, \nconstipation or BRBPR. No dysuria. Denied arthralgias or \nmyalgias.  \n\n \nPast Medical History:\nHx diverticulitis s/p sigmoid resection ___  \nAnxiety  \nAllergic rhinitis  \nGERD  \nEczema  \nMigraine headaches  \nEustacian tube dysfunction  \n\n \nSocial History:\n___\nFamily History:\nFather with hx of colitis, F died lung Ca, Aunt with breast ___, \nPaternal GM with stomach Ca, Mother with CHF and DM2 \n \nPhysical Exam:\nVitals: T: 97.6 BP: 96/62 P: 68 R:18 O2: 99% on RA  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, non-distended, bowel sounds present, TTP in RLQ \nwith deep palpation only, no rebound tenderness or guarding, no \norganomegaly  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n\n \nPertinent Results:\nLaboratory Findings:\n___ 03:30AM BLOOD WBC-11.3* RBC-3.93* Hgb-12.2 Hct-34.9* \nMCV-89 MCH-31.0 MCHC-34.8 RDW-12.8 Plt ___\n___ 03:30AM BLOOD Neuts-76.5* ___ Monos-2.8 Eos-1.8 \nBaso-0.4\n___ 05:26AM BLOOD ___\n___ 03:30AM BLOOD Glucose-123* UreaN-16 Creat-0.8 Na-137 \nK-4.6 Cl-101 HCO3-25 AnGap-16\n___ 03:30AM BLOOD ALT-16 AST-37 AlkPhos-36 TotBili-0.5\n___ 03:30AM BLOOD Lipase-28\n___ 05:27AM BLOOD Calcium-8.3* Phos-2.0*# Mg-2.0\n___ 03:39AM BLOOD Lactate-0.9\n___ 05:26AM BLOOD WBC-5.4 RBC-3.41* Hgb-10.6* Hct-30.6* \nMCV-90 MCH-31.1 MCHC-34.7 RDW-12.5 Plt ___\n___ 05:26AM BLOOD Glucose-88 UreaN-5* Creat-0.7 Na-144 \nK-4.1 Cl-106 HCO3-28 AnGap-14\n___ 03:30AM URINE Color-Straw Appear-Clear Sp ___\n___ 03:30AM URINE Blood-TR Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-MOD\n___ 03:30AM URINE RBC-<1 WBC-3 Bacteri-FEW Yeast-NONE Epi-0\n\nMicrobiology:\nURINE CULTURE (Final ___:    <10,000 organisms/ml\nBlood Culture ___: No growth (not final at time of \ndischarge)\n\nImaging:\nPelvic U/S ___: FINDINGS: Transabdominally the uterus measures \n8.6 x 4.6 x 5.4 cm, and is slightly heterogeneous in appearance \nwith no distinct fibroids seen. Transvaginal exam was performed \nfor better evaluation of the uterus and adnexa. The endometrial \nstripe measures 5 mm. The left ovary measures 3.5 x 1.6 x 1.8 \ncm. The right ovary measures 2.9 x 1.4 x 1.7 cm. There is a \nsmall echogenic focus within the right ovary measuring 5 x 4 x 4 \nmm, likely a small hemorrhagic cyst. Both ovaries demonstrate \nnormal arterial and venous waveforms.   \nIMPRESSION:  \n1. No evidence of ovarian torsion.  \n2. Small right ovarian hemorrhagic cyst. \n.\nCT abd/pelvis w/o contrast ___:  Scattered calcified \ngranulomas in \nthe lung bases are stable. There is no new focal pulmonary \nnodule, \nconsolidation, or effusion. The cardiac apex is within normal \nlimits.  \nComplete evaluation of the intra-abdominal viscera is limited by \nthe \nnon-contrast technique. However, the liver appears homogeneous \nwithout focal lesion. No intra- or extra-hepatic biliary ductal \ndilatation is identified.  The gallbladder, spleen, and pancreas \nappear within normal limits. The adrenal glands are symmetric \nwithout focal nodule. The kidneys appear homogeneous without \nfocal lesion or hydronephrosis. The abdominal aorta is \nnon-aneurysmal throughout its visualized course. The second and \nthird portions of the duodenum are equivocally thickened which \nmay be due to underdistension. No small bowel obstruction is \nidentified. The appendix is well visualized and is normal in \nappearance. There is no free fluid or free air. \n  \nCT PELVIS WITHOUT INTRAVENOUS CONTRAST ___: Initial images \ndemonstrated a solid mass like abnormality in the cecal tip \nmeasuring approximately 3 cm (2:51).  As this was potentially \nconcerning for a cecal mass, rescanning of a limited portion of \npelvis was performed after passage of oral contrast, confirming \nthe finding and demonstrating a 3 cm mass with thickening of the \nadjacent cecal wall (601:15). The adjacent appendix is normal \nand there is no pericecal inflammatory change.  \nThe remainder of the colon is normal without evidence of \nobstruction or \ninflammation. The surgical anastomosis within the lower midline \npelvis \nappears unremarkable. There is no pelvic free fluid. The uterus \nand adnexa \nappear within normal limits. The bladder is markedly distended \nbut is \notherwise unremarkable. No pathologically enlarged pelvic or \ninguinal lymph nodes are identified. \nOSSEOUS STRUCTURES: No bone destructive lesion or acute fracture \nis \nidentified.  \nIMPRESSION: \n1. Findings consistent with a 3 cm cecal mass and thickening of \nthe cecal tip concerning for neoplasm. Atypical infectious \nprocess causing this appearance is felt less likely due to lack \nof inflammatory stranding. Recommend colonoscopy for further \nevaluation.  \n2. Normal appendix, no signs of inflammation. \n3. No small or large bowel obstruction. \n4. Equivocal thickening of duodenum likely related to \nunderdistention.  \n\nColonoscopy ___:\nFindings:  \n Lumen: Evidence of a previous end to end ___ \nanastomosis was seen at the sigmoid colon.  \n Protruding Lesions A ulcerated 3 cm mass of malignant \nappearance was found in the cecum. The scope traversed the \nlesion. Cold forceps biopsies were performed for histology at \nthe cecum.  \n Excavated Lesions Multiple diverticula with small openings were \nseen in the descending colon.  \nImpression: Mass in the cecum (biopsy)\nDiverticulosis of the descending colon\nPrevious end to end ___ anastomosis of the sigmoid \ncolon\nOtherwise normal colonoscopy to cecum and terminal ileum \n.\nPATHOLOGY:\nDIAGNOSIS: \n\"Cecal mass\", mucosal biopsies: \nColonic mucosa with focal ischemic change and abundant \nassociated ulceration, exudate, and granulation tissue \nformation; no carcinoma or dysplasia in these samples.  Five \nlevels are examined.\n\n \n\n \nBrief Hospital Course:\nThe patient is a ___ year-old female with history significant for \ndiverticulitis s/p sigmoid resection in ___, who presented with \nabdominal pain and was found to have cecal mass.  \n.  \n# Abdominal pain: Was most likely related to hemorrhagic ovarian \ncyst.  Initially, patient had significant pain that was not \nrelieved with dilaudid.  However, over the course of several \ndays her pain resolved on its own and she no longer required any \npain medications.  Bloodwork and imaging were not suggestive of \nany intra-abdominal infection.  The patient was advised to \nfollow-up with her gynecologist regarding her ovarian cyst, and \nthe need for continued therapy with low dose oral contraceptive. \n  \n.  \n# Cecal Mass: During the workup of this patient's abdominal \npain, a CT of the abdomen and pelvis revealed a 3 cm cecal mass \nconcerning for malignancy.  During this hospitalization she \nunderwent colonoscopy with biopsy of the mass.  She was \ninstructed to follow-up with her outpatient gastroenterologist \nregarding the results of this biopsy in one week.  The biopsy \nwas negative for malignancy.   \n.  \n# Anxiety - Patient was continued on home regimen of zoloft and \nativan.  \n.  \n# Gerd - Patient continued on omeprazole, zantac BID per \noutpatient regimen.  \n\n \nMedications on Admission:\n-Fish Oil 1,000 mg Cap  \n-Axert 12.5 mg Tab  \n1 Tablet(s) by mouth at onset of HA may repeat in 2 hour up till \n2 a day  \n-Lexapro 10 mg Tab daily  \n-Cholecalciferol (Vitamin D3) 1,000 unit Tab  \n-lorazepam 0.5 mg Tab qd prn  \n-Omeprazole 20 mg Cap, Delayed Release BID  \n-tramadol 50 mg Tab every six (6) hours as needed for pain  \n-oxycodone 5 mg Tab  \n___ Tablet(s) by mouth qhs prn as needed for pain  \n-Multivitamin Cap  \n-Zantac 150 mg Cap 1 Capsule(s) by mouth twice a day  \n-Fluticasone 50 mcg/Actuation Nasal Spray, Susp  \n2 sprays(s) intranasally for 7d, then 1 spray qd  \n-Calcium Citrate 1,000 mg Tab  \n-OCPs - Camrasce? started 2 weeks ago  \n\n \nDischarge Medications:\n1. omega-3 fatty acids     Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n2. Axert 12.5 mg Tablet Sig: One (1) Tablet PO once a day as \nneeded for migraine.  \n3. escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n4. cholecalciferol (vitamin D3) 1,000 unit Capsule Sig: One (1) \nCapsule PO once a day.  \n5. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO HS (at \nbedtime) as needed for anxiety.  \n6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO BID (2 times a day).  \n7. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n8. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n9. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n10. calcium carbonate 500 mg calcium (1,250 mg) Tablet Sig: Two \n(2) Tablet PO once a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCecal Mass\nHemorrhagic ovarian cyst\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital for abdominal pain, which we \nthink was related to a hemorrhagic ovarian cyst.  You were \ntreated with analgesics, and your pain resolved.  You also had a \nCAT scan showing a mass in the cecum.  You underwent a \ncolonoscopy to biopsy this mass, and you should follow-up with \nyour gastroenterologist. \n\nYou should also see your gynecologist regarding the need to \nrestart your oral contraceptive.\n\nWe did not make any changes to your home medications. \n \nFollowup Instructions:\n___\n"
        ],
        [
         "34",
         "10001401-DS-17",
         "10001401",
         "21544441",
         "DS",
         "17",
         "2131-06-15 00:00:00",
         "2131-06-15 13:24:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: UROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nBladder cancer\n \nMajor Surgical or Invasive Procedure:\nrobotic anterior exenteration and open ileal conduit\n\n \nHistory of Present Illness:\n___ with invasive bladder cancer, pelvic MRI concerning for \ninvasion into anterior vaginal wall, now s/p robotic anterior \nexent (Dr ___ and open ileal conduit (Dr ___.\n \nPast Medical History:\nHypertension, laparoscopic cholecystectomy\nsix months ago, left knee replacement six to ___ years ago,\nlaminectomy of L5-S1 at age ___, two vaginal deliveries.\n\n \nSocial History:\n___\nFamily History:\nNegative for bladder CA.\n\n \nPhysical Exam:\nA&Ox3\nBreathing comfortably on RA\nWWP\nAbd S/ND/appropriate postsurgical tenderness to palpation\nUrostomy pink, viable\n \nPertinent Results:\n___ 06:50AM BLOOD WBC-7.6 RBC-3.41* Hgb-10.6* Hct-32.5* \nMCV-95 MCH-31.1 MCHC-32.6 RDW-14.4 RDWSD-50.2* Plt ___\n___ 06:50AM BLOOD Plt ___\n___ 06:45AM BLOOD Glucose-117* UreaN-23* Creat-0.6 Na-136 \nK-4.4 Cl-104 HCO3-23 AnGap-13\n___ 06:45AM BLOOD Calcium-7.9* Phos-3.4 Mg-2.0\n \nBrief Hospital Course:\nMs. ___ was admitted to the Urology service after \nundergoing [robotic anterior exenteration with ileal conduit]. \nNo concerning intrao-perative events occurred; please see \ndictated operative note for details. Patient received \n___ intravenous antibiotic prophylaxis and deep vein \nthrombosis prophylaxis with subcutaneous heparin. The \npost-operative course was notable for several episodes of emesis \nprompting NGT placement on ___.  Pt self removed the NGT on ___, \nbut nausea/emesis resolved thereafter and pt was gradually \nadvanced to a regular diet with passage of flatus without issue. \n With advacement of diet, patient was transitioned from IV pain \nmedication to oral pain medications. The ostomy nurse\nsaw the patient for ostomy teaching. At the time of discharge \nthe wound was healing well with no evidence of erythema, \nswelling, or purulent drainage. Her drain was removed. The \nostomy was perfused and patent, and one ureteral stent had \nfallen out spontaneously.  ___ was consulted and recommended \ndisposition to rehab.  Post-operative follow up appointments \nwere arranged/discussed and the patient was discharged to rehab \nfor further recovery.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Heparin 5000 UNIT SC ONCE \nStart: in O.R. Holding Area \n2. Losartan Potassium 50 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Levothyroxine Sodium 175 mcg PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q6H  \n2.  Docusate Sodium 100 mg PO BID \ntake while taking narcotic pain meds \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice \na day Disp #*50 Capsule Refills:*0 \n3.  Enoxaparin Sodium 40 mg SC DAILY \nStart: ___, First Dose: Next Routine Administration Time \nRX *enoxaparin 40 mg/0.4 mL 40 mg sc daily Disp #*28 Syringe \nRefills:*0 \n4.  Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY \ntake while ureteral stents are in place \nRX *nitrofurantoin monohyd/m-cryst [Macrobid] 100 mg 1 \ncapsule(s) by mouth daily Disp #*14 Capsule Refills:*0 \n5.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - \nModerate \nRX *oxycodone 5 mg 1 tablet(s) by mouth q4h prn Disp #*30 Tablet \nRefills:*0 \n6.  Atorvastatin 10 mg PO QPM  \n7.  Levothyroxine Sodium 175 mcg PO DAILY  \n8.  Losartan Potassium 50 mg PO DAILY  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nBladder cancer\n\n \nDischarge Condition:\nWdWn, NAD, AVSS\nAbdomen soft, appropriately tender along incision\nIncision is c/d/I (steris)\nStoma is well perfused; Urine color is yellow\nUreteral stent noted via stoma\nJP drain has been removed\nBilateral lower extremities are warm, dry, well perfused.  There \nis no reported calf pain to deep palpation. No edema or pitting\n\n \nDischarge Instructions:\n-Please also refer to the handout of instructions provided to \nyou by your Urologist\n-Please also refer to the instructions provided to you by the \nOstomy nurse specialist that details the required care and \nmanagement of your Urostomy\n-You will be sent home with Visiting Nurse ___ \nservices to facilitate your transition to home care of your \nurostomy\n-Resume your pre-admission/home medications except as noted. \nAlways call to inform, review and discuss any medication changes \nand your post-operative course with your primary care doctor\n-___ you have been prescribed IBUPROFEN, please note that you may \ntake this in addition to the prescribed NARCOTIC pain \nmedications and/or tylenol. FIRST, alternate Tylenol \n(acetaminophen) and Ibuprofen for pain control.\n-REPLACE the Tylenol with the prescribed narcotic if the \nnarcotic is combined with Tylenol (examples include brand names \n___, Tylenol #3 w/ codeine and their generic \nequivalents). ALWAYS discuss your medications (especially when \nusing narcotics or new medications) use with the pharmacist when \nyou first retrieve your prescription if you have any questions. \nUse the narcotic pain medication for break-through pain that is \n>4 on the pain scale.\n-The MAXIMUM dose of Tylenol (ACETAMINOPHEN) is 4 grams (from \nALL sources) PER DAY and remember that the prescribed narcotic \npain medication may also contain Tylenol (acetaminophen) so this \nneeds to be considered when monitoring your daily dose and \nmaximum.\n-If you are taking Ibuprofen (Brand names include ___ \nthis should always be taken with food. If you develop stomach \npain or note black stool, stop the Ibuprofen.\n-Please do NOT drive, operate dangerous machinery, or consume \nalcohol while taking narcotic pain medications.\n-Do NOT drive and until you are cleared to resume such \nactivities by your PCP or urologist. You may be a passenger\n-Colace may have been prescribed to avoid post surgical \nconstipation and constipation related to narcotic pain \nmedication. Discontinue if loose stool or diarrhea develops. \nColace is a stool-softener, NOT a laxative.\n-You may shower 2 days after surgery, but do not tub bathe, \nswim, soak, or scrub incision for 2 weeks\n-If you had a drain or skin clips (staples) removed from your \nabdomen; bandage strips called steristrips have been applied \nto close the wound OR the site was covered with a gauze \ndressing. Allow any steristrips/bandage strips to fall off on \ntheir own ___ days). PLEASE REMOVE any \"gauze\" dressings within \ntwo days of discharge. Steristrips may get wet.\n-No heavy lifting for 4 weeks (no more than 10 pounds). Do \"not\" \nbe sedentary. Walk frequently. Light household chores (cooking, \nfolding laundry, washing dishes) are generally ok but AGAIN, \navoid straining, pulling, twisting (do NOT vacuum).\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "35",
         "10001401-DS-18",
         "10001401",
         "26840593",
         "DS",
         "18",
         "2131-07-02 00:00:00",
         "2131-07-08 09:02:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: UROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain, distention, nausea\n \nMajor Surgical or Invasive Procedure:\nInterventional radiology placement of abdominal abscess drain\n\n \nHistory of Present Illness:\n___ F with h/o muscle invasive bladder cancer, returning to \nthe ED POD 15 with abdominal pain, nausea, and distension. She \nhas been obstipated for nearly three days. KUB and CT scan \nnotable for dilated loops, air fluids, and tapering small bowel \nwithout an obvious transition point. Labwork notable for ___ \nand\nleukocytosis. Concerned for small bowel obstruction or an ileus \nin presence ___ and leukocytosis she was re-admitted for IVF, \nbowel rest, NGT decompression. \n \nPast Medical History:\nHypertension, laparoscopic cholecystectomy, left knee \nreplacement six to ___ years ago, laminectomy of L5-S1 at age \n___, two vaginal deliveries.\n\ns/p ___: \n1.  Robot-assisted laparoscopic bilateral pelvic lymph node \ndissection.\n2. Robot-assisted hysterectomy and bilateral oophorectomy for \nlarge uterus, greater than 300 grams, with large fibroid.\n3. Laparoscopic radical cystectomy and anterior vaginectomy with \nvaginal reconstruction.\n\n \nSocial History:\n___\nFamily History:\nNegative for bladder CA.\n\n \nPhysical Exam:\nWdWn, NAD, AVSS\nAbdomen soft, appropriately tender along incision\nIncision is c/d/I\nStoma is well perfused; Urine color is yellow\nBilateral lower extremities are warm, dry, well perfused.  There \nis no reported calf pain to deep palpation. Bilateral lower \nextremities have 2+ pitting edema but no erythema, callor, pain. \n\nPigtail drain has been removed - dressing c/d/i\n \nPertinent Results:\n___ 05:58AM BLOOD WBC-9.9 RBC-2.76* Hgb-8.2* Hct-26.2* \nMCV-95 MCH-29.7 MCHC-31.3* RDW-13.9 RDWSD-47.3* Plt ___\n___ 06:45AM BLOOD WBC-10.3* RBC-2.87* Hgb-8.7* Hct-27.7* \nMCV-97 MCH-30.3 MCHC-31.4* RDW-14.0 RDWSD-49.4* Plt ___\n___ 05:13AM BLOOD WBC-11.6* RBC-3.27* Hgb-9.8* Hct-31.0* \nMCV-95 MCH-30.0 MCHC-31.6* RDW-13.6 RDWSD-47.5* Plt ___\n___ 07:06PM BLOOD WBC-22.5*# RBC-3.58* Hgb-10.9* Hct-34.0 \nMCV-95 MCH-30.4 MCHC-32.1 RDW-13.9 RDWSD-47.9* Plt ___\n___ 07:06PM BLOOD Neuts-89* Bands-1 Lymphs-5* Monos-3* \nEos-0 Baso-0 ___ Metas-1* Myelos-0 Hyperse-1* AbsNeut-20.48* \nAbsLymp-1.13* AbsMono-0.68 AbsEos-0.00* AbsBaso-0.00*\n___ 01:04PM BLOOD ___ PTT-30.9 ___\n___ 05:58AM BLOOD Glucose-106* UreaN-26* Creat-0.4 Na-136 \nK-4.6 Cl-107 HCO3-26 AnGap-8\n___ 06:45AM BLOOD Glucose-114* UreaN-32* Creat-0.4 Na-137 \nK-4.1 Cl-106 HCO3-25 AnGap-10\n___ 06:00AM BLOOD Glucose-121* UreaN-39* Creat-0.4 Na-140 \nK-3.6 Cl-107 HCO3-26 AnGap-11\n___ 07:06PM BLOOD Glucose-117* UreaN-60* Creat-1.7*# Na-133 \nK-5.0 Cl-96 HCO3-21* AnGap-21*\n___ 08:30AM BLOOD ALT-20 AST-19 AlkPhos-77\n\n___ 05:58AM BLOOD Calcium-7.6* Phos-2.8 Mg-2.2\n___ 06:45AM BLOOD Calcium-7.7* Phos-2.4* Mg-2.1\n\n___ 08:30AM BLOOD Albumin-1.8* Calcium-7.7* Phos-3.5 Mg-2.1 \nIron-23*\n___ 07:06PM BLOOD Calcium-8.0* Phos-5.5* Mg-2.2\n___ 08:30AM BLOOD calTIBC-116* Ferritn-789* TRF-89*\n___ 05:09AM BLOOD Triglyc-106\n___ 08:30AM BLOOD Triglyc-89\n\n___ 07:06PM BLOOD Lactate-1.5\n\n___ 03:00PM ASCITES Creat-0.4 Amylase-18 Triglyc-29 \nLipase-8\n___ 03:00PM OTHER BODY FLUID Creat-0.5\n\n___ 7:12 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___: \n      CITROBACTER KOSERI.    FINAL SENSITIVITIES. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             CITROBACTER KOSERI\n                             |   \nCEFEPIME--------------   <=1 S\nCEFTAZIDIME-----------   <=1 S\nCEFTRIAXONE-----------   <=1 S\nCIPROFLOXACIN---------<=0.25 S\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nPIPERACILLIN/TAZO-----   <=4 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----   <=1 S\n\n   Aerobic Bottle Gram Stain (Final ___: \n      GRAM NEGATIVE ROD(S). \n      Reported to and read back by ___ ___, @14:35 ON \n___. \n\n___ 3:00 pm ABSCESS      .  PELVIC ASPIRATION. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      4+   (>10 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n\n   WOUND CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Final ___: \n      BACTEROIDES FRAGILIS GROUP.    SPARSE GROWTH. \n         BETA LACTAMASE POSITIVE. \n\n___ 10:52 am STOOL     CONSISTENCY: NOT APPLICABLE\n      Source: Stool. \n\n                            **FINAL REPORT ___\n\n   C. difficile DNA amplification assay (Final ___: \n      Negative for toxigenic C. difficile by the Illumigene DNA\n      amplification assay. \n           (Reference Range-Negative). \n\n \nBrief Hospital Course:\nMs. ___ was admitted to Dr. ___ service for \nmanagement of ileus.  Upon admission, a nasogastric tube was \nplaced for decompression.  On ___, PICC was placed and TPN \nstarted.  Blood cultures grew gram negative rods and ceftriaxone \nwas started.  On ___, pt started to pass small amount of \nflatus.  ___ CT scan demonstrated improving ileus, but concern \nfor possible urine leak and increased free fluid.  On ___, a \nLLQ drain was placed by interventional radiology.  on ___, pt \npassed clamp trial and NGT was removed.  Pt continued to pass \nflatus and also started to have bowel movements.  On ___, pt \nwas advanced to a clear liquid diet.  Repeat blood cultures were \nnegative and positive blood culture from admission grew \ncitrobacter.  Diet was gradually advanced and ensure added. IV \nmedications were gradually converted to PO and she was \nre-evaluated by physical therapy for rehabilitative services. \nShe was ambulating with walker assistance and prepared for \ndischarge to her ___ facility (___). TPN was \ncontinued up until day before discharge. At time of discharge, \nshe was tolerating regular diet, passing flatus regularly and \nhaving bowel movements. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Atorvastatin 10 mg PO QPM \n2. Levothyroxine Sodium 175 mcg PO DAILY \n3. Losartan Potassium 50 mg PO DAILY \n4. Acetaminophen 650 mg PO Q6H \n5. Docusate Sodium 100 mg PO BID \n6. Enoxaparin Sodium 40 mg SC DAILY \n7. Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY \n8. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate \n\n\n \nDischarge Medications:\n1.  Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days \nLast dose ___  \n2.  MetroNIDAZOLE 500 mg PO Q6H Duration: 7 Days \nLast dose ___  \n3.  Senna 8.6 mg PO BID  \n4.  Acetaminophen 650 mg PO Q6H  \n5.  Atorvastatin 10 mg PO QPM  \n6.  Docusate Sodium 100 mg PO BID  \n7.  Enoxaparin Sodium 40 mg SC DAILY \nStart: ___, First Dose: Next Routine Administration Time  \n8.  Levothyroxine Sodium 175 mcg PO DAILY  \n9.  LORazepam 0.25 mg PO BID:PRN anxiety  \n10.  Losartan Potassium 50 mg PO DAILY  \n11.  Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY  \n12.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - \nModerate  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nbladder cancer, post-operative ileus, bacteremia (CITROBACTER \nKOSERI) and abdominal-pelvic abscess (BACTEROIDES FRAGILIS \nGROUP) requiring ___ drainage\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n-Please also refer to the instructions provided to you by the \nOstomy nurse specialist that details the required care and \nmanagement of your Urostomy\n\n-Resume your pre-admission/home medications except as noted. \nAlways call to inform, review and discuss any medication changes \nand your post-operative course with your primary care doctor\n\n-___ (acetaminophen) and Ibuprofen for pain control.\n\n-Ciprofloxacin and Metronidazole are new ANTIBIOTIC medications \nto treat your infection. Continue for 7 days through ___.\n\n-The MAXIMUM dose of Tylenol (ACETAMINOPHEN) is 3 grams (from \nALL sources) PER DAY \n\n-If you are taking Ibuprofen (Brand names include ___ \nthis should always be taken with food. If you develop stomach \npain or note black stool, stop the Ibuprofen.\n\n-Please do NOT drive, operate dangerous machinery, or consume \nalcohol while taking narcotic pain medications.\n\n-Do NOT drive and until you are cleared to resume such \nactivities by your PCP or urologist. You may be a passenger\n\n-Colace may have been prescribed to avoid post surgical \nconstipation and constipation related to narcotic pain \nmedication. Discontinue if loose stool or diarrhea develops. \nColace is a stool-softener, NOT a laxative.\n\n-No heavy lifting for 4 weeks (no more than 10 pounds). Do \"not\" \nbe sedentary. Walk frequently. Light household chores (cooking, \nfolding laundry, washing dishes) are generally ok but AGAIN, \navoid straining, pulling, twisting (do NOT vacuum).\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "36",
         "10001401-DS-19",
         "10001401",
         "24818636",
         "DS",
         "19",
         "2131-08-04 00:00:00",
         "2131-08-04 15:04:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\n dyspnea on exertion \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPatient is a ___ year old woman s/p robotic radical cystectomy \n___ (with ileal conduit creation) with postop course \ncomplicated by bacteremia and abscess, LLE DVT (on prophylactic \ndosing lovenox) who presents with dyspnea on exertion for past 3 \ndays. \n\nBriefly, patient was initially admitted to the Urology service \nfrom ___ for robotic anterior exenteration with ileal \nconduit. She was discharged to rehab on prophylactic dosing \nlovenox for 1 month. She was then readmitted from ___ for \nileus requiring NGT decompression, TPN. BCx grew Citrobacter, \nfor which CTX was started. CT showed intra-abdominal, interloop, \nsimple fluid collection and LLQ drain was placed by ___. Patient \nimproved, passing BMs and tolerating PO, and was discharged on \ncipro/flagyl. She was also discharged on PO Bactrim for presumed \nUTI, though unclear if she actually took this. During this \nadmission, she was noted to have new bilateral ___ edema. LENIs \nat the time showed aute deep vein thrombosis of the duplicated \nmid and distal left femoral veins. She was discharged on  \nEnoxaparin Sodium 40 mg SC daily. She reports that her PCP \nstarted PO ___ 20mg daily and since then there has been \nimprovement of the swelling. Per her report, a repeat ___ at \nthe rehab facility (___) was negative for DVT.\n\nPatient reports that she recovered well post-operatively and was \ndoing well at her assisted living facility up until a week ago \nwhen she began experiencing dyspnea on exertion. She states that \nshe typically is able to ambulate a block before stopping to \ncatch her breath, however in the past week she has been unable \nto take more than a few steps. She states that it has become \nincreasingly more difficult to ambulate from her bedroom to the \nbathroom. When visited by the NP her ambulatory saturation was \nnoted to be in the ___ with associated tachycardia to 110, \npallor and diaphoresis. She endorses associated leg swelling \nleft worse than right, and she states that her thighs \"feel \nheavy\". She denies any associated chest pain, fever, chills, \npain with deep inspiration, abdominal pain, rashes, dizziness, \nlightheadedness.  \n\nIn the ED, initial VS were: 97.7 72 136/93 20 100% Nasal Cannula \n\nED physical exam was recorded as patient resting comfortably \nwith NC, pursed lip breathing, unable to speak in full sentences \nbefore becoming short of breath, urostomy pouch in RLQ, stoma \npink, 2+ edema to bilateral lower extremities L>R. \n\nED labs were notable for: Hb 9, Hct 29, plt 479, UA: large ___, \n>182 WBC, many bact 0 epi. Trop neg x1, proBNP normal\n\nCTA chest showed:\n1. Extensive pulmonary embolism with thrombus seen extending \nfrom the right main pulmonary artery into the segmental and \nsubsegmental right upper, middle, and lower lobe pulmonary \narteries. No right heart strain identified. 2. Additionally, \nthere are smaller pulmonary emboli seen in the segmental and \nsubsegmental branches of the left upper and lower lobes. 3. \nSeveral pulmonary nodules are noted, as noted previously, with \nthe largest appearing spiculated and measuring up to 1 cm in the \nright middle lobe, suspicious for malignancy on the previous \nPET-CT. 4. Re- demonstration of 2 left breast nodules for which \ncorrelation with mammography and ultrasound is suggested.\n\nEKG showed NSR with frequent PAC\n\nPatient was given:\n___ 20:26 PO/NG Ciprofloxacin HCl 500 mg \n___ 20:26 IV Heparin 6600 UNIT \n___ 20:26 IV Heparin  \n\nTransfer VS were: 98.1 77 145/63 20 99% Nasal Cannula \n When seen on the floor, she reports significant dyspnea with \nminimal exertion. Denies chest pain, palpitations, \nlightheadedness.\nA ten point ROS was conducted and was negative except as above \nin the HPI.\n \nPast Medical History:\nHypertension, laparoscopic cholecystectomy, left knee \nreplacement six to ___ years ago, laminectomy of L5-S1 at age \n___, two vaginal deliveries.\n\ns/p ___: \n1.  Robot-assisted laparoscopic bilateral pelvic lymph node \ndissection.\n2. Robot-assisted hysterectomy and bilateral oophorectomy for \nlarge uterus, greater than 300 grams, with large fibroid.\n3. Laparoscopic radical cystectomy and anterior vaginectomy with \nvaginal reconstruction.\n\n \nSocial History:\n___\nFamily History:\nNegative for bladder CA.\n\n \nPhysical Exam:\nADMISSION EXAM:\n Gen: NAD, speaking in 3 word sentences, pursed lip breathing, \nno accessory muscle use, lying in bed\n Eyes: EOMI, sclerae anicteric  \n ENT: MMM, OP clear\n Cardiovasc: RRR, no MRG, full pulses, 1+ edema bilaterally with \ncompression stockings in place, no JVD \n Resp: normal effort, no accessory muscle use, lungs CTA ___ to \nanterior auscultation.\n GI: soft, NT, ND, BS+. Urostomy site does not appear infected\n MSK: No significant kyphosis. No palpable synovitis.\n Skin: No visible rash. No jaundice.\n Neuro: AAOx3. No facial droop.\n Psych: Full range of affect \n\nDISCHARGE EXAM:\nvitals: 98.3 140/42 90 24 96% 1L\nGen: Lying in bed in no apparent distress\nHEENT: Anicteric, MMM\nCardiovascular: RRR normal S1, S2, no right sided heave, ___ \nsystolic murmur \nPulmonary: Lung fields clear to auscultation throughout. No \ncrackles or wheezing. \nGI: Soft, distended, nontender, bowel sounds present, urostomy \nin place.\nExtremities: no edema, though left leg appears larger than right \nleg, warm, well perfused with motor function intact. Her left \nlower leg is wrapped. \n\n \nPertinent Results:\nLABS:\n==========================\nAdmission labs:\n___ 02:40PM   GLUCOSE-101* UREA N-22* CREAT-0.7 SODIUM-136 \nPOTASSIUM-4.1 CHLORIDE-98 TOTAL CO2-22 ANION GAP-20\n___ 02:40PM   cTropnT-<0.01\n___ 02:40PM   proBNP-567\n___ 02:40PM   WBC-7.7 RBC-3.07* HGB-9.0* HCT-29.1* MCV-95 \nMCH-29.3 MCHC-30.9* RDW-14.9 RDWSD-52.1*\n___ 02:40PM   PLT COUNT-479*\n___ 02:40PM   ___ PTT-33.4 ___\n\nDischarge labs:\n___ 06:55AM BLOOD WBC-11.0* RBC-2.60* Hgb-7.5* Hct-24.5* \nMCV-94 MCH-28.8 MCHC-30.6* RDW-14.8 RDWSD-51.4* Plt ___\n___ 06:55AM BLOOD Glucose-99 UreaN-10 Creat-0.5 Na-141 \nK-4.3 Cl-105 HCO3-26 AnGap-14\n___ 06:55AM BLOOD Calcium-8.2* Phos-3.8 Mg-2.0\n___ 07:15AM BLOOD calTIBC-134* Ferritn-507* TRF-103*\n___ 07:15AM BLOOD Iron-18*\n\nMICROBIOLOGY\n==========================\n___ 4:30 pm URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n      ENTEROCOCCUS SP..    >100,000 CFU/mL. \n         PREDOMINATING ORGANISM INTERPRET RESULTS WITH CAUTION. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             ENTEROCOCCUS SP.\n                             |   \nAMPICILLIN------------   <=2 S\nNITROFURANTOIN--------  <=16 S\nTETRACYCLINE----------   <=1 S\nVANCOMYCIN------------     1 S\n\nIMAGING\n==========================\n___ CXR\nIMPRESSION: Hilar congestion without frank edema.  No convincing \nsigns of pneumonia.\n\n___ CTA chest showed:\n1. Extensive pulmonary embolism with thrombus seen extending \nfrom the right main pulmonary artery into the segmental and \nsubsegmental right upper, middle, and lower lobe pulmonary \narteries. No right heart strain identified. 2. Additionally, \nthere are smaller pulmonary emboli seen in the segmental and \nsubsegmental branches of the left upper and lower lobes. 3. \nSeveral pulmonary nodules are noted, as noted previously, with \nthe largest appearing spiculated and measuring up to 1 cm in the \nright middle lobe, suspicious for malignancy on the previous \nPET-CT. 4. Re- demonstration of 2 left breast nodules for which \ncorrelation with mammography and ultrasound is suggested.\n\n___ ___:\nIMPRESSION:\n1. Interval progression of deep vein thrombosis in the left \nlower extremity, with occlusive thrombus involving the entire \nfemoral vein, previously only involving the mid and distal \nfemoral vein.  There is additional nonocclusive thrombus in the \ndeep femoral vein.  The left common femoral and popliteal veins \nare patent.\n2. The bilateral calf veins were not visualized due to an \noverlying dressing. Otherwise no evidence of deep venous \nthrombosis in the right lower extremity.\n\n___ TTE:\nConclusions\nThe left atrium is normal in size. The estimated right atrial \npressure is ___ mmHg. Left ventricular wall thickness, cavity \nsize, and global systolic function are normal (LVEF>55%). \nDoppler parameters are most consistent with Grade I (mild) left \nventricular diastolic dysfunction. Right ventricular chamber \nsize and free wall motion are normal. The aortic valve leaflets \nare mildly thickened (?#). There is no aortic valve stenosis. \nTrivial mitral regurgitation is seen. There is mild pulmonary \nartery systolic hypertension. \n\n___ CXR\nIMPRESSION: \nCompared to chest radiographs ___ through ___. \nHeart size top-normal.  Lungs grossly clear.  No pleural \nabnormality or evidence of central lymph node enlargement.\n\n \nBrief Hospital Course:\nMs. ___ is a ___ woman s/p robotic radical cystectomy \n___omplicated by bacteremia and \nabscess, LLE DVT, currently on daily lovenox who presents with \ndyspnea on exertion and dyspnea on exertion and found to have \nlarge PE and progression of DVT.\n\n# PE/DVT: Likely due to undertreatment of known LLE DVT with \nprophylactic dosing of lovenox. Given underdosing of lovenox, \nthis was not thought to be treatment failure and IVC filter was \ndeferred. She had no signs of right heart strain on imaging, \nEKG, exam. TTE showed no evidence of right heart strain. She was \ntreated with a heparin gtt, then transitioned to treatment dose \nlovenox given malignancy associated thrombosis as noted in CLOT \ntrial. She is quite symptomatic and requires oxygen \nsupplementation, though improved during hospitalization. Please \nwean oxygen as tolerated.\n\n# Pulmonary nodules: Known spiculated masses that were noted on \nCT in ___, concerning for primary lung malignancy vs mets. \nCurrent CT showed stable nodules still concerning for \nmalignancy. She was evaluated by the thoracic team who \nrecommended CT biopsy vs. surveillance. Given her current \nPE/DVT, the family and the patient decided for surveillance at \nthis time. They will follow up with her primary care provider. \n\n# Enterococcal UTI\nShe was noted to have rising WBC in the setting of UCX from \nurostomy growing Enterococcus. Given her rising leukocytosis, we \nproceeded with treatment. She was started on IV Ampicillin and \ntransitioned to macrobid, based on sensitivies. Leukocytosis \nimproved on antibiotics. She should complete a 7 day course (day \n1: ___, day 7: ___. \n\n# Normocytic Anemia: No signs of bleeding, or hemolysis. Hb \ndropped to nadir of 7.3, stable at discharge at 7.5. Iron \nstudies consistent with likely combination iron deficiency \nanemia and anemia of chronic disease with low iron but elevated \nferritin and low TIBC. Would recommend checking again as \noutpatient and work-up as needed.\n\n# ___ swelling: Likley multifactorial including venous \ninsufficiency, as well as known LLE DVT. She responded quite \nwell with compression stockings.\n\n# Hx of bladder cancer: s/p ___ TURBT, high-grade TCC, T1 \n(no muscle identified). Then in ___, pelvic MRI showed \nbladder mass invasion, perivesical soft tissue, anterior vaginal \nwall on right (C/W T4 lesion). In ___, underwent robotic \nTAH-BSO, lap radical cystectomy and anterior vaginectomy with \npathology showing pT2b, node and margins negative. No plan for \nany further therapy at this time per Dr ___.\n\nThe patient is safe to discharge today, and >30min were spent on \ndischarge day management services.\n\nTransitional issues:\n- She will need follow up chest CT for pulmonary nodules in 3 \nmonths (___)\n- To complete 7 day course for UTI with macrobid (day 7: ___\n- Continue oxygen therapy and wean as tolerated to maintain O2 \nsat > 92% \n- Please check CBC on ___ to ensure stability of h/h \nand demonstrate resolution of leukocytosis\n- HCP: son, Dr. ___ ___\n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Acetaminophen 650 mg PO Q6H \n2. Docusate Sodium 100 mg PO BID \n3. Enoxaparin Sodium 40 mg SC DAILY \nStart: ___, First Dose: Next Routine Administration Time \n4. Levothyroxine Sodium 175 mcg PO DAILY \n5. Atorvastatin 10 mg PO QPM \n6. Losartan Potassium 50 mg PO DAILY \n7. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate \n\n8. LORazepam 0.25 mg PO BID:PRN anxiety \n9. Senna 8.6 mg PO BID \n\n \nDischarge Medications:\n1.  Nitrofurantoin Monohyd (MacroBID) 100 mg PO Q12H \nLast day: ___.  Enoxaparin Sodium 90 mg SC Q12H \nStart: Today - ___, First Dose: Next Routine Administration \nTime  \n3.  LORazepam 0.25 mg PO QHS:PRN insomnia \nRX *lorazepam 0.5 mg 0.5 (One half) tab by mouth QHS:prn Disp \n#*3 Tablet Refills:*0 \n4.  Acetaminophen 650 mg PO Q6H  \n5.  Atorvastatin 10 mg PO QPM  \n6.  Docusate Sodium 100 mg PO BID  \n7.  Levothyroxine Sodium 175 mcg PO DAILY  \n8.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - \nModerate \nRX *oxycodone 5 mg 1 tablet(s) by mouth Q8H:prn Disp #*3 Tablet \nRefills:*0 \n9.  Senna 8.6 mg PO BID  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPE\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nMs. ___ it was a pleasure taking care you during your \nadmission to ___. You were admitted for a clot in your lungs \nand leg. You were treated with a blood thinner. You will need to \ncontinue the blood thinner. You were also treated for a urinary \ntract infection. For your pulmonary nodules, you should follow \nup with your primary care doctor. \n \nFollowup Instructions:\n___\n"
        ],
        [
         "37",
         "10001401-DS-20",
         "10001401",
         "27060146",
         "DS",
         "20",
         "2131-10-05 00:00:00",
         "2131-10-05 16:11:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nsubjective fevers, lethargy, and bloody drain output \n \nMajor Surgical or Invasive Procedure:\n___: For the large pelvic fluid collections, CT-guided \nrepositioning of existing drain and placement of an additional \ndrain.\n\n___: Removal of more recently placed drain  \n\n \nHistory of Present Illness:\nMs. ___ is an ___ with PMH of hypertension and bladder \ncancer (high grade invasive urothelial carcinoma pT2b) s/p \nTAH/BSO, radical cystectomy w/ileal conduit c/b intra-abdominal \ninfection and pelvic fluid collection s/p ___ guided drain \nplacement ___ who presents with 2 days of generalized \nmalaise and 1 day of fevers.  \n Patient underwent ___ guided JP drain placement for \nintra-abdominal fluid collection and infection, thought to be \ncomplicated of recent TAH/BSO, radical cystectomy and pelvic \nlymph node biopsy. This procedure was done on ___. Over the \npast 2 days she had noticed generalized malaise and 1 day of \nfever w/rigors to Tmax 101.5 at home. She notes that the \ndrainage from her intra-abdominal drain is darker, but her \nurostomy output has been unchanged. She notes some associated \nmild LLQ pain. She denies diarrhea, BRBPR, rash, cough, \nheadache, neck stiffness. She presented initially to OSH, where \nshe was evaluated with BCx and drain culture and was started on \nzosyn and vancomycin and given 650mg acetaminophen. She was \ntransferred to ___ for further management.  \n\n \nPast Medical History:\n- Hypertension  \n - s/p lap chole  \n - s/p left knee replacement  \n - s/p laminectomy of L5-S1 at age ___  \n - Bladder Cancer high grade TCC, T1 diagnosed in ___, then \n___ pelvic MRI w/invasion into bladder wall, perivesical \nsoft tissue and anterior vaginal wall c/w T4 staging  \n - s/p hysterectomy and bilateral oophorectomy for large uterus \nw/fibroid, s/p laparascopic b/l pelvic lymph node resection, s/p \nradical cystectomy and anterior vaginectomy with vaginal \nreconstruction with ileal conduit creation ___, course \ncomplicated by bacteremia and development of intra-abdominal \nfluid collection, no s/p drain placement by ___ ___  \n - h/o LLE DVT and PE on lovenox  \n\n \nSocial History:\n___\nFamily History:\nNegative for bladder CA.\n\n \nPhysical Exam:\nADMISSION EXAM:\n===============\n Vital Signs: 100.9 PO 130 / 54 L Lying 80 24 95 RA  \n General: Alert, oriented, no acute distress  \n HEENT: Sclerae anicteric, MMM, oropharynx clear  \n CV: RRR, normal S1 S2, systolic murmur RUBS, no rubs, gallops  \n Lungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \n Abdomen: Soft, non-tender, non-distended, bowel sounds present, \n+ileal conduit drain in RLQ, with pigtail drain in LLQ draining \ndark/sang fluid  \n GU: No foley  \n Ext: Warm, well perfused, 1+ nonpitting edema LLE  \n Neuro: CN2-12 grossly intact, moving all extremities \nspontaneously\n\nDISCHARGE EXAM: \n===============\n Vital signs: 98.3  134/64  71  20  96 RA \n General: AxO x3\n HEENT: Sclera anicteric\n Neck: supple \n Lungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi on anterior auscultation \n CV: Regular rate and rhythm, normal S1 + S2, III/VI SEM\n Abdomen: +BS, ileal conduit draining clear yellow urine.  Has \none LLQ drain in place draining serosanguinous fluid. \n Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 07:10PM BLOOD WBC-19.4*# RBC-2.53* Hgb-6.9* Hct-22.9* \nMCV-91 MCH-27.3 MCHC-30.1* RDW-15.1 RDWSD-49.5* Plt ___\n___ 07:10PM BLOOD Neuts-81.4* Lymphs-9.4* Monos-7.4 \nEos-0.0* Baso-0.1 Im ___ AbsNeut-15.77*# AbsLymp-1.81 \nAbsMono-1.43* AbsEos-0.00* AbsBaso-0.02\n___ 07:10PM BLOOD ___ PTT-33.4 ___\n___ 07:10PM BLOOD Ret Aut-2.9* Abs Ret-0.07\n___ 07:10PM BLOOD Glucose-118* UreaN-25* Creat-1.1 Na-133 \nK-5.0 Cl-97 HCO3-23 AnGap-18\n___ 07:10PM BLOOD ALT-9 AST-9 AlkPhos-56 TotBili-0.3\n___ 07:10PM BLOOD Lipase-9\n___ 07:10PM BLOOD Albumin-2.5* Iron-6*\n___ 07:10PM BLOOD calTIBC-170* Hapto-518* Ferritn-489* \nTRF-131*\n___ 07:13PM BLOOD Lactate-1.0\n\nDISCHARGE LABS:\n===============\n___ 06:00AM BLOOD WBC-6.9 RBC-2.92* Hgb-8.3* Hct-26.8* \nMCV-92 MCH-28.4 MCHC-31.0* RDW-15.4 RDWSD-52.4* Plt ___\n___ 06:00AM BLOOD ___ PTT-31.2 ___\n___ 06:00AM BLOOD Plt ___\n___ 06:00AM BLOOD Glucose-86 UreaN-8 Creat-0.8 Na-143 K-3.6 \nCl-106 HCO3-25 AnGap-16\n___ 06:00AM BLOOD Calcium-7.5* Phos-3.7 Mg-2.3\n\nMICROBIOLOGY:\n=============\nBlood cultures x3 pending\n\n___ 4:35 pm pelvic aspiration\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n   FLUID CULTURE (Final ___:    NO GROWTH. \n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH. \n\nPERTINENT IMAGING:\n==================\nCT ABD&PEL W/ CONTRAST \n___\n1. Interval decrease in size of the right hemipelvis fluid \ncollection (7.0 x 6.5 x 11.3 cm, previously 10.0 x 12.7 x 14.8 \ncm) with the anterior approach pigtail catheter unchanged in \nposition.  The pigtail is again located partly within the \ncollection and partly outside its wall. \n2. Interval increase in size of the left pelvic fluid \ncollection, now \nmeasuring 14.7 x 16.2 x 23.3 cm (previously 13.6 x 13.9 x 23.0 \ncm). Increased peripheral enhancement may suggest superimposed \ninfection. \n3. No new fluid collection identified. \n  \nCTA ABD & PELVIS\n___\n1. Decrease in size of right lower quadrant fluid collection \nthat has \npercutaneous drain within it, with areas of high attenuation on \nnoncontrast exam consistent with blood products, and associated \nhyperemia which is likely inflammatory, but without evidence of \ncontrast extravasation. \n2. There is large stable fluid collection in the low left \nabdomen, pelvis with mild linear peripheral enhancement, \ninfection cannot be excluded. \n3. There is severe left, and moderate to severe right \nhydroureteronephrosis, with delayed left nephrogram, stable from \ntoday.  Mass effect about anastomosis between distal ureters and \nneobladder has resolved all since ___, and while \nhydronephrosis may be from residual edema, if this does not \nresolve, alternative etiologies including stenosis, tumor \ninfiltration should be excluded. \n4. Tiny hepatic lesion segment ___, attention to this area on \nsubsequent \nfollowups recommended. \n\nCT INTERVENTIONAL PROCEDURE\n___ \n1.  Complete collapse the patient has recently drained left \nlower quadrant \ncollection.  The catheter from this collection was removed. \n2.  Near complete collapse of the patient is originally drained \ncollection in the mid pelvis, with pigtail catheter in place. \n3.  Left lower quadrant and deep pelvic collections as above.  \nThese findings were discussed with the team.  Given the \npatient's improving clinical status, the decision was made to \npursue no further collection drainage at this time. \n4.  Severe bilateral hydronephrosis, as on prior examinations. \nRECOMMENDATION:  Given persistence of severe hydronephrosis, \npercutaneous \nnephrostomy tubes should be considered. \n\n \nBrief Hospital Course:\nBRIEF SUMMARY:\n==============\n___ year old women with a history of bladder cancer s/p \ncystectomy, hysterectomy, and BSO now with ileal conduit, whose \npost operative course has been complicated by DVT/PE, ileus, and \npelvic fluid collections w/ one LLQ drain presented with \nsubjective fevers, lethargy, and bloody drain output. She was \nfound to have worsening anemia and was given 2 units of pRBC \nwith appropriate increase in hemoglobin noted. She was also \nfound on CT imaging to have an interval increase in size of a \nleft abdominal fluid collection. Decision was made to place a \ndrain per ID. Fluid was sent and revealed: negative cultures, \nnegative malignant cells, no evidence of lymphatic or urinary \nfluid. This new drain was subsequently removed per ___ as fluid \ncollection was completely drained. The prior drain was still \ndraining serosanguinous fluid and was kept in but repositioned. \nID was consulted for the fevers, leukocytosis and fluid \ncollections and was deemed to need antibiotics and tranisitioned \nfrom broad spectrum to IV ertapenem at discharge. Will require \nmultiple follow ups and imaging as specified in the transitional \nissues. \n \nACUTE ISSUES:\n=============\n#Pelvic fluid collections: patient arrived with one anterior \ndrain putting out serosanguinous fluid. CT abdomen/pelvis \nrevealed enlarging left fluid collection, and decision was made \nto place a drain per ___. The fluid was negative for malignant \ncells. The fluid had Cr 1 and triglycerides <9 suggesting that \nfluid collection is neither urine nor lymphatic fluid. Fluid \nculture was negative for bacteria. On interval imaging, the new \nenlarging fluid collection had completely collapsed and the \ndrain was removed. As for the other fluid collection that \nalready had a drain putting out serosanguinous fluid, it \ncontinued to drain serosanguinous fluid but at a lower rate than \nprior to admission. The drain was left in place as the fluid \ncollection on imaging had not completely collapsed. BID - N \ncultures for the aforementioned fluid collection came back \npositive for MSSA but per ID, does not reflect rue \nintra-abdominal infection. Given that patient had a fever at OSH \nand a leukocytosis, she was placed on broad spectrum antibiotics \nwith vanc, ceftaz and flagyl. This was tapered per ID team to IV \nzosyn. On discharge, ID recommended ertapenem for approximately \n4 weeks with final length of treatment to be determined by fluid \ncollection changes on repeat imaging on outpatient basis. Mrs. \n___ remained afebrile, and leukocytosis resolved. \n\n#Pulmonary embolism: Likely developed in the setting of being \ndiagnosed with a post-op DVT. She was placed on lovenox.  She \nwas transitioned to heparin ggt as she needed ___ procedures and \nwas transitioned back to lovenox but at a lower dose per weight \ndosing to 70mg q12H upon discharge. \n\n#Acute renal injury: SCr has been steadily rising from a \nbaseline of around 0.04-0.06 in ___ to 1.1, likely \n___ obstructed uropathy ___ large pelbic fluid collections. ___ \nresolved over the course of her hospital stay with final Cr 0.8. \n\n\n#Hydronephrosis: bilateral and worsening on interval imaging \nfrom prior studies. Given patient's age, adequate urinary \noutput, adequate creatinine clearance, and no significant \nelectrolyte abnormalities, patient likely would not \nsignificantly benefit from intervention at this time. Per \nurology consult, deemed stable for discharge and recommended \noutpatient urology followup. \n\n#Anemia: likely a combination of anemia of chronic inflammation \nand acute blood loss ___ to anterior abdominal drain showing \nserosanguinous fluid. Labs not consistent with hemolysis. \nReceived 2 units of pRBC with appropriate response. Patient was \ndischarged with Hgb of 8.3 per hem/onc recommendation for \nthreshold Hgb>8 as patient feels and functionally performs \nbetter with higher blood counts. \n\n#Hypokalemia: was hypokalemic and was repleted with oral KCl \nPRN. \n\nCHRONIC ISSUES:\n===============\n#Invasive high-grade urothelial carcinoma, involving the deep \nmuscularis propria\nS/p cystectomy, hysterectomy, and BSO now with ileal conduit, \nwhose post operative course has been complicated by DVT/PE, \nileus, and pelvic fluid collections.  Patient stating that there \nis no plan for chemo and radiation, her PET scan does show \nconcerning foci of metastatic disease in the lung and \nperitoneum. Per patient's son, Mrs. ___ has seen a doctor \nto work up the lung mass. Will need ongoing discussion with \noutpatient hem/onc regarding how to best manage concerning \nlesions. \n\n#Breast mass ___ mammogram showing BI-RADS 5, Solid mass \nin the 3 o'clock left breast with features of a highly \nsuspicious for malignancy. Per patient's son, she has seen a \ndoctor for evaluating the new breast mass. Would recommend \nongoing discussion with aforementioned doctor and outpatient \nhem/onc about plan to manage.\n\n# HLD: continued atorvastatin without changes. Consider \nevaluation regarding stopping atorvastatin on outpatient basis \n \n# Hypothyroidism: continued levothyroxine without changes.   \n  \n#HCP:  Dr. ___ (son, ___ physician) ___\n#Code status: full code (confirmed with patient on ___ \n\nTRANSITIONAL ISSUES:\n====================\n[ ] Will need infectious disease follow up. If ID has not \ncontacted Mrs ___ by ___, she should call ___ \nto set up an appointment. The ID appointment needs to be AFTER \nher CT abdomen/pelvis has already been done \n[ ] Assure that Mrs ___ has her CT abdomen & pelvis with \ncontrast in the week of ___\n[ ] She should get weekly lab draws of the following: CBC with \ndifferential, BUN, Cr, AST, ALT, TB, ALK PHOS. ALL LAB REQUESTS \nSHOULD BE ANNOTATED WITH: **ATTN: ___ CLINIC - FAX: \n___\n[ ] If possible, please give ertapenem at night-time so it does \nnot interfere with her daily activities. Tentatively, she will \nbe receiving ertapenem for ___ weeks but with final treatment \nlength determined by the infectious disease team. \n[ ] Will need ongoing discussion with outpatient PCP and hem/onc \nregarding how to manage new breast lesion and lung/peritoneum \nlesions. \n[ ] Reevaluate need for atorvastatin\n[ ] Will need outpatient follow up with urology, Dr. ___ \nhis team regarding worsening hydronephrosis\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q6H \n2. Atorvastatin 10 mg PO QPM \n3. Enoxaparin Sodium 90 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n4. Levothyroxine Sodium 175 mcg PO DAILY \n5. LORazepam 0.25-0.5 mg PO DAILY:PRN anxiety \n\n \nDischarge Medications:\n1.  Ertapenem Sodium 1 g IV 1X Duration: 1 Dose \nplease give ertapenem daily, preferably at nighttime to not \ninterfere with her daily activities  \n2.  Milk of Magnesia 30 mL PO Q6H:PRN constipation  \n3.  Enoxaparin Sodium 70 mg SC Q12H \nStart: Today - ___, First Dose: Next Routine Administration \nTime  \n4.  Acetaminophen 650 mg PO Q6H  \n5.  Atorvastatin 10 mg PO QPM  \n6.  Levothyroxine Sodium 175 mcg PO DAILY  \n7.  LORazepam 0.25-0.5 mg PO DAILY:PRN anxiety  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis: Pelvic fluid collection infection, ___, acute \nblood loss anemia\n\nSecondary diagnosis: acute renal failure, acute on chronic \nanemia, recent pulmonary embolism, invasive high-grade \nurothelial carcinoma, left breast mass (BIRADS 5), \nhypothyroidism  \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear ___,\n\n___ did you come to the hospital?\n- You were feeling tired and your drain output was bloody. \n\nWhat happened at the hospital?\n- A CT scan showed very large fluid collections in your pelvis \n- The radiologists placed another drain and removed it once it \nappeared that the large fluid collection was gone\n- You were given a blood transfusion\n- We placed a PICC (a long IV) so that you can receive \nantibiotics after you get discharged from the hospital\n\nWhat needs to happen when you leave the hospital?\n- Please continue seeing the doctors that are ___ your \nlung and breast lesions and follow their recommendations. \n- Continue taking Lovenox every day to treat the blood clot in \nyour lung. \n- If the infectious disease doctor has not contacted you by ___, please call the following number to set up an appointment: \n___. \n- Please make sure you have a repeat CT scan done BEFORE your \nappointment with the infectious disease doctor\n- You will be getting IV antibiotics for several weeks. The \ninfectious disease doctor ___ determine how long you will need \nto be on it. \n\nIt was a pleasure taking care of you. \nYour ___ team \n \nFollowup Instructions:\n___\n"
        ],
        [
         "38",
         "10001401-DS-21",
         "10001401",
         "28058085",
         "DS",
         "21",
         "2131-11-15 00:00:00",
         "2131-11-20 19:51:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nHematuria, weakness\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ y/o female with h/o PE (on lovenox), bladder cancer s/p  \nRobotic TAH-BSO, lap radical cystectomy with ileal loop \ndiversion and anterior vaginectomy in ___ c/b abdominal \nfluid requiring placement of drainage catheters. Recent \nabdominal imaging noted worsening of her bilateral severe \nhydronephrosis and her Cr was noted to have risen from 0.8 to \n1.3(outside lab value). Patient recently underwent bilateral \nnephrostomy tube placement by ___ on ___.\n\nShe first started feeling weak during ___ yesterday doing the \nexercises. Had palpitations with ambulation. Has tightness in \nchest with ambulating since yesterday. Felt light headed with \nambulation. SNF noticed increased hematuria with R bag darker \nthan L bag since yesterday. Her Urostomy (placed in ___ \nalso positive for hematuria. She was transferred to ___ ED for \nfurther management.\n\nIn the ED, initial vitals were:  \n\nTemp. 98.1, HR 72, BP 139/56, RR 16, 99% RA\n  \n- Labs notable for:  \nWBC 5.9, Hg 8.1, platelets 374. Na 140, K 4.3, Cl 103, biacrb \n22, BUN 29, Cr 1.0\n\nUA from bilateral nephrostomy tubes with > 100 WBC, moderate \nleukocytes, and large blood.\n\n- Imaging was notable for: \nCT abd/pelvis w/o contrast:\nInterval placement of bilateral percutaneous nephroureterostomy \ntubes with resolved hydroureteronephrosis. No RP hematoma.\n \n- Patient was given:  \nLR\n\nUpon arrival to the floor, patient reports that she noticed \nshortness of breath today with walking in conjunction with \nbloody output from her ostomy tubes. She notes that the output \nfrom her nephrostomy tubes was pink tinged when she left the \nhospital 2 days ago. She also endorses associated chest \ntightness but no pain or pressure. She denies cough, fever, \nchills, abdominal pain, or diarrhea. She notes that she has an \nostomy and nephroureterostomy without sensation of dysuria. \nPatient notes feeling dizzy and lightheaded previously though is \ncurrently asymptomatic. \n\n \nPast Medical History:\n- Hypertension  \n - s/p lap chole  \n - s/p left knee replacement  \n - s/p laminectomy of L5-S1 at age ___  \n - Bladder Cancer high grade TCC, T1 diagnosed in ___, then \n___ pelvic MRI w/invasion into bladder wall, perivesical \nsoft tissue and anterior vaginal wall c/w T4 staging  \n - s/p hysterectomy and bilateral oophorectomy for large uterus \nw/fibroid, s/p laparascopic b/l pelvic lymph node resection, s/p \nradical cystectomy and anterior vaginectomy with vaginal \nreconstruction with ileal conduit creation ___, course \ncomplicated by bacteremia and development of intra-abdominal \nfluid collection, no s/p drain placement by ___ ___  \n - h/o LLE DVT and PE on lovenox  \n\n \nSocial History:\n___\nFamily History:\nNegative for bladder CA.\n\n \nPhysical Exam:\n=========================\nADMISSION PHYSICAL EXAM: \n========================= \nVITAL SIGNS: Temp. 98.1 PO BP 158 / 66 HR 72 RR 18 Spo2 95 RA \nGENERAL: well-appearing elderly woman in no acute distress \nCARDIAC: RRR, no murmurs\nLUNGS: clear to auscultation bilaterally \nABDOMEN: soft, non-tender to palpation, normal bowel sounds. \nOstomy draining brown stool. Nephroureterostomy draining dark \nred bloody urine. Bilateral nephrostomy tubes draining blood \nurine. \nEXTREMITIES: No edema, warm and well-perfused.\n\n=========================\nDISCHARGE PHYSICAL EXAM: \n========================= \nVS -  98.3 PO 139/67 71 18 94 RA \nGENERAL: well-appearing elderly woman in no acute distress \nCARDIAC: RRR, no murmurs\nLUNGS: clear to auscultation bilaterally \nABDOMEN: soft, non-tender to palpation, normal bowel sounds.  \nNephroureterostomy draining dark red bloody urine. Bilateral \nnephrostomy tubes capped. \nEXTREMITIES: No edema, warm and well-perfused\n\n \nPertinent Results:\n================\nADMISSION LABS\n================\n___ 05:20PM BLOOD WBC-5.9 RBC-2.90* Hgb-8.1* Hct-26.6* \nMCV-92 MCH-27.9 MCHC-30.5* RDW-15.4 RDWSD-51.2* Plt ___\n___ 05:48AM BLOOD WBC-4.6 RBC-2.46* Hgb-7.0* Hct-22.6* \nMCV-92 MCH-28.5 MCHC-31.0* RDW-15.3 RDWSD-51.7* Plt ___\n___ 05:20PM BLOOD Neuts-56.3 ___ Monos-12.6 Eos-1.5 \nBaso-0.3 Im ___ AbsNeut-3.29# AbsLymp-1.69 AbsMono-0.74 \nAbsEos-0.09 AbsBaso-0.02\n___ 05:20PM BLOOD Glucose-101* UreaN-29* Creat-1.0 Na-140 \nK-4.3 Cl-103 HCO3-22 AnGap-19\n\n=================\nIMAGING/STUDIES\n=================\n\n___ CT Abd/Pel w/o Contrast: \nIMPRESSION:   \n1. Interval placement of bilateral percutaneous \nnephroureterostomy tubes with resolved hydroureteronephrosis.  \nNo RP hematoma. \n2. Partially imaged nodular opacity in the right middle lobe \nwhich can be \nfurther assessed on a nonemergent dedicated CT chest. \n\n___ CXR\nAP portable upright view of the chest.   Right upper extremity \naccess PICC \nline is seen with its tip in the upper SVC.  Overlying EKG leads \nare present.  Lungs are clear.  Cardiomediastinal silhouette is \nstable.  Bony structures are intact. \n\n==============\nMICROBIOLOGY\n==============\n___ 6:35 pm URINE      LEFT NEPHROSTOMY TUBE. \n                            **FINAL REPORT ___\n   URINE CULTURE (Final ___:    NO GROWTH. \n\n================\nDISCHARGE LABS\n================\n___ 05:08AM BLOOD WBC-5.4 RBC-2.86* Hgb-8.2* Hct-26.5* \nMCV-93 MCH-28.7 MCHC-30.9* RDW-15.3 RDWSD-51.8* Plt ___\n___ 05:08AM BLOOD Glucose-94 UreaN-29* Creat-0.9 Na-143 \nK-4.0 Cl-106 HCO3-26 AnGap-15\n___ 05:08AM BLOOD Calcium-8.8 Phos-5.2* Mg-2.1\n \nBrief Hospital Course:\nMs. ___ is an ___ year old woman with history of provoked \nDVT/PE (on lovenox), bladder cancer s/p Robotic TAH-BSO, lap \nradical cystectomy with ileal loop diversion and anterior \nvaginectomy in ___ c/b abdominal fluid requiring \nplacement of drainage catheters, and recent hydronephrosis \nrequiring placement of bilateral PCN tubes on ___, presenting \nfrom rehab with hematuria and weakness.\n\nOn arrival, pt had evidence of frank hematuria in her urostomy \nbag and PCN tubes. Her hemoglobin was initially 8.1, which \nsubsequently dropped to 7.0 Her lovenox was held, and she was \ntransfused with 1 U PRBC with an appropriate hemoglobin bump to \n8.2. Hematuria was likely caused by recent instrumentation in \nthe setting of anticoagulation. Her hematuria improved, as did \nher dizziness/weakness. ___ was consulted and recommending \ncapping her PCN tubes. After discussion with the patient's \nhematologist, it was decided to stop her lovenox treatment given \nthat her DVT/PE were provoked in the setting of her recovery \nfrom surgery, and that she had received almost 6 months of \ntreatment.\n\nSecondary Issues:\n\n# Asymptomatic bacteruria: Patient with asymptomatic bacteruria \nin setting of recent procedural manipulation. She was afebrile \nand without leukocytosis, so treatment with antibiotics was \ndeferred.\n\n# Hyperlipidemia: continued atorvastatin 10 mg daily\n\n# Hypothyroidism: continue levothyroxine 175 mcg daily\n\n===================\nTRANSITIONAL ISSUES\n===================\nMedication Changes: Lovenox stopped \n[ ] CT Abdomen/Pelvis showed partially imaged nodular opacity in \nthe right middle lobe which can be further assessed on a \nnonemergent dedicated CT chest. \n[ ] Pt's PCN tubes were capped per ___ recommendation during her \nhospitalization; she was discharged with scheduled followup to \ndecide on long term management\n[ ] If pt develops hematuria and/or lightheadedness or other \nsymptoms of anemia, a CBC should be rechecked to assess for \nbleeding\n[ ] Hemoglobin/Hematocrit on discharge: 8.2/26.5\n\n# CODE: presumed full\n# CONTACT: ___ (MD) ___ (cell) \n___ (home) \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Atorvastatin 10 mg PO QPM \n2. Enoxaparin Sodium 70 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n3. Levothyroxine Sodium 175 mcg PO DAILY \n4. Multivitamins 1 TAB PO DAILY \n5. Probiotic-Digestive Enzymes (L. acidophilus-dig ___ 5) \n___ mg oral daily \n\n \nDischarge Medications:\n1.  Atorvastatin 10 mg PO QPM  \n2.  Levothyroxine Sodium 175 mcg PO DAILY  \n3.  Multivitamins 1 TAB PO DAILY  \n4.  Probiotic-Digestive Enzymes (L. acidophilus-dig ___ 5) \n___ mg oral daily  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnoses: Hematuria, anemia\n\nSecondary Diagnoses: Bladder cancer, hydronephrosis, \nhypothyroidism, DVT/PE\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nIt was a pleasure taking care of you at ___. \n\nWHY DID YOU COME TO THE HOSPITAL?\nYou noticed blood in your urine, and you were feeling \nweak/lightheaded.\n\nWHAT HAPPENED WHILE YOU WERE HERE?\nWe did not give you your blood thinner medication (Lovenox), and \nwe gave you a unit of blood. The blood in your urine cleared up. \n\n\nWHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL?\nAlong with your oncologist Dr. ___ have decided that you \nno longer need to take any Lovenox. You should continue to \nfollow up with your doctors, and take all of your medications as \nprescribed. Your followup appointments are listed below.\n\nAgain, it was a pleasure taking care of you!\n\nSincerely, \n\nYour ___ Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "39",
         "10001401-DS-22",
         "10001401",
         "27012892",
         "DS",
         "22",
         "2133-07-13 00:00:00",
         "2133-07-13 17:38:00",
         " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nFevers and chills\n \nMajor Surgical or Invasive Procedure:\n___ -- stent exchange\n\n \nHistory of Present Illness:\nMs. ___ is a ___ female with the past\nmedical history notable for history of bladder cancer status \npost\nrobotic TAH-BSO, lap radical cystectomy with ileal loop \ndiversion\nand anterior vaginectomy in ___ complicated by abdominal\nfluid requiring placement of drainage catheters, further\ncomplicated by a severe bilateral hydronephrosis requiring\nbilateral urostomy tube placement and then ultimately ureteral\nstent placements with improvement who presented to the hospital\nfor routine stent exchange and cystoscopy.  The patient \nunderwent\nan uncomplicated procedure but then postoperatively in the PACU\nshe developed a fever to 102.4 and was tachycardic 105 and as\nsuch was felt to need admission for treatment of sepsis.  At \nthat\ntime she was given ampicillin and gentamicin given her history \nof\ndrug resistant organisms.  She reported at that time she was\nfeeling feverish and chills with nausea and vomiting x1.  She\nreceived IV fluids and her IV antibiotics and her symptoms\nimproved.  She was admitted to the medical service for further\nevaluation and management\n\nOn the floor the patient reports that she continues to have\npersistent chills.  She feels slightly nauseous.  She denies any\nabdominal pain.  She otherwise reports that she is feeling \nbetter\nthan she did immediately postprocedural but is still\nsignificantly off of her baseline.  She reports that she has a\nhistory of urinary tract infections and was most recently on\nciprofloxacin and ___.  She reports that she was on\nthis medication for 7-day course.  No ___ acute complaints.\n\n \nPast Medical History:\n- Hypertension  \n - s/p lap chole  \n - s/p left knee replacement  \n - s/p laminectomy of L5-S1 at age ___  \n - Bladder Cancer high grade TCC, T1 diagnosed in ___, then \n___ pelvic MRI w/invasion into bladder wall, perivesical \nsoft tissue and anterior vaginal wall c/w T4 staging  \n - s/p hysterectomy and bilateral oophorectomy for large uterus \nw/fibroid, s/p laparascopic b/l pelvic lymph node resection, s/p \n\nradical cystectomy and anterior vaginectomy with vaginal \nreconstruction with ileal conduit creation ___, course \ncomplicated by bacteremia and development of intra-abdominal \nfluid collection, no s/p drain placement by ___ ___  \n - h/o LLE DVT and PE no longer on anticoagulation. \n \nSocial History:\n___\nFamily History:\nNegative for bladder CA.\n\n \nPhysical Exam:\nADMISSION EXAM:\n\nVITALS: ___ 2227 Temp: 99.3 PO BP: 119/54 HR: 80 RR: 16 O2\nsat: 98% O2 delivery: RA Dyspnea: 0 RASS: 0 Pain Score: ___ \nGENERAL: Alert and in no apparent distress, facial twitches\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nCV: Heart regular, no murmur, no S3, no S4.  No JVD.\nRESP: Lungs clear to auscultation with good air movement\nbilaterally.  Breathing is non-labored\nGI: Abdomen soft, non-distended, non-tender to palpation.  Bowel\nsounds present.  No HSM\nGU: No suprapubic fullness or tenderness to palpation, foley\ncatheter in place\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs\nSKIN: No rashes or ulcerations noted\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nspeech fluent, moves all limbs, sensation to light touch grossly\nintact throughout\nPSYCH: pleasant, appropriate affect\n\nDISCHARGE EXAM:\n\nAVSS, ambulating comfortably at baseline. Urostomy bag in place \nwith no surround erythema or pain.\n \nPertinent Results:\nLABORATORY RESULTS:\n\n___ 05:30AM BLOOD WBC-16.5* RBC-3.23* Hgb-9.8* Hct-31.8* \nMCV-99* MCH-30.3 MCHC-30.8* RDW-14.5 RDWSD-52.3* Plt ___\n___ 06:09AM BLOOD WBC-14.1* RBC-3.39* Hgb-10.2* Hct-33.2* \nMCV-98 MCH-30.1 MCHC-30.7* RDW-14.6 RDWSD-52.7* Plt ___\n___ 06:10AM BLOOD WBC-10.0 RBC-3.55* Hgb-10.5* Hct-33.6* \nMCV-95 MCH-29.6 MCHC-31.3* RDW-14.1 RDWSD-49.9* Plt ___\n___ 05:30AM BLOOD Glucose-115* UreaN-34* Creat-1.6* Na-142 \nK-4.2 Cl-106 HCO3-22 AnGap-14\n___ 06:10AM BLOOD Glucose-99 UreaN-29* Creat-1.3* Na-141 \nK-3.8 Cl-104 HCO3-23 AnGap-14\n___ 05:30AM BLOOD Calcium-8.1* Phos-3.4 Mg-1.8\n\nMICROBIOLOGY:\n\n___ 3:00 pm URINE     Site: CYSTOSCOPY      RIGHT KIDNEY \nWASH. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      ENTEROCOCCUS FAECIUM.    >10,000 CFU/ML. \n         ___ (___) REQUESTS SUSCEPTIBILITY TESTING \n___. \n      STAPHYLOCOCCUS, COAGULASE NEGATIVE.    1,000 - 10,000 \nCFU/ML. \n      CORYNEBACTERIUM SPECIES (DIPHTHEROIDS).    1,000 - 10,000 \nCFU/ML. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             ENTEROCOCCUS FAECIUM\n                             |   \nAMPICILLIN------------     8 S\nNITROFURANTOIN--------  <=16 S\nTETRACYCLINE----------  =>16 R\nVANCOMYCIN------------     2 S\n\nBlood cultures NGTD\n \nBrief Hospital Course:\nMs. ___ was admitted with sepsis from a urinary tract \ninfection after her stent exchange. She was placed empirically \non vancomycin and cefepime (narrowed to vanc/ceftriaxone on \nHD#1), because of her history of resistant organisms. She \nrapidly improved. Her urine grew E. faecium, sensitive to \nampicillin. Therefore, a PICC line was placed, and she will \ncomplete two weeks total of ampicillin for a complicated urinary \ntract infection (additional day days). She will follow up with \nDr. ___ as an outpatient. She will stop her prophylactic TMP \nwhile on ampicillin, but then resume after finishing her course.\n- ampicillin 500 mg TID x 9 additional days\n- restart TMP 100 mg daily for ppx after antibiotic course\n- follow up with Dr. ___\n\n___ problems addressed this hospitalization:\n\n1. ___. Ms. ___ initially had an ___, likely prerenal from \nher sepsis. She received IV fluids and antibiotics as above, and \nher creatinine down-trended. Losartan was initially held, but \nrestarted on discharge.\n\n2. Hyperlipidemia: continued atorvastatin 10 mg daily\n\n3. Hypothyroidism: continue levothyroxine 175 mcg daily\n\n> 30 minutes spent on discharge activities.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever \n2. Atorvastatin 10 mg PO QPM \n3. Cyanocobalamin 1000 mcg PO DAILY \n4. Docusate Sodium 100 mg PO BID \n5. Levothyroxine Sodium 175 mcg PO DAILY \n6. LORazepam 0.5 mg PO Q12H:PRN anxiety \n7. Losartan Potassium 50 mg PO BID \n8. Multivitamins 1 TAB PO DAILY \n9. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First \nLine \n10. Trimethoprim 100 mg PO Q24H \n\n \nDischarge Medications:\n1.  Ampicillin 500 mg IV Q8H \nRX *ampicillin sodium 500 mg 500 mg IV Every eight hours Disp \n#*15 Vial Refills:*0\nRX *ampicillin sodium 500 mg 500 mg IV Every eight hours Disp \n#*27 Vial Refills:*0 \n2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  \n3.  Atorvastatin 10 mg PO QPM  \n4.  Cyanocobalamin 1000 mcg PO DAILY  \n5.  Docusate Sodium 100 mg PO BID  \n6.  Levothyroxine Sodium 175 mcg PO DAILY  \n7.  LORazepam 0.5 mg PO Q12H:PRN anxiety  \n8.  Losartan Potassium 50 mg PO BID  \n9.  Multivitamins 1 TAB PO DAILY  \n10.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First \nLine  \n11. HELD- Trimethoprim 100 mg PO Q24H  This medication was held. \nDo not restart Trimethoprim until after you finish your \nampicillin.\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nComplicated E. faecium UTI\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou were admitted to the hospital after you developed fevers and \nchills after you developed fevers and chills from your stent \nexchange. Your urine grew the enterococcus species -- the source \nof your infection. Because it was enterococcus, a PICC line was \nplaced and you will finish a total 14-day course of IV \nampicillin.\n\nYou also had kidney injury, likely from infection, that resolved \nwith antibiotics and fluids. It was a pleasure taking care of \nyou!\n \nFollowup Instructions:\n___\n"
        ],
        [
         "40",
         "10001663-DS-17",
         "10001663",
         "23405714",
         "DS",
         "17",
         "2145-03-15 00:00:00",
         "2145-03-15 19:55:00",
         " \nName:  ___               ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nSulfa (Sulfonamides) / Penicillins\n \nAttending: ___\n \nChief Complaint:\nFacial weakness\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nHPI: ___ RHF w/ hx GERD, mild depression, and prior migraines,\npresents now with episode of facial numbness. She had been lying\non her left face, watching TV, and noticed when she got up that\nher left face was numb as if she were injected with novacaine, \nin\na distribution that she traces along mid-V2 down to her jaw \nline.\nShe initially thought it was ___ the way she was lying, but\nbecame concerned when it persisted. She endorsed a mild diffuse\ndull HA that is not unusual for her. She states in some ways, it\nfelt as though a migraine were coming on, though the HA she had\nwas not typical of her past migraines. The numbness lasted 90\nminutes, and has now resolved completely. There was no \nassociated\nweakness, no sensory changes outside of her face, no VC, \nvertigo,\nor language impairment. She cannot recall something like this\nhappening before, and states that her day was otherwise routine.\nOn ROS, she notes that about 2 weeks ago she had diarrhea for 1\nweek which resolved spontaneously. She also endorses feeling\n\"achey\" 4 days ago, otherwise, her health has been normal. \n\n \nPast Medical History:\nGERD \nmild depression\nmigraines (throbing HA's assoc with visual flashes of light),\nlast ___ years ago \nbunions\n \nSocial History:\n___\nFamily History:\nFather with HD, sustained a stroke after a cardiac cath. Later \nin\nlife father developed a meningioma and subsequent seizures. \n\n \nPhysical Exam:\n98.4F 69 134/79 15 100%RA \n\nGen: Lying in bed, NAD\nHEENT: NC/AT, moist oral mucosa   \nNeck: No tenderness to palpation, normal ROM, supple, no carotid\nor vertebral bruit\nCV: RRR, Nl S1 and S2, no murmurs/gallops/rubs \nLung: Clear to auscultation bilaterally \naBd: +BS soft, nontender \next: no c/c/e; equal radial and pedal pulses B/L. \n\n \nNeurologic examination: \nMental status: Awake and alert, cooperative with exam, normal \naffect.  Oriented to person, place, and date.  Attentive, says\n___ backwards.  Speech is fluent with normal comprehension and\nrepetition; naming intact. No dysarthria. Reading intact. No\nright left confusion. No evidence of apraxia or neglect.\n \nCranial Nerves:  \nPupils equally round and reactive to light, 4 to 2 mm\nbilaterally. Visual fields are full to confrontation. Retinas\nwith sharp disc margins B/L. Extraocular movements intact\nbilaterally, no nystagmus. Sensation intact V1-V3 to both LT and\nPP.  Facial movement symmetric.  Hearing intact to finger rub\nbilaterally.  Palate elevation symmetrical.  Sternocleidomastoid\nand trapezius normal bilaterally. Tongue midline, movements\nintact\n \nMotor: \nNormal bulk bilaterally. Tone normal. No observed myoclonus or\ntremor\nNo pronator drift\n  Del Tri Bi  WF WE FE FF  IP  H  Q DF PF TE TF\nR  ___  ___  ___  ___  5  5\nL  ___  ___  ___  ___  5  5  \n\nSensation: Intact to light touch, pinprick, and proprioception\nthroughout. \n\nReflexes: \n+2 and symmetric throughout.  \nToes downgoing bilaterally \n \nCoordination: finger-nose-finger normal, heel to shin normal, FT\nand RAMs normal. \n \nGait: Narrow based, steady. Able to tandem walk without\ndifficulty\n\nRomberg: Negative\n\n \nPertinent Results:\n___ 06:10AM BLOOD WBC-5.3 RBC-4.38 Hgb-11.5* Hct-36.1 \nMCV-82 MCH-26.2* MCHC-31.8 RDW-13.3 Plt ___\n___ 11:14PM BLOOD Neuts-52.1 ___ Monos-4.7 Eos-2.0 \nBaso-0.5\n___ 11:14PM BLOOD ___ PTT-33.7 ___\n___ 06:10AM BLOOD Glucose-82 UreaN-16 Creat-0.8 Na-140 \nK-4.0 Cl-105 HCO3-26 AnGap-13\n___ 11:14PM BLOOD ALT-13 AST-19 CK(CPK)-69 AlkPhos-70 \nTotBili-0.2\n___ 11:14PM BLOOD CK-MB-NotDone cTropnT-<0.01\n___ 11:14PM BLOOD TotProt-7.1 Albumin-4.5 Globuln-2.6 \nCalcium-9.5 Phos-3.7 Mg-2.1\n___ 02:26AM BLOOD %HbA1c-5.7\n___ 11:14PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n\nRadiology Report MRA BRAIN W/O CONTRAST Study Date of ___ \n9:44 AM \n1. No acute intracranial abnormality; specifically, there is no \nevidence of \neither acute or previous ischemic event. \n2. Normal cranial and cervical MRA, with no significant mural \nirregularity or \nflow-limiting stenosis. \n\n \nBrief Hospital Course:\nMs. ___ is a ___ yo woman with a hx of depression, GERD and \nmigraines, presenting with an episode of facial numbness.\n\n1. Facial numbness.  As this episode preceeded a headache, \nsuspect likely due to a migraine equivalent, however episode \ncould also be due to a TIA in the thalamus.  The patient had an \nMRI, which showed no signs of ischemia, and normal vasculature, \nmaking migraine equivalent a much more likely diagnosis.  \nHowever, given the possibility of TIA, she has been started on a \ndaily aspirin for future stroke prophylaxis.  Exam on discharge \nwas notable for mild symmetric hyperreflexia in the lower \nextremities, but otherwise normal neurological exam, with no \nresidual sensory deficits.\n \nMedications on Admission:\nNEXIUM 40 mg--1 capsule(s) by mouth once a day\nPROZAC 20 mg--1 capsule(s) by mouth once a day\n\n \nDischarge Medications:\n1. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \n2. Fluoxetine 20 mg Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n3. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO DAILY (Daily).  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nMigraine \n \nDischarge Condition:\nMild symmetric hyperreflexia in the lower extremities, otherwise \nnormal neurological exam.\n\n \nDischarge Instructions:\nYou were admitted for left sided facial numbness.  You had an \nMRI which showed no signs of ischemia.  It is suspected that \nthis was related to migraine headaches, but we recommend that \nyou start taking a full dose of aspirin.\n\nIf you notice new numbness, weakness, worsening headaches, or \nother new concerning symptoms, please return to the nearest ED \nfor further evaluation.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "41",
         "10001667-DS-10",
         "10001667",
         "22672901",
         "DS",
         "10",
         "2173-08-24 00:00:00",
         "2173-08-24 15:04:00",
         " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nslurred speech\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ year old right-handed woman with hx of Atrial fibrillation on \nEliquis (only once daily), hypertension, hyperlipidemia, CHF\npresents as transfer from OSH after she had acute onset \ndysarthria and CTA showed possible partial thrombus or stenosis \nin superior division of L MCA. Transferred here for closer \nmonitoring and possible thrombectomy if her exam acutely \nworsens.\n\nHistory obtained from patient and daughter at bedside. Patient \nis an excellent historian. \n\nOn ___, she had dinner with friends and then returned to her \napartment and was fooling around on her computer. Last known \nwell\nwas around 8:00 ___. Then, she had an odd sensation and started \nthrowing her arms around. She went to living room to sit down \nand\ntried to read but could not see the words very clearly. Then, \ntwo family members were knocking at the door and she had a tough \ntime\nstanding up to open door. She was able to eventually stand up \nwith great difficulty and walked with her walker. She usually \nwalks with a walker because of knee replacement. Finally, got up \nout of chair with walker and walked to the door to unlock. She \nnoticed problems talking to family members. She had difficulty \nforming words and pronouncing words. Denies word finding \ndifficulty. She could tell it was slurred like a person who had \ntoo much to drink. EMTs asked if she was intoxicated but she was \nnot. She was very aware of her dysarthria and told her daughters \nthat she thinks she's having a stroke. Then, she said she had \ntrouble sitting down but has no idea why she thought that. When \nshe was standing, she was able to walk with walker but she felt \nunsteady and almost fell. No visual changes. No numbness or \ntingling. Denies focal weakness; she just had trouble standing \nup. She was able to unlock her door without issue but she felt \nshaky. \n\nShe was brought by EMS to ___ where NIHSS was 1 for \nslurred speech. There, she felt the same but her symptoms \nstarted to improve when she started to be transferred. \nParamedics said her speech was improving rapidly en route.  \n\nLast month, started needing naps. Her hearing is poor at \nbaseline and she normally uses hearing aids. \n\nFor the past ___ months, she has had ___ nocturia nightly. No \ndysuria. \n\nShe has noticed more frequent headaches lately in the past ___ \nmonths. Last headache was yesterday. She takes tramadol and \nacetaminophen up to a couple times a night. She reports \nheadaches at night which wake her up. She denies that the \nheadache is\npositional; it is the same sitting up or lying down. She has had \nsome gradual weight loss over the past ~12 months; ___ year ago \nshe was almost 140 lbs, and now she is ___ lbs. Her appetite is \nstill good and she enjoys eating but she is less hungry that she \nused to be.  \n\nDaughter says that she has had marked decline in memory in past \n___ weeks. Over past few years, she has been forgetting plans, \ntimes for pickpup, and dinner plans, which has become normal. \nOver the past ___ weeks, family has noticed dramatic worsening. \nShe doesn't remember which grandkids were coming to visit when \nshe bought the plane tickets herself.\n\nShe endorses 2 pillow orthopnea. \n \nPast Medical History:\nDivertoculosis\nAtrial fibrillation on Eliquis\nCHF\nHypercholesterolemia\nHypertension\n \nSocial History:\n___\nFamily History:\nFather - severe alcoholic, schizophrenia\nMother - CHF\nBrother - stroke, carotid stenosis\n \nPhysical Exam:\nADMISSION EXAM:\nVitals: T:97.9   HR: 79   BP: 164/121   RR: 19   SaO2: 94% on RA\n\nGeneral: Awake, cooperative elderly woman, NAD.\nHEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in\noropharynx.\nNeck: Supple. No nuchal rigidity.\nPulmonary: Normal work of breathing.\nCardiac: RRR, warm, well-perfused.\nAbdomen: Soft, non-distended.\nExtremities: No ___ edema.\nSkin: ecchymoses in L shin, more extensive on R shin. \n \nNeurologic:\n-Mental Status: Alert, oriented ___.\nAble to relate history without difficulty. Attentive, able to\nname ___ backward without difficulty. Language is fluent with\nintact repetition and comprehension. Normal prosody. There were\nno paraphasic errors. Able to name both high and low frequency\nobjects.  Able to read without difficulty. No dysarthria. Able \nto\nfollow both midline and appendicular commands. There was no\nevidence of apraxia or neglect.\n\n-Cranial Nerves:\nII, III, IV, VI:  PERRL 3 to 2mm and brisk. EOMI without\nnystagmus. Normal saccades. VFF to confrontation. \nV: Facial sensation intact to light touch and pinprick.\nVII: No facial droop, facial musculature symmetric.\nVIII: Hearing intact to finger snapping b/l. Did not bring her\nhearing aids. \nIX, X: Palate elevates symmetrically.\nXI: ___ strength in trapezii bilaterally.\nXII: Tongue protrudes in midline with good excursions. Strength\nfull with tongue-in-cheek testing.\n\n-Motor: Normal bulk and tone throughout. No pronator drift. No\nadventitious movements, such as tremor or asterixis noted.\n  [___]\nL    5    5    5    5    5    5   5    5    5   5    5    5\nR    5    5    5    5    5    5   5    5    5   5    5    5\n\n-Sensory: No deficits to light touch, pinprick, temperature\nthroughout. Decreased vibratory sense in b/l feet up to ankles.\nJoint position sense intact in b/l great toes. No extinction to\nDSS. Romberg absent.\n\n-Reflexes:\n  [Bic] [Tri] [___] [Pat] [Ach]\nL   2+    2      2      2+    0\nR   2+    2      2      2+    0 \nPlantar response was flexor bilaterally.\n\n-Coordination: No intention tremor.  No dysmetria on FNF\nbilaterally. HKS with L heel without dysmetria. Unable to bend R\nknee due to knee surgery. \n\n-Gait: unable to assess as patient needs a walker at baseline\n\nDISCHARGE EXAM:\n24 HR Data (last updated ___ @ 419)\nTemp: 97.4 (Tm 98.6), BP: 146/76 (116-155/65-94), HR: 53 \n(53-86),\nRR: 17 (___), O2 sat: 96% (92-97), O2 delivery: Ra\n\nGeneral: Awake, cooperative elderly woman, NAD.\nHEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in\noropharynx.\nNeck: Supple. No nuchal rigidity.\nPulmonary: Normal work of breathing.\nCardiac: NR, RR, warm, well-perfused.\nAbdomen: Soft, non-distended.\nExtremities: No ___ edema.\nSkin: ecchymoses in L shin, more extensive on R shin. \n \nNeurologic:\n-Mental Status: Alert, oriented to person and situation. Able to\nrelate history without difficulty. Attentive to examiner.\nLanguage is fluent with intact comprehension. Normal prosody.\nThere were no paraphasic errors. No dysarthria. Able to follow\nboth midline and appendicular commands. There was no evidence of\napraxia or neglect.\n\n-Cranial Nerves:\nII, III, IV, VI:  PERRL 3 to 2mm and brisk. EOMI without\nnystagmus. Normal saccades.\nV: Facial sensation intact to light touch.\nVII: No facial droop, facial musculature symmetric.\nVIII: Hearing intact to conversation.\nIX, X: Palate elevates symmetrically.\nXI: ___ strength in trapezii bilaterally.\nXII: Tongue protrudes in midline with good excursions.\n\n-Motor: Normal bulk and tone throughout. No pronator drift. No\nadventitious movements, such as tremor or asterixis noted.\n  [Delt][Bic][Tri][ECR][FEx][IO][IP][Quad][Ham][TA][Gas]\nL    5    5    5    5    5    5   5    5    5   5    5    \nR    5    5    5    5    5    5   5    *    *   5    5    \n*Knee cannot bend after prior surgery\n\n-Sensory: No deficits to light touch throughout.\n\n-Coordination: No intention tremor.  No dysmetria on FNF\nbilaterally. \n\n-Gait: needs a walker at baseline\n \nPertinent Results:\n___ 01:50AM BLOOD WBC-7.2 RBC-4.75 Hgb-14.6 Hct-45.5* \nMCV-96 MCH-30.7 MCHC-32.1 RDW-13.2 RDWSD-46.5* Plt ___\n___ 01:50AM BLOOD Neuts-53.1 ___ Monos-8.2 Eos-1.5 \nBaso-0.3 Im ___ AbsNeut-3.81 AbsLymp-2.63 AbsMono-0.59 \nAbsEos-0.11 AbsBaso-0.02\n___ 01:50AM BLOOD ___ PTT-29.7 ___\n___ 01:50AM BLOOD Glucose-97 UreaN-18 Creat-0.7 Na-139 \nK-4.3 Cl-102 HCO3-26 AnGap-11\n___ 07:35AM BLOOD CK-MB-4 cTropnT-<0.01\n___ 07:35AM BLOOD Calcium-9.3 Phos-3.6 Mg-1.8 Cholest-207*\n___ 07:35AM BLOOD Triglyc-62 HDL-69 CHOL/HD-3.0 LDLcalc-126\n___ 10:57AM BLOOD %HbA1c-5.5 eAG-111\n___ 05:22AM BLOOD VitB12-249\n___ 05:22AM BLOOD TSH-5.8*\n___ 05:22AM BLOOD Trep Ab-NEG\n___ 03:12AM URINE Color-Straw Appear-Clear Sp ___\n___ 03:12AM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n\n___ OSH CTA head/neck ___ opinion (___)\nIMPRESSION: \n1.  Segmental left vertebral artery occlusion of indeterminate \nchronicity.  No evidence of ischemia.\n2.  Somewhat small caliber attenuated left M2 inferior branch, \nwithout evidence of focal occlusion.\n3.  No acute intracranial abnormality on noncontrast CT head.\n\n___ MRI head w/o contrast\nIMPRESSION:\n1. No acute intracranial abnormality.  Specifically, no large \nterritory infarction or hemorrhage.\n2. Scattered foci of T2/high-signal intensity in the subcortical \nand periventricular white matter are nonspecific and may reflect \nchanges due to chronic small vessel disease.\n\n___ TTE\nIMPRESSION: No structural source of thromboembolism identified \n(underlying rhythm predisposes to thrombus formation). Preserved \nleft ventricular systolic function in the setting of \nbeat-to-beat variability due to arrhythmia. Mild to moderate \nmitral and tricuspid regurgitation. Normal pulmonary pressure. \nVery small pericardial effusion\n \nBrief Hospital Course:\nMs. ___ is a ___ year old female with AFib on Eliquis, CHF, \nHLD, HTN who presented w/ sudden onset dysarthria, abnormal arm \nmovements, and poor balance (walker at baseline). NIHSS 1 for \nslurred speech at OSH. There, a CTA head and neck was completed, \nand there was concern for left M2 branch attenuation concerning \nfor stenosis or occlusion, and she was subsequently transferred \nfor consideration of thrombectomy but NIHSS 0 on arrival so she \nwas not deemed a candidate. She was admitted to the Neurology \nstroke service for further evaluation of possible TIA vs stroke. \nNo further symptoms noted during admission. MRI head w/o \ncontrast were without evidence of stroke. Reports recent \nechocardiogram per outpatient PCP/cardiologist, reported as no \nacute findings and so this was not repeated. She mentioned \nconcern about worsening memory, but able to perform ADLs w/ \nmeals/cleaning provided by ALF (moved 10 months ago); it appears \nthere has been no acute change. She was taking apixiban 2.5mg \nonce daily (unclear why as this is a BID medication), and so her \ndose was increased to 2.5mg BID (she was not a candidate for 5mg \nBID due to her age and weight). She was started on atorvastatin \nfor her hyperlipidemia (LDL 126). EP cardiology was consulted \nfor frequent sinus pauses noted on telemetry that persisted \ndespite holding home atenolol, recommending discontinuing home \ndigoxin and close cardiology ___. Discharged to home w/ \n___ & ___ and close PCP ___.\n\n#Transient slurred speech and instability, c/f TIA\n- ___ consult - cleared for home with home services\n- Started on atorvastatin for HLD and increased home apixaban to \ntherapeutic level\n- ___ with stroke neurology after discharge\n\nHer stroke risk factors include the following:\n1) DM: A1c 5.5%\n2) Likely chronic segmental left vertebral artery occlusion and \nsomewhat small caliber attenuated left M2 inferior branch\n3) Hyperlipidemia: LDL 126\n4) Obesity\n5) No concern noted for sleep apnea - she does not carry the \ndiagnosis\nAn echocardiogram did not show a PFO on bubble study.\n\nAHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic \nAttack\n1. Dysphagia screening before any PO intake? (X) Yes, confirmed \ndone - () Not confirmed () No\n2. DVT Prophylaxis administered? (X) Yes - () No\n3. Antithrombotic therapy administered by end of hospital day 2? \n(X) Yes - () No\n4. LDL documented? (X) Yes (LDL = 126) - () No\n5. Intensive statin therapy administered? (simvastatin 80mg, \nsimvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, \nrosuvastatin 20mg or 40mg, for LDL > 100) (X) Yes - () No [if \nLDL if LDL >70, reason not given:\n[ ] Statin medication allergy\n[ ] Other reasons documented by physician/advanced practice \nnurse/physician ___ (physician/APN/PA) or pharmacist\n[ ] LDL-c less than 70 mg/dL]\n6. Smoking cessation counseling given? () Yes - (X) No [reason \n(X) non-smoker - () unable to participate]\n7. Stroke education (personal modifiable risk factors, how to \nactivate EMS for stroke, stroke warning signs and symptoms, \nprescribed medications, need for followup) given (verbally or \nwritten)? (X) Yes - () No\n8. Assessment for rehabilitation or rehab services considered? \n(X) Yes - () No\n9. Discharged on statin therapy? (X) Yes - () No [if LDL >70, \nreason not given:\n[ ] Statin medication allergy\n[ ] Other reasons documented by physician/advanced practice \nnurse/physician ___ (physician/APN/PA) or pharmacist\n[ ] LDL-c less than 70 mg/dL\n10. Discharged on antithrombotic therapy? (X) Yes [Type: () \nAntiplatelet - (X) Anticoagulation] - () No\n11. Discharged on oral anticoagulation for patients with atrial \nfibrillation/flutter? (X) Yes - () No - () N/A\n\n#Cognitive complaints\n- B12 249 - one time IM supplementation, then start oral B12 \nsupplementation\n- Treponemal antibodies negative\n- consider cognitive neurology referral as outpatient for memory \ndifficulties not appreciated on our examination\n\n#Afib\n#frequent sinus pauses\n- stopped digoxin, will ___ closely w/ otpt cardiologist \n(also PCP)\n- increased to appropriate therapeutic dosing at Eliquis 2.5 mg \nBID (reduced dose given age and weight <60 kg)\n\n#HLD\n- started atorvastatin\n\n#HTN\n- continue home antihypertensives\n\n#elevated troponin (RESOLVED)\n- Troponin elevated at OSH, negative on admission\n\n#elevated TSH\n- should recheck as otpt w/ PCP ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Atenolol 50 mg PO DAILY \n2. Apixaban 2.5 mg PO DAILY \n3. Losartan Potassium 50 mg PO DAILY \n4. Digoxin 0.125 mg PO DAILY \n5. LevoFLOXacin 500 mg PO Q24H \n\n \nDischarge Medications:\n1.  Atorvastatin 40 mg PO QPM \nRX *atorvastatin 40 mg 1 tablet(s) by mouth once daily at \nbedtime Disp #*30 Tablet Refills:*5 \n2.  Cyanocobalamin 500 mcg PO DAILY \nRX *cyanocobalamin (vitamin B-12) 500 mcg 1 tablet(s) by mouth \nonce daily Disp #*30 Tablet Refills:*5 \n3.  Apixaban 2.5 mg PO BID  \n4.  Atenolol 50 mg PO DAILY  \n5.  LevoFLOXacin 500 mg PO Q24H  \n6.  Losartan Potassium 50 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\ntransient dysarthria not secondary to TIA or stroke\nMild Vitamin B12 deficiency\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were hospitalized due to symptoms of slurred speech due to \nconcern for an ACUTE ISCHEMIC STROKE, a condition where a blood \nvessel providing oxygen and nutrients to the brain is blocked by \na clot. The brain is the part of your body that controls and \ndirects all the other parts of your body, so damage to the brain \nfrom being deprived of its blood supply can result in a variety \nof symptoms. However, the MRI of your brain did not show \nevidence of stroke or TIA. Your symptoms could have been related \nto blood pressure, dehydration, alcohol use, or a combination of \nthese factors.\n\nWe are changing your medications as follows:\nIncrease apixaban to 2.5mg twice daily\nStart Vitamin B12 daily supplement\n\nPlease take your other medications as prescribed.\n\nPlease follow up with your primary care physician as listed \nbelow. You should also follow up with your cardiologist as you \nwere noted to have occasional pauses on cardiac monitoring.\n\nIf you experience any of the symptoms below, please seek \nemergency medical attention by calling Emergency Medical \nServices (dialing 911). In particular, please pay attention to \nthe sudden onset and persistence of these symptoms:\n- Sudden partial or complete loss of vision\n- Sudden loss of the ability to speak words from your mouth\n- Sudden loss of the ability to understand others speaking to \nyou\n- Sudden weakness of one side of the body\n- Sudden drooping of one side of the face\n- Sudden loss of sensation of one side of the body\n\nSincerely,\nYour ___ Neurology Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "42",
         "10001725-DS-12",
         "10001725",
         "25563031",
         "DS",
         "12",
         "2110-04-14 00:00:00",
         "2110-04-19 17:44:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nCodeine / gabapentin / morphine / Amoxicillin / metronidazole / \npropoxyphene / rofecoxib / Macrobid / furosemide / Amitiza / \nSulfa (Sulfonamide Antibiotics) / Tylenol / Hydromorphone / \nToradol\n \nAttending: ___\n \nChief Complaint:\nFor admission: elective gynecologic surgery for urinary \nretention\nFor MICU transfer: Anaphylaxis\n \nMajor Surgical or Invasive Procedure:\nStage 2 interstim w/ posterior colporrhaphy for rectocele + \nenterocele ___\n \nHistory of Present Illness:\nHistory of Present Illness:  Ms. ___ is a ___ w/ Hx \nof cervical CA s/p radical hysterectomy c/b chronic ___ \nlymphedema and urinary retention, for which she frequently \nself-caths, Asthma, GERD, IBS, anxiety/depression, fibromyalgia \nand other issues who was admitted for an elective gynecologic \nsurgery (stage 2 interstim and posterior colporrhaphy w/ graft) \nfor urinary retention and rectocele + enterocele.  \n \nPast Medical History:\nCervical CA s/p radical hysterectomy c/b chronic ___ lymphedema\nADHD\nAnxiety/Depression\nAsthma\nInsomnia\nGERD\nRaynaud's\nIBS\nFibromyalgia  \n\n \nSocial History:\n___\nFamily History:\n+Hx of atopy in son, daughter; both w/ frequent allergy rxns \nrequiring epi pens\n \nPhysical Exam:\nMICU ADMISSION EXAM:\n--------------------\n\nVitals: T: 98.7 BP: 113/83 P: 79 R: 18 O2: 97% ___  \n___: Well appearing female in no acute distress, slightly \nmuffled voice, somewhat flushed skin\nHEENT: Moist mucous membranes, mild lip swelling, tongue not \ngrossly edematous, no angioedema\nNeck: JVP non elevated\nCV: Regular rate and rhythm, normal S1 S2, no murmurs\nLungs: Clear to auscultation bilaterally, no \nwheezes/rales/rhonchi\nAbdomen: Soft, normoactive bowel sounds, nontender, \nnondistended, no rebound or guarding\nGU: Foley in place\nExt:  Warm, trace ___ edema, peripheral pulses 2+ ___\nNeuro: alert and oriented to person, hospital, and date\n\nMICU DISCHARGE EXAM:\n--------------------\n\nVitals: T: 97.5 BP: 107/62 P: 84 R: 16 O2: 99% ___  \n___: Well appearing female in no acute distress, normal \nvoice, somewhat flushed skin, most prominent in malar \ndistribution on face\nHEENT: Moist mucous membranes, appearance of face unchanged from \nyesterday, tongue not edematous, no angioedema\nNeck: JVP non elevated\nCV: Regular rate and rhythm, normal S1 S2, no murmurs\nLungs: Clear to auscultation bilaterally, no \nwheezes/rales/rhonchi\nAbdomen: Soft, normoactive bowel sounds, nontender, \nnondistended, no rebound or guarding\nGU: Foley in place\nExt:  Warm, trace ___ edema, peripheral pulses 2+ ___\nNeuro: alert and oriented to person, hospital, and date\n\nGYN Floor discharge exam:\nVSS, AF\nGen: NAD A&O x 3\nResp: no visible respiratory distress, speaking in full \nsentences\nAbd: soft, NT ND\nExt: moving all 4 extremities\n\n \nPertinent Results:\nMICU ADMISSION LABS:\n\n___ 06:02PM BLOOD WBC-17.0* RBC-4.33 Hgb-13.9 Hct-39.1 \nMCV-90 MCH-32.2* MCHC-35.6* RDW-11.8 Plt ___\n___ 06:02PM BLOOD Neuts-94.5* Lymphs-4.3* Monos-0.7* \nEos-0.1 Baso-0.3\n___ 06:02PM BLOOD ___ PTT-31.8 ___\n___ 06:02PM BLOOD Glucose-146* UreaN-16 Creat-0.8 Na-140 \nK-3.9 Cl-106 HCO3-24 AnGap-14\n___ 06:02PM BLOOD Calcium-9.1 Phos-3.1 Mg-1.5*\n___ 06:02PM BLOOD TRYPTASE-PND\n\nMICU DISCHARGE LABS:\n\n___ 02:59AM BLOOD WBC-20.1* RBC-3.98* Hgb-12.6 Hct-36.3 \nMCV-91 MCH-31.6 MCHC-34.7 RDW-11.9 Plt ___\n___ 02:59AM BLOOD Plt ___\n___ 02:59AM BLOOD Glucose-152* UreaN-18 Creat-0.8 Na-138 \nK-3.5 Cl-102 HCO3-24 AnGap-16\n___ 02:59AM BLOOD Calcium-9.1 Phos-4.0 Mg-2.8*\n\nPERTINENT LABS:\n\n___ 06:02PM BLOOD WBC-17.0* RBC-4.33 Hgb-13.9 Hct-39.1 \nMCV-90 MCH-32.2* MCHC-35.6* RDW-11.8 Plt ___\n___ 06:02PM BLOOD Neuts-94.5* Lymphs-4.3* Monos-0.7* \nEos-0.1 Baso-0.3\n___ 06:02PM BLOOD ___ PTT-31.8 ___\n___ 06:02PM BLOOD Glucose-146* UreaN-16 Creat-0.8 Na-140 \nK-3.9 Cl-106 HCO3-24 AnGap-14\n___ 06:02PM BLOOD Calcium-9.1 Phos-3.1 Mg-1.5*\n___ 06:02PM BLOOD TRYPTASE-PND\n\nPERTINENT IMAGING:\n\nNone\n\nPERTINENT MICRO:\n\nNone\n \nBrief Hospital Course:\nMs. ___ is a ___ y/o F w/ Hx of cervical CA s/p radical \nhysterectomy c/b chronic ___ lymphedema and urinary retention, \nAsthma, GERD, anxiety/depression, fibromyalgia. Please refer to \nthe operative report for full details.\n\nHer post-operative course was uncomplicated. Immediately \npost-op, her pain was controlled with IV dilaudid and toradol. \nHowever, in the PACU, the patient started feeling itchy.  Once \nthe pt returned to the floor, she noted sensation of tongue / \nlip swelling, difficulty swallowing secretions, and a change in \nher voice.  No SOB, no flushing, no stridor or wheeze.  She was \nadministered an Epi-pen, Solumedrol 100 mg IV, Famotidine 20 mg \nIV, and Hydroxyzine 25 mg IM.  She was transferred to the MICU \nfor closer monitoring. \n\nThe patient has numerous drug allergies and was administered the \nfollowing medications intra-operatively: Midazolam, Rocuronium, \nFentanyl, Dexamethasone, Hydromorphone, Ondansetron, Lidocaine, \nPropofol, Cefazolin, Glycopyrrolate, Phenylephrine, and \nKetorolac.\n\nIn the MICU, initial VS were HR 87, BP 100/63, RR 17, S 100% \n___.  The patient was in NAD, without wheeze or poor air \nmovement on exam, but complained of persistent voice change and \ndifficulty swallowing, for which she required 2 more epi pens.  \nHas remained hemodynamically stable and without respiratory \ncompromise.\n\nACTIVE ISSUES:\n\n*) Post operative care\nHer pain was controlled immediately post-op with IV dilaudid and \ntoradol. This was transitioned to po oxycodone as it was \ndifficult to determine what was causing an allergic reaction in \nMs. ___.\n\nHer vaginal packing was removed on POD 1, on post-operative day \n2, her urine output was adequate and her Foley was removed. The \npatient was able to void spontaneously, but did require \nself-catheterization ___ times a day based on a sensation of \nbladder fullness. \n\n*) Anaphylaxis: \nIn the PACU the patient awoke and started feeling pruritis. Once \nshe arrived to the floor, the patient noted difficulty talking, \nsubjectively swollen lips/tongue, and vocal changes. No SOB, no \nflushing, no stridor or wheeze. A trigger was called for \nanaphyllaxis and she recieved an Epi-pen, Solumedrol 100 mg IV, \nFamotidine 20 mg IV, and Hydroxyzine 25 mg IM.  She was \ntransferred to the MICU for closer monitoring. \n\nIn the MICU, initial VS were HR 87, BP 100/63, RR 17, S 100% \n___.  The patient was in NAD, without wheeze or poor air \nmovement on exam, but complained of persistent voice change and \ndifficulty swallowing, for which she required 2 more epi pens.  \nHas remained hemodynamically stable and without respiratory \ncompromise. \n\nOf note, patient was lying comfortable in bed around 2200 and \ncontinuing to inquire about more Epi-pens vs epinephrine gtt \ndespite comfortable respiration, vocalization, non-edematous \noral structures. She also perseverated about her Ativan and \nAmbien, as well as her propranolol for essential tremor despite \nexplanation that beta blockers can worsen bronchoconstriction \nand respiratory compromise in anaphylaxis.\n\nOn the day she was called out to the floor, the pt complained of \npersistent facial flushing.  She was afebrile, hemodynamically \nstable, and without respiratory compromise or systemic symptoms. \n Symptomatic care with hydroxyzine and eucerin lotion was \nprovided.\n\nUpon step down to the floor, the patient again reported to \nnursing that she felt throat constriction. Epinephrine and \nsolumedrol were given and the patient felt relief. Allergy was \nconsulted, and they asked us to stop all new medications given \nto her while at the hospital, and to report all of them as \nallergies. In addition, we sent out a tryptase level, as well as \ncoordinated outpatient follow-up with them. \n\n#Chronic ___ edema: Continue home Metolazone, spironolactone, \npotassium repletion as not hypotensive.  We monitored her K \nduring her stay, which was WNL.\n\n#Asthma: Home Albuterol use ___ per week, did not require in \nthe MICU. \n\n#GERD: Nexium (was initially held on admission, but per pt \nrequest was given on ___ prior to advancing diet)\n\n#ADHD: On Adderall, held on admission\n\n# Anxiety/depression/fibromyalgia: lorazepam \n\n# Insomnia: zolpidem\n\nBy post-operative day 1, she was tolerating a regular diet, \nambulating independently, and pain was controlled with oral \nmedications. She was the  discharged home in stable condition \nwith outpatient follow-up scheduled. She was also scheduled to \nhave an appointment with Allergy and Immunology.\n\n \nMedications on Admission:\nAlbuterol sulfate 2.5 mg/3 mL (0.083 %) Neb TID PRN\nAlbuterol ProAir HFA 90 mcg INH 1 puff BID PRN \nCephalexin 250 mg Q6H\nAdderall XR 15 mg BID\nErgocalciferol (vitamin D2) 50,000 U Q week\nNexium 40 mg ___ QAM\nVivelle 0.075 mg/24 hr Transderm Patch 2x / week \nDiflucan 200 mg Q ___ \nHydroxyzine HCl 25 mg QD PRN \nIbuprofen 600 mg Q8H PRN\nLinzess (linactolide) 145 mcg QD\nAtivan 1 mg QD PRN \nMetolazone 2.5 mg QD\nZofran 8 mg PO PRN \nOxycodone 5 mg PO Q6H PRN \nPotassium chloride 10 % Oral Liquid 30ml PO QID\nPropranolol ER 80 mg ER QHS\nSpironolactone 100 mg QD\nTrimethoprim 100 mg tablet QD\nAmbien 10 mg QHS\n#14 ___ catheter \nDocusate sodium 100 mg BID\nLACTOBACILLUS COMBINATION\n \nDischarge Medications:\n1. Docusate Sodium (Liquid) 100 mg PO BID \nRX *docusate sodium 100 mg 1 tablet by mouth twice a day Disp \n#*60 Capsule Refills:*0\n2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation \nRX *bisacodyl 5 mg ___ tablet,delayed release (___) by \nmouth constipation Disp #*20 Tablet Refills:*0\n3. Metolazone 2.5 mg PO DAILY \n4. NexIUM (esomeprazole magnesium) 40 mg Oral once Duration: 1 \nDose \n5. OxycoDONE (Immediate Release)  ___ mg PO Q6H:PRN pain \ndo not drive and drink on this medication \nRX *oxycodone 5 mg ___ tablet(s) by mouth every 6 hrs Disp #*20 \nTablet Refills:*0\n6. Propranolol LA 80 mg PO DAILY \n7. Spironolactone 100 mg PO DAILY \n8. Zolpidem Tartrate 5 mg PO HS \n9. Trimethoprim 100 mg PO DAILY \n10. Vivelle (estradiol) 0.075 mg/24 hr Transdermal twice/week \n11. Lorazepam 1 mg PO DAILY:PRN anxiety \n12. Potassium Chloride 40 mEq PO DAILY Duration: 24 Hours \nHold for K > \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nurinary retention, rectocele\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\nYou were admitted to the Gynecology service after your scheduled \nStage 2 Insterstim placement and posterior colporrhaphy with \ngraft for urinary retention and rectocele and enterocele.  You \ntolerated the procedure well. However, after your operation, you \nhad a severe allergic reaction, and had to go to the ICU for \nmonitoring. Since then, you have recovered well, and we have \ndetermined that you are in stable condition for discharge. \nPlease take your medication and follow-up at your appointments \nas scheduled.\n\n___ instructions:  \n* Take your medications as prescribed.  \n* Do not drive while taking narcotics. \n* Take a stool softener such as colace while taking narcotics to \nprevent constipation \n* Do not combine narcotic and sedative medications or alcohol  \n* Do not take more than 4000mg acetaminophen (APAP) in 24 hrs  \n* No strenuous activity until your post-op appointment  \n* Nothing in the vagina (no tampons, no douching, no sex) for 6 \nweeks\n* No heavy lifting of objects >10lbs for 6 weeks.    \n* You may eat a regular diet  \n* or anything that concerns you\n\nIncision care:  \n* You may shower and allow soapy water to run over incision; no \nscrubbing of incision. No bath tubs for 6 weeks.  \n \nCall your doctor for:  \n* fever > 100.4  \n* severe abdominal pain  \n* difficulty urinating  \n* vaginal bleeding requiring >1 pad/hr  \n* abnormal vaginal discharge  \n* redness or drainage from incision  \n* nausea/vomiting where you are unable to keep down fluids/food \nor your medication  \n* or anything that concerns you\n\nTo reach medical records to get the records from this \nhospitalization sent to your doctor at home, call ___. \n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "43",
         "10001860-DS-12",
         "10001860",
         "21441082",
         "DS",
         "12",
         "2188-03-30 00:00:00",
         "2188-03-29 12:56:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Penicillins\n \nAttending: ___.\n \nChief Complaint:\nneck pain s/p fall\n \nMajor Surgical or Invasive Procedure:\nNone on this Admission\n \nHistory of Present Illness:\n___ male transferred from outside hospital for \nevaluation of cervical ___ fracture. Today the patient was \nattempting to use the bathroom and bent forward and fell hitting \nthe back of his head. There was no loss of consciousness. The \npatient complains of headache and neck pain. The outside \nhospital the patient had the head laceration stapled. A CT scan \ndid demonstrate the fracture. The patient denies any numbness, \ntingling in his arms or legs. No weakness in his arms or legs. \nDenies any bowel incontinence or bladder retention. No saddle \nanesthesia. Denies any chest pain, shortness of breath or \nabdominal pain.\n  \n\n \nPast Medical History:\nPMH: a. fib, colon ca, htn, copd\n  \nMED: warfarin, allopurinol, asacol\n  \nALL: pcn, sulfa\n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nC collar in place\n\nUEC5C6C7C8T1\n(lat arm)  (thumb) (mid fing) (sm finger) (med arm)\nRintact      intact        intact        intact        intact\nLintact      intact        intact        intact        intact\n\nT2-L1 (Trunk) intact\n\n___      L2        L3  L4  L5S1S2\n(Groin)(Knee)    (Med Calf) (Grt Toe) (Sm Toe) (Post Thigh)\nRintactintactintactintact       intactintact\nLintactintactintactintact       intactintact\n\nMotor:\nUEDlt(C5)Bic(C6)WE(C6)Tri(C7)WF(C7)FF(C8)FinAbd(T1)\nR   5   5    5    5    ___\nL   5   5    5    5    ___\n\n___  Flex(L1) Add(L2) Quad(L3)  TA(L4) ___ ___\nR   ___    5    5    5       5      \nL   ___    5    5    5    5\n\n             \nBabinski:  negative \nClonus: not present\n  \n\n \nBrief Hospital Course:\nPatient was admitted to the ___ ___ Surgery Service for \nobservation after a C2 fracture.  TEDs/pnemoboots were used for \npostoperative DVT prophylaxis.  Diet was advanced as tolerated.  \nThe patient was tolerated oral pain medication. Physical therapy \nwas consulted for mobilization OOB to ambulate.  He remained \nhypertensive from 160 - >180.  Medicine consult appreciated - \nfelt this was long standing.  recommended PRN antihypertensives \nbut cautioned against bringing pressure too low too quickly.  \nHospital course was otherwise unremarkable.  On the day of \ndischarge the patient was afebrile with stable vital signs, \ncomfortable on oral pain control and tolerating a regular diet. \n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q4H:PRN pain, temp >100.5, headache \n2. Allopurinol ___ mg PO DAILY \n3. Mesalamine ___ 400 mg PO TID \n4. Metoprolol Tartrate 25 mg PO BID \n5. Omeprazole 20 mg PO DAILY \n6. Warfarin 1 mg PO DAILY \n7. OxycoDONE (Immediate Release)  2.5-5 mg PO Q4H:PRN pain \n8. Diazepam 2 mg PO Q12H:PRN spasms \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nC2 fracture\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou have undergone the following operation: Anterior Cervical \nDecompression and Fusion\n\nImmediately after the operation:\n-Activity: You should not lift anything greater than 5 lbs for \n2 weeks. You will be more comfortable if you do not sit in a car \nor chair for more than ~45 minutes without getting up and \nwalking around.\n\n-Rehabilitation/ Physical Therapy: \no2-3 times a day you should go for a walk for ___ minutes as \npart of your recovery.  You can walk as much as you can \ntolerate.  \noIsometric Extension Exercise in the collar: 2x/day x ___xercises as instructed.\n\n-Swallowing: Difficulty swallowing is not uncommon after this \ntype of surgery. This should resolve over time.  Please take \nsmall bites and eat slowly.  Removing the collar while eating \ncan be helpful  however, please limit your movement of your \nneck if you remove your collar while eating.\n\n-Cervical Collar / Neck Brace: You need to wear the brace at \nall times until your follow-up appointment which should be in 2 \nweeks.  You may remove the collar to take a shower.  Limit your \nmotion of your neck while the collar is off. Place the collar \nback on your neck immediately after the shower.\n\n-Wound Care: Monitor laceration at scalp for drainage/redness.  \nYour PCP may take these staples out.\n\n-You should resume taking your normal home medications.\n\n-You have also been given Additional Medications to control \nyour pain.  Please allow 72 hours for refill of narcotic \nprescriptions, so plan ahead.  You can either have them mailed \nto your home or pick them up at the clinic located on ___. \n We are not allowed to call in narcotic (oxycontin, oxycodone, \npercocet) prescriptions to the pharmacy.   In addition, we are \nonly allowed to write for pain medications for 90 days from the \ndate of surgery.\n\n-Follow up:\noPlease Call the office ___ and make an appointment \nwith Dr. ___ 2 weeks after the day of your operation if \nthis has not been done already.\noAt the 2-week visit we will check your incision, take baseline \nx rays and answer any questions.\noWe will then see you at 6 weeks from the day of the operation. \nAt that time we will most likely obtain Flexion/Extension X-rays \nand often able to place you in a soft collar which you will wean \nout of over 1 week.  \n\nPlease call the office if you have a fever>101.5 degrees \nFahrenheit, drainage from your wound, or have any questions.\n\nPhysical Therapy:\nactivity as tolerated\nC-collar full time for 12 weeks\nmay use ambulatory assistive devices for safety\nno  bending twisting, or lifting >5lbs\nTreatment Frequency:\nmonitor skin at chin and back of head for breakdown in C-collar\n \nFollowup Instructions:\n___\n"
        ],
        [
         "44",
         "10001877-DS-19",
         "10001877",
         "25679292",
         "DS",
         "19",
         "2149-05-27 00:00:00",
         "2149-05-27 11:29:00",
         " \nName:  ___                ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROSURGERY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nGait instability, multiple falls\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMr ___ is a pleasant right handed ___ year old male with Afib, \non coumadin, who is quite independent, living with his wife and \nwas in a good state of health until mid last year. At that time \nhis wife reports that he began having periods of disorganized \nspeech and gait instability. He did not have a fall until 3 \nmonths ago when he broke several ribs on his coffee table. He \ndid not have any head trauma and was not scanned at an OSH. His \ngarbled speech and unsteadiness have waxed and waned over the \npast 6 months and his wife reports that they are much improved \nwhen he takes his diuretics. Over this period he has lost ~20 \nlbs. \nLast night he was sorting papers at the dining room table when \nhe fell from standing because of the dizziness. He reports no \nLOC, no head trauma and was able to stand back up and continue \nhis work. His wife placed him on the couch, but he got back up \nand fell in the bathroom - again he denies any LOC or head \ntrauma, blaming his instability and ___ weakness. He had no \ntongue biting or loss of bowel/bladder continence. He went to \nbed last night, but the morning of presentation his wife was \nconcerned about his falls and brought him to the ED. He does \nhave a diagnosis of DM II from just over a month ago and has \nstarted oral hypoglycemics for which he reports having low ___ at \nhome. He was seen by an outside neurologist the week prior who \nhad ordered a CT head to be completed the following week. In the \nED his head was scanned which revealed no bleed but a 3x3 L \nfrontal lobe extra-axial mass with compressive effect but\nno midline shift. Neurosurgery was contacted for evaluation of \nthe mass and its possible role in the patient's recent symptoms. \n\n \nPast Medical History:\nDM II, HTN, HL, MI (in past), AF on coumadin, prostate CA \ntreated non-operatively\n\n \nSocial History:\n___\nFamily History:\nNon-contributory \n \nPhysical Exam:\nAt Admission: \n\nGen: WD/WN, comfortable, NAD.\nHEENT: Pupils: 4->3    EOMs intact b/l\nLungs: CTA bilaterally.\nCardiac: irreg irreg with ___ holosystolic murmur.\nAbd: Soft, NT, BS+\nExtrem: Warm and well-perfused.\nNeuro:\nMental status: Awake and cooperative with exam, normal affect.\nOrientation: Oriented to person, place, and date.\nRecall: ___ objects at 5 minutes.\nLanguage: Speech is fluent, good comprehension. Difficulty with\nrepitition. Naming intact. No dysarthria or paraphasic errors.\n\nCranial Nerves:\nI: Not tested\nII: Pupils equally round and reactive to light, to\nmm bilaterally. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Facial strength and sensation intact and symmetric.\nVIII: Hearing intact to voice.\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\n\nMotor: Normal bulk and tone bilaterally. No abnormal movements,\ntremors. Strength full power ___ throughout. Mild R sided\npronator drift. Gait unsteady, rhomberg test with unsteadiness.\n\nSensation: Intact to light touch, propioception, pinprick and\nvibration bilaterally.\n\nReflexes: B T Br Pa Ac\nRight     ___ 1  1\nLeft      ___ 1  1\n\nToes downgoing bilaterally\n\nCoordination: heel to shin intact, finger nose-finger slowed and\novershooting with R hand. Difficulty with rapid alternating\nmovements with R hand.\n\nAT DISCHARGE: \nAfeb, VSS\nGen: NAD.\nHEENT: Pupils: 3->2  EOMs intact b/l\nLungs: clear b/l\nCardiac: irreg irreg with ___ holosystolic murmur.\nAbd: non-tender/non-distended\nExtrem: no edema or erythema, warm well perfused.\n\nNeuro:\nMental status: Awake and cooperative with exam, normal affect.\nOrientation: Oriented to person, place, and date.\nLanguage: Speech is fluent, good comprehension.\n\nCranial Nerves:\nII-XII tested and intact b/l\n\nMotor: ___ strength b/l in UE and ___. No pronator drift. Gait \nsteady, walking without assistance.\n\nSensation: Grossly intact b/l.\n\nReflexes: B T Br Pa Ac\nRight     ___ 1  1\nLeft      ___ 1  1\n\nToes downgoing bilaterally\n \nPertinent Results:\n___ 04:55AM BLOOD WBC-3.9* RBC-4.39* Hgb-13.5* Hct-40.7 \nMCV-93 MCH-30.7 MCHC-33.1 RDW-15.5 Plt ___\n___ 04:55AM BLOOD ___\n___ 04:55AM BLOOD Glucose-115* UreaN-33* Creat-1.2 Na-142 \nK-3.7 Cl-104 HCO3-33* AnGap-9\n___ 06:25AM BLOOD Albumin-3.2*\n___ 02:39PM BLOOD %HbA1c-7.7* eAG-174*\n___ 06:25AM BLOOD Phenyto-4.6*\n\nCT Head ___: \nIMPRESSION: \n1. Extra-axial lesion, containing foci of calcifications \nmeasuring up to 3 cm, which likely reflects an extra-axial mass \nsuch as a meningioma. An \nextra-axial hematoma, which would be subacute to chronic, is \nconsidered less likely. \n2. Loss of gray-white differentiation in the high left \nfrontoparietal lobe, could reflect an acute infarct. \n\nMRI Head ___:\nAcute to subacute bilateral infarctions with the largest focus \nin the left post-central gyrus. Appearance of the post-gyrus \nlesion is somewhat \nheterogeneous however and recommend attention on followup \nimaging for further evaluation to exclude the presence of an \nunderlying mass. Two meningiomas in the left frontal region \nwithout significant mass effect.\n\nECHO ___:\nMarked symmetric left ventricular hypertrophy with normal cavity \nsize and regional/global systolic function. Mild aortic valve \nstenosis. Mild aortic regurgitation. Right ventricular free wall \nhypertrophy. Pulmonary artery systolic hypertension. Dilated \nascending aorta. \nCLINICAL IMPLICATIONS: \nThe patient has mild aortic stenosis. Based on ___ ACC/AHA \nValvular Heart Disease Guidelines, a follow-up echocardiogram is \nsuggested in ___ years. \nBased on ___ AHA endocarditis prophylaxis recommendations, the \necho findings indicate prophylaxis is NOT recommended. Clinical \ndecisions regarding the need for prophylaxis should be based on \nclinical and echocardiographic data. \n\nMRA Head/Neck ___:\nMild atherosclerotic disease of the basilar artery. There is no \nevidence of acute vascular abnormalities involving the \nintracranial arteries \n\n \n\n \nBrief Hospital Course:\nMr. ___ was admitted to the neurosurgical service on ___ \nfrom the emergency room after having a series of falls on \n___. A CT of the head demonstrated a left frontal \nextra-axial mass as well as a more acute lesion in the parietal \nlobe on the left. Because of his recent falls, his coumadin was \nheld and he was placed on an insulin sliding scale as there was \nsome concern for hypoglycemia contributing to the unsteadiness. \n\nAn MRI of this head was obtained which confirmed a meningioma \noverlying the L frontal lobe and a sub-acute infarct in the \npost-central gyrus on the left. While he did have distinct right \nsided weakness in the emergency room, on hospital day #2 this \nweakness had nearly completely resolved and his confusion was \nalso better. A neurology consult was obtained given what \nappeared to be a sub-acute stroke on his MRI - they recommended \nrestarting the pt's coumadin, holding the dilantin and checking \nan EEG, these were done while he was an inpatient. He also \nunderwent a surface echo and an MRA of the brain and neck given \nthe likely embolic nature of his strokes. \n\nNeurology will see him in 3 months with a repeat head MRI. \n___ also saw him for his diabetes managment \nand recommended changing his glipizide to 10 BID, and not \nstarting insulin. His sugars were well controlled while in house \nand he did not have any episodes of hypoglycemia. From a \nneurologic standpoing, in-house he did quite well with resultion \nof his right sided weakness although his unsteadiness continued \nand he needed support while ambulating. \n\n___ recommended he go to a short term rehab until he was better \nable to compete transfers and ambulate with a walker. He will \nfollow up with neurology and neurosurgery to discuss how to best \nmanage his ischemic strokes and address the meningioma, \nrespectively.\n \nMedications on Admission:\nCoumadin 2.5', prandin 0.5''', glipizide 5'', isosorbide \ndinitrate 10'', lisinopril 20, allopurinol ___, torsemide 5, \nmetoprolol 50''', lipitor 10'\n\n \nDischarge Medications:\n1. Isosorbide Dinitrate 10 mg Tablet Sig: One (1) Tablet PO BID \n(2 times a day).  \n2. Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n3. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO TID \n(3 times a day).  \n4. Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n5. Allopurinol ___ mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. Warfarin 2.5 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 \n___.  \n7. Torsemide 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n8. Glipizide 10 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n-\n \nDischarge Diagnosis:\nLeft frontal meningioma, left parietal sub-acute infarct, \nDiabetes\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nYou should take your coumadin as prescribed.\nYou do not need anti-seizure medications any longer.\nYou should follow up with Dr. ___ Dr. ___ as \nlisted below. You will need a follow up MRI to evaluate the \nsmall stroke you had on the left side of your brain. Take all \nmedications as prescribed and follow up with Dr. ___ \nthis week to check in.\n\nGeneral Instructions/Information\nTake your pain medicine as prescribed.\nExercise should be limited to walking; no lifting, straining, \nor excessive bending.\nIncrease your intake of fluids and fiber, as narcotic pain \nmedicine can cause constipation. We generally recommend taking \nan over the counter stool softener, such as Docusate (Colace) \nwhile taking narcotic pain medication.\nUnless directed by your doctor, do not take any \nanti-inflammatory medicines such as Motrin, Aspirin, Advil, and \nIbuprofen etc.  \n If you are being sent home on steroid medication, make sure \nyou are taking a medication to protect your stomach (Prilosec, \nProtonix, or Pepcid), as these medications can cause stomach \nirritation.  Make sure to take your steroid medication with \nmeals, or a glass of milk. \nClearance to drive and return to work will be addressed at your \npost-operative office visit.\nMake sure to continue to use your incentive spirometer while \nat home.\nCALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE \nFOLLOWING\n\nNew onset of tremors or seizures.\nAny confusion or change in mental status. \nAny numbness, tingling, weakness in your extremities.\nPain or headache that is continually increasing, or not \nrelieved by pain medication.\nFever greater than or equal to 101 F.\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "45",
         "10001877-DS-20",
         "10001877",
         "21320596",
         "DS",
         "20",
         "2150-11-23 00:00:00",
         "2150-11-23 16:47:00",
         " \nName:  ___                ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nLower extremity swelling\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ with AF on warfarin, DM, and recent steroid pulse p/w \nbilaterally swollen and painful ankles. Pt had no complaints in \nthe ED, but his wife was concerned about his increasing swelling \nand his inability to walk without pain. He had a fall over a \nbathtub one week ago (reports no head strike). He was at a \n___ in ___ at that time and went to the local ___ \n___. He was found to have a vertebral fracture and was \ngiven a back brace, which he has been wearing inconsistently.  \n\nIn the ED, exam was remarkable for bilateral ankle swelling with \n3+ pitting edema, cold and mottled toes, + dopplerable dorsalis \npedis pulses with no sensory disturbances. BNP was elevated at \n6310. CXR showed pulmonary edema. LENIs were negative for DVT. \nED bedside US showed no evidence of pericardial effusion or IVC \nvolume depletion  \n\nHe was given 40mg IV Lasix. Nursing in the ED noted that pt able \nto stand and weight bear but unsteady, fall risk. T-spine film \nwas also done in the ED and was without fractures or \ndislocations.  \n\nHe triggered for hypotension to mid ___ and bradycardia to mid \n___ x 2, responded well to 250cc fluid boluses. Vitals prior to \ntransfer: T 98.8, HR 63, RR 15, BP 118/85, 02 100% on RA  \n\n \nPast Medical History:\nDM II, HTN, HL, MI (in past), AF on coumadin, prostate CA \ntreated non-operatively\n\n \nSocial History:\n___\nFamily History:\nNon-contributory \n \nPhysical Exam:\nVS: T 96.6, BP 140/palp, HR 64, RR 24, 98% on RA  \nGENERAL: Well-appearing man in NAD, comfortable, appropriate.  \nHEENT: NC/AT, sclerae anicteric, MMM  \nHEART: irregularly irregular, III/VI systolic ejection murmur \nloudest at the LUS boarder, nl S1-S2.  \nLUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored. \n \nABDOMEN: Normoactive BS, soft/NT/ND, no masses or HSM, no \nrebound/guarding.  \nEXTREMITIES: Bruising of the toes of the left foot. B/L edema, \nmost pronounced at the feet/ankles, 3+ to the thighs.  \nNEURO: Awake, alert, conversant, grossly intact  \n\n \nPertinent Results:\nADMISSION LABS\n___ 06:30PM BLOOD WBC-6.2# RBC-4.17* Hgb-13.3* Hct-40.3 \nMCV-97 MCH-32.0 MCHC-33.1 RDW-14.8 Plt ___\n___ 06:30PM BLOOD ___ PTT-35.9* ___\n___ 06:30PM BLOOD Glucose-210* UreaN-56* Creat-1.6* Na-141 \nK-3.6 Cl-99 HCO3-33* AnGap-13\n___ 06:30PM BLOOD ALT-49* AST-46* LD(LDH)-440* CK(CPK)-173 \nAlkPhos-66 TotBili-0.8\n___ 06:30PM BLOOD CK-MB-10 MB Indx-5.8 proBNP-6310*\n \nDISCHARGE LABS\n___ 06:07AM BLOOD WBC-4.9 RBC-4.10* Hgb-12.9* Hct-39.3* \nMCV-96 MCH-31.5 MCHC-32.9 RDW-14.6 Plt Ct-95*\n___ 08:05AM BLOOD ___\n___ 08:05AM BLOOD UreaN-40* Creat-1.4* Na-140 K-3.5 Cl-103 \nHCO3-28 AnGap-13\n___ 06:07AM BLOOD CK-MB-7 cTropnT-0.01\n\nCXR ___: 1. Mild congestive heart failure.  \n2. Widened superior mediastinum with leftward deviation of the \ntrachea, similar when compared to the prior study. Findings may \nreflect the presence of a thyroid goiter, and clinical \ncorrelation is recommended, and if indicated, this could be \nconfirmed with a CT of the chest.  \n  \nL-spine film ___: Five non-rib-bearing lumbar-type vertebral \n \nbodies are present. There are multilevel degenerative changes, \nwith loss of intervertebral disc height at multiple levels, \nendplate sclerotic changes, and anterior osteophyte formation. \nThere is no fracture or vertebral compression deformity \nidentified. There is likely mild grade 1 L5 on S1 \nanterolisthesis, which is likely degenerative in etiology. Facet \nhypertrophic changes are noted within the lower lumbar spine \nprimarily affecting L3 through L5 levels. Vascular \ncalcifications are visualized. The sacroiliac joints are not \ndiastatic.  \nIMPRESSION: No fracture identified.  \n\nCT head ___:\nThere is no acute intracranial hemorrhage, edema or acute \nvascular \nterritorial infarction. Note is made of areas of \nencephalomalacia involving the parietal lobe on the left, which \nappear unchanged as does an area of hypodensity on the right \nadjacent to the caudat.. Similarly unchanged are two left \nfrontal meningiomas, the larger of which is partially calcified, \nand better depicted on the prior MRI (2:24, 601:19). Ventricles \nand sulci are enlarged, reflecting parenchymal volume loss. Note \nis made of atherosclerotic calcification at the carotid siphons \nbilaterally as well as of both V4 segments. There is no \nfracture. The mastoid air cells are clear. \nIMPRESSION: No acute intracranial abnormality, and unchanged \nfindings of \nprevious infarcts and meningiomas. \n\nLENIs ___:\nWaveforms in the common femoral veins are symmetric bilaterally \nwith appropriate responses to Valsalva maneuvers. In both lower \nextremities, the common femoral, proximal greater saphenous, \nsuperficial femoral and popliteal veins are normal with \nappropriate compressibility, wall-to-wall flow on color Doppler \nanalysis and response to waveform augmentation. Wall-to-wall \nflow is also visualized in the posterior tibial and peroneal \nveins of both calves.\nIMPRESSION: No deep venous thrombosis in either lower extremity. \n\n  \n\nMICROBIOLOGY: \n___: Blood culture - no growth to date\n\n \nBrief Hospital Course:\n___ yo M with DM, afib, and CHF presenting with pulm edema and \nworsening ___ edema.\n \n# CHF: Likely an acute on chronic worsening of diastolic \ncongestive heart failure (most recent LVEF >55%) and recent \ndecrease in mobility from fall. Ruled out for MI. Likely his \nworsening edema is due to medication non-compliance versus \nworsening of his aortic stenosis. His most recent echo is from \n___, and it was recommended this be repeated as an outpatient. \nHe was never hypoxic, though lung exam suggested increased pulm \nedema. His legs were elevated and compression stockings were \nused. His torsemide was dosed at 10mg daily, though it's unclear \nif this was an increase from 5mg or the same dose, and the \npatient and wife were unable to clarify. There was slight \nimprovement in swelling on discharge.\n \n# RECENT FALLS: Patient reports falling twice recently at home \nand on a trip. He was evaluated by physical therapy, who felt he \nis unsteady on his feet but safe for discharge home with ___ and \na walker/commode. The wife was instructed to maintain 24 hour \ncare for him in the home to help prevent further falls. \n\n# ___: Cr up to 1.6 on admission. Improved to 1.3 the next day, \nlikely closer to baseline. \n   \n# DM: Glipizide and actos held while in hospital. Covered with \nan insulin sliding scale and oral medications restarted on \ndischarge.\n  \n# HTN: Continued isosorbide and lisinopril (held for one day \ngiven ___. Metoprolol dose was lowered to 25mg TID given his \nbradycardia.\n\n# Afib: INR was 2.9 on admission, and unclear if he had taken \nhis daily coumadin dose. He was restarted at 2.5mg daily. His \nwife noted that he had been switched to alternate 1.25mg with \n2.5mg. He was discharged with home services to follow INRs.\n\nTRANSITIONAL ISSUES:\nBlood culture ___ ___ needs to be follow up - no growth to \ndate.\n \nMedications on Admission:\n-Allopurinol ___ MG (100 MG TABLET Take 1) PO QD ___  \n-Cyanocobalamin 1000 MCG (1000MCG/ML VIAL Take 1 ML) IM QMONTH \n___  \n-Dexamethasone 0.5 MG (0.5 MG TABLET Take 1) PO QD ___  \n-Glipizide 10 MG (10 MG TABLET Take 1) PO BID ___  \n-Goserelin acetate 10.8 MG (10.8MG IMPLANT Take 1) SC QMONTH \n___  \n-Isosorbide dinitrate 10 MG (10 MG TABLET Take 1) PO BID \n___  \n-Lisinopril 20 MG (20 MG TABLET Take 1) PO QD ___  \n-Memantine PO ___  \n-Metoprolol tartrate 50 MG (50 MG TABLET Take 1) PO TID ___ \n \n-Nilutamide 150 MG (150 MG TABLET Take 1) PO QD ___  \n-Nitroglycerin PO ___  \n-Oxycodone 5 MG (5MG TABLET Take 1) PO Q6H PRN pain ___  \n-Prednisone Taper (10 MG TABLET Take 1) PO x 19 days ___  \n-Simvastatin 20 MG (20 MG TABLET Take 1) PO QPM ___  \n-Torsemide 5 MG (5 MG TABLET Take 1) PO QD ___  \n-Warfarin sodium 2.5 MG (2.5 MG TABLET Take 1) PO as directed  \n\n \nDischarge Medications:\n1. dexamethasone 0.5 mg Tablet Sig: One (1) Tablet PO once a \nday.  \n2. glipizide 10 mg Tablet Sig: One (1) Tablet PO once a day.  \n3. goserelin 10.8 mg Implant Sig: One (1) implant Subcutaneous \nas directed.  \n4. isosorbide dinitrate 10 mg Tablet Sig: One (1) Tablet PO \ntwice a day.  \n5. lisinopril 20 mg Tablet Sig: One (1) Tablet PO once a day.  \n6. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO three \ntimes a day.\nDisp:*90 Tablet(s)* Refills:*0*\n7. nilutamide 150 mg Tablet Sig: One (1) Tablet PO once a day.  \n8. oxycodone 5 mg Tablet Sig: One (1) Tablet PO every six (6) \nhours as needed for pain.  \n9. simvastatin 40 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).  \n10. torsemide 10 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*0*\n11. cyanocobalamin (vitamin B-12) 1,000 mcg/15 mL Liquid Sig: \nOne (1) dose PO once a week.  \n12. memantine 10 mg Tablet Sig: One (1) Tablet PO twice a day.  \n13. allopurinol ___ mg Tablet Sig: Two (2) Tablet PO once a day. \n \n14. warfarin 2.5 mg Tablet Sig: One (1) Tablet PO ___, Th, Sa: \nand 0.5 tablets on Mo, We, Fr and ___.  \n15. Vitamin D 1,000 unit Tablet Sig: One (1) Tablet PO once a \nday.  \n16. insulin glargine 100 unit/mL Cartridge Sig: Ten (10) units \nSubcutaneous at bedtime.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY\nAcute on chronic diastolic congestive heart failure\n\nSECONDARY\nAtrial fibrillation\nDiabetes\nHypertension\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nMr. ___,\n \nYou were admitted to the hospital for swelling in your legs, \nlikely due to your heart failure. We increased your diuretic \ndosing and had you work with physical therapy.\n\nPlease weigh yourself daily and notify your doctor if your \nweight increases by more than 3 pounds\n\nMedication changes:\n# CONTINUE torsemide 10mg daily to help remove fluid\n# REDUCE metoprolol to 25mg daily as your blood pressure has \nbeen low while you were hospitalized.  Your doctor may decide to \nincrease it again at your office visit.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "46",
         "10001884-DS-24",
         "10001884",
         "21268656",
         "DS",
         "24",
         "2125-10-20 00:00:00",
         "2125-10-24 14:10:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAtypical chest pain\n \nMajor Surgical or Invasive Procedure:\nStess Echo\n\n \nHistory of Present Illness:\n___ y/o woman with intermittent chest pain past several months. \nPain is located on left posterior shoulder and radiates down arm \nto fingers where it turns into \"pins-n-needles\" symptom. No \nSOB/N/V. Patient does endorse some minimal diaphoresis and gerd \nlike symptoms accompanying it. Pain has been controlled with \ntylenol #3. \n \nPast Medical History:\nHTN  \nAsthma  \nDiverticulitis several years ago  \nR hip replacement in ___  \n\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___  \n\n \nPhysical ___:\nVtals: T: 97.6 BP: 167/88 P: 83 R: 20 O2: 99% 2L  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, non-tender, non-distended, bowel sounds present, \nno rebound tenderness or guarding, no organomegaly  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n\n \nPertinent Results:\n___ 03:20PM BLOOD WBC-6.2 RBC-4.51 Hgb-13.1 Hct-38.6 MCV-86 \nMCH-29.1 MCHC-33.9 RDW-15.4 Plt ___\n___ 07:15AM BLOOD WBC-6.0 RBC-4.91 Hgb-13.8 Hct-41.7 MCV-85 \nMCH-28.1 MCHC-33.0 RDW-15.1 Plt ___\n___ 07:50AM BLOOD WBC-5.2 RBC-4.67 Hgb-13.4 Hct-39.4 MCV-84 \nMCH-28.7 MCHC-34.1 RDW-15.2 Plt ___\n___ 03:20PM BLOOD Glucose-95 UreaN-21* Creat-0.8 Na-139 \nK-3.5 Cl-100 HCO3-30 AnGap-13\n___ 09:10PM BLOOD Glucose-120* UreaN-17 Creat-0.9 Na-137 \nK-3.3 Cl-99 HCO3-31 AnGap-10\n___ 07:15AM BLOOD Glucose-100 UreaN-15 Creat-0.8 Na-138 \nK-4.4 Cl-98 HCO3-35* AnGap-9\n___ 03:20PM BLOOD cTropnT-<0.01\n___ 09:10PM BLOOD CK-MB-3 cTropnT-<0.01\n___ 07:15AM BLOOD CK-MB-4 cTropnT-<0.01\n.\n___ ___ F  ___  ___ \n \nCardiology Report Stress Study Date of ___   \n \n  \nEXERCISE RESULTS \n\n \n  \nRESTING DATA \nEKG:  SINUS WITH AEA, LBBB   \nHEART RATE:  68 BLOOD PRESSURE:  146/86 \n  \nPROTOCOL MODIFIED ___ - TREAD___ \nSTAGE TIME SPEED ELEVATION HEART BLOOD RPP \n  (MIN) (MPH) (%) RATE PRESSURE   \n0 ___ 1.0 8 100 176/88 ___ \n1 ___ 1.7 10 114 178/92 ___ 2.5 12 126 184/98 ___ \n  \nTOTAL EXERCISE TIME:  9 % MAX HRT RATE ACHIEVED:  83 \n \nSYMPTOMS: ATYPICAL PEAK INTENSITY: ___ \n \n  \nINTERPRETATION: ___ yo woman was referred to evaluate an atypical \n\nchest discomfort. The patient completed 9 minutes of a Gervino \nprotocol \nrepresenting a fair exercise tolerance for her age; ~ ___ METS. \nThe \nexercise test was stopped at the patient's request secondary to \nfatigue. \nDuring exercise, the patient reported a non-progressive, \nisolated upper \nleft-sided chest discomfort; ___. The area of discomfort was \nreportedly \ntender to palpation. This discomfort resolved with rest and was \nabsent \n2.5 minutes post-exercise. In the presence of the LBBB, the ST \nsegments \nare uninterpretable for ischemia. The rhythm was sinus with \nfrequent \nisolated APDs and occasional atrial couplets and atrial \ntriplets. \nResting mild systolic hypertension with normal blood pressure \nresponse \nto exercise. The heart rate response to exercise was mildly \nblunted. \n  \nIMPRESSION: Fair exercise tolerance. No anginal symptoms with \nuninterpretable ECG to achieved workload. Resting mild systolic \nhypertension with appropriate blood pressure response to \nexercise. \nSuboptimal study - target heart rate not achieved. \n \nSIGNED:  ___ \n \n\n \nBrief Hospital Course:\n___ ___ with several month history of left sided arm and chest \nwall pain in the setting of LBBB presenting for ___.  \n.  \n.  \n# Chest Pain:The patient's symptoms were not typically anginal \nin nature to suggest ACS. However she does have several cardiac \nrisk factors and a LBBB, so  physicians could  not r/oMI with \nEKG alone. Trop. results were negative x3. Stress Echo revealed \nnew regional dysfunction with hypokinesis of the inferior and \ninferolateral walls consistent with single vessel disease in the \nPDA distribution. A cardiology consult was obtained and they \nfelt she could be managed medically. Patient was already on an \naspirin, and a statin. Given history to suggest asthma B-blocker \nwas contraindicated. She was discharged on 120 mg extended \nrelease diltiazem with instructions to follow up in cardiology \nand with her PCP. \n.\n# Supraventricular tachycardia: The patient had multiple runs of \nSVT that was likley MAT in the setting of severe obstructive \nlung disease and chronic theophylline use. Cardiology \nreccomended that we discontinue her theophylline. We spoke with \nher pulmonologist who agreed this would be the best course of \naction for her. She was discharged with instructions to \ndiscontinue use of theophylline and follow up with her \npulmonologist and cardiology.\n\n \nMedications on Admission:\nTylenol ___ Q4h PRN pain  \nAlbuterol Sulfate 2 puffs q4-6h PRN SOB  \nFluticasone 50 mcg spray/suspension 2 whiffs PRN allergies  \nAdviar 500/50 1 INH BID  \nHCTZ 50mg One PO daily  \nSingulari 10mg tablet One PO QD  \nomeprazole 20mg 1 PO QD  \nsimvastatin 20mg 1 PO QD  \ntheophylline 200mg sustained release one PO TID  \nspiriva 18 mcg w/ inhalation  \nASA 81mg  \nCalcium sig unknown  \nCod liver oil Sig unk  \nMultivitamin  \n\n \nDischarge Medications:\n1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q4H (every \n4 hours) as needed for pain.  \n2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for SOB \nwheeze.  \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n4. fluticasone 50 mcg/Actuation Spray, Suspension Sig: ___  \nNasal once a day as needed for allergy symptoms.  \n5. hydrochlorothiazide 50 mg Tablet Sig: One (1) Tablet PO once \na day.  \n6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n7. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.  \n8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n9. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n10. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n11. diltiazem HCl 120 mg Tablet Sustained Release 24 hr Sig: One \n(1) Tablet Sustained Release 24 hr PO once a day.\nDisp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*\n12. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \nSublingual every 5 min as needed for chest pain: take one at \nonset of chest pain. ___ repeat every 5 min x3 with continued \nchest pain. Call PCP if chest pain persists.\nDisp:*30 tabs* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCoronary Artery Disease\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to ___ because you had back and arm pain \nthat was worrisome for heart disease. A strees test found that \nyou have coronary artery disease. You were started on a new \nblood pressure medication and tolerated this well. You should \nkeep all of you follow up appointments as listed below. \n.\nWhile you were here we made the following changes to your \nmedications:\n.\nWe STARTED you on Diltiazem 120mg once a day\n.\nWe STOPPED ___ theophylline\n.\nWe STARTED nitroglycerine to take when you have chest pain\n.\nYOU NEED TO STOP SMOKING. IT WILL KILL YOU.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "47",
         "10001884-DS-25",
         "10001884",
         "26679629",
         "DS",
         "25",
         "2125-10-27 00:00:00",
         "2125-10-27 18:03:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nChest Pain  \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n Ms. ___ is a ___ y/o female with a history of \nhypertension, asthma and recent diagnosis of CAD based on stress \necho done on ___, thought to be single vessel disease who \npresents with intermittent chest pain since her recent discharge \non ___. During her recent hospitalization she was ruled out \nfor an MI with three negative sets of cardiac enzymes, she had a \nstress echo which showed inducible ischemia at the achieved \nworkload, thought to be single vessel disease per the echo \nreport. At that time the plan was for medical management, given \nher severe underlying pulmonary disease she was not started on a \nbeta blocker, but was started on diltiazem 120mg daily. Also \nduring that admission she was found to have intermittent \nepisodes of MAT. Today she was on the phone with her ___ year \nold aunt, who is very hard or hearing, she says that she became \nfrustrated when her aunt was ___ to hear her on the phone and \nshe started to have some chest pain. The pain began in the \n___ her chest, as a dull pain then moved up to her left \nshoulder and under her left breast, at its worst was a ___. \nShe took three SL nitro's at home, with some minor improvement \nin her CP but when it did not resolve she called Dr. ___ \nreferred her to the ER. She denied any associated SOB, \nnausea/vomiting. She denies any orthopnea, PND, ___ edema or \npalpitations.  \n.  \nIn the ED, initial vitals were 98.7, 73, 183/92, 20, 98% on RA. \nHer EKG had a LBBB that was unchanged from prior, CXR with no \nacute process. Patient given aspirin 243mg since she had already \ntaken 81mg of aspirin at home. She was not given anything for \nher episodes of chest pain as they resolved without further \nintervention. Vitals on transfer were 71, 121/56, 22, 100% on \nRA.  \n.  \nOn arrival to the floor, patient's initial VS were: 98.9, \n140/86, 68, 18, 97% on RA. She says that she currently may have \na little bit of cental CP, but otherwise feels well and has no \ncomplaints.  \n \nPast Medical History:\nHTN  \nAsthma  \nDiverticulitis several years ago  \nR hip replacement in ___  \nExertional Atypical Chest Pain\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___  \n\n \nPhysical ___:\nOn Admission:\nVS: T=98.9 BP=140/86 HR=68 RR=18 O2 sat=97% on RA  \nGENERAL: WDWN female in NAD. Oriented x3. Mood, affect \nappropriate.  \nHEENT: NCAT. Sclera anicteric. Conjunctiva were pink, no pallor \nor cyanosis of the oral mucosa. No xanthalesma.  \nNECK: Supple  \nCARDIAC: RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 \nor S4.  \nLUNGS: No chest wall deformities, scoliosis or kyphosis. Resp \nwere unlabored, no accessory muscle use. decreased breath sounds \nthroughout, although CTA, no crackles, wheezes or rhonchi.  \nABDOMEN: Soft, NTND. No tenderness.  \nEXTREMITIES: No c/c/e.  \nSKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  \nPULSES:  \nRight: DP 2+ ___ 2+  \nLeft: DP 2+ ___ 2+  \n\n \nPertinent Results:\n___ 03:55PM   ___ PTT-26.0 ___\n___ 03:55PM   PLT COUNT-215\n___ 03:55PM   NEUTS-53.2 ___ MONOS-5.7 EOS-0.9 \nBASOS-0.5\n___ 03:55PM   WBC-5.6 RBC-4.66 HGB-13.2 HCT-39.4 MCV-85 \nMCH-28.3 MCHC-33.4 RDW-15.0\n___ 03:55PM   cTropnT-<0.01\n___ 03:55PM   estGFR-Using this\n___ 03:55PM   GLUCOSE-94 UREA N-21* CREAT-0.9 SODIUM-138 \nPOTASSIUM-4.0 CHLORIDE-100 TOTAL CO2-27 ANION GAP-15\n___ 04:04PM   GLUCOSE-91 K+-4.1\n___ 12:00AM   CK-MB-3 cTropnT-<0.01\n___ 12:00AM   CK(CPK)-189\n\nCXR: Emphysema without superimposed pneumonia or CHF.\n \nBrief Hospital Course:\nASSESSMENT AND PLAN: Ms. ___ is a ___ year old female with \na recent diagnosis of CAD, HTN and asthma who presents with \nintermittent episodes of chest pain since her recent discharge.  \n\n......................................\nActive Issues:\n.  \n# CORONARIES: patient with intermittent episodes of left chest \nburning, that are not typical of angina since they resolve \nwithout intervention, are not relieved by nitro and have no \nassociation with exercise. However, given the findings on her \nrecent stress echo of inducible ischemia it is concerning that \nher current symptoms could be related to her underlying CAD. Her \ntroponins were negative during this hospital stay.  On this \nadmission, she was started on Imdur 30 in addition to the \nmedications started on last discharge as it was decided that she \nmay need better medical management prior to resorting to PCI \n(which may be a possibility in the future). After administration \nof IMDUR, we walked the patient down the hall, as well as up \nseveral flights of stairs. She denied feeling short of breath, \nnor did she endorse any other cardiac symtpoms, such as chest \npain. In fact, she stated that she felt well walking. \n.  \n# RHYTHM: LBBB on EKG from yesterday, regular. patient with a \nnew diagnosis of MAT on last admission. We continued her on \nDiltiazem. She had several episodes of MAT on tele, but was \nasymptomatic. Given frequent PAT, ___ of Hearts monitor was \narranged for her on discharge to exclude the possibility that \nsymptoms are due to a tachyarrhythmia. \n.............................................\nInactive Issues:\n# Hypertension: continued home HCTZ and diltiazem..  \n# Asthma:continued home medications.    \n# GERD: continued home omeprazole  \n.    \nCODE: full code  \n.....................................  \nTransitional Issues:\n1) Patient was started on Imdur 30mg daily in additon to her \nother medications. She is being medically managed for her \ncoronary artery disease but may be a candidate for PCI in the \nfuture if the symtpoms of chest pain return.\n2) Follow-up event monitor for evaluation of arrhythmias\n \nMedications on Admission:\n-acetaminophen 325 mg Q4H as needed for pain.  \n-albuterol sulfate 90 mcg: Two (2) Puff Inhalation Q6H (every 6 \nhours) as needed for SOB or wheeze.  \n-fluticasone-salmeterol 500-50 mcg: Inhalation BID  \n-fluticasone 50 mcg: ___ Nasal once a day  \n-hydrochlorothiazide 50 mg once a day.  \n-omeprazole 20 mg DAILY  \n-simvastatin 20 mg once a day.  \n-tiotropium bromide 18 mcg DAILY  \n-aspirin 81 mg once a day.  \n-multivitamin 1 Tablet DAILY  \n-diltiazem HCl 120 mg Tablet Sustained Release 24 hr daily  \n-singulair 10mg QHS  \n \nDischarge Medications:\n1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four \n(4) hours as needed for pain.  \n2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for sob, \nwheezing .  \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n4. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n5. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nonce a day.  \n6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n7. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.  \n8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n9. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n10. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n11. montelukast 10 mg Tablet Sig: One (1) Tablet PO QHS (once a \nday (at bedtime)).  \n12. isosorbide mononitrate 30 mg Tablet Sustained Release 24 hr \nSig: One (1) Tablet Sustained Release 24 hr PO once a day.\nDisp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*\n13. diltiazem HCl 180 mg Capsule, Sust. Release 24 hr Sig: One \n(1) Capsule, Sust. Release 24 hr PO once a day.\nDisp:*30 Capsule, Sust. Release 24 hr(s)* Refills:*2*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY:\n1. atypical chest pain\n\nSecondary: \n1. Hypertension\n2. Asthma\n3. Diverticulitis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital for atypical chest pain. You \nwere monitored on telemetry. Your EKG was unchanged. Your \ncardiac enzymes were normal, without evidence for heart damage \nor heart attack. We have started you on a long acting nitrate \nmedication to control your chest pain symptoms. We also \nincreased your diltiazem for better blood pressure and heart \nrate control.\n.\nFinally, we have set you up with a 48 hour holter monitor to get \na better idea of your heart rhythm over time. Please discuss \nthese results with ___. ___ at your upcoming \ncardiology appointment.\n.\nMEDICATION CHANGES:\n- START imdur 30 mg daily\n- INCREASE diltiazem to 180 mg daily\n.\nPlease continue your other medications as prescribed.\n.\nPlease seek medical attention for worsening chest pain, \nshortness of breath, or any other symptoms.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "48",
         "10001884-DS-26",
         "10001884",
         "23594368",
         "DS",
         "26",
         "2125-12-03 00:00:00",
         "2125-12-05 15:55:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nFever, non-productive cough\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo F w/ HTN, CAD, COPD p/w fevers, non-productive cough, \nsince ___. Pt said she was in her usual state of health until \n___ evening when she developed a cough producing ___ \nsputum.  She took some robitussin and went to bed.  She woke up \nthe next morning and had general malaise, nasal congestion, \nintermittently productive cough.  She did not want to eat and \nhad 4 episodes of water diarrhea and one episode of vomiting \nwithout nausea.  She denied fevers, chills or sweats at that \ntime.  She called her PCP who prescribed ___ Z-pack.  Her symptoms \npersisted and she developed pain with coughing around her upper \nabdomen and lower chest.  Denies other joint or muscle pain.  \nShe went to see her PCP on the day of admission.  In her PCP's \noffice was hypoxic on RA, here is 89% on RA. Has had flu vaccine \nthis year and pneumovax last year. wheezy on exam, on 2L with o2 \nsat mid-90s.  \n.\nIn ED VS were afebrile 70 113/66 94%2L, On exam had wheezes with \npeak flow of 150 (no baseline), speaking in full sentences and \nno accessory muscle use, euvolemic and no ___ edema.  Flu screen \nnot performed, CXR unremarkable compared to prior.  Given \nlevoflox, nebs, pred 50 mg.\n\n \nPast Medical History:\nASTHMA   \nHYPERTENSION   \nHYPERLIPIDEMIA   \nHEADACHE   \nOSTEOARTHRITIS   \nATYPICAL CHEST PAIN   \nTOBACCO ABUSE   \nABNORMAL CHEST XRAY   \nCOPD  \n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___  \n\n \nPhysical ___:\nOn Admission:\nVS: T:  , BP: 142/70, HR: 70, RR 20, O2 93% on RA (96% 2L)\nGA: AOx3, pt with nasal cannula on in no respiratory distress\nHEENT:  MMM. no LAD. no JVD. neck supple. \nCards: RRR S1/S2 heard. no murmurs/gallops/rubs.\nPulm: CTAB no crackles or wheezes, good inspiratory effort, but \nnot great air movement, slightly prolonged expiratory phase.\nAbd: soft, NT, +BS. no g/rt. neg HSM.\nExtremities: wwp, no edema. DPs, PTs 2+.\nSkin: no noticeable rashes\nNeuro/Psych: CNs II-XII intact\n.\nON DISCHARGE:\nVS: T:  , BP: 142/70, HR: 70, RR 20, O2 93% on RA (96% 2L)\nGA: AOx3, pt with nasal cannula on in no respiratory distress\nHEENT:  MMM. no LAD. no JVD. neck supple. \nCards: RRR S1/S2 heard. no murmurs/gallops/rubs.\nPulm: CTAB no crackles or wheezes, good inspiratory effort, but \nnot great air movement, slightly prolonged expiratory phase.\nAbd: soft, NT, +BS. no g/rt. neg HSM.\nExtremities: wwp, no edema. DPs, PTs 2+.\nSkin: no noticeable rashes\nNeuro/Psych: CNs II-XII intact\n \nPertinent Results:\nLABS:\n___ 03:26PM BLOOD WBC-4.9 RBC-4.25 Hgb-12.7 Hct-36.5 MCV-86 \nMCH-30.0 MCHC-34.9 RDW-15.3 Plt ___\n___ 06:50AM BLOOD WBC-8.2# RBC-4.03* Hgb-12.2 Hct-34.8* \nMCV-87 MCH-30.4 MCHC-35.1* RDW-15.3 Plt ___\n___ 03:26PM BLOOD Glucose-123* UreaN-14 Creat-0.9 Na-136 \nK-3.3 Cl-97 HCO3-31 AnGap-___ 06:50AM BLOOD Glucose-95 UreaN-17 Creat-0.8 Na-139 \nK-3.5 Cl-98 HCO3-30 AnGap-15\n.\nMICRO:\n    **FINAL REPORT ___\n\n   DIRECT INFLUENZA A ANTIGEN TEST (Final ___: \n      POSITIVE FOR INFLUENZA A VIRAL ANTIGEN. \n         REPORTED BY PHONE TO ___ AT 1153  ___.\n.\nIMAGING:\nCXR ___:\nIMPRESSION: \n1. No acute chest pathology with stable pleural parenchymal \nscar. \n2. Flattening of the hemidiaphragms consistent with COPD. \n\n \nBrief Hospital Course:\nA/P: ___ year old woman with recent onset of fevers, productive \ncough and costochondral vs. pleuritic pain who tested positive \nfor influenza A.\n.\n# Fevers, malaise, cough: Pt seemed to have onset of symptoms \nconsistent with viral infection.  She was admitted to the \nhospital and placed on droplet precautions because there was \nconcern that she had the flu.  She was empirically started on \nOseltamivir 75mg PO BID.  nasopharyngeal swab was positive for \ninfluenza A.  She was continued on a five day regiment of \noseltamivir for her flu and will follow up with Dr. ___ in the \noutpatient setting.\n.\n# COPD exacerbation:  Pt tested positive for the flu, but seemed \nto also be having a COPD exacerbation with worsening dyspnea and \nsputum production.  She was started on prednisone 50mg PO Daily, \nAzithromycin and O2 via nasal cannula.  Her resting O2 sat was \ninitially 85%, but at the time of discharge she was satting 96% \non RA, but would desaturate to 84% after walking 75-100feet.  \nShe Was given a 5 day course of azithromycin, 5 days of \nprednisone at 50mg PO Daily and then a week long taper and \ndischarged on home O2 while her symptoms improved.  The patient \nwas breathing more comfortably and ambulating well at the time \nof discharge.  She will follow up with Dr. ___ as well as Dr. \n___ in the outpatient setting.\n.\n# ASTHMA: pt with wheezing in the ED and at PCP office, but not \npresent on my exams, however, she had received duonebs prior to \nmy exam.  Likely having asthma symptoms in setting of COPD \nexacerbations.  She was continued on her home regiment and also \non standing nebulizers.  She was discharged with nebulizer \ntreamtents as well as her home medications.  Respiratory status \nwas described above.\n.\nHYPERTENSION: Pt slightly hypertensive in the ED, but will \ncontinue meds at current regiment and reassess in the morning.  \nHer BP meds are actively being uptitrated in the outpatient \nsetting.  She remained normotensive during her hospital stay on \nthe floor.  We continued Diltiazem ER 360mg PO Q24H, HCTZ 12.5mg \nPO DAILY, IMDUR ER 60 mg PO DAILY.\n.  \nGERD: Currently asymptomatic.  We continued omeprazole 20mg PO \nDaily\n. \nCAD: Pt was recently diagnosed with single vessel disease.  She \nis asymptomatic at this time, but we will continue to monitor \nher for symptoms during this admission. \nWe continued aspirin 81mg PO DAILY\n.\nTOBACCO ABUSE: Pt had been smoking for many years, but said that \nshe quit yesterday and has no need for a nicotine patch or gum \nat this time.  \n.\n\n \nMedications on Admission:\n1. Lisinopril 5mg PO Daily\n2. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap  \n\nPO DAILY (Daily).  \n3. cinacalcet 30 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \n \n4. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY  \n(Daily).  \n5. metoprolol succinate 100 mg Tablet Sustained Release 24 hr  \nSig: One (1) Tablet Sustained Release 24 hr PO once a day.  \n6. doxazosin 4 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). \n \n7. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable  \n\nPO DAILY (Daily).  \n8. venlafaxine 75 mg Capsule, Sust. Release 24 hr Sig: Two (2)  \nCapsule, Sust. Release 24 hr PO DAILY (Daily).  \n9. venlafaxine 37.5 mg Capsule, Sust. Release 24 hr Sig: One (1) \n \nCapsule, Sust. Release 24 hr PO DAILY (Daily).  \n10. sevelamer HCl 400 mg Tablet Sig: Six (6) Tablet PO TID  \nW/MEALS (3 TIMES A DAY WITH MEALS).  \nDisp:*540 Tablet(s)* Refills:*2*  \n11. clonazepam 1 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n\n \nDischarge Medications:\n1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four \n(4) hours as needed for pain.  \n2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2)  Inhalation every ___ hours.  \n3. azithromycin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every \n24 hours) for 2 days.\nDisp:*2 Tablet(s)* Refills:*0*\n4. oseltamivir 75 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day) for 3 days.\nDisp:*5 Capsule(s)* Refills:*0*\n5. prednisone 10 mg Tablet Sig: Five (5) Tablet PO once a day \nfor 7 days: Take 5 tabs for 2 days, then 4 tabs for 2 days, then \n2 tabs for 2 days, then 1 tab for 2 days.\nDisp:*19 Tablet(s)* Refills:*0*\n6. diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO DAILY (Daily).  \n7. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n8. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n9. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n10. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr \nSig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  \n11. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n13. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n14. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO DAILY (Daily).  \n15. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n16. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n17. Oxygen\nHome Oxygen @ 2LPM Continuous via nasal cannula, conserving \ndevice for portability.  Pulse dose for portability.\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\nInfluenza\nCOPD exacerbation\n.\nSecondary Diagnosis:\nASTHMA   \nHYPERTENSION   \nHYPERLIPIDEMIA   \nHEADACHE   \nOSTEOARTHRITIS   \nATYPICAL CHEST PAIN   \nTOBACCO ABUSE   \nABNORMAL CHEST XRAY   \nCOPD \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou are being discharged from ___.  It \nwas a pleasure taking care of you.  You were admitted to the \nhospital for symptoms that were similar to a common cold as well \nas worsening respiratory status.  You tested positive for the \nflu and we also believe that you are having a COPD exacerbation. \n You were started on high dose steroids, azithromycin, tamiflu \nand nebulizers.  You were also placed on oxygen.  You are now \ndoing better, but may require O2 at home for some time as your \ninfection resolves and your inflammation improves.\n.\nThe Following medications were STARTED:\nPrednisone 50mg 1 day, on ___ decrease to 40mg Daily for 2 \ndays, on ___ decrease to 20mg Daily for 2 days, on ___ \ntake 10mg Daily for 2 days then stop  \nAzithromycin 250mg by mouth Daily 1 day (last dose on ___\nTamiflu 75mg two times a day for 2.5 days (last dose on ___\nYou will also be sent on home O2\n.\nPlease take your other medications as prescribed.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "49",
         "10001884-DS-27",
         "10001884",
         "21577720",
         "DS",
         "27",
         "2125-12-27 00:00:00",
         "2125-12-29 20:03:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\ns/p tachyarrhythmia\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo F smoker with PMH of asthma/COPD on theophylline, CAD, \nHTN, hyperlipidemia, and atypical chest pain presenting with \nmalaise and SOB during an episode of tachyarrythmia at home \nwhich has since resolved.  Pt recalls that she took her VS on \nthe telehealth monitor, then nurse called and asked her to \nrecheck them.  ___ services came and measured HR at 110s, but pt \nwas without CP, SOB, visual sx, HA, palps.  Also denies F/C, \nN/V, abd pain, change in bowel or bladder.  Per her PCP, ___ \n___, the patient does have a history of tachyarrythmias even \nthough the patient denies this history.  She also took \ntheophylline for some time, although it is not on her med list \nand she states she hasn't taken it since ___.  However, PCP \nconcern is that the theophylline may be contributing.  Recent \nstress test with reversible lesion being treated conservatively. \n   \n.\nIn ED VS were 98.8 78 154/82 20 95%.  Has CXR in ED which was \nunremarkable.  Transfer VS were HR=60, BP=126/75, RR=18, POx=94% \nRA\n.\nOn the floor, pt asymptomatic and feels well.  Only upset \nbecause she's been in the hospital every month so far this year.\n\n \nPast Medical History:\n-ASTHMA   \n-HYPERTENSION   \n-HYPERLIPIDEMIA   \n-HEADACHE   \n-OSTEOARTHRITIS   \n-ATYPICAL CHEST PAIN   \n-TOBACCO ABUSE   \n-ABNORMAL CHEST XRAY   \n-COPD  \n\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n\n \nPhysical ___:\nADMISSION PEx:\nVS: 97.9, 155/90, 64, 16@94%(RA)\nGA: AOx3, NAD\nHEENT:  PERRLA. MMM. no LAD. no JVD. neck supple. \nCards: PMI palpable at ___ IC space. No RVH. RRR S1/S2 heard. \nno murmurs/gallops/rubs.\nPulm: scattered exp wheezing with minimal air movment\nAbd: soft, NT, +BS. no g/rt.\nExtremities: wwp, no edema. DPs, PTs 2+.\nSkin: no rashes, eccymoses, lesions \nNeuro/Psych: CNs II-XII intact. ___ strength in muscle groups \ntested, sensation symmetric. \n\nDISCHARGE PEx:\n\n \nPertinent Results:\nRelevant and representative labs:\nCBC and coags:\n-___ 03:30PM BLOOD WBC-6.7 RBC-4.40 Hgb-13.2 Hct-38.9 \nMCV-88 MCH-29.9 MCHC-33.9 RDW-15.7* Plt ___\n-___ 05:55AM BLOOD WBC-5.9 RBC-4.32 Hgb-12.8 Hct-38.4 \nMCV-89 MCH-29.6 MCHC-33.2 RDW-15.6* Plt ___\n-___ 03:30PM BLOOD ___ PTT-26.2 ___\n\nChem:\n-___ 03:30PM BLOOD Glucose-105* UreaN-18 Creat-0.9 Na-139 \nK-3.5 Cl-101 HCO3-31 \n-___ 05:55AM BLOOD Glucose-101* UreaN-20 Creat-0.9 Na-139 \nK-4.2 Cl-99 HCO3-32\n\nCEs:\n-___ 03:30PM BLOOD cTropnT-<0.01\n-___ 09:10PM BLOOD CK-MB-4 cTropnT-<0.01\n-___ 05:55AM BLOOD CK-MB-3 cTropnT-<0.01\n\nMisc:\n-___ 05:55AM BLOOD Triglyc-96 HDL-50 CHOL/HD-3.2 LDLcalc-90 \nCholest-159\n \nBrief Hospital Course:\nTo Do:\n1) follow-up theophylline level\n___ yo F smoker with PMH of asthma/COPD managed with theophylline \nuntil ___ when theophylline was discontinued because of \ntachycardia, CAD, HTN, and hyperlipidemia who presented from \nhome with asymptomatic tachyarrythmia.\n.  \nACTIVE ISSUES:\n.\n# Tachycarrhymia in context of recent inducible ischemia seen on \nECHO stress test (___):  At the time of admission, her \nsymptoms had resolved, no abnormalities were seen on imaging or \nlabs, and her VS and PEx were remarkable only for non-acute lung \nfindings.  MI was ruled out by trop negative x3, no EKG changes. \n Cardiology was consulted to evaluate need for catheterization \nvs other intervention, but did not feel that any urgent \ninpatient work-up was necessary, especially in the context of \nasymptomatic tachycardia.  She had already had Holter and ECHO \nprior to this admission.  Cardiology recommended restarting \ntheophylline if, in fact, she received such benefit from \npulmonary point of view.  She was restarted on theophylline \n200mg TID, which was her dose prior to discontinuation.  She \nreceived tobacco cessation education, was continued on home \ndiltiazem and aspirin (dose was temporarily increased to 325mg \nprior to ruling out MI).  Admission theopylline level was \npending at the time of discharge.\n.  \n# Asthma and COPD: patient was given Albuterol and ipratropium \nnebs, and she was continued on her home doses of fluticasone, \nmontelukast, fluticasone-salmetrol.  She was given O2 PRN.  \nAfter cardiology consult, she was restarted on her theophylline \nat 200mg TID, with pulm and cardiology follow-up.\n.  \n# Tobacco abuse: she declined nicotine patch, and education was \ngiven regarding the health hazards of smoking.\n.  \n# HL: patient was continued oh her simvastatin, but because her \nLDL was not at goal (<70), her dose was increased to 40mg daily.\n.\nINACTIVE ISSUES:\n.\n# HTN: continued isosorbide and hydrochlorothiazide at home \ndoses.\n.\n# Code: Full\n \nMedications on Admission:\n-acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four \n(4) hours as needed for pain.  \n-albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2)  Inhalation every ___ hours.  \n-diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO DAILY (Daily).  \n-fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n-fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n-hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n-isosorbide mononitrate 60 mg Tablet Extended Release 24 hr \nSig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  \n-montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n-omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n-tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n-calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO DAILY (Daily).  \n-multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n-aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n-simvastatin 20mg qday\n \nDischarge Medications:\n1. simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*0*\n2. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n3. fluticasone 50 mcg/Actuation Spray, Suspension Sig: ___ \nSprays Nasal DAILY (Daily) as needed for congestion.  \n4. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr \nSig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  \n5. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n7. acetaminophen-codeine 300-30 mg Tablet Sig: One (1) Tablet PO \nevery four (4) hours as needed for pain.  \n8. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) puffs Inhalation every ___ hours as needed for shortness \nof breath or wheezing.  \n9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n10. Spiriva with HandiHaler 18 mcg Capsule, w/Inhalation Device \nSig: One (1) capsule Inhalation once a day.  \n11. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n12. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO DAILY (Daily).  \n13. diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO DAILY (Daily).  \n14. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n15. theophylline 200 mg Capsule, Ext Release 24 hr Sig: One (1) \nCapsule, Ext Release 24 hr PO three times a day.\nDisp:*90 Capsule, Ext Release 24 hr(s)* Refills:*0*\n16. albuterol sulfate 0.63 mg/3 mL Solution for Nebulization \nSig: One (1) treatment Inhalation every ___ hours as needed for \nshortness of breath or wheezing for 15 doses.\nDisp:*15 ampules* Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\n-Tachyarrhythmia\n-Hyperlipidemia\n-Asthma, COPD\n\nSecondary:\n-Hypertension \n-Tobacco Use  \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMrs. ___,\n\n___ were hospitalized because the visiting nurses were concerned \nabout an elevated heart rate, but by the time ___ came to the \nhospital, your elevated heart rate had resolved.  Nevertheless, \n___ were admitted to ensure that your heart hadn't suffered any \ndamage, and to see the inpatient cardiologist.  Your labs were \nunremarkable from a cardiac standpoint, and ___ saw the \ncardiologist (who recommend no intervention at this time).  ___ \nshould follow-up with your pulmonologist as an outpatient for \nyour breathing issues.  The best thing ___ can do for your lung \nhealth is to quit smoking, and we encourage ___ to do so.\n\nThe following changes were made to your medications:\n-INCREASE your simvastatin to 40mg daily in order to lower your \ncholesterol to goal (as recommended by the cardiologist)\n-RESTART theophylline 200mg three times a day\n-We will also be giving ___ a prescription for albuterol \nnebulizers to use instead of your inhaler (when needed), but \nrefills will have to be through your primary physician or \npulmonologist\n\n___ discuss your theophylline dose and breathing status with \nyour primary provider (Dr. ___ and your pulmonologist (Dr. \n___.  \n \nFollowup Instructions:\n___\n"
        ]
       ],
       "shape": {
        "columns": 8,
        "rows": 100
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>note_id</th>\n",
       "      <th>subject_id</th>\n",
       "      <th>hadm_id</th>\n",
       "      <th>note_type</th>\n",
       "      <th>note_seq</th>\n",
       "      <th>charttime</th>\n",
       "      <th>storetime</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10000032-DS-21</td>\n",
       "      <td>10000032</td>\n",
       "      <td>22595853</td>\n",
       "      <td>DS</td>\n",
       "      <td>21</td>\n",
       "      <td>2180-05-07 00:00:00</td>\n",
       "      <td>2180-05-09 15:26:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10000032-DS-22</td>\n",
       "      <td>10000032</td>\n",
       "      <td>22841357</td>\n",
       "      <td>DS</td>\n",
       "      <td>22</td>\n",
       "      <td>2180-06-27 00:00:00</td>\n",
       "      <td>2180-07-01 10:15:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10000032-DS-23</td>\n",
       "      <td>10000032</td>\n",
       "      <td>29079034</td>\n",
       "      <td>DS</td>\n",
       "      <td>23</td>\n",
       "      <td>2180-07-25 00:00:00</td>\n",
       "      <td>2180-07-25 21:42:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10000032-DS-24</td>\n",
       "      <td>10000032</td>\n",
       "      <td>25742920</td>\n",
       "      <td>DS</td>\n",
       "      <td>24</td>\n",
       "      <td>2180-08-07 00:00:00</td>\n",
       "      <td>2180-08-10 05:43:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10000084-DS-17</td>\n",
       "      <td>10000084</td>\n",
       "      <td>23052089</td>\n",
       "      <td>DS</td>\n",
       "      <td>17</td>\n",
       "      <td>2160-11-25 00:00:00</td>\n",
       "      <td>2160-11-25 15:09:00</td>\n",
       "      <td>\\nName:  ___                    Unit No:   __...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>10002430-DS-7</td>\n",
       "      <td>10002430</td>\n",
       "      <td>26295318</td>\n",
       "      <td>DS</td>\n",
       "      <td>7</td>\n",
       "      <td>2129-06-24 00:00:00</td>\n",
       "      <td>2129-06-24 16:51:00</td>\n",
       "      <td>\\nName:  ___              Unit No:   ___\\n \\n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>10002443-DS-15</td>\n",
       "      <td>10002443</td>\n",
       "      <td>21329021</td>\n",
       "      <td>DS</td>\n",
       "      <td>15</td>\n",
       "      <td>2183-10-20 00:00:00</td>\n",
       "      <td>2183-10-20 19:18:00</td>\n",
       "      <td>\\nName:  ___                       Unit No:  ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>10002495-DS-13</td>\n",
       "      <td>10002495</td>\n",
       "      <td>24982426</td>\n",
       "      <td>DS</td>\n",
       "      <td>13</td>\n",
       "      <td>2141-05-29 00:00:00</td>\n",
       "      <td>2141-05-30 02:29:00</td>\n",
       "      <td>\\nName:  ___                  Unit No:   ___\\...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>10002528-DS-17</td>\n",
       "      <td>10002528</td>\n",
       "      <td>23193578</td>\n",
       "      <td>DS</td>\n",
       "      <td>17</td>\n",
       "      <td>2168-12-20 00:00:00</td>\n",
       "      <td>2168-12-20 17:28:00</td>\n",
       "      <td>\\nName:  ___                 Unit No:   ___\\n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>10002528-DS-18</td>\n",
       "      <td>10002528</td>\n",
       "      <td>28605730</td>\n",
       "      <td>DS</td>\n",
       "      <td>18</td>\n",
       "      <td>2170-03-18 00:00:00</td>\n",
       "      <td>2170-03-18 16:39:00</td>\n",
       "      <td>\\nName:  ___                 Unit No:   ___\\n...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows  8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           note_id  subject_id   hadm_id note_type  note_seq  \\\n",
       "0   10000032-DS-21    10000032  22595853        DS        21   \n",
       "1   10000032-DS-22    10000032  22841357        DS        22   \n",
       "2   10000032-DS-23    10000032  29079034        DS        23   \n",
       "3   10000032-DS-24    10000032  25742920        DS        24   \n",
       "4   10000084-DS-17    10000084  23052089        DS        17   \n",
       "..             ...         ...       ...       ...       ...   \n",
       "95   10002430-DS-7    10002430  26295318        DS         7   \n",
       "96  10002443-DS-15    10002443  21329021        DS        15   \n",
       "97  10002495-DS-13    10002495  24982426        DS        13   \n",
       "98  10002528-DS-17    10002528  23193578        DS        17   \n",
       "99  10002528-DS-18    10002528  28605730        DS        18   \n",
       "\n",
       "              charttime            storetime  \\\n",
       "0   2180-05-07 00:00:00  2180-05-09 15:26:00   \n",
       "1   2180-06-27 00:00:00  2180-07-01 10:15:00   \n",
       "2   2180-07-25 00:00:00  2180-07-25 21:42:00   \n",
       "3   2180-08-07 00:00:00  2180-08-10 05:43:00   \n",
       "4   2160-11-25 00:00:00  2160-11-25 15:09:00   \n",
       "..                  ...                  ...   \n",
       "95  2129-06-24 00:00:00  2129-06-24 16:51:00   \n",
       "96  2183-10-20 00:00:00  2183-10-20 19:18:00   \n",
       "97  2141-05-29 00:00:00  2141-05-30 02:29:00   \n",
       "98  2168-12-20 00:00:00  2168-12-20 17:28:00   \n",
       "99  2170-03-18 00:00:00  2170-03-18 16:39:00   \n",
       "\n",
       "                                                 text  \n",
       "0    \\nName:  ___                     Unit No:   _...  \n",
       "1    \\nName:  ___                     Unit No:   _...  \n",
       "2    \\nName:  ___                     Unit No:   _...  \n",
       "3    \\nName:  ___                     Unit No:   _...  \n",
       "4    \\nName:  ___                    Unit No:   __...  \n",
       "..                                                ...  \n",
       "95   \\nName:  ___              Unit No:   ___\\n \\n...  \n",
       "96   \\nName:  ___                       Unit No:  ...  \n",
       "97   \\nName:  ___                  Unit No:   ___\\...  \n",
       "98   \\nName:  ___                 Unit No:   ___\\n...  \n",
       "99   \\nName:  ___                 Unit No:   ___\\n...  \n",
       "\n",
       "[100 rows x 8 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "b138885f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[10000032 10000084 10000117 10000248 10000560 10000764 10000826 10000883\n",
      " 10000935 10000980 10001176 10001186 10001217 10001338 10001401 10001663\n",
      " 10001667 10001725 10001860 10001877 10001884 10001919 10002013 10002131\n",
      " 10002155 10002167 10002221 10002348 10002428 10002430 10002443 10002495\n",
      " 10002528]\n"
     ]
    }
   ],
   "source": [
    "test_list = df[\"subject_id\"].unique()\n",
    "print(test_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "9f0f5305",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "note_id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "subject_id",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "hadm_id",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "charttime",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "text",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "a48cb34f-f384-472f-8338-20dfce745848",
       "rows": [
        [
         "0",
         "10000032-DS-21",
         "10000032",
         "22595853",
         "2180-05-07 00:00:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nWorsening ABD distension and pain \n \nMajor Surgical or Invasive Procedure:\nParacentesis\n\n \nHistory of Present Illness:\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \nbioplar, PTSD, presented from OSH ED with worsening abd \ndistension over past week.  \nPt reports self-discontinuing lasix and spirnolactone ___ weeks \nago, because she feels like \"they don't do anything\" and that \nshe \"doesn't want to put more chemicals in her.\" She does not \nfollow Na-restricted diets. In the past week, she notes that she \nhas been having worsening abd distension and discomfort. She \ndenies ___ edema, or SOB, or orthopnea. She denies f/c/n/v, d/c, \ndysuria. She had food poisoning a week ago from eating stale \ncake (n/v 20 min after food ingestion), which resolved the same \nday. She denies other recent illness or sick contacts. She notes \nthat she has been noticing gum bleeding while brushing her teeth \nin recent weeks. she denies easy bruising, melena, BRBPR, \nhemetesis, hemoptysis, or hematuria.  \nBecause of her abd pain, she went to OSH ED and was transferred \nto ___ for further care. Per ED report, pt has brief period of \nconfusion - she did not recall the ultrasound or bloodwork at \nosh. She denies recent drug use or alcohol use. She denies \nfeeling confused, but reports that she is forgetful at times.  \nIn the ED, initial vitals were 98.4 70 106/63 16 97%RA  \nLabs notable for ALT/AST/AP ___ ___: ___, \nTbili1.6, WBC 5K, platelet 77, INR 1.6  \n\n \nPast Medical History:\n1. HCV Cirrhosis  \n2. No history of abnormal Pap smears.  \n3. She had calcification in her breast, which was removed  \npreviously and per patient not, it was benign.  \n4. For HIV disease, she is being followed by Dr. ___ Dr.  \n___.  \n5. COPD  \n6. Past history of smoking.  \n7. She also had a skin lesion, which was biopsied and showed  \nskin cancer per patient report and is scheduled for a complete  \nremoval of the skin lesion in ___ of this year.  \n8. She also had another lesion in her forehead with purple  \ndiscoloration. It was biopsied to exclude the possibility of  \n___'s sarcoma, the results is pending.  \n9. A 15 mm hypoechoic lesion on her ultrasound on ___  \nand is being monitored by an MRI.  \n10. History of dysplasia of anus in ___.  \n11. Bipolar affective disorder, currently manic, mild, and PTSD. \n \n12. History of cocaine and heroin use.  \n\n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  \ntalking to most of them. She only has one brother that she is in \n \ntouch with and lives in ___. She is not aware of any  \nknown GI or liver disease in her family.  \nHer last alcohol consumption was one drink two months ago. No  \nregular alcohol consumption. Last drug use ___ years ago. She  \nquit smoking a couple of years ago.  \n\n \nPhysical Exam:\nVS: 98.1 107/61 78 18 97RA  \nGeneral: in NAD  \nHEENT: CTAB, anicteric sclera, OP clear  \nNeck: supple, no LAD  \nCV: RRR,S1S2, no m/r/g  \nLungs: CTAb, prolonged expiratory phase, no w/r/r  \nAbdomen: distended, mild diffuse tenderness, +flank dullness, \ncannot percuss liver/spleen edge ___ distension  \nGU: no foley  \nExt: wwp, no c/e/e, + clubbing  \nNeuro: AAO3, converse normally, able to recall 3 times after 5 \nminutes, CN II-XII intact  \n\nDischarge:\n\nPHYSICAL EXAMINATION:  \nVS: 98 105/70 95\nGeneral: in NAD  \nHEENT: anicteric sclera, OP clear  \nNeck: supple, no LAD  \nCV: RRR,S1S2, no m/r/g  \nLungs: CTAb, prolonged expiratory phase, no w/r/r  \nAbdomen: distended but improved, TTP in RUQ, \nGU: no foley  \nExt: wwp, no c/e/e, + clubbing  \nNeuro: AAO3,  CN II-XII intact  \n\n \nPertinent Results:\n___ 10:25PM   GLUCOSE-109* UREA N-25* CREAT-0.3* SODIUM-138 \nPOTASSIUM-3.4 CHLORIDE-105 TOTAL CO2-27 ANION GAP-9\n___ 10:25PM   estGFR-Using this\n___ 10:25PM   ALT(SGPT)-100* AST(SGOT)-114* ALK PHOS-114* \nTOT BILI-1.6*\n___ 10:25PM   LIPASE-77*\n___ 10:25PM   ALBUMIN-3.3*\n___ 10:25PM   WBC-5.0# RBC-4.29 HGB-14.3 HCT-42.6 MCV-99* \nMCH-33.3* MCHC-33.5 RDW-15.7*\n___ 10:25PM   NEUTS-70.3* LYMPHS-16.5* MONOS-8.1 EOS-4.2* \nBASOS-0.8\n___ 10:25PM   PLT COUNT-71*\n___ 10:25PM   ___ PTT-30.9 ___\n___ 10:25PM   ___\n.\n\nCXR: No acute cardiopulmonary process.  \nU/S:  \n1. Nodular appearance of the liver compatible with cirrhosis. \nSigns of portal  \nhypertension including small amount of ascites and splenomegaly. \n \n2. Cholelithiasis.  \n3. Patent portal veins with normal hepatopetal flow.  \nDiagnostic para attempted in the ED, unsuccessful.  \nOn the floor, pt c/o abd distension and discomfort.\n \nBrief Hospital Course:\n___ HCV cirrhosis c/b ascites, hiv on ART, h/o IVDU, COPD, \nbioplar, PTSD, presented from OSH ED with worsening abd \ndistension over past week and confusion.  \n\n# Ascites - p/w worsening abd distension and discomfort for last \nweek. likely ___ portal HTN given underlying liver disease, \nthough no ascitic fluid available on night of admission. No \nsigns of heart failure noted on exam. This was ___ to med \nnon-compliance and lack of diet restriction. SBP negative\ndiuretics:  \n> Furosemide 40 mg PO DAILY  \n> Spironolactone 50 mg PO DAILY, chosen over the usual 100mg \ndose d/t K+ of 4.5.   \n CXR was wnl, UA negative, Urine culture blood culture negative. \n \nPt was losing excess fluid appropriately with stable lytes on \nthe above regimen. Pt was scheduled with current PCP for \n___ check upon discharge.   \nPt was scheduled for new PCP with Dr. ___ at ___ and \nfollow up in Liver clinic to schedule outpatient screening EGD \nand ___.   \n \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Furosemide 20 mg PO DAILY \n2. Spironolactone 50 mg PO DAILY \n3. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n4. Raltegravir 400 mg PO BID \n5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n6. Nicotine Patch 14 mg TD DAILY \n7. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n\n \nDischarge Medications:\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing, SOB \n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n3. Furosemide 40 mg PO DAILY \nRX *furosemide 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet \nRefills:*3\n4. Ipratropium Bromide Neb 1 NEB IH Q6H SOB \n5. Nicotine Patch 14 mg TD DAILY \n6. Raltegravir 400 mg PO BID \n7. Spironolactone 50 mg PO DAILY \n8. Acetaminophen 500 mg PO Q6H:PRN pain \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAscites from Portal HTN\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\nIt was a pleasure taking care of you! You came to us with \nstomach pain and worsening distension. While you were here we \ndid a paracentesis to remove 1.5L of fluid from your belly. We \nalso placed you on you 40 mg of Lasix and 50 mg of Aldactone to \nhelp you urinate the excess fluid still in your belly. As we \ndiscussed, everyone has a different dose of lasix required to \nmake them urinate and it's likely that you weren't taking a high \nenough dose. Please take these medications daily to keep excess \nfluid off and eat a low salt diet. You will follow up with Dr. \n___ in liver clinic and from there have your colonoscopy \nand EGD scheduled. Of course, we are always here if you need us. \nWe wish you all the best!\nYour ___ Team.  \n \nFollowup Instructions:\n___\n"
        ],
        [
         "1",
         "10000032-DS-22",
         "10000032",
         "22841357",
         "2180-06-27 00:00:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPercocet\n \nAttending: ___.\n \nChief Complaint:\nabdominal fullness and discomfort\n \nMajor Surgical or Invasive Procedure:\n___ diagnostic paracentesis\n___ therapeutic paracentesis\n\n \nHistory of Present Illness:\n___ with HIV on HAART, COPD, HCV cirrhosis complicated by \nascites and HE admitted with abdominal distention and pain. She \nwas admitted to ___ for the same symptoms \nrecently and had 3L fluid removed (no SBP) three days ago and \nfelt better. Since discharge, her abdomen has become \nincreasingly distended with pain. This feels similar to prior \nepisodes of ascites.  \nHer diuretics were recently decreased on ___ due to worsening \nhyponatremia 128 and hyperkalemia 5.1. Patient states she has \nbeen compliant with her HIV and diuretic medications but never \nfilled out the lactulose prescription. She states she has had \n___ BMs daily at home. She has had some visual hallucinations \nand forgetfulness. Her appetite has been poor.  \nIn the ED, initial vitals were 98.9 88 116/88 18 97% RA. CBC \nnear baseline, INR 1.4, Na 125, Cr 0.6. AST and ALT mildly above \nbaseline 182 and 126 and albumin 2.8. Diagnostic para with 225 \nWBC, 7% PMN, total protein 0.3. UA with few bact, 6 WBC, mod \nleuk, neg nitr, but contaminated with 6 epi. CXR clear. RUQ US \nwith no PV thrombus, moderate ascites. She was given ondansetron \n4mg IV and morphine 2.5mg IV x1 in the ED.  \nOn the floor, she is feeling improved but still has abdominal \ndistention and discomfort.  \nROS: +Abdominal distention and pain. No black/bloody stools. No \n___ pain or swelling. No fevers or chills. Denies chest pain, \nnausea, vomiting. No dysuria or frequency. \n \nPast Medical History:\n1. HCV Cirrhosis  \n2. No history of abnormal Pap smears.  \n3. She had calcification in her breast, which was removed  \npreviously and per patient not, it was benign.  \n4. For HIV disease, she is being followed by Dr. ___ Dr.  \n___.  \n5. COPD  \n6. Past history of smoking.  \n7. She also had a skin lesion, which was biopsied and showed  \nskin cancer per patient report and is scheduled for a complete  \nremoval of the skin lesion in ___ of this year.  \n8. She also had another lesion in her forehead with purple  \ndiscoloration. It was biopsied to exclude the possibility of  \n___'s sarcoma, the results is pending.  \n9. A 15 mm hypoechoic lesion on her ultrasound on ___  \nand is being monitored by an MRI.  \n10. History of dysplasia of anus in ___.  \n11. Bipolar affective disorder, currently manic, mild, and PTSD. \n \n12. History of cocaine and heroin use.  \n\n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  talking to most of \nthem. She only has one brother that she is in  touch with and \nlives in ___. She is not aware of any known GI or liver \ndisease in her family.  \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS: T98.1 105/57 79 20 97RA 44.6kg  \nGENERAL: Thin chronically ill appearing woman in no acute \ndistress  \nHEENT: Sclera anicteric, MMM, no oral lesions  \nHEART: RRR, normal S1 S2, no murmurs  \nLUNGS: Clear, no wheezes, rales, or rhonchi  \nABD: Significant distention with visible veins, bulging flanks, \nnontender to palpation, tympanitic on percussion, normal bowel \nsounds  \nEXT: no ___ edema, 2+ DP and ___ pulses  \nNEURO: alert and oriented, not confused, no asterixis\n\nDISCHARGE PE:\nVS: T 98.4 BP 95/55 (SBP ___ HR 80 RR 18 O2 95RA  \nI/O 240/150 this am  \nGENERAL: Thin chronically ill appearing woman in no acute \ndistress  \nHEENT: Sclera anicteric, MMM, no oral lesions  \nHEART: RRR, normal S1 S2, no murmurs  \nLUNGS: Clear, no wheezes, rales, or rhonchi  \nABD: Significant distention with visible veins, bulging flanks, \nnontender to palpation, tympanitic on percussion, normal bowel \nsounds  \nEXT: no ___ edema, 2+ DP and ___ pulses  \nNEURO: alert and oriented, not confused, no asterixis\n \nPertinent Results:\nLABS ON ADMISSION:\n___ 04:10PM BLOOD ___ \n___ Plt ___\n___ 04:10PM BLOOD ___ \n___\n___ 04:10PM BLOOD ___ \n___\n___ 04:10PM BLOOD ___ \n___\n___ 04:10PM BLOOD ___\n___ 04:39PM BLOOD ___\n\nLABS ON DISCHARGE:\n___ 05:10AM BLOOD ___ \n___ Plt ___\n___ 05:10AM BLOOD ___ ___\n___ 05:10AM BLOOD ___ \n___\n___ 05:10AM BLOOD ___ \n___\n___ 05:10AM BLOOD ___\n\nMICRO:\n___ 10:39 pm URINE      Source: ___. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n\n___ 7:00 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH.\n\n___ 7:00 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH. \n\nDiagnositc Para:\n___ 07:00PM ASCITES ___ \n___\n___ 07:00PM ASCITES ___\n\nIMAGING:\n___ CXR- No acute cardiopulmonary abnormality.  \n___ RUQ US-  \n1. Extremely coarse and nodular liver echotexture consistent \nwith a history of cirrhosis.  \n2. Moderate ascites.  \n3. Patent portal vein.\n \nBrief Hospital Course:\n___ with HIV on HAART, HCV cirrhosis with ascites and HE, h/o \nIVDU, COPD, bipolar disorder presents with abdominal discomfort \ndue to ___ ascites.  \n \n# ASCITES. Now diuretic refractory given last tap was three days \nago with 3L removed and she has already built up moderate \nascites. Infectious workup negative, with CXR clear, UA \ncontaminated but not grossly positive so will f/u culture, \ndiagnostic para with only 225 WBC, RUQ US with no PV thrombus. \nCompliant with diuretics but not following low sodium diet or \nfluid restriction. Dr. ___ discussed possible TIPS in \nthe office but due to lung disease, that was on hold pending \nfurther cardiac evaluation. Diuretics were recently decreased \ndue to hyponatremia and hyperkalemia. Held spironolactone for \nnow due to K 5.2 and increased lasix 20 -> 40. No evidence of \nsevere hyponatremia (Na<120) or renal failure Cr>2.0 to stop \ndiuretics at present. Diagnostic paracentesis negative for \ninfection. Ascitic total protein 0.3 so warrants SBP prophylaxis \n(<1.0) and fortunately already on Bactrim for PCP prophylaxis \nwhich would be appropriate for SBP ppx also. Patient did admit \nto eating pizza and some ___ food prior to \nadmission. She had therapeutic paracentesis with 4.3L removed \nand received 37.5G albumin IV post procedure. She felt much \nbetter with resolution of abdominal discomfort. Patient is \nscheduled for repeat paracentesis as outpatient on ___.  \n\n# HEPATIC ENCEPHALOPATHY. History of HE from Hep C cirrhosis. \nNow with mild encephalopathy (hallucinations and forgetfulness) \ndue to medication noncompliance, but not acutely encephalopathic \nand without asterixis on exam. Infectious workup negative thus \nfar. Continue lactulose 30mL TID and titrate to 3 BMs daily and \ncontinue rifaximin 550mg BID. \n \n# HYPONATREMIA. Na 125 on admission, 128 four days ago, and 135 \none month ago. Likely due to third spacing from worsening \nascites and fluid overload. 1.5L fluid restriction, low salt \ndiet. S/p therapeutic paracentesis with albumin replacement.\n\n# CIRRHOSIS, HEPATITIS C. MELD score of 10 and Child's ___ \nclass B on this admission. Now decompensated due to ascites. \nHepatitis C genotype IIIB. Dr. ___ starting \n___ and ___ with patient in clinic and the \ninsurance process was started by her office. No history of EGD, \nneeds this as outpatient for varices screening.  \n \n# NUTRITION. Unclear if truly compliant with low salt diet. Poor \noral intake. Low albumin 2.8 on admission. Met with nutrition. \n \n# COAGULOPATHY. INR 1.4 four days ago. No evidence of active \nbleeding. Very mild thrombocytopenia with plts 143.  \n \n# HIV. Most recent CD4 173. On HAART. No established ID \nprovider. Continue Truvada and Isentress, Bactrim DS daily for \nPCP ___. Needs outpatient ID appointment  \n\n# COPD. Stable. States she is on intermittent home O2 for \ncomfort at night and with abdominal distentiom. Continued home \nCOPD meds and home O2 as needed \n\n**Transitional Issues**\n- Discontinued spironolactone ___ elevated potassium\n- Increased furosemide to 40mg daily\n- Please recheck electrolytes at next visit\n- Had paracentesis ___ with 4.3 L removed, received 37.5G \nalbumin\n- Needs outpatient ID provider\n- ___ needs more frequent paracentesis\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, SOB \n2. ___ (Truvada) 1 TAB PO DAILY \n3. Furosemide 20 mg PO DAILY \n4. Raltegravir 400 mg PO BID \n5. Spironolactone 50 mg PO DAILY \n6. Acetaminophen 500 mg PO Q6H:PRN pain,fever \n7. Tiotropium Bromide 1 CAP IH DAILY \n8. Rifaximin 550 mg PO BID \n9. Calcium Carbonate 1250 mg PO BID \n10. Lactulose 15 mL PO TID \n11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 500 mg PO Q6H:PRN pain,fever \n2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, SOB \n3. Calcium Carbonate 1250 mg PO BID \n4. ___ (Truvada) 1 TAB PO DAILY \n5. Furosemide 40 mg PO DAILY \n6. Lactulose 15 mL PO TID \n7. Raltegravir 400 mg PO BID \n8. Rifaximin 550 mg PO BID \n9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY \n10. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:  diuretic refractory ascites\nSecondary: HCV cirrhosis, HIV, hyponatremia, COPD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\n___ was a pleasure to take care of you at ___ \n___. You were admitted with abdominal fullness and \npain from your ascites. You had a diagnostic and therapeutic \nparacentesis with 4.3 L removed. Your spironolactone was \ndiscontinued because your potassium was high. Your lasix was \nincreased to 40mg daily. You are scheduled for another \nparacentesis on ___ prior to your other appointments that day. \nPlease call tomorrow to find out the time of the paracentesis. \nPlease continue to follow a low sodium diet and fluid \nrestriction. You should call your liver doctor or return to the \nemergency room if you have abdominal pain, fever, chills, \nconfusion, or other concerning symptoms.\n\nSincerely,\nYour ___ medical team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "2",
         "10000032-DS-23",
         "10000032",
         "29079034",
         "2180-07-25 00:00:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPercocet / Vicodin\n \nAttending: ___\n \nChief Complaint:\naltered mental status\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nMrs. ___ is a ___ female with HIV on HAART, COPD, HCV \ncirrhosis complicated by ascites and hepatic encephalopathy who \ninitially presented to the ED yesterday with hypotension after a \nparacentesis.  \nThe patient has had accelerated decompensation of her cirrhosis \nrecently with worsening ascites, and she is maintained on twice \nweekly paracentesis. She was at her regular session yesterday \nwhen she had hypotension to SBP ___ and felt lightheadedness. \nPer the patient, that's when her memory started to get fuzzy. \nShe does not have much recollection of what happened since then. \nHer outpatient hepatologist saw her and recommended that she go \nto the ED. In the ED, she was evaluated and deemed to have \nstable blood pressure. She was discharged home. At home, she had \nworsening mental status with her daughter getting concerned, and \nshe returned to the ED.  \nIn the ED, initial vitals were 98.7 77 96/50 16 98% RA. The \npatient was only oriented to person. Her labs were notable for \nNa 126, K 6.7, Cr 0.7 (baseline 0.4), ALT 153, AST 275, TBili \n1.9, Lip 66, INR 1.5. Initial EKG showed sinus rhythm with \npeaked T waves. Her head CT was negative for any acute \nprocesses. She received ceftriaxone 2gm x1, regular insulin 10U, \ncalcium gluconate 1g, lactulose 30 mL x2, and 25g 5% albumin.  \nOn transfer, vitals were 99.0 93 84/40 16 95% NC. On arrival to \nthe MICU, patient was more alert and conversant. She has no \nabdominal pain, nausea, vomiting, chest pain, or difficulty \nbreathing. She has a chronic cough that is not much changed. She \nhas not had any fever or chills. She reports taking all of her \nmedications except for lactulose, which she thinks taste \ndisgusting.  \n \nPast Medical History:\n- HCV Cirrhosis: genotype 3a  \n- HIV: on HAART, ___ CD4 count 173, ___ HIV viral load \nundetectable  \n- COPD: ___ PFT showed FVC 1.95 (65%), FEV1 0.88 (37%), \nFEFmax 2.00 (33%)  \n- Bipolar Affective Disorder  \n- PTSD  \n- Hx of cocaine and heroin abuse  \n- Hx of skin cancer per patient report  \n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  talking to most of \nthem. She only has one brother that she is in  touch with and \nlives in ___. She is not aware of any known GI or liver \ndisease in her family.  \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals T: 98.7 BP: 84/48 P: 91 R: 24 O2: 98% NC on 2L  \nGENERAL: Alert, oriented, no acute distress  \nLUNGS: Decreased air movement on both sides, scattered \nexpiratory wheezes  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, \ngallops  \nABD: Soft, non-tender, distended, flank dullness bilaterally, \nbowel sounds present  \nEXT: Warm, well perfused, 2+ pulses, no cyanosis or edema  \n\nDISCHARGE PHYSICAL EXAM:\nVitals- Tm 99.5, Tc 98.7, ___ 79-96/43-58 20 95% on 3L NC, \n7BM.  \nGeneral- Cachectic-appearing woman, alert, oriented, no acute \ndistress  \nHEENT- Sclera anicteric, MMM, oropharynx clear, poor dentition \nwith partial dentures  \nNeck- supple, JVP not elevated, no LAD  \nLungs- Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen- Mildly distended and firm, non-tender, bowel sounds \npresent, no rebound tenderness or guarding  \nGU- no foley  \nExt- warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNeuro- AOx3, No asterixis.  \n \nPertinent Results:\nADMISSION LABS:\n=================\n___ 06:39AM BLOOD WBC-6.9 RBC-3.98* Hgb-14.1 Hct-41.1 \nMCV-103* MCH-35.4* MCHC-34.3 RDW-15.8* Plt ___\n___ 06:39AM BLOOD Neuts-72.7* Lymphs-14.7* Monos-9.8 \nEos-2.5 Baso-0.3\n___ 06:39AM BLOOD ___ PTT-32.4 ___\n___ 06:39AM BLOOD Glucose-102* UreaN-49* Creat-0.7 Na-126* \nK-6.7* Cl-95* HCO3-25 AnGap-13\n___ 06:39AM BLOOD ALT-153* AST-275* AlkPhos-114* \nTotBili-1.9*\n___ 06:39AM BLOOD Albumin-3.6\n\nIMAGING/STUDIES:\n================\n___ CT HEAD:\nNo evidence of acute intracranial process.\nThe left zygomatic arch deformity is probably chronic as there \nis no\nassociated soft tissue swelling.\n\n___ CXR:\nNo acute intrathoracic process.\n\nDISCHARGE LABS:\n===============\n___ 04:45AM BLOOD WBC-4.8 RBC-3.15* Hgb-11.2* Hct-32.1* \nMCV-102* MCH-35.4* MCHC-34.8 RDW-15.8* Plt Ct-95*\n___ 04:45AM BLOOD ___ PTT-37.6* ___\n___ 04:45AM BLOOD Glucose-121* UreaN-35* Creat-0.4 Na-130* \nK-5.2* Cl-97 HCO3-27 AnGap-11\n___ 04:45AM BLOOD ALT-96* AST-168* AlkPhos-69 TotBili-1.7*\n___ 04:45AM BLOOD Calcium-8.6 Phos-2.4* Mg-2.___ w/ HIV on HAART, COPD on 3L home O2, HCV cirrhosis \ndecompensated (ascites requiring biweekly therapeutic \nparacenteses, hepatic encephalopathy; not on transplant list ___ \ncomorbidities) w/ AMS, hypotension, ___, and hyperkalemia. \nAltered mental status improved with lactulose. Hypotension was \nfelt to be due to fluid shifts from paracentesis on the day \nprior to admission as well as low PO intake in the setting of \nAMS. Hypotension and ___ resolved with IV albumin. Hyperkalemia \nresolved with insulin and kayexalate.\n\n# Hypotension: Patient presented with SBP in ___ and improved \nwith albumin in the ED to ___. It was felt to be due to \nfluid shifts from paracentesis on ___, as well as likely \nhypovolemia given AMS and decreased PO intake. No concern for \nbleeding or sepsis with baseline CBC and lack of fever. She \ncontinued to received IV albumin during her hospital course, \nwith which her SBP improved to ___ and patient remained \nasymptomatic.  \n\n# Hyperkalemia: Patient presented with K 6.7 with EKG changes. \nGiven low Na, likely the result of low effective arterial volume \nleading to poor K excretion, with likely exacerbation from ___. \nAM cortisol was normal. K improved with insulin and kayexalate \nand K was 5.2 on day of discharge. Bactrim was held during \nhospital course. \n\n# ___: Patient presented with Cr 0.7 from baseline Cr is \n0.3-0.4. It was felt to be likely due to volume shift from her \nparacentesis on the day prior to admission as well as now low \neffective arterial volume, likely ___ poor PO intake ___ AMS. Cr \nimproved to 0.4 with albumin administration. Furosemide and \nBactrim were held during hospital course.   \n\n#GOC: The ___ son (HCP) met with Dr. ___ \noutpatient hepatologist) during ___ hospital course. They \ndiscussed that the patient is not a transplant candidate \ngivenevere underlying lung disease (FEV1 ~0.8), hypoxia, RV \ndilation and very low BMI. A more conservative approach was \nrecommended and the patient was transitioned to DNR/DNI. The \npatient agreed with this plan. She was treated with the goal of \ntreating any any correctable issues. Social work met with the \npatient prior to discharge. The patient was interested in \nfollowing up with palliative care, for which an outpatient \nreferral was made. \n \n# Altered Mental Status: Patient presented with confusion that \nwas most likely secondary to hepatic encephalopathy. Based on \noutpatient records, patient has had steady decline in \ndecompensated cirrhosis and mental status. No signs of infection \nand head CT was negative as well. Mental status improved with \nlactulose in the ED and patient reports that she has not been \ntaking lactulose regularly at home. Patient was also continued \non rifaximin.   \n\n# HCV Cirrhosis: Genotype 3a. Patient is decompensated with \nincreasing ascites and worsening hepatic encephalopathy. She is \ndependent on twice weekly paracentesis. Spironolactone was \nrecently stopped due to hyperkalemia. Patient is not a \ntransplant candidate given her comorbidities COPD per outpatient \nhepatologist. The patient would like to continue biweekly \nparacenteses as an outpatient.\n\n# HIV: Most recent CD4 count 173 on ___. HIV viral load on \n___ was undetectable. She was continued on her home regimen \nof raltegravir, emtricitabine, and tenofovir. Bactrim \nprophylaxis was held during admission because of hyperkalemia.   \n\n\n# COPD: Patient on 3L NC at home. She was continued on her home \nregimen.\n\nTRANSITIONAL ISSUES:\n-Follow up with Palliative Care as outpatient\n-Bactrim prophylaxis (HIV+) was held during hospital course due \nto ___. Consider restarting as outpatient.\n-Furosemide was held due to ___, consider restarting as \noutpatient\n-Follow up with hepatology\n-Continue biweekly therapeurtic paracenteses\n-Code status: DNR/DNI\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lactulose 15 mL PO TID \n2. Tiotropium Bromide 1 CAP IH DAILY \n3. Raltegravir 400 mg PO BID \n4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n5. Furosemide 40 mg PO DAILY \n6. TraMADOL (Ultram) 50 mg PO Q8H:PRN Pain \n7. Fluticasone Propionate 110mcg 1 PUFF IH BID \n8. Calcium Carbonate 500 mg PO BID \n9. Rifaximin 550 mg PO BID \n10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY \n\n \nDischarge Medications:\n1. Calcium Carbonate 500 mg PO BID \n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n3. Fluticasone Propionate 110mcg 1 PUFF IH BID \n4. Lactulose 30 mL PO TID \n5. Raltegravir 400 mg PO BID \n6. Rifaximin 550 mg PO BID \n7. TraMADOL (Ultram) ___ mg PO Q6H:PRN pain \n8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n9. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\nHypotension\nHyperkalemia\nAcute Kidney Injury\n\nSecondary:\nHIV\nCirrhosis\nCOPD\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ because of confusion, low blood \npressure, and a high potassium value. Your confusion improved \nwith lactulose. Your blood pressure improved with extra fluids \nand your potassium improved as well. You also had small degree \nof kidney injury when you came to the hospital, and this also \nimproved with fluids. While you were here, you discussed \nchanging your goals of care to focusing on symptom management \nand treatment of reversible processes, such as an infection. \nWhile you were in the hospital, you were seen by one of our \nsocial workers. You will also follow up with Palliative Care in \ntheir clinic and will continue to have therapeutic paracenteses.\n\nIt has been a pleasure taking care of you and we wish you all \nthe best,\nYour ___ Care team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "3",
         "10000032-DS-24",
         "10000032",
         "25742920",
         "2180-08-07 00:00:00",
         " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPercocet / Vicodin\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\n___ Paracentesis\n\n \nHistory of Present Illness:\n___ w/ HIV on HAART, COPD on 3L home O2 (though sat'ing fine on \nRA on admission), HCV cirrhosis c/b ascites requiring biweekly \ntherapeutic paracenteses, hepatic encephalopathy; not on \ntransplant list ___ comorbidities) p/w worsening girth and abd \npain. She'd been having pain from her ascites, and felt overdue \nfor a paracentesis. She last had paracentesis on the ___. \nShe reported that she began feeling worsening abdominal pain \n(constant, epigastric and radiates to back, not a/w food) on \n___, which increased in severity throughout the course of the \nday. She was brought to the ED by her son because of this pain. \nShe had no confusion and was alert and oriented x3. The patient \nalso reported she recently ran out of most of her home \nmedications. She denied any fever, chills, shortness of breath, \ncough, dysuria. She reported loose stool a bit more than usual, \nbut attributed it to lactulose use. In the ED, vitals were: 99.4 \n105 106/57 18 96% ra. Labs were significant for Na 127 K 5.3 \nlactate 2.1 INR 1.7. ALT 135 AST 244 AP 123. no leukocytosis. \nAscitic fluid showed 220 WBC. She was given Morphine Sulfate 5 \nmg IV ONCE MR1, and a GI cocktail.\n \nPast Medical History:\n- HCV Cirrhosis: genotype 3a  \n- HIV: on HAART, ___ CD4 count 173, ___ HIV viral load \nundetectable  \n- COPD: ___ PFT showed FVC 1.95 (65%), FEV1 0.88 (37%), \nFEFmax 2.00 (33%)  \n- Bipolar Affective Disorder  \n- PTSD  \n- Hx of cocaine and heroin abuse  \n- Hx of skin cancer per patient report  \n \nSocial History:\n___\nFamily History:\nShe a total of five siblings, but she is not  talking to most of \nthem. She only has one brother that she is in touch with and \nlives in ___. She is not aware of any known GI or liver \ndisease in her family.  \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\n=======================\nVitals - T 97, BP 98/65, HR 103, RR 18, O2 94RA, Glucose 128.  \nGENERAL: NAD, lying on her right side.\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, good dentition  \nNECK: nontender supple neck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: distended, + fluid wave, not tense. NABS, nontender  \nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose\nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact, AAO3, no asterxis  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n\nDISCHARGE PHYSICAL EXAM\n=======================\nVitals - Tm 98.6, Tc 98.2, BP 82-98/42-68, HR 80-95, RR ___, \nO2 91-99% RA.\nGENERAL: NAD, lying on her right side.\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, good dentition  \nNECK: nontender supple neck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: soft, decreased distension, not tense. NABS, nontender  \n\nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose\nPULSES: 2+ DP pulses bilaterally  \nNEURO: CN II-XII intact, AAO3, no asterxis  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 09:20PM BLOOD WBC-8.2# RBC-3.48* Hgb-12.3 Hct-36.7 \nMCV-106* MCH-35.5* MCHC-33.6 RDW-16.5* Plt ___\n___ 09:28PM BLOOD ___ PTT-31.8 ___\n___ 09:20PM BLOOD Glucose-118* UreaN-33* Creat-0.6 Na-127* \nK-5.3* Cl-97 HCO3-24 AnGap-11\n___ 09:20PM BLOOD ALT-135* AST-244* AlkPhos-123* \nTotBili-1.3\n___ 09:20PM BLOOD Albumin-3.5 Calcium-8.3* Phos-3.3 Mg-2.3\n___ 09:27PM BLOOD Lactate-2.1*\n\nNOTABLE LABS\n============\n___ 12:30AM ASCITES WBC-220* ___ Polys-17* \nLymphs-48* Monos-19* Mesothe-2* Macroph-12* Other-2*\n___ 12:30AM ASCITES TotPro-0.7 Glucose-129\n\nMICROBIOLOGY\n============\n___ 12:30 am PERITONEAL FLUID\n\n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary):    NO GROWTH.\n\n___ VRE screen: No VRE isolated.\n\nIMAGING/STUDIES\n===============\nCXR ___\nNo acute cardiopulmonary process.\n\nRUQUS ___\nCirrhotic, mild splenomegaly and ascites.  A solid 3cm nodule in \nthe left lobe of the liver is stable in size and appearance. \n\nDISCHARGE LABS\n==============\n___ 06:15AM BLOOD WBC-5.6 RBC-3.27* Hgb-11.6* Hct-33.5* \nMCV-103* MCH-35.5* MCHC-34.5 RDW-16.1* Plt ___\n___ 06:15AM BLOOD ___ PTT-36.0 ___\n___ 06:15AM BLOOD Glucose-87 UreaN-29* Creat-0.4 Na-123* \nK-5.4* Cl-93* HCO3-24 AnGap-11\n___ 06:15AM BLOOD ALT-112* AST-176* AlkPhos-101 \nTotBili-2.8*\n___ 06:15AM BLOOD Albumin-3.5 Calcium-8.8 Phos-3.4 Mg-2.___ w/ HIV on HAART, COPD on 3L home O2, HCV cirrhosis \ndecompensated (ascites requiring biweekly therapeutic \nparacenteses, hepatic encephalopathy; not on transplant list ___ \n \ncomorbidities) p/w worsening abd girth and pain.\n\n# Goals of care:  The patient expressed that her desire to \"let \ngo\" and be at peace. She is tired of \"fighting\" her end stage \nliver disease and does not feel that she has a good quality of \nlife. She wished to meet with a representative from hospice, \nwhich we were able to arrange, and she decided that she would \nlike to go home with hospice. A conversation was held with the \npatient regarding code status. She noted that she would probably \nbe DNR/DNI, but would like to discuss it with her son (HCP). \nTherefore, at this time, she remains full code. We also \ndiscussed the possibility of her getting a pleurex catheter \nplaced because of her repeated paracenteses. She was discharged \nto home with hospice on ___.\n\n# Decompensated HCV cirrhosis with ascites: The patient \npresented with worsening ascites. Her pain was initially managed \nwith tramadol and morphine. She underwent ___ paracentesis \non ___ with removal of 3.5L and she received albumin. Studies \non the fluid were negative, and she reported a significant \nimprovement in her pain.\n \n# Hyperkalemia: During her hospitalization, it was noted that \nshe had hyperkalemia 5.3 -> 5.9 -> 6.9 without EKG changes. \nAfter treatment with calcium gluconate 2gm x2, insulin and D50 x \n2, and kayexelate, her K downtrended to 5.4. Her K has been \npersistently elevated in the past and should continue to be \nmonitored.\n\n# Hepatic encephalopathy: The patient's mental status was A+Ox3 \non admission. She was continued on rifaximin and lactulose \nin-house and at discharge.\n\nCHRONIC ISSUES\n==============\n\n# Hyponatremia - The patient has a history of asymptomatic \nhyponatremia. It is most likely hypervolemic hyponatremia \nrelated to underlying liver disease as well as aldosterone axis \ndysfunction related to liver disease. She remained asymptomatic \nthrough her hospitalization. Because she was also started on \n10mg of furosemide to help prevent fluid re-accumulation, she \nwill require BMPs twice weekly in the outpatient setting.\n\n# HIV: Emtricitabine-Tenofovir (Truvada) and Raltegravir were \ncontinued in-house and at discharge.  \n\n# COPD: fluticasone, tiotropium and albuterol were continued \nin-house and at discharge.\n\nTRANSITIONAL ISSUES\n===================\n[ ] Follow-up peritoneal fluid culture\n[ ] New/changed medications: Furosemide 10mg daily (new)\n[ ] For hyperkalemia and hyponatremia, the patient should have \nbiweekly BMPs (script written). If K > 5.3, she should be given \nkayexelate once weekly. Lab results will be faxed/sent to Dr. \n___.\n[ ] Continue conversation regarding pleurex catheter placement \nand code status.\n[ ] She will continue to have twice weekly paracenteses\n\n# Code: full  \n# Emergency Contact: ___ ___ \n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Calcium Carbonate 500 mg PO BID \n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n3. Fluticasone Propionate 110mcg 1 PUFF IH BID \n4. Lactulose 30 mL PO TID \n5. Raltegravir 400 mg PO BID \n6. Rifaximin 550 mg PO BID \n7. TraMADOL (Ultram) ___ mg PO Q6H:PRN pain \n8. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n9. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Medications:\n1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN \nWheezing \n2. Calcium Carbonate 500 mg PO BID \n3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n4. Fluticasone Propionate 110mcg 1 PUFF IH BID \n5. Lactulose 30 mL PO TID \n6. Raltegravir 400 mg PO BID \n7. Rifaximin 550 mg PO BID \n8. Tiotropium Bromide 1 CAP IH DAILY \n9. TraMADOL (Ultram) ___ mg PO Q6H:PRN pain \n10. Furosemide 10 mg PO DAILY \nRX *furosemide 20 mg 0.5 (One half) tablet(s) by mouth Please \ntake 1 tablet daily. Disp #*15 Tablet Refills:*0\n11. Outpatient Lab Work\nPlease obtain biweekly BMP to monitor K and Na. Please fax \nresults to Dr. ___ at the ___ at ___.\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\n=================\n-Decompensated HCV cirrhosis\n-Hyperkalemia\n\nSECONDARY DIAGNOSES\n===================\n-HIV\n-COPD\n-Hyponatremia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you during your stay at ___. You \nwere admitted because of worsening abdominal pain. It is likely \nthat this pain was due to increasing fluid in the abdomen from \nyour cirrhosis. After a paracentesis in which much of this fluid \nwas removed, your pain improved significantly. You were noted to \nhave a high potassium during your hospitalization, which came \ndown with treatment but this should continue to be followed as \nan outpatient. You also emphasized your desire to speak with a \nrepresentative from hospice. Because of your repeated \nparacenteses, we also discussed the possibility of a pleurex \ncatheter placement. We arranged for you to meet with hospice \ncoordinators, and you will be discharged home with hospice.\n\nWe wish you all the best!\n\nYour ___ care team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "14",
         "10000935-DS-18",
         "10000935",
         "29541074",
         "2183-11-04 00:00:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nSulfonamides / Codeine / Bactrim\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain and vomiting\n \nMajor Surgical or Invasive Procedure:\n___ Exploratory laparotomy, lysis of adhesions, small\nbowel resection with enteroenterostomy.\n\n \nHistory of Present Illness:\nThe patient is a ___ year old woman s/p hysterectomy for uterine \nfibroids and s/p R lung resection for carcinoid tumor who is \nseen in surgical consultation for abdominal pain, nausea, and \nvomiting. The patient was feeling well until early this morning \nat approximately 1:00am, when she developed cramping abdominal \npain associated with nausea and bilious emesis without blood.  \nShe\nvomited approximately ___ times which prompted her presentation \nto the ED.  At the time of her emesis, she had diarrhea and \nmoved her bowels > 3 times.  She has never had this or similar \npain in the past, and she states that she has never before had a \nsmall bowel obstruction.  She has never had a colonoscopy. \n\n \n\n \n\n \nPast Medical History:\nPMH: \ncarcinoid tumor as above\nVitamin B12 deficiency\ndepression\nhyperlipidemia\n\nPSH: \ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nnon contributory\n \nPhysical Exam:\nTemp 96.9  HR 105  BP 108/92 100%RA\nNAD, appears non-toxic but uncomfortable\nheart tachycardic but regular, no murmurs appreciated\nlungs clear to auscultation; decreased breath sounds on R;\nwell-healed R thoracotomy scar present\nabdomen soft, very obese, minimally distended, somewhat tender \nto\npalpation diffusely across abdomen; no guarding; no rebound\ntenderness, low midline abdominal wound c/d/i, no drainage, no \nerythema\n\n \nPertinent Results:\n___ 04:40AM   WBC-12.5*# RBC-4.46 HGB-13.6 HCT-39.7 MCV-89 \nMCH-30.5 MCHC-34.2 RDW-13.0\n___ 04:40AM   NEUTS-91.1* LYMPHS-7.4* MONOS-0.8* EOS-0.3 \nBASOS-0.2\n___ 04:40AM   PLT COUNT-329\n___ 04:40AM   GLUCOSE-151* UREA N-10 CREAT-0.8 SODIUM-142 \nPOTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-28 ANION GAP-13\n___ 04:40AM   ALT(SGPT)-12 AST(SGOT)-16 LD(LDH)-180 ALK \nPHOS-62 \n\n___ CT of abdomen and pelvis :1. Slightly dilated loops of \nsmall bowel with fecalization of small bowel contents and distal \ncollapsed loops, together indicating early complete or partial \nsmall-bowel obstruction. \n2. Post-surgical changes noted at the right ribs as detailed \nabove.\n\n___ CT of abdoman and pelvis :  \n1. Interval worsening of small bowel obstruction. Transition \npoint in the \nleft mid abdomen. (The patient went to the OR on the evening of \nthe study). \n2. Trace free fluid in the pelvis is likely physiologic.  \n\n  \n\n___ 10:57PM URINE  COLOR-Yellow APPEAR-Hazy SP ___\n___ 10:57PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-15 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 10:57PM URINE  RBC->50 ___ BACTERIA-MOD YEAST-NONE \nEPI-0\n___ 10:57PM URINE  MUCOUS-OCC\n___ 04:40AM   GLUCOSE-151* UREA N-10 CREAT-0.8 SODIUM-142 \nPOTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-28 ANION GAP-13\n___ 04:40AM   estGFR-Using this\n___ 04:40AM   ALT(SGPT)-12 AST(SGOT)-16 LD(LDH)-180 ALK \nPHOS-62 TOT BILI-0.2\n___ 04:40AM   LIPASE-17\n___ 04:40AM   WBC-12.5*# RBC-4.46 HGB-13.6 HCT-39.7 MCV-89 \nMCH-30.5 MCHC-34.2 RDW-13.0\n___ 04:40AM   NEUTS-91.1* LYMPHS-7.4* MONOS-0.8* EOS-0.3 \nBASOS-0.2\n___ 04:40AM   PLT COUNT-329\n \nBrief Hospital Course:\nThis ___ year old female was admitted to the hospital and was \nmade NPO, IV fluids were started and she had a nasogastric tube \nplaced.  She was pan cultured for a temperature of 101 and was \nfollowed with serial KUB's and physical exam. Her nasogastric \ntube was clamped on hospital day 2 and she soon developed \nincreased abdominal pain prompting repeat CT of abdomen and \npelvis.  This demonstrated an increase in the degree of \nobstruction and she was subsequently taken to the operating room \nfor the aforementioned procedure.\n\nShe tolerated the procedure well, remained NPO  with nasogastric \ntube in place and treated with IV fluids.  Her pain was \ninitially controlled with a morphine PCA .  Her nasogastric tube \nwas removed on post op day #2 and she began a clear liquid diet \nwhich she tolerated well.  This was gradually advanced over 36 \nhours to a regular diet and was tolerated well.  She was having \nbowel movements and tolerated oral pain medication.  Her \nincision was healing well and staples were intact.  After an \nuncomplicated course she was discharged home on ___\n \nMedications on Admission:\nAlbuteral MDI prn wheezes\nFlovent inhaler prn wheezes\nSrtraline 200 mg oral daily\nSimvastatin 20 mg oral daily\nTrazadone 100 mg oral daily at bedtime\nWellbutrin 75 mg oral twice a day\n \nDischarge Medications:\n1. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for \nwheezing, shortness of breath.  \n2. Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff \nInhalation BID (2 times a day).  \n3. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ4H (every 4 hours) as needed for pain.\nDisp:*40 Tablet(s)* Refills:*0*\n4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n5. Simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n6. Trazodone 100 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n7. Wellbutrin 75 mg Tablet Sig: One (1) Tablet PO twice a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nHigh grade small bowel obstruction\n\n \nDischarge Condition:\nHenodynamically stable, tolerating a regular diet, having bowel \nmovements, adequate pain control\n\n \nDischarge Instructions:\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n\n*You experience new chest pain, pressure, squeezing or \ntightness.\n\n*New or worsening cough, shortness of breath, or wheeze.\n\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications , unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\n\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\nIncision Care:\n\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \nsite.\n\n*Avoid swimming and baths until your follow-up appointment.\n\n*You may shower, and wash surgical incisions with a mild soap \nand warm water. Gently pat the area dry.\n\n*If you have staples, they will be removed at your follow-up \nappointment.\n\n*If you have steri-strips, they will fall off on their own. \nPlease remove any remaining strips ___ days after surgery.\n\n*Please look at the site every day for signs of infection \n(increased redness or pain, swelling, odor, yellow or bloody \n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "15",
         "10000935-DS-19",
         "10000935",
         "21738619",
         "2187-07-12 00:00:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Codeine / Bactrim\n \nAttending: ___\n \nChief Complaint:\nnausea, vomiting, cough\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ female, with past medical history significant for \ndepression, hyperlipidemia, Hysterectomy, B12 deficiency, back \npain, carcinoid, cervical DJD, depression, hyperlipidemia, \nosteoarthritis, and history of Exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy for \na high grade SBO ___ who presents with nausea, vomiting, \nweakness x 2 weeks. She has been uable to tolerate PO liquids, \nand solids. Had similar presentation ___ for high grade SBO. \nDenies passing flatus today. However reports having last normal \nbowel movement this AM, without hematochezia, melena. Also \nreporting subjective fever (100.0), non productive cough. Denies \nHA, myalgias. Takes NSAIDS sparingly. Denies alcohol use. Denies \nsick contacs/ travel or recent consumption of raw foods. Has \nnever had a colonoscopy.  \n.  \nIn ED VS were 97.8 120 121/77 20 98% RA  \nLabs were remarkable for lactate 2.8, alk phos 293, HCT 33, WBC \n13.9  \nImaging: CT abdomen showed mult masses in the liver, consistent \nwith malignancy. CXR also showed multiple nodules  \nEKG: sinus, 112, NA, NI, TWI in III, but largely unchanged from \nprior  \nInterventions: zofran, tylenol, 2L NS, GI was contacted and they \nare planning on upper / lower endoscopy for cancer work-up.  \n.  \nVitals on transfer were 99.2 113 119/47 26 98%  \n\n \nPast Medical History:\nPMH: \n# high grade SBO ___ s/p exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy \n# carcinoid\n# hyperlipidemia\n# vitamin B12 deficiency\n# cervical DJD\n# osteoarthritis \n\nPSH: \ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nnon contributory\n \nPhysical Exam:\nOn admission\n\nVS: 98.9 137/95 117 20 100 RA  \nGENERAL: AOx3, NAD  \nHEENT: MMM. no JVD. neck supple.  \nHEART: Regular tachycardic, S1/S2 heard. no \nmurmurs/gallops/rubs.  \nLUNGS: CTAB, non labored  \nABDOMEN: soft, tender to palpation in epigastrium.  \nEXT: wwp, no edema. DPs, PTs 2+.  \nSKIN: dry, no rash  \nNEURO/PSYCH: CNs II-XII intact. strength and sensation in U/L \nextremities grossly intact. gait not assessed.  \n\nOn Discharge: \nVS: 98.7   118/78   97  20 99RA\nGENERAL: Patient is sitting in a chair, appears comfortable, \nA+Ox3, cooperative.   \nHEENT: EOMI, PERRLA, No Pallor or Jaundice, MMM, no JVD, neck \nsupple.  \nHEART: RRR, no m/r/g.  \nLUNGS: CTAB  \nABDOMEN: obese, soft, mild tenderness on mid +right epigastrium \nw/o peritoneal signs, no shifting dullness, difficult to \nappreciate organomegaly.  \nEXT: wwp, no edema, no signs of DVT  \nSKIN: no rash, normal turgor  \nNEURO: no gross deficits \nPSYCH: appropriate affect, no preceptual disturbances, no SI, \nnormal judgment.   \n\n \nPertinent Results:\n___ 03:14PM   ___\n___ 12:50PM URINE  HOURS-RANDOM\n___ 12:50PM URINE  UHOLD-HOLD\n___ 12:50PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 12:50PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 \nLEUK-TR\n___ 12:50PM URINE  RBC-2 WBC-2 BACTERIA-NONE YEAST-NONE \nEPI-2\n___ 09:54AM   LACTATE-2.8*\n___ 09:45AM   GLUCOSE-96 UREA N-7 CREAT-0.5 SODIUM-138 \nPOTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-27 ANION GAP-15\n___ 09:45AM   estGFR-Using this\n___ 09:45AM   ALT(SGPT)-17 AST(SGOT)-46* ALK PHOS-293* TOT \nBILI-0.5\n___ 09:45AM   LIPASE-14\n___ 09:45AM   ALBUMIN-3.0*\n___ 09:45AM   ___ AFP-1.7\n___ 09:45AM   WBC-13.9* RBC-3.94* HGB-9.8* HCT-33.0* \nMCV-84# MCH-25.0*# MCHC-29.9* RDW-16.1*\n___ 09:45AM   NEUTS-75.2* LYMPHS-17.9* MONOS-5.9 EOS-0.7 \nBASOS-0.3\n___ 09:45AM   PLT COUNT-657*#\n\nCT abdomen/pelvis\n1. Innumerable hepatic and pulmonary metastases.  No obvious \nprimary \nmalignancy is identified on this study. \n  \n2. No evidence of small bowel obstruction, ischemic colitis, \nfluid collection, \nor perforation. \n\nCXR: \n \nNew nodular opacities within both upper lobes, left greater than \nright. \nFindings are compatible with metastases, as was noted in the \nlung bases on the \nsubsequent CT of the abdomen and pelvis performed later the same \nday. \n\n \nBrief Hospital Course:\n___ Female with PMH significant for depression, \nhyperlipidemia, Hysterectomy, B12 deficiency, OA, carcinoid, \ncervical DJD, depression, SBO who presented with nausea, \nvomiting, weakness x 2 weeks and was found to have multiple \nliver and lung masses per CT consistent with metastatic cancer \nof unknown primary. \n\nPatient was treated with IV fluids overnight for dehydration. \nShe refused to stay in the hospital for any further work-up or \ntreatment and stated she would rather go home to to think and \nsee to her affairs over the weekend and consider pursuing \nfurther work-up as an outpatient. She tolerated oral fluids well \nw/o vomiting. She remained hemodynamically stable and afebrile \nthroughout her stay. \n\nOf note patient has psychiatric history of depressive symptoms \nand isolation tendencies. She denied any SI/SA or any risk to \nherself.  She has little social supports but does have a good \nrelationship with her driver and friend who came in and was \nupdated by the medical team on the morning of discharge and will \nbe taking her home. She sees a mental health provider at ___ \nonce a month and has a good relationship with her primary care \nphysician. Patient was dischaerged home at her request. Home \nmedications were continued to which we added some symptomatic \ntreatment for her cough with benzonatate and Guaifenesin. We \nheld off on anti-emetics for now as she did not want to stay \ninhouse to make sure these would be well tolerated (would need \nto monitor for drug interactions given multiple QTc prolonging \nand serotonergic medications on her home meds).  She was \ninstructed to maintain good hydration and try a soft diet at \nhome if she can not tolerate regular diet. The patient met with \nSW who provided her with resources for community councelling. \nOutpatient appointments with oncology, GI and her PCP were set \nup and her PCP and mental health provider were updated. Her PCP \n___ also ___ with her later today by telephone. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN wheezing/SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO TID \n4. Ibuprofen 800 mg PO Q8H:PRN pain \n5. Sertraline 200 mg PO DAILY \n6. Simvastatin 40 mg PO DAILY \n7. Tizanidine 4 mg PO BID:PRN muscle spasms/pain \n8. traZODONE 100 mg PO HS:PRN sleep \n9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP TID \n\n \nDischarge Medications:\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO TID \n4. Sertraline 200 mg PO DAILY \n5. Simvastatin 40 mg PO DAILY \n6. Tizanidine 4 mg PO BID:PRN muscle spasms/pain \n7. traZODONE 100 mg PO HS:PRN sleep \n8. Ibuprofen 800 mg PO Q8H:PRN pain \n9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP TID \n10. Benzonatate 100 mg PO TID:PRN cough \nRX *benzonatate 100 mg 1 capsule(s) by mouth TID: PRN cough Disp \n#*60 Capsule Refills:*0\n11. Guaifenesin ___ mL PO Q6H:PRN cough \nRX *guaifenesin 100 mg/5 mL ___ ml by mouth Q6H:PRN cough Disp \n#*1 Bottle Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nLiver and Lung Mets of unkown primary\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___, \n\n___ were seen in the ED for ongoing cough, nausea and vomiting \nand had imaging studies which unfortunately showed spots in your \nliver and lungs which are likely due to wide-spread cancer. ___ \nwere admitted for further work-up and treatment of your \nsymptoms. ___ chose to not have any more work-up in the hospital \nand wanted to be discharged home as soon as possible. \nPlease make sure ___ keep well hydrated by taking water sips \nthroughout the day. I also prescribed some symptomatic treatment \nfor your nausea and cough. \nI updated your PCP and ___ and have set up ___ \nappointments as below.  \n \nFollowup Instructions:\n___\n"
        ],
        [
         "16",
         "10000935-DS-20",
         "10000935",
         "26381316",
         "2187-08-27 00:00:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Codeine / Bactrim\n \nAttending: ___.\n \nChief Complaint:\n Weakness, nausea/vomiting  \n\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nThis is a ___ yo f with h/o recently diagnosed metastatic cancer \nof unknown prior presenting with nausea, vomiting, and fever to \n101 today. Patient has been vomiting over the past 6 - 8 weeks, \nsince before she was diagnosed with metastatic cancer. She also \nreports pain over her upper abdomen and has very poor PO intake. \nShe has been feeling progressively weak over this time period. \nHer vomiting and abdominal pain has not increased from the past \nweeks, but she just feels more fatigued. She has a chronic \nnon-productive cough as well. No URI symptoms, no urinary \ncomplaints. She has been constipated, which improves when she \nstops her anti-emetics. Last bowel movement was yesterday. She \nis passing gas. She has lower extremity edema, which has been \npresent for the past several weeks.  \nOf note, she was supposed to have one of her liver mets biopsied \nin the past several weeks, but she was taking ibuprofen so the \nbiopsy had to be postponed.  \n \nIn the ED, initial VS were: 97.6 117 128/74 18 95% RA. Labs were \nsignificant for WBC of 18.7, with 77% polys. UA was significant \nfor ketones. Patient received zofran, NS. She had a CXR that \nshowed new left sided opacity that may reflect PNA superimposed \non metastatic diseae vs. lymphangiitic spread of cancer. She \nreceived vanc and cefepime for pneumonia. Vitals on transfer \nare: 99.6 110 118/78 20 99%.  \nCurrently, she continues to feel weak and nauseous. She is \ntrying to take her pants off, but feels too weak and tired to do \nso.  \nREVIEW OF SYSTEMS:  \n(+) per HPI  \n(-) night sweats, headache, vision changes, rhinorrhea, \ncongestion, sore throat, BRBPR, melena, hematochezia, dysuria, \nhematuria.  \n \n\n \nPast Medical History:\nPMH: \n# high grade SBO ___ s/p exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy \n# carcinoid\n# hyperlipidemia\n# vitamin B12 deficiency\n# cervical DJD\n# osteoarthritis \n\nPSH: \ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nMother - ___ cancer d. at ___  \nYoungest of ___ - not in touch with siblings  \nFather - ___ d. at ___  \n\n \nPhysical Exam:\nAdmission Physical Exam: \nVS: 98.6, 130/80, 111, 24, 98% on RA  \nGENERAL: Obese woman, appears comfortable, in no acute distress  \n\nHEENT: PERRLA, EOMI, sclerae anicteric, slightly dry mucus \nmembranes  \nNECK: supple, obese  \nLUNGS: Distant breath sounds, decreased on the right, few \ncrackles b/l  \nHEART: RRR, no MRG, nl S1-S2  \nABDOMEN: + bowel sounds, soft, epigastric and RUQ tenderness to \npalpation, markedly enlarged liver, with liver edge palpable 5 \ncm below rib cage. No rebound/guarding.  \nEXTREMITIES: 2+ lower extremity edema, 2+ pulses radial and dp  \nNEURO: awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout  \n\nDischarge Physical Exam:\nVitals-  Tm 99.8 BP 125/76 HR 105 RR 20 99RA\nGeneral- Alert, oriented, no acute distress, obese appearing \nwoman  \nHEENT- Sclera anicteric, MMM, oropharynx clear  \nNeck- supple, JVP not elevated, no LAD  \nLungs- Clear to auscultation bilaterally with decreased breath \nsound on left posterior basilar lung field, no wheezes, rales, \nronchi  \nCV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen- soft, obese, diffusely tender, non-distended, bowel \nsounds present, no rebound tenderness or guarding, no \norganomegaly  \nGU- no foley  \nExt- warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ \npitting edema  \nNeuro- CNs2-12 intact, motor function grossly normal  \nLabs: Reviewed, please see below.  \n\n \nPertinent Results:\nADMIT LABS:\n\n___ 04:35PM BLOOD WBC-18.7*# RBC-3.49* Hgb-9.2* Hct-31.2* \nMCV-90 MCH-26.5* MCHC-29.6* RDW-18.6* Plt ___\n___ 04:35PM BLOOD Neuts-77.4* Lymphs-14.9* Monos-6.8 \nEos-0.5 Baso-0.4\n___ 04:35PM BLOOD Plt ___\n___ 04:35PM BLOOD Glucose-90 UreaN-8 Creat-0.5 Na-139 K-3.5 \nCl-99 HCO3-29 AnGap-15\n___ 04:35PM BLOOD ALT-12 AST-48* AlkPhos-328* TotBili-0.9\n___ 07:45AM BLOOD Calcium-8.4 Phos-2.5*# Mg-2.0\n___ 04:35PM BLOOD Albumin-2.8*\n___ 06:42PM BLOOD Lactate-2.0\n\nDISCHARGE  LABS:\n\n___ 06:05AM BLOOD WBC-16.8* RBC-3.20* Hgb-8.3* Hct-28.7* \nMCV-90 MCH-25.9* MCHC-28.9* RDW-18.1* Plt ___\n___ 06:05AM BLOOD Glucose-87 UreaN-10 Creat-0.4 Na-136 \nK-3.7 Cl-99 HCO3-27 AnGap-14\n___ 06:05AM BLOOD ALT-11 AST-45* LD(LDH)-517* AlkPhos-282* \nTotBili-0.8\n___ 06:05AM BLOOD Calcium-8.4 Phos-2.7 Mg-2.2\n\nIMAGING: ___\nFinal Report \nHISTORY:  New diagnosis of metastatic cancer with unknown \nprimary.  Assess for extent of lesions.   \nCOMPARISON:  CT abdomen and pelvis dated ___.  \nTECHNIQUE:  Multidetector CT of the torso was performed with \nintravenous and oral contrast.  Coronal and sagittal \nreformations were provided.  Images are substantially degraded \ndue to the patient's body habitus.   \nFINDINGS: \nCHEST:  \nThere are innumerable pulmonary nodules, which have an upper \nlobe \npredilection, particularly in the left upper lobe.  The largest \nnodule \nmeasures 6 mm in diameter (sequence 3 image 8).  Calcification \nis noted within  the right pleural cavity (sequence 3 image 24), \nwhich is likely related to the patient's history of previous \nright lung surgery.  No pleural effusion.  No pneumothorax.  \nNo significant mediastinal, axillary or hilar adenopathy.  \nCardiac size is \nnormal.  No pericardial effusion.  \nABDOMEN:  \nThe liver is enlarged and there are innumerable ___ density \nlesions throughout both lobes of the liver which are replacing \nthe vast majority of the hepatic parenchyma.  The portal vein is \npatent.  No intra or extrahepatic duct dilatation.  The \ngallbladder is unremarkable.  There is a small amount of ascites \nadjacent to the right lobe of the liver.   \n  \nThe right kidney is mildly compressed anteriorly due to the \nenlarged liver. There is a subcentimeter ___ density lesion in \nthe upper pole of the right kidney, likely representing a \nsubcentimeter cyst (sequence 5 image 31).  The right kidney is \notherwise unremarkable.  The left kidney is within normal \nlimits.  The adrenals and spleen are unremarkable.  The pancreas \nis within normal limits.  The small and large bowel are \nunremarkable.  No retroperitoneal or mesenteric adenopathy.  \n  \nPELVIS:  \nThe images of the pelvis are substantially degraded secondary to \nthe patient's body habitus.  No pelvic masses are identified.  \nThe bladder is unremarkable.  The patient is status post \nsupracervical hysterectomy.  No pelvic adenopathy. No free fluid \nwithin the pelvis.  \n  \nOSSEOUS STRUCTURES:  \nBilateral symmetrical sclerosis is identified on the iliac side \nof the \nsacroiliac joints, consistent with osteitis condensans ilii.  \nThere is severe degenerative change within the right hip joint \nwith joint space loss and osteophyte formation.  No destructive \nosseous lesions.   \n  \nIMPRESSION: \nMultiple pulmonary and hepatic metastases.  No separate primary \nlesion \nidentified.   \n\n \nBrief Hospital Course:\n___ yo f with h/o recently diagnosed metastatic cancer of unknown \nprimary presenting with nausea, vomiting, and fever to 101 on \nday of admission.  \n.\n# Fever/leukocytosis: Patient presented with fever and \nleukocytosis, which was initially concerning for post \nobstructive PNA. Patient was treated with vanc-cefepime-azithro \nfor a day and a half, however CT torso was concerning for \nongoing malignancy without evidence of primary tumor. There was \nno concern for a pneumonia. Consequently, abx were stopped on \n___. Patient felt weak and unable to go home, as she lives \nalone and so was screened by physical therapy and discharged to \nrehab facility. \n.\n# Failure to thrive: Patient presents with 6 weeks of nausea, \nvomiting and poor PO intake likely from her enlarged liver. She \ncontinues to have bowel movements and pass gas. Patient now with \nalbumin of 2.8, ketones in her urine, weight loss and new \nperipheral edema, concerning for poor nutrition/starvation \nketosis. Nutrition consult followed the patient throughout her \nhospital stay and recommended ___ fat Carnation Instant \nBreakfast with Beneprotein.\n.\n# Chronic back pain:  Patient was continued on her home \ngabapentin. \n.\n# Depression:  Patient was continued on home bupropion, \nsertraline  \n.\n# HCTZ: Patient's hctz was discontinued during her \nhospitalization due to poor PO intake and concern for \ndehydration. Blood pressures were well-controlled such that HCTZ \nwas not deemed necessary. This issue should be readdressed by \nPCP.\n.\n# Hyperlipidemia: Given patient's metastatic process, statin was \ndiscontinued during hospitalization to simplify her medical \nregimen.  \n.\n# Insomnia: Continued home trazodone  \n.\nTRANSITION ISSUES\n# CODE: FULL (Confirmed)  \n# CONTACT: ___ (friend) ___  \n# HCTZ discontinued on admission- consider restarting if \nconsidered medically necessary by PCP \n# ___ fat Carnation Instant Breakfast with Beneprotein with \nmeals\n# Follow up with oncology for further diagnosis and management \nof malignancy\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO HS \n4. Sertraline 200 mg PO DAILY \n5. Simvastatin 40 mg PO DAILY \n6. traZODONE 100 mg PO HS:PRN sleep \n7. Ibuprofen 800 mg PO Q12H:PRN pain \n8. Hydrochlorothiazide 12.5 mg PO DAILY \n9. Ondansetron 4 mg PO Q8H:PRN nausea \n\n \nDischarge Medications:\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO HS \n4. Sertraline 200 mg PO DAILY \n5. traZODONE 100 mg PO HS:PRN sleep \n6. Ondansetron 4 mg PO Q8H:PRN nausea \n7. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n8. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \nplease hold for sedation, RR<10 \nRX *oxycodone 5 mg 1 tablet(s) by mouth every 6 hours Disp #*30 \nTablet Refills:*0\n9. Enoxaparin Sodium 40 mg SC DAILY \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nMetastatic disease of unknown primary: Weakness and nausea \nlikely from tumor burden\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ for evaluation of several weeks of \nweakness and nausea. You had some markers of infection, so you \nwere initially given antibiotics. However, a scan of your torso \nshowed metastatic disease from a cancer of unknown origin in \nyour liver and lungs. Your weakness and nausea are most likely \ndue to your enlarged liver. \n\nYou are scheduled to see your oncologist this week, so please \nfollow-up with them so that they may proceed with the further \ndiagnosis and treatment of your malignancy.\n\nYou are being discharged to a rehabilitation facility to help \nyou regain some strength before going home. Your anticipated \nlength of stay is LESS THAN 30 DAYS. \n\nPlease see the attached sheet for your updated medication list. \n\nIt was a pleasure taking care of you in the hospital. We wish \nyou all the best.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "17",
         "10000935-DS-21",
         "10000935",
         "25849114",
         "2187-10-26 00:00:00",
         " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics) / Codeine / Bactrim\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nPercutaneous liver biopsy\n \nHistory of Present Illness:\nMs. ___ is a ___ with metastatic cancer of unknown primary \n(known lesions in lungs and liver) presenting with shortness of \nbreath. She initially presented to ___ in ___ with abdominal \npain and failure to thrive. Evaluation at that time included an \nabdominal CT scan that showed multiple lung and liver \nmetastases. She has yet to undergo definite diagnosis with \nbiopsy, and per recent oncology documentation seems disengaged \nwith care.  \nShe was reportedly in her usual state of health until the \nevening prior to admission, when she developed acute on chronic \nshortness of breath while at rest. She reported midsternal chest \nache associated with this shortness of breath. Pain is \nexacerbated by direct pressure; nothing seems to alleviate pain. \nShe denied any pleuritic or exertional component to the chest \npain or shortness of breath. She feels that symptoms are \nsecondary to her \"cancer\" and \"feels as if the cancer has \nspread\". She reports stable, chronic nonproductive cough, which \nhas been present over the preceding months.  \nShe was seen recently in the ED for evaluation of left greater \nthan right lower extremity edema with lower extremity venous \nultrasounds negative, without change in edema since since that \nvisit. She denies associated fever, chills, sweats, PND, \northopnea, or positional component to pain. \nIn the ED, initial vital signs were: 98.0 116 100/49 24 99% RA. \nLabs notable for leukocytosis to 17.9, hematocrit of 32, and \nlactate of 2.8. Urinalysis was positive, but with 19 epithelial \ncells. CTA was negative for central pulmonary embolus, focal \nconsolidation, or pleural effusion, though did reveal \ninnumerable pulmonary nodules, as well as enlarged liver with \nstable metastases. EKG was interpreted as sinus tachycardia and \nwas overall consistent with prior. Ceftriaxone/azithromycin were \ninitiated for possible pneumonia. Vital signs on  transfer were \nas follows: 97.9 107 100/60 22 100% RA. On arrival to the floor, \nshe reports that shortness of breath has improved and that she \nis chest pain free.\n \nPast Medical History:\nPer OMR:\n# metastatic cancer of unknown primary\n# high grade SBO ___ s/p exploratory laparotomy, lysis of \nadhesions, and small bowel resection with enteroenterostomy \n# carcinoid\n# hyperlipidemia\n# vitamin B12 deficiency\n# cervical DJD\n# osteoarthritis \n\ns/p R lung resection in ___ at ___\ns/p hysterectomy in ___\ns/p R arm surgery\n\n \nSocial History:\n___\nFamily History:\nPer OMR:\nMother - Died of pancreatic cancer at age ___.  \nFather - Died of ___ disease at age ___. \n \nPhysical Exam:\nOn admission:\nVS: 97.9 114/71 105 sinus 18 95%2L  \nGENERAL: non-toxic appearing, speaking in full sentences  \nHEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM  \nNECK: supple, no LAD, no JVD  \nCHEST: mild reproducible pain on palp of midsternum; no palpable \nmass  \nLUNGS: poor aeration but relatively CTA bilat, no r/rh/wh, resp \nunlabored, no accessory muscle use  \nHEART: clear and audible heart sounds, tachycardiac but regular \nrhythm, sofy SEM, nl S1-S2  \nABDOMEN: normal bowel sounds, soft, mild tenderness to palp \nthroughout and more pronounced in the RUQ, non-distended, no \nrebound or guarding, palpable liver edge  \nEXTREMITIES: left > right 1+ pitting edema to mid shin, 2+ \npulses radial and dp  \nNEURO: awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact\n\nAt discharge:\nVS - Tc 99.7, 116/59, 131, 18, 99% RA\nGENERAL: obese, NAD, lying in bed comfortably, flat affect and \npoor eye contact\nHEENT: NCAT, EOMI, mild scleral icterus, pink conjunctiva, MMM, \npoor dentition, mild palor of conjunctiva \nNECK: supple, no LAD  \nCARDIAC: tachycardic but regular, S1/S2, no m/r/g\nLUNG: CTAB in anterior fields, decreased breath sounds at right \nbase, exam limited secondary to body habitus and mobility, no \nw/r/r, no accessory muscle use\nABDOMEN: obese, ND, +BS, no rebound/guarding, localized area of \nfirmness in mid-upper abdomen and tender to palpation over this \narea \nEXTREMITIES: WWP, 2+ DP pulses bilaterally, 1+ pitting edema to \ntorso bilateraly \nNEURO: no asterixis, moving all four extremities, minimal \nmovement ___ to gravity but distal muscles 4+/5, good hand \ngrip strength today\n \nPertinent Results:\nOn admission:\n___ 12:50PM BLOOD WBC-17.9* RBC-3.69* Hgb-9.5* Hct-32.1* \nMCV-87 MCH-25.8* MCHC-29.7* RDW-19.1* Plt ___\n___ 12:50PM BLOOD Neuts-82.8* Lymphs-11.7* Monos-4.4 \nEos-0.7 Baso-0.3\n___ 12:50PM BLOOD ___ PTT-31.2 ___\n___ 12:50PM BLOOD Glucose-97 UreaN-12 Creat-0.6 Na-140 \nK-2.7* Cl-92* HCO3-31 AnGap-20\n___ 12:50PM BLOOD ALT-17 AST-73* LD(___)-586* CK(CPK)-218* \nAlkPhos-340* TotBili-2.6* DirBili-1.8* IndBili-0.8\n___ 12:50PM BLOOD CK-MB-1 cTropnT-<0.01\n___ 12:50PM BLOOD Albumin-2.5* Mg-2.2\n___ 12:50PM BLOOD Hapto-307*\n___ 05:12PM BLOOD Lactate-2.8*\n\n___ 06:00PM URINE Color-YELLOW Appear-Cloudy Sp ___\n___ 06:00PM URINE Blood-NEG Nitrite-NEG Protein-30 \nGlucose-NEG Ketone-10 Bilirub-SM  Urobiln-8* pH-6.0 Leuks-MOD\n___ 06:00PM URINE RBC-0 WBC-66* Bacteri-FEW Yeast-NONE \nEpi-14\n___ 06:00PM URINE CastHy-6*\n\nAt discharge:\n___ 08:30AM BLOOD WBC-16.1* RBC-3.06* Hgb-8.3* Hct-29.2* \nMCV-95 MCH-27.1 MCHC-28.5* RDW-22.5* Plt ___\n___ 08:30AM BLOOD Glucose-95 UreaN-7 Creat-0.3* Na-143 \nK-3.5 Cl-110* HCO3-20* AnGap-17\n___ 08:30AM BLOOD Calcium-8.3* Phos-2.4* Mg-1.9\n\nMicrobiology:\nBlood x2 (___): No growth\nUrine (___): No growth\nBlood x2 (___): No growth\n\nPathology:\nLiver biopsy (___):\nLiver, core needle biopsy (A):\nAdenocarcinoma, involving the liver (see note).\nNote: Immunohistochemical stains are performed.  The tumor cells \nare positive for CK20 and CDX-2, and negative for CK7 and TTF-1. \n These results are consistent with metastasis from a colorectal \nprimary.\n\nImaging:\nEKG (___):\nSinus tachycardia. Low voltage. Diffuse non-specific \nrepolarization\nabnormalities. Compared to the previous tracing of ___ \nrepolarization\nabnormalities are slightly more prominent.\n___\n___\n\nPortable CXR (___):\nInnumerable pulmonary metastases.  Possible mild pulmonary \nvascular\ncongestion.  Low lung volumes.\n\nCTA (___):\n1.  No central or segmental filling defect in the pulmonary \narteries.\nEvaluation is slightly limited due to suboptimal IV bolus. \n2.  Innumerable bilateral pulmonary nodules, simas seen on the \nprior CT study on ___, slightly increased.  No focal \nconsolidation or pleural effusion.  \n3.  Enlarged liver with multiple hypodense lesions, with \nsuggestion of\nincreased burden of disease.\n\nRight upper quadrant ultrasound (___):\nExtensive diffuse hepatic metastatic disease.  No evidence of \nbiliary duct\nobstruction.\n\nPortable CXR (___):\n1. Low lung volumes and mild pulmonary vascular congestion is \nunchanged. \n2. New small right fissural pleural effusion.\n3. No new focal opacities to suggest pneumonia.  \n\nNoncontrast head CT (___):\nNo acute intracranial process.  No mass is identified.  MRI is \nmore sensitive for evaluation of metastases.\n\nLeft hip XR (___):\nNo definite lytic lesion; however, an MRI can be performed to \nevaluate for an osseous lesion if indicated.\n\nPortable abdomen (___):\nRadiographs of the abdomen and pelvis demonstrate a \nnonobstructed\nbowel gas pattern.  A relative paucity of bowel gas is present \nin the upper and mid abdomen, likely due to marked enlargement \nof the liver, displacing bowel loops.  Note that the upright \nview is technically suboptimal, and limits evaluation for free \nintraperitoneal air.  If free intraperitoneal air is suspected \nclinically, a left lateral decubitus view of the abdomen would \nbe recommended.\n \nBrief Hospital Course:\nMs. ___ is a ___ with metastatic cancer of unknown primary, \nincluding lesions in the liver and lungs, who initially \npresented with shortness of breath, likely due to worsening \nintrapulmonary tumor burden, and later underwent percutaneous \nliver biopsy with pathology consistent with metastatic colon \ncancer, prompting transfer to the oncology service and \neventually discharged home with hospice.\n\nActive Issues:\n(1) Metastatic colon adenocarcinoma: CTA to exclude pulmonary \nembolus and right upper quadrant ultrasound on admission \ndemonstrated progression of previously recognized metastatic \ncancer of unknown primary involving the liver and lungs, which \nhad evaded diagnosis in the outpatient setting due to patient \nreluctance to engage with care. Percutaneous liver biopsy \nultimately revealed primary colonic adenocarcinoma. Following \ndiscussion with her outpatient oncology providers, she was \ntransferred to the inpatient oncology service for potential \ntrial of FLOX. However, given the patient's very poor functional \nand nutritional status a goals of care discussion was held with \nthe patient's HCP, ___ and it was decided to focus \ngoals of care of comfort and symptom management and the patient \nwas discharged home with home hospice. \n\n(2) Left thigh weakness/spinous tenderness: She was found to \nhave focal left thigh weakness in association with diffuse \nspinous tenderness of unclear chronicity in the setting of \npreserved rectal tone without saddle anesthesia. She was noted \nto be incontinent of urine, but not feces. Given underlying \nmalignancy, there was concern for bony metastases or cord \ninvolvement, with alternative consideration given to epidural \nabscess, prompting transient initiation of empiric antibiotic \ncoverage with vancomycin/cefepim ___ to ___. Despite \nfrequent persuasive efforts, she declined multiple attempts at \nlumbosacral MRI, including with lorazepam premedication, citing \nclaustrophobia. Neuro exam was monitored and remained stable.\n\n(3) Abdominal pain: She experienced intermittent abdominal pain \nand tenderness without peritoneal signs, concerning for \nobstruction in the setting of intraabdominal malignancy, \nparticularly given episodes of emesis/hematemesis as below. \nWhile multiple KUBs were negative for obstruction, CT abdomen \nwas planned to evaluate for alternative sources of \nintraabdominal pathology, but she declined on multiple \noccasions. Pain was controlled with acetaminophen and tramadol \nas needed.\n\n(4) ? Hematemesis: She experienced a single episode of small \nvolume emesis, reportedly approximately 100cc, streaked with \nblood and found to be guiac positive. Vital signs and hematocrit \nremained stable. IV pantoprazole was initiated for \ngastrointestinal prophylaxis, with subsequent discontinuation of \nPPI given no recurrence and questionable if first episode was \ntrue blood vs. red popsicle was eating at time. \nEsophagogastroduodenoscopy was deferred in the absence of \nrecurrent hematemesis; no prior EGDs were available in OMR. \n\n(5) Altered mental status: She was intermittently altered \nthroughout admission, never oriented to more than person and \nplace, with occasional difficulty following simple commands as \ncompared to an uncertain baseline. Infectious work up, including \nblood and urine cultures and CTA on admission with subsequent \nCXRs, was unrevealing. Noncontrast head CT was negative for \nacute intracranial process. Brain MRI for definitive exclusion \nof metastases could not be obtained due to claustrophobia/MRI \naversion as above.  ABG on ___ without signs of CO2 retention. \nHistory of opiates making patient sleepy per HCP as possible \ncontributing factor and therefore these were discontinued. \nHepatic encephalopathy also on differential given metastatic \nlesions to liver and asterixis on exam.  AMS could also be ___ \nto severe depression. Mental status monitored and remained \nstable and patient at baseline per HCP on discharge.\n\n(6) Shortness of breath: She presented with acute onset \nshortness of breath without frank hypoxia. CTA on admission was \nnegative for pulmonary embolus, though (subsegmental clot could \nnot be excluded definitively), pleural effusion, or focal \ninfiltrate. EKG and cardiac enzymes were reassuring against \nacute coronary syndrome.  Low voltages on EKG were consistent \nwith prior, hence limited suspicion for pericardial effusion. \nShortness of breath resolved over the course of admission \nwithout dedicated treatment, with the exception of nebulizers \nand expectorants as needed.\n\n(7) Leukocytosis: White blood cell count was elevated and peaked \nat 20.6, consistent with recent baseline, likely reflecting \nunderlying malignancy. As noted above, infectious work up \nincluding CTA, urine and blood cultures, and CXRs, was \nunrevealing. She remained afebrile, with the exception of \nisolated transient fever to 100, with stable vital signs. \n\n(8 )Liver function test abnormalities: AST remained elevated ___ \nto ___, alkaline phosphatase 260s to 380s, and total bilirubin \n2.1 to 2.6, likely due to hepatic infiltration of malignancy. \nRight upper quadrant ultrasound was negative for cholecystitis \nor obstructive process. The possibility of superimposed \nintraabdominal process, such as infection, could not be excluded \nin the setting of abdominal pain with emesis as above, but she \ndeclined CT for further evaluation.\n\n(9) Elevated lactate: Lactate was found to be 2.7-3.8 throughout \nadmission despite copious IV fluids, likely reflecting \ncompromised hepatic clearance in the setting of malignant \ninfiltration. \n\n(10) Sinus tachycardia: She remained persistently tachycardic \n100s to 115s throughout admission in the setting of poor PO \nintake, but incompletely responsive to copious IV fluids. \nTachycardia has been present since at least ___. Despite \nconcurrent leukocytosis and elevated lactate, there was no clear \ninfectious source, hence low suspicion for sepsis. Subsegmental \npulmonary embolus could not be excluded on the basis of \nadmission CTA, but shortness of breath was short lived, and she \nwas never hypoxic. Hematocrit remained stable without signs of \nactive bleeding, with the exception of transient hematemesis as \nabove.\n\n(11) Depression: She appeared depressed with flat affect and \nseeming anhedonia throughout admission, with underlying \ndepression likely affecting motivation to seek diagnosis and \ntreatment of known malignancy. She denied active suicidal \nideation and frequently declined home sertraline, particularly \nprior to liver biopsy, believing that it was supposed to be held \npreprocedurally despite explanation to the contrary. She was \nseen by social work throughout admission.\n\n(12) Normocytic anemia: Hematocrit remained stable and \nconsistent with recent baseline at 27 to 33 throughout \nadmission, seemingly due to anemia of chronic disease on the \nbasis of preadmission labs. Vital signs remained stable, with \nthe exception of persistent tachycardia, without signs of active \nbleeding apart from isolated blood streaked emesis as above.\n\n(13) Coagulopathy: INR of 1.2 to 1.8 was felt to reflect \nsynthetic dysfunction in the setting of hepatic infiltration of \nmalignancy, as well as poor oral intake. There were no signs of \nactive bleeding, with the exception of transient hematemesis as \nabove.\n\nTransitional Issues:\n-Patient discharge home with home hospice\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n2. BuPROPion 150 mg PO DAILY \n3. Gabapentin 300 mg PO HS \n4. Sertraline 200 mg PO DAILY \n5. traZODONE 100 mg PO HS:PRN sleep \n6. Ondansetron 4 mg PO Q8H:PRN nausea \n7. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n8. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \nplease hold for sedation, RR<10 \n9. Enoxaparin Sodium 40 mg SC DAILY \n\n \nDischarge Medications:\n1. BuPROPion 150 mg PO DAILY \n2. Ondansetron 4 mg PO Q8H:PRN nausea \n3. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain \nRX *tramadol 50 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*60 Tablet Refills:*0\n4. Senna 1 TAB PO BID:PRN constipation \nRX *sennosides [___] 8.6 mg 1 tablet by mouth twice a \nday Disp #*60 Tablet Refills:*0\n5. Omeprazole 20 mg PO DAILY \nRX *omeprazole 20 mg 1 capsule,delayed ___ by \nmouth Daily Disp #*30 Capsule Refills:*0\n6. Hospital Bed\nBariatric Hospital Bed and\nTherapeutic Mattress: BariMaxxII\n\n7. Hospice Order\nPlease Screen and Admit to Hospice.\n8. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n9. Docusate Sodium 100 mg PO BID \n10. Sertraline 200 mg PO DAILY \n11. traZODONE 100 mg PO HS:PRN sleep \n12. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nMetastatic colon adenocarcinoma\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Bedbound.\n\n \nDischarge Instructions:\nDear Ms. ___,\nIt was a pleasure taking part in your care during your admission \nto ___. As you know, you were \nadmitted for shortness of breath, likely due to your underlying \ncancer, and there was no evidence of pneumonia or blood clot in \nthe blood vessels of your lungs. Your shortness of breath \nresolved, but you were found to have weakness in your left thigh \nand abdominal pain. You declined imaging studies for further \ninvestigation of these findings. You underwent biopsy of your \nliver that revealed that the cancer known to affect your liver \nand lungs originated in your colon (large bowel). You were \ntransferred to the oncology service, but unfortunately \nchemotherapy would do more harm for you than good.  After a long \ndiscussion with you and your health care proxy, it was decided \nthat you will go home to be with your family and loved ones.  We \nwill also set up hospice services for you so that they can help \nwith any issues that arise while you are at home.  \n \nFollowup Instructions:\n___\n"
        ],
        [
         "46",
         "10001884-DS-24",
         "10001884",
         "21268656",
         "2125-10-20 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAtypical chest pain\n \nMajor Surgical or Invasive Procedure:\nStess Echo\n\n \nHistory of Present Illness:\n___ y/o woman with intermittent chest pain past several months. \nPain is located on left posterior shoulder and radiates down arm \nto fingers where it turns into \"pins-n-needles\" symptom. No \nSOB/N/V. Patient does endorse some minimal diaphoresis and gerd \nlike symptoms accompanying it. Pain has been controlled with \ntylenol #3. \n \nPast Medical History:\nHTN  \nAsthma  \nDiverticulitis several years ago  \nR hip replacement in ___  \n\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___  \n\n \nPhysical ___:\nVtals: T: 97.6 BP: 167/88 P: 83 R: 20 O2: 99% 2L  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, non-tender, non-distended, bowel sounds present, \nno rebound tenderness or guarding, no organomegaly  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n\n \nPertinent Results:\n___ 03:20PM BLOOD WBC-6.2 RBC-4.51 Hgb-13.1 Hct-38.6 MCV-86 \nMCH-29.1 MCHC-33.9 RDW-15.4 Plt ___\n___ 07:15AM BLOOD WBC-6.0 RBC-4.91 Hgb-13.8 Hct-41.7 MCV-85 \nMCH-28.1 MCHC-33.0 RDW-15.1 Plt ___\n___ 07:50AM BLOOD WBC-5.2 RBC-4.67 Hgb-13.4 Hct-39.4 MCV-84 \nMCH-28.7 MCHC-34.1 RDW-15.2 Plt ___\n___ 03:20PM BLOOD Glucose-95 UreaN-21* Creat-0.8 Na-139 \nK-3.5 Cl-100 HCO3-30 AnGap-13\n___ 09:10PM BLOOD Glucose-120* UreaN-17 Creat-0.9 Na-137 \nK-3.3 Cl-99 HCO3-31 AnGap-10\n___ 07:15AM BLOOD Glucose-100 UreaN-15 Creat-0.8 Na-138 \nK-4.4 Cl-98 HCO3-35* AnGap-9\n___ 03:20PM BLOOD cTropnT-<0.01\n___ 09:10PM BLOOD CK-MB-3 cTropnT-<0.01\n___ 07:15AM BLOOD CK-MB-4 cTropnT-<0.01\n.\n___ ___ F  ___  ___ \n \nCardiology Report Stress Study Date of ___   \n \n  \nEXERCISE RESULTS \n\n \n  \nRESTING DATA \nEKG:  SINUS WITH AEA, LBBB   \nHEART RATE:  68 BLOOD PRESSURE:  146/86 \n  \nPROTOCOL MODIFIED ___ - TREAD___ \nSTAGE TIME SPEED ELEVATION HEART BLOOD RPP \n  (MIN) (MPH) (%) RATE PRESSURE   \n0 ___ 1.0 8 100 176/88 ___ \n1 ___ 1.7 10 114 178/92 ___ 2.5 12 126 184/98 ___ \n  \nTOTAL EXERCISE TIME:  9 % MAX HRT RATE ACHIEVED:  83 \n \nSYMPTOMS: ATYPICAL PEAK INTENSITY: ___ \n \n  \nINTERPRETATION: ___ yo woman was referred to evaluate an atypical \n\nchest discomfort. The patient completed 9 minutes of a Gervino \nprotocol \nrepresenting a fair exercise tolerance for her age; ~ ___ METS. \nThe \nexercise test was stopped at the patient's request secondary to \nfatigue. \nDuring exercise, the patient reported a non-progressive, \nisolated upper \nleft-sided chest discomfort; ___. The area of discomfort was \nreportedly \ntender to palpation. This discomfort resolved with rest and was \nabsent \n2.5 minutes post-exercise. In the presence of the LBBB, the ST \nsegments \nare uninterpretable for ischemia. The rhythm was sinus with \nfrequent \nisolated APDs and occasional atrial couplets and atrial \ntriplets. \nResting mild systolic hypertension with normal blood pressure \nresponse \nto exercise. The heart rate response to exercise was mildly \nblunted. \n  \nIMPRESSION: Fair exercise tolerance. No anginal symptoms with \nuninterpretable ECG to achieved workload. Resting mild systolic \nhypertension with appropriate blood pressure response to \nexercise. \nSuboptimal study - target heart rate not achieved. \n \nSIGNED:  ___ \n \n\n \nBrief Hospital Course:\n___ ___ with several month history of left sided arm and chest \nwall pain in the setting of LBBB presenting for ___.  \n.  \n.  \n# Chest Pain:The patient's symptoms were not typically anginal \nin nature to suggest ACS. However she does have several cardiac \nrisk factors and a LBBB, so  physicians could  not r/oMI with \nEKG alone. Trop. results were negative x3. Stress Echo revealed \nnew regional dysfunction with hypokinesis of the inferior and \ninferolateral walls consistent with single vessel disease in the \nPDA distribution. A cardiology consult was obtained and they \nfelt she could be managed medically. Patient was already on an \naspirin, and a statin. Given history to suggest asthma B-blocker \nwas contraindicated. She was discharged on 120 mg extended \nrelease diltiazem with instructions to follow up in cardiology \nand with her PCP. \n.\n# Supraventricular tachycardia: The patient had multiple runs of \nSVT that was likley MAT in the setting of severe obstructive \nlung disease and chronic theophylline use. Cardiology \nreccomended that we discontinue her theophylline. We spoke with \nher pulmonologist who agreed this would be the best course of \naction for her. She was discharged with instructions to \ndiscontinue use of theophylline and follow up with her \npulmonologist and cardiology.\n\n \nMedications on Admission:\nTylenol ___ Q4h PRN pain  \nAlbuterol Sulfate 2 puffs q4-6h PRN SOB  \nFluticasone 50 mcg spray/suspension 2 whiffs PRN allergies  \nAdviar 500/50 1 INH BID  \nHCTZ 50mg One PO daily  \nSingulari 10mg tablet One PO QD  \nomeprazole 20mg 1 PO QD  \nsimvastatin 20mg 1 PO QD  \ntheophylline 200mg sustained release one PO TID  \nspiriva 18 mcg w/ inhalation  \nASA 81mg  \nCalcium sig unknown  \nCod liver oil Sig unk  \nMultivitamin  \n\n \nDischarge Medications:\n1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q4H (every \n4 hours) as needed for pain.  \n2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for SOB \nwheeze.  \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n4. fluticasone 50 mcg/Actuation Spray, Suspension Sig: ___  \nNasal once a day as needed for allergy symptoms.  \n5. hydrochlorothiazide 50 mg Tablet Sig: One (1) Tablet PO once \na day.  \n6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n7. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.  \n8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n9. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n10. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n11. diltiazem HCl 120 mg Tablet Sustained Release 24 hr Sig: One \n(1) Tablet Sustained Release 24 hr PO once a day.\nDisp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*\n12. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \nSublingual every 5 min as needed for chest pain: take one at \nonset of chest pain. ___ repeat every 5 min x3 with continued \nchest pain. Call PCP if chest pain persists.\nDisp:*30 tabs* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCoronary Artery Disease\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to ___ because you had back and arm pain \nthat was worrisome for heart disease. A strees test found that \nyou have coronary artery disease. You were started on a new \nblood pressure medication and tolerated this well. You should \nkeep all of you follow up appointments as listed below. \n.\nWhile you were here we made the following changes to your \nmedications:\n.\nWe STARTED you on Diltiazem 120mg once a day\n.\nWe STOPPED ___ theophylline\n.\nWe STARTED nitroglycerine to take when you have chest pain\n.\nYOU NEED TO STOP SMOKING. IT WILL KILL YOU.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "47",
         "10001884-DS-25",
         "10001884",
         "26679629",
         "2125-10-27 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nChest Pain  \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n Ms. ___ is a ___ y/o female with a history of \nhypertension, asthma and recent diagnosis of CAD based on stress \necho done on ___, thought to be single vessel disease who \npresents with intermittent chest pain since her recent discharge \non ___. During her recent hospitalization she was ruled out \nfor an MI with three negative sets of cardiac enzymes, she had a \nstress echo which showed inducible ischemia at the achieved \nworkload, thought to be single vessel disease per the echo \nreport. At that time the plan was for medical management, given \nher severe underlying pulmonary disease she was not started on a \nbeta blocker, but was started on diltiazem 120mg daily. Also \nduring that admission she was found to have intermittent \nepisodes of MAT. Today she was on the phone with her ___ year \nold aunt, who is very hard or hearing, she says that she became \nfrustrated when her aunt was ___ to hear her on the phone and \nshe started to have some chest pain. The pain began in the \n___ her chest, as a dull pain then moved up to her left \nshoulder and under her left breast, at its worst was a ___. \nShe took three SL nitro's at home, with some minor improvement \nin her CP but when it did not resolve she called Dr. ___ \nreferred her to the ER. She denied any associated SOB, \nnausea/vomiting. She denies any orthopnea, PND, ___ edema or \npalpitations.  \n.  \nIn the ED, initial vitals were 98.7, 73, 183/92, 20, 98% on RA. \nHer EKG had a LBBB that was unchanged from prior, CXR with no \nacute process. Patient given aspirin 243mg since she had already \ntaken 81mg of aspirin at home. She was not given anything for \nher episodes of chest pain as they resolved without further \nintervention. Vitals on transfer were 71, 121/56, 22, 100% on \nRA.  \n.  \nOn arrival to the floor, patient's initial VS were: 98.9, \n140/86, 68, 18, 97% on RA. She says that she currently may have \na little bit of cental CP, but otherwise feels well and has no \ncomplaints.  \n \nPast Medical History:\nHTN  \nAsthma  \nDiverticulitis several years ago  \nR hip replacement in ___  \nExertional Atypical Chest Pain\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___  \n\n \nPhysical ___:\nOn Admission:\nVS: T=98.9 BP=140/86 HR=68 RR=18 O2 sat=97% on RA  \nGENERAL: WDWN female in NAD. Oriented x3. Mood, affect \nappropriate.  \nHEENT: NCAT. Sclera anicteric. Conjunctiva were pink, no pallor \nor cyanosis of the oral mucosa. No xanthalesma.  \nNECK: Supple  \nCARDIAC: RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 \nor S4.  \nLUNGS: No chest wall deformities, scoliosis or kyphosis. Resp \nwere unlabored, no accessory muscle use. decreased breath sounds \nthroughout, although CTA, no crackles, wheezes or rhonchi.  \nABDOMEN: Soft, NTND. No tenderness.  \nEXTREMITIES: No c/c/e.  \nSKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  \nPULSES:  \nRight: DP 2+ ___ 2+  \nLeft: DP 2+ ___ 2+  \n\n \nPertinent Results:\n___ 03:55PM   ___ PTT-26.0 ___\n___ 03:55PM   PLT COUNT-215\n___ 03:55PM   NEUTS-53.2 ___ MONOS-5.7 EOS-0.9 \nBASOS-0.5\n___ 03:55PM   WBC-5.6 RBC-4.66 HGB-13.2 HCT-39.4 MCV-85 \nMCH-28.3 MCHC-33.4 RDW-15.0\n___ 03:55PM   cTropnT-<0.01\n___ 03:55PM   estGFR-Using this\n___ 03:55PM   GLUCOSE-94 UREA N-21* CREAT-0.9 SODIUM-138 \nPOTASSIUM-4.0 CHLORIDE-100 TOTAL CO2-27 ANION GAP-15\n___ 04:04PM   GLUCOSE-91 K+-4.1\n___ 12:00AM   CK-MB-3 cTropnT-<0.01\n___ 12:00AM   CK(CPK)-189\n\nCXR: Emphysema without superimposed pneumonia or CHF.\n \nBrief Hospital Course:\nASSESSMENT AND PLAN: Ms. ___ is a ___ year old female with \na recent diagnosis of CAD, HTN and asthma who presents with \nintermittent episodes of chest pain since her recent discharge.  \n\n......................................\nActive Issues:\n.  \n# CORONARIES: patient with intermittent episodes of left chest \nburning, that are not typical of angina since they resolve \nwithout intervention, are not relieved by nitro and have no \nassociation with exercise. However, given the findings on her \nrecent stress echo of inducible ischemia it is concerning that \nher current symptoms could be related to her underlying CAD. Her \ntroponins were negative during this hospital stay.  On this \nadmission, she was started on Imdur 30 in addition to the \nmedications started on last discharge as it was decided that she \nmay need better medical management prior to resorting to PCI \n(which may be a possibility in the future). After administration \nof IMDUR, we walked the patient down the hall, as well as up \nseveral flights of stairs. She denied feeling short of breath, \nnor did she endorse any other cardiac symtpoms, such as chest \npain. In fact, she stated that she felt well walking. \n.  \n# RHYTHM: LBBB on EKG from yesterday, regular. patient with a \nnew diagnosis of MAT on last admission. We continued her on \nDiltiazem. She had several episodes of MAT on tele, but was \nasymptomatic. Given frequent PAT, ___ of Hearts monitor was \narranged for her on discharge to exclude the possibility that \nsymptoms are due to a tachyarrhythmia. \n.............................................\nInactive Issues:\n# Hypertension: continued home HCTZ and diltiazem..  \n# Asthma:continued home medications.    \n# GERD: continued home omeprazole  \n.    \nCODE: full code  \n.....................................  \nTransitional Issues:\n1) Patient was started on Imdur 30mg daily in additon to her \nother medications. She is being medically managed for her \ncoronary artery disease but may be a candidate for PCI in the \nfuture if the symtpoms of chest pain return.\n2) Follow-up event monitor for evaluation of arrhythmias\n \nMedications on Admission:\n-acetaminophen 325 mg Q4H as needed for pain.  \n-albuterol sulfate 90 mcg: Two (2) Puff Inhalation Q6H (every 6 \nhours) as needed for SOB or wheeze.  \n-fluticasone-salmeterol 500-50 mcg: Inhalation BID  \n-fluticasone 50 mcg: ___ Nasal once a day  \n-hydrochlorothiazide 50 mg once a day.  \n-omeprazole 20 mg DAILY  \n-simvastatin 20 mg once a day.  \n-tiotropium bromide 18 mcg DAILY  \n-aspirin 81 mg once a day.  \n-multivitamin 1 Tablet DAILY  \n-diltiazem HCl 120 mg Tablet Sustained Release 24 hr daily  \n-singulair 10mg QHS  \n \nDischarge Medications:\n1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four \n(4) hours as needed for pain.  \n2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for sob, \nwheezing .  \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n4. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n5. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nonce a day.  \n6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n7. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.  \n8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n9. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n10. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n11. montelukast 10 mg Tablet Sig: One (1) Tablet PO QHS (once a \nday (at bedtime)).  \n12. isosorbide mononitrate 30 mg Tablet Sustained Release 24 hr \nSig: One (1) Tablet Sustained Release 24 hr PO once a day.\nDisp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*\n13. diltiazem HCl 180 mg Capsule, Sust. Release 24 hr Sig: One \n(1) Capsule, Sust. Release 24 hr PO once a day.\nDisp:*30 Capsule, Sust. Release 24 hr(s)* Refills:*2*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY:\n1. atypical chest pain\n\nSecondary: \n1. Hypertension\n2. Asthma\n3. Diverticulitis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital for atypical chest pain. You \nwere monitored on telemetry. Your EKG was unchanged. Your \ncardiac enzymes were normal, without evidence for heart damage \nor heart attack. We have started you on a long acting nitrate \nmedication to control your chest pain symptoms. We also \nincreased your diltiazem for better blood pressure and heart \nrate control.\n.\nFinally, we have set you up with a 48 hour holter monitor to get \na better idea of your heart rhythm over time. Please discuss \nthese results with ___. ___ at your upcoming \ncardiology appointment.\n.\nMEDICATION CHANGES:\n- START imdur 30 mg daily\n- INCREASE diltiazem to 180 mg daily\n.\nPlease continue your other medications as prescribed.\n.\nPlease seek medical attention for worsening chest pain, \nshortness of breath, or any other symptoms.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "48",
         "10001884-DS-26",
         "10001884",
         "23594368",
         "2125-12-03 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nFever, non-productive cough\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo F w/ HTN, CAD, COPD p/w fevers, non-productive cough, \nsince ___. Pt said she was in her usual state of health until \n___ evening when she developed a cough producing ___ \nsputum.  She took some robitussin and went to bed.  She woke up \nthe next morning and had general malaise, nasal congestion, \nintermittently productive cough.  She did not want to eat and \nhad 4 episodes of water diarrhea and one episode of vomiting \nwithout nausea.  She denied fevers, chills or sweats at that \ntime.  She called her PCP who prescribed ___ Z-pack.  Her symptoms \npersisted and she developed pain with coughing around her upper \nabdomen and lower chest.  Denies other joint or muscle pain.  \nShe went to see her PCP on the day of admission.  In her PCP's \noffice was hypoxic on RA, here is 89% on RA. Has had flu vaccine \nthis year and pneumovax last year. wheezy on exam, on 2L with o2 \nsat mid-90s.  \n.\nIn ED VS were afebrile 70 113/66 94%2L, On exam had wheezes with \npeak flow of 150 (no baseline), speaking in full sentences and \nno accessory muscle use, euvolemic and no ___ edema.  Flu screen \nnot performed, CXR unremarkable compared to prior.  Given \nlevoflox, nebs, pred 50 mg.\n\n \nPast Medical History:\nASTHMA   \nHYPERTENSION   \nHYPERLIPIDEMIA   \nHEADACHE   \nOSTEOARTHRITIS   \nATYPICAL CHEST PAIN   \nTOBACCO ABUSE   \nABNORMAL CHEST XRAY   \nCOPD  \n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___  \n\n \nPhysical ___:\nOn Admission:\nVS: T:  , BP: 142/70, HR: 70, RR 20, O2 93% on RA (96% 2L)\nGA: AOx3, pt with nasal cannula on in no respiratory distress\nHEENT:  MMM. no LAD. no JVD. neck supple. \nCards: RRR S1/S2 heard. no murmurs/gallops/rubs.\nPulm: CTAB no crackles or wheezes, good inspiratory effort, but \nnot great air movement, slightly prolonged expiratory phase.\nAbd: soft, NT, +BS. no g/rt. neg HSM.\nExtremities: wwp, no edema. DPs, PTs 2+.\nSkin: no noticeable rashes\nNeuro/Psych: CNs II-XII intact\n.\nON DISCHARGE:\nVS: T:  , BP: 142/70, HR: 70, RR 20, O2 93% on RA (96% 2L)\nGA: AOx3, pt with nasal cannula on in no respiratory distress\nHEENT:  MMM. no LAD. no JVD. neck supple. \nCards: RRR S1/S2 heard. no murmurs/gallops/rubs.\nPulm: CTAB no crackles or wheezes, good inspiratory effort, but \nnot great air movement, slightly prolonged expiratory phase.\nAbd: soft, NT, +BS. no g/rt. neg HSM.\nExtremities: wwp, no edema. DPs, PTs 2+.\nSkin: no noticeable rashes\nNeuro/Psych: CNs II-XII intact\n \nPertinent Results:\nLABS:\n___ 03:26PM BLOOD WBC-4.9 RBC-4.25 Hgb-12.7 Hct-36.5 MCV-86 \nMCH-30.0 MCHC-34.9 RDW-15.3 Plt ___\n___ 06:50AM BLOOD WBC-8.2# RBC-4.03* Hgb-12.2 Hct-34.8* \nMCV-87 MCH-30.4 MCHC-35.1* RDW-15.3 Plt ___\n___ 03:26PM BLOOD Glucose-123* UreaN-14 Creat-0.9 Na-136 \nK-3.3 Cl-97 HCO3-31 AnGap-___ 06:50AM BLOOD Glucose-95 UreaN-17 Creat-0.8 Na-139 \nK-3.5 Cl-98 HCO3-30 AnGap-15\n.\nMICRO:\n    **FINAL REPORT ___\n\n   DIRECT INFLUENZA A ANTIGEN TEST (Final ___: \n      POSITIVE FOR INFLUENZA A VIRAL ANTIGEN. \n         REPORTED BY PHONE TO ___ AT 1153  ___.\n.\nIMAGING:\nCXR ___:\nIMPRESSION: \n1. No acute chest pathology with stable pleural parenchymal \nscar. \n2. Flattening of the hemidiaphragms consistent with COPD. \n\n \nBrief Hospital Course:\nA/P: ___ year old woman with recent onset of fevers, productive \ncough and costochondral vs. pleuritic pain who tested positive \nfor influenza A.\n.\n# Fevers, malaise, cough: Pt seemed to have onset of symptoms \nconsistent with viral infection.  She was admitted to the \nhospital and placed on droplet precautions because there was \nconcern that she had the flu.  She was empirically started on \nOseltamivir 75mg PO BID.  nasopharyngeal swab was positive for \ninfluenza A.  She was continued on a five day regiment of \noseltamivir for her flu and will follow up with Dr. ___ in the \noutpatient setting.\n.\n# COPD exacerbation:  Pt tested positive for the flu, but seemed \nto also be having a COPD exacerbation with worsening dyspnea and \nsputum production.  She was started on prednisone 50mg PO Daily, \nAzithromycin and O2 via nasal cannula.  Her resting O2 sat was \ninitially 85%, but at the time of discharge she was satting 96% \non RA, but would desaturate to 84% after walking 75-100feet.  \nShe Was given a 5 day course of azithromycin, 5 days of \nprednisone at 50mg PO Daily and then a week long taper and \ndischarged on home O2 while her symptoms improved.  The patient \nwas breathing more comfortably and ambulating well at the time \nof discharge.  She will follow up with Dr. ___ as well as Dr. \n___ in the outpatient setting.\n.\n# ASTHMA: pt with wheezing in the ED and at PCP office, but not \npresent on my exams, however, she had received duonebs prior to \nmy exam.  Likely having asthma symptoms in setting of COPD \nexacerbations.  She was continued on her home regiment and also \non standing nebulizers.  She was discharged with nebulizer \ntreamtents as well as her home medications.  Respiratory status \nwas described above.\n.\nHYPERTENSION: Pt slightly hypertensive in the ED, but will \ncontinue meds at current regiment and reassess in the morning.  \nHer BP meds are actively being uptitrated in the outpatient \nsetting.  She remained normotensive during her hospital stay on \nthe floor.  We continued Diltiazem ER 360mg PO Q24H, HCTZ 12.5mg \nPO DAILY, IMDUR ER 60 mg PO DAILY.\n.  \nGERD: Currently asymptomatic.  We continued omeprazole 20mg PO \nDaily\n. \nCAD: Pt was recently diagnosed with single vessel disease.  She \nis asymptomatic at this time, but we will continue to monitor \nher for symptoms during this admission. \nWe continued aspirin 81mg PO DAILY\n.\nTOBACCO ABUSE: Pt had been smoking for many years, but said that \nshe quit yesterday and has no need for a nicotine patch or gum \nat this time.  \n.\n\n \nMedications on Admission:\n1. Lisinopril 5mg PO Daily\n2. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap  \n\nPO DAILY (Daily).  \n3. cinacalcet 30 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \n \n4. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY  \n(Daily).  \n5. metoprolol succinate 100 mg Tablet Sustained Release 24 hr  \nSig: One (1) Tablet Sustained Release 24 hr PO once a day.  \n6. doxazosin 4 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). \n \n7. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable  \n\nPO DAILY (Daily).  \n8. venlafaxine 75 mg Capsule, Sust. Release 24 hr Sig: Two (2)  \nCapsule, Sust. Release 24 hr PO DAILY (Daily).  \n9. venlafaxine 37.5 mg Capsule, Sust. Release 24 hr Sig: One (1) \n \nCapsule, Sust. Release 24 hr PO DAILY (Daily).  \n10. sevelamer HCl 400 mg Tablet Sig: Six (6) Tablet PO TID  \nW/MEALS (3 TIMES A DAY WITH MEALS).  \nDisp:*540 Tablet(s)* Refills:*2*  \n11. clonazepam 1 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n\n \nDischarge Medications:\n1. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four \n(4) hours as needed for pain.  \n2. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2)  Inhalation every ___ hours.  \n3. azithromycin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every \n24 hours) for 2 days.\nDisp:*2 Tablet(s)* Refills:*0*\n4. oseltamivir 75 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day) for 3 days.\nDisp:*5 Capsule(s)* Refills:*0*\n5. prednisone 10 mg Tablet Sig: Five (5) Tablet PO once a day \nfor 7 days: Take 5 tabs for 2 days, then 4 tabs for 2 days, then \n2 tabs for 2 days, then 1 tab for 2 days.\nDisp:*19 Tablet(s)* Refills:*0*\n6. diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO DAILY (Daily).  \n7. fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n8. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n9. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n10. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr \nSig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  \n11. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n13. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n14. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO DAILY (Daily).  \n15. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n16. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n17. Oxygen\nHome Oxygen @ 2LPM Continuous via nasal cannula, conserving \ndevice for portability.  Pulse dose for portability.\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\nInfluenza\nCOPD exacerbation\n.\nSecondary Diagnosis:\nASTHMA   \nHYPERTENSION   \nHYPERLIPIDEMIA   \nHEADACHE   \nOSTEOARTHRITIS   \nATYPICAL CHEST PAIN   \nTOBACCO ABUSE   \nABNORMAL CHEST XRAY   \nCOPD \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou are being discharged from ___.  It \nwas a pleasure taking care of you.  You were admitted to the \nhospital for symptoms that were similar to a common cold as well \nas worsening respiratory status.  You tested positive for the \nflu and we also believe that you are having a COPD exacerbation. \n You were started on high dose steroids, azithromycin, tamiflu \nand nebulizers.  You were also placed on oxygen.  You are now \ndoing better, but may require O2 at home for some time as your \ninfection resolves and your inflammation improves.\n.\nThe Following medications were STARTED:\nPrednisone 50mg 1 day, on ___ decrease to 40mg Daily for 2 \ndays, on ___ decrease to 20mg Daily for 2 days, on ___ \ntake 10mg Daily for 2 days then stop  \nAzithromycin 250mg by mouth Daily 1 day (last dose on ___\nTamiflu 75mg two times a day for 2.5 days (last dose on ___\nYou will also be sent on home O2\n.\nPlease take your other medications as prescribed.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "49",
         "10001884-DS-27",
         "10001884",
         "21577720",
         "2125-12-27 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\ns/p tachyarrhythmia\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo F smoker with PMH of asthma/COPD on theophylline, CAD, \nHTN, hyperlipidemia, and atypical chest pain presenting with \nmalaise and SOB during an episode of tachyarrythmia at home \nwhich has since resolved.  Pt recalls that she took her VS on \nthe telehealth monitor, then nurse called and asked her to \nrecheck them.  ___ services came and measured HR at 110s, but pt \nwas without CP, SOB, visual sx, HA, palps.  Also denies F/C, \nN/V, abd pain, change in bowel or bladder.  Per her PCP, ___ \n___, the patient does have a history of tachyarrythmias even \nthough the patient denies this history.  She also took \ntheophylline for some time, although it is not on her med list \nand she states she hasn't taken it since ___.  However, PCP \nconcern is that the theophylline may be contributing.  Recent \nstress test with reversible lesion being treated conservatively. \n   \n.\nIn ED VS were 98.8 78 154/82 20 95%.  Has CXR in ED which was \nunremarkable.  Transfer VS were HR=60, BP=126/75, RR=18, POx=94% \nRA\n.\nOn the floor, pt asymptomatic and feels well.  Only upset \nbecause she's been in the hospital every month so far this year.\n\n \nPast Medical History:\n-ASTHMA   \n-HYPERTENSION   \n-HYPERLIPIDEMIA   \n-HEADACHE   \n-OSTEOARTHRITIS   \n-ATYPICAL CHEST PAIN   \n-TOBACCO ABUSE   \n-ABNORMAL CHEST XRAY   \n-COPD  \n\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n\n \nPhysical ___:\nADMISSION PEx:\nVS: 97.9, 155/90, 64, 16@94%(RA)\nGA: AOx3, NAD\nHEENT:  PERRLA. MMM. no LAD. no JVD. neck supple. \nCards: PMI palpable at ___ IC space. No RVH. RRR S1/S2 heard. \nno murmurs/gallops/rubs.\nPulm: scattered exp wheezing with minimal air movment\nAbd: soft, NT, +BS. no g/rt.\nExtremities: wwp, no edema. DPs, PTs 2+.\nSkin: no rashes, eccymoses, lesions \nNeuro/Psych: CNs II-XII intact. ___ strength in muscle groups \ntested, sensation symmetric. \n\nDISCHARGE PEx:\n\n \nPertinent Results:\nRelevant and representative labs:\nCBC and coags:\n-___ 03:30PM BLOOD WBC-6.7 RBC-4.40 Hgb-13.2 Hct-38.9 \nMCV-88 MCH-29.9 MCHC-33.9 RDW-15.7* Plt ___\n-___ 05:55AM BLOOD WBC-5.9 RBC-4.32 Hgb-12.8 Hct-38.4 \nMCV-89 MCH-29.6 MCHC-33.2 RDW-15.6* Plt ___\n-___ 03:30PM BLOOD ___ PTT-26.2 ___\n\nChem:\n-___ 03:30PM BLOOD Glucose-105* UreaN-18 Creat-0.9 Na-139 \nK-3.5 Cl-101 HCO3-31 \n-___ 05:55AM BLOOD Glucose-101* UreaN-20 Creat-0.9 Na-139 \nK-4.2 Cl-99 HCO3-32\n\nCEs:\n-___ 03:30PM BLOOD cTropnT-<0.01\n-___ 09:10PM BLOOD CK-MB-4 cTropnT-<0.01\n-___ 05:55AM BLOOD CK-MB-3 cTropnT-<0.01\n\nMisc:\n-___ 05:55AM BLOOD Triglyc-96 HDL-50 CHOL/HD-3.2 LDLcalc-90 \nCholest-159\n \nBrief Hospital Course:\nTo Do:\n1) follow-up theophylline level\n___ yo F smoker with PMH of asthma/COPD managed with theophylline \nuntil ___ when theophylline was discontinued because of \ntachycardia, CAD, HTN, and hyperlipidemia who presented from \nhome with asymptomatic tachyarrythmia.\n.  \nACTIVE ISSUES:\n.\n# Tachycarrhymia in context of recent inducible ischemia seen on \nECHO stress test (___):  At the time of admission, her \nsymptoms had resolved, no abnormalities were seen on imaging or \nlabs, and her VS and PEx were remarkable only for non-acute lung \nfindings.  MI was ruled out by trop negative x3, no EKG changes. \n Cardiology was consulted to evaluate need for catheterization \nvs other intervention, but did not feel that any urgent \ninpatient work-up was necessary, especially in the context of \nasymptomatic tachycardia.  She had already had Holter and ECHO \nprior to this admission.  Cardiology recommended restarting \ntheophylline if, in fact, she received such benefit from \npulmonary point of view.  She was restarted on theophylline \n200mg TID, which was her dose prior to discontinuation.  She \nreceived tobacco cessation education, was continued on home \ndiltiazem and aspirin (dose was temporarily increased to 325mg \nprior to ruling out MI).  Admission theopylline level was \npending at the time of discharge.\n.  \n# Asthma and COPD: patient was given Albuterol and ipratropium \nnebs, and she was continued on her home doses of fluticasone, \nmontelukast, fluticasone-salmetrol.  She was given O2 PRN.  \nAfter cardiology consult, she was restarted on her theophylline \nat 200mg TID, with pulm and cardiology follow-up.\n.  \n# Tobacco abuse: she declined nicotine patch, and education was \ngiven regarding the health hazards of smoking.\n.  \n# HL: patient was continued oh her simvastatin, but because her \nLDL was not at goal (<70), her dose was increased to 40mg daily.\n.\nINACTIVE ISSUES:\n.\n# HTN: continued isosorbide and hydrochlorothiazide at home \ndoses.\n.\n# Code: Full\n \nMedications on Admission:\n-acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every four \n(4) hours as needed for pain.  \n-albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2)  Inhalation every ___ hours.  \n-diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO DAILY (Daily).  \n-fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) \nSpray Nasal DAILY (Daily).  \n-fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n-hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n-isosorbide mononitrate 60 mg Tablet Extended Release 24 hr \nSig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  \n-montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n-omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n-tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n-calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO DAILY (Daily).  \n-multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n-aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n-simvastatin 20mg qday\n \nDischarge Medications:\n1. simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*0*\n2. hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO \nDAILY (Daily).  \n3. fluticasone 50 mcg/Actuation Spray, Suspension Sig: ___ \nSprays Nasal DAILY (Daily) as needed for congestion.  \n4. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr \nSig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  \n5. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n6. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n7. acetaminophen-codeine 300-30 mg Tablet Sig: One (1) Tablet PO \nevery four (4) hours as needed for pain.  \n8. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) puffs Inhalation every ___ hours as needed for shortness \nof breath or wheezing.  \n9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n10. Spiriva with HandiHaler 18 mcg Capsule, w/Inhalation Device \nSig: One (1) capsule Inhalation once a day.  \n11. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n12. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO DAILY (Daily).  \n13. diltiazem HCl 180 mg Capsule, Extended Release Sig: Two (2) \nCapsule, Extended Release PO DAILY (Daily).  \n14. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n15. theophylline 200 mg Capsule, Ext Release 24 hr Sig: One (1) \nCapsule, Ext Release 24 hr PO three times a day.\nDisp:*90 Capsule, Ext Release 24 hr(s)* Refills:*0*\n16. albuterol sulfate 0.63 mg/3 mL Solution for Nebulization \nSig: One (1) treatment Inhalation every ___ hours as needed for \nshortness of breath or wheezing for 15 doses.\nDisp:*15 ampules* Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\n-Tachyarrhythmia\n-Hyperlipidemia\n-Asthma, COPD\n\nSecondary:\n-Hypertension \n-Tobacco Use  \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMrs. ___,\n\n___ were hospitalized because the visiting nurses were concerned \nabout an elevated heart rate, but by the time ___ came to the \nhospital, your elevated heart rate had resolved.  Nevertheless, \n___ were admitted to ensure that your heart hadn't suffered any \ndamage, and to see the inpatient cardiologist.  Your labs were \nunremarkable from a cardiac standpoint, and ___ saw the \ncardiologist (who recommend no intervention at this time).  ___ \nshould follow-up with your pulmonologist as an outpatient for \nyour breathing issues.  The best thing ___ can do for your lung \nhealth is to quit smoking, and we encourage ___ to do so.\n\nThe following changes were made to your medications:\n-INCREASE your simvastatin to 40mg daily in order to lower your \ncholesterol to goal (as recommended by the cardiologist)\n-RESTART theophylline 200mg three times a day\n-We will also be giving ___ a prescription for albuterol \nnebulizers to use instead of your inhaler (when needed), but \nrefills will have to be through your primary physician or \npulmonologist\n\n___ discuss your theophylline dose and breathing status with \nyour primary provider (Dr. ___ and your pulmonologist (Dr. \n___.  \n \nFollowup Instructions:\n___\n"
        ],
        [
         "50",
         "10001884-DS-28",
         "10001884",
         "25758848",
         "2128-07-17 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol\n \nAttending: ___.\n \nChief Complaint:\nPneumonia identified by outpatient CXR\n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ PMH of Asthma, COPD, tobacco use,  p/w 4 days of \"cold like\" \nsymptoms. Pt noted that she has a chronic cough at baseline, \nworse at night, but noted that her cough was now productive of \n___ sputum and was a/w wheezing and subjective fevers (but did \nnot take her temperature). Pt also noted that baseline DOE \nincreased to mild shortness of breath at rest during the same \ntime period. Pt took tylenol and robitussin to good effect. Pt \ndenied any CP, but noted that she felt her heart \"flutter\" \nduring this time period. No changed in her 2 pillow orthopnea.\n\nPt did not have any recent sick contacts and denied any \nassociation w/ headache, sore throat, sneezing, rhinorrhea, \nnausea, vomiting, diarrhea, abdominal pain.  \n\nIn ED VS were T97.8 P78 BP136/97 R18 O296%NC. WBC was normal but \npt noted to have wheezing on exam, and CXR was suggestive of RML \nPNA so was given 125mg methylprednisone, 750mg levaquin, and \ncombo nebs (albuterol/ipratropim). CHEM/Coags/UA negative. \n\nGiven co-morbidities, decision was made to admit pt while \ninitiating Abx therapy. \n\n \nPast Medical History:\nASTHMA/COPD/Tobacco use\nPeripheral Arterial disease s/p recent common iliac stenting\nATRIAL TACHYCARDIA   \nATYPICAL CHEST PAIN   \nCERVICAL RADICULITIS   \nCERVICAL SPONDYLOSIS   \nCORONARY ARTERY DISEASE   \nHEADACHE   \nHIP REPLACEMENT   \nHYPERLIPIDEMIA   \nHYPERTENSION   \nOSTEOARTHRITIS   \nHERPES ZOSTER   \nTOBACCO ABUSE   \nATRIAL FIBRILLATION   \nANXIETY    \nGASTROINTESTINAL BLEEDING   \nOSTEOARTHRITIS   \nATHEROSCLEROTIC CARDIOVASCULAR DISEASE   \nPERIPHERAL VASCULAR DISEASE   \nURINARY TRACT INFECTION   \nCATARACT SURGERY ___ \n\nSurgery:\nBILATERAL COMMON ILIAC ARTERY STENTING ___ \nBUNIONECTOMY   \nHIP REPLACEMENT   \nPRIOR CESAREAN SECTION   \nGANGLION CYST \n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n\n \nPhysical ___:\nADMISSION PHYSICAL EXAM:\n============================\nTm98.4, BP141/82, P71, R20, O297%RA\nGENERAL: AOx3, pleasant affect, NAD\nHEENT: MMM. no LAD. no JVD\nHEART: RRR, S1/S2 normal, no murmurs/gallops/rubs.\nLUNGS: Coarse breath sounds b/l with expiratory wheezing \ndiffusely, RML/RLL crackles, no incr WOB (no accessory muscle \nuse), no resp distress\nABDOMEN: soft, nontender, nondistended. normoactive BS  \nEXT: Warm, dry, well perfused, 1+ peripheral edema to mid calves \nb/l \nSKIN: dry, warm, no rashes\nNEURO/PSYCH: AOx3, fluent speech, MAE spontaneously\n\nDISCHARGE PHYSICAL EXAM:\n============================\nTm:98.7, BP148-154/76-89, P72-81, R20, O29___-99RA\nGENERAL: AOx3, pleasant affect, NAD\nHEENT: MMM. no LAD. no JVD\nHEART: RRR, S1/S2 normal, no murmurs/gallops/rubs.\nLUNGS: Coarse breath sounds b/l with scant expiratory wheeze, no \nincr WOB (no accessory muscle use), no resp distress\nABDOMEN: soft, nontender, nondistended. normoactive BS  \nEXT: Warm, dry, well perfused, 1+ peripheral edema to mid calves \nb/l \nSKIN: dry, warm, no rashes\nNEURO/PSYCH: AOx3, fluent speech, MAE spontaneously\n\n \nPertinent Results:\nPERTINENT LABS:\n==========================\n___ 05:13PM BLOOD WBC-5.0 RBC-4.70 Hgb-13.8 Hct-42.7 MCV-91 \nMCH-29.3 MCHC-32.3 RDW-14.3 Plt ___\n___ 06:05AM BLOOD WBC-9.0# RBC-4.25 Hgb-12.6 Hct-38.6 \nMCV-91 MCH-29.7 MCHC-32.7 RDW-14.4 Plt ___\n___ 05:13PM BLOOD Neuts-53.9 ___ Monos-6.6 Eos-0.5 \nBaso-0.8\n___ 05:13PM BLOOD ___ PTT-31.7 ___\n___ 12:39PM BLOOD UreaN-16 Creat-0.8 Na-138 K-3.5 Cl-98 \nHCO3-29 AnGap-15\n___ 06:05AM BLOOD Glucose-142* UreaN-15 Creat-0.7 Na-138 \nK-3.5 Cl-100 HCO3-29 AnGap-13\n___ 12:39PM BLOOD proBNP-233\n___ 05:13PM BLOOD Calcium-9.9 Phos-2.5* Mg-1.8\n___ 05:35PM BLOOD Lactate-1.5\n\nPERTINENT MICRO:\n==========================\nUrinalysis:\n___ 05:30PM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG\n___ 05:30PM URINE RBC-0 WBC-<1 Bacteri-NONE Yeast-NONE \nEpi-1\n\nBlood Cx (___): NGTD (preliminary)\n\nPERTINENT STUDIES:\n==========================\n\nEKG: Sinus rhythm with frequent atrial premature beats. Left \nbundle-branch block with extensive repolarization abnormalities. \nCompared to the previous tracing of ___ the rhythm is now \nsinus \n\nCXR (___): Right middle lobe opacity concerning for \npneumonia.\n \nBrief Hospital Course:\nBRIEF HOSPITAL COURSE:\n===========================\n___ PMH of Asthma, COPD, CAD, tobacco use, who presented w/ 4 \ndays of shortness of breath and productive cough ___ sputum), \nwho was found to have RML opacity on CXR at outpatient clinic so \nwas referred to the ED.\n\nACTIVE ISSUES:\n===========================\n#Community Acquired Pneumonia\nPt presented to outpatient cardiology appointment w/ 4 days of \nshortness of breath and productive cough ___ sputum), and was \nreferred to primary care clinic (Dr. ___. Dr ___ \n___ a CXR which showed RML opacity on CXR. Given pt's \nunderlying lung pathology (COPD ___ longstanding tobacco use), \nand multiple co-morbidities, she was admitted briefly to \ninitiate antibiotics/steroids and ensure that she remained \nclinically stable.\n\nWhile RML opacification was suggestive of CAP, COPD flare was \nalso consideration given afebrile status and normal WBC. Exam \nsignificant for afebrile status, saturation of 97% on RA \n(baseline 95% RA), and coarse breath sounds w/ diffuse \nexpiratory wheezing.\n\nPt was treated w/ Levaquin 750mg daily (planned 5d course), \nsteroids (recieved 125 methylprednisone then 4d course of PO \nprednisone), and had nebulizer treatments for symptom relief. \n\nGiven her clinical stability, she was discharged home with an \noutpatient f/u w/ PCP (Dr. ___ on ___. Until then, \npt will need to complete course of Antibiotics and Steroids. Pt \nwas instructed to continue her outpatient COPD treatment regimen \non discharge.\n\nCHRONIC ISSUES:\n==========================\n#Coronary Artery Disease\nPt has a known history of CAD, but did not have any chest pain \nduring this hospitalization and EKG was unchanged from prior. \nAccordingly, she was continued on home dosages of plavix, \naspirin, isosorbid mononitrate and diltiazem\n\n#Hypertension\nPt has a known history of hypertension and was continued on her \nhome dose hydrochlorothiazide.\n\n#Glaucoma\nPt was continued on latanoprost drops before bed.\n\n#Hyperlipidemia\nPt was continued on home dose simvastatin.\n\nTransitional Issues:\n=====================\n1. Pt will need to continue Levaquin 750mg daily to complete 5 \nday course (Day 1 - ___\n2. Pt will need to continue Prednisone 40mg daily to complete 4 \nday course (Day 1 - ___\n3. Pt will need to f/u w/ PCP ___ ___ to assess response to \ntx and for general health care maintenance\n4. Pt will need to use Nebulizer treatments at home for \nsymptomatic relief for the next wk until pneumonia clears\n\nCode Status: FULL (confirmed w/ pt)\nContact: ___ (husband ___, ___ (___)\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of \nbreath \n2. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n3. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation \ninhalation BID \n4. Clopidogrel 75 mg PO DAILY \n5. Diltiazem Extended-Release 180 mg PO DAILY \n6. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal \ncongestion \n7. Hydrochlorothiazide 50 mg PO DAILY \n8. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n9. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS \n10. Simvastatin 20 mg PO DAILY \n11. Theophylline ER 300 mg PO BID \n12. Tiotropium Bromide 1 CAP IH DAILY \n13. Acetaminophen 325 mg PO Q4H:PRN pain \n14. Aspirin 81 mg PO DAILY \n15. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) \n315/200 mg oral daily \n16. cod liver oil 1,250-135 unit oral BID \n17. Multivitamins W/minerals 1 TAB PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q4H:PRN pain \n2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of \nbreath \n3. Aspirin 81 mg PO DAILY \n4. Clopidogrel 75 mg PO DAILY \n5. Diltiazem Extended-Release 180 mg PO DAILY \n6. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal \ncongestion \n7. Hydrochlorothiazide 50 mg PO DAILY \n8. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n9. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS \n10. Multivitamins W/minerals 1 TAB PO DAILY \n11. Simvastatin 20 mg PO DAILY \n12. Theophylline ER 300 mg PO BID \n13. Tiotropium Bromide 1 CAP IH DAILY \n14. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n15. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) \n315/200 mg oral daily \n16. cod liver oil 1,250-135 unit oral BID \n17. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation \nINHALATION BID \n18. Cepastat (Phenol) Lozenge 2 LOZ PO Q2H:PRN sore throat \nRX *phenol [Cepastat] 14.5 mg 2 lozenges every ___ as needed \nfor sore throat Disp #*36 Lozenge Refills:*0\n19. Levofloxacin 750 mg PO Q24H Duration: 2 Days \nRX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*2 \nTablet Refills:*0\n20. PredniSONE 40 mg PO DAILY Duration: 2 Days \nRX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*4 Tablet \nRefills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCommunity Acquired Pneumonia\nCOPD\nAsthma\n\n \nDischarge Condition:\nDischarge Condition: Stable\nMental Status: AOx3 (Baseline)\nAmbulatory Status: Baseline\n\n \nDischarge Instructions:\nMs. ___,\n\nIt was a pleasure taking care of you while you were hospitalized \nat ___. As you know, you were \nadmitted for initial treatment of pneumonia, to ensure that you \nwere responding well to the antibiotics, given your history of \nCOPD/Asthma. Fortunately, you responded quite well to the \nAntiobiotics, Steroids, and Nebulizer treatments that were \nadministered. Since your breathing was stable and you were \nresponding appropriately to treatments, you were discharged to \nhome. However, you should be vigilant in making sure that you \ncontinue the antibiotics & steroids for the short course listed \non the medication page. You should also be sure to see Dr. ___ \nat your next appointment to ensure that your pneumonia has \nresolved.\n \nFollowup Instructions:\n___\n"
        ],
        [
         "51",
         "10001884-DS-29",
         "10001884",
         "29675586",
         "2130-04-09 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nDyspnea \n \nMajor Surgical or Invasive Procedure:\nNone.\n\n \nHistory of Present Illness:\n___ y/o F with asthma, CAD s/p stents (reported by patient), \nCOPD, PAD, HTN, who presents with shortness of breath. The \npatient was sitting at home ewhen she suddenly felt short of \nbreath. She drank some water and took nebulizers which she felt \nhelped some. She also has noticed hoarseness of her voice.  \nShe presented because her symptoms have gotten worse throughout \nthe day. Denies fever/chills, sore throat. Says she does have a \ncough from asthma and noticed increased wheezing. She had an \nepisode of substernal chest pain this morning that lasted ___ \nminutes that was nonextertional. No radiation to jaw, arm, or \nback. It resolved without any intervention. She reported some \nleg swelling but says that has resolved. She denies PND, \northopnea.  \n\nIn the ED, initial vitals were:\n96.5 77 143/68 22 97% RA  \n\nLabs were notable for: \n- Labs were significant for neg trop x1, normal CBC, normal \nchemistry panel.  \n- CXR was negative. EKG shows LBBB consistent with prior.  \n\nPatient was given:\nThe patient was given albuterol/ipra nebs, prednisone 60 mg x 1.\n\nConsults:\nED spoke with Dr. ___ wanted admission for stress test \nin morning. ED did not feel she is CDU candidate given she is on \ntheophylline and would require more than one day in hospital.  \n\nVitals prior to transfer were: 71 149/73 20 94% RA  \nOn arrival to floor, she denies chest pain. Shortness of breath \nhas improved after receiving inhalers.\n \nPast Medical History:\nASTHMA/COPD/Tobacco use, Peripheral Arterial disease s/p recent \ncommon iliac stenting, ATRIAL TACHYCARDIA, ATYPICAL CHEST PAIN, \nCERVICAL RADICULITIS, CERVICAL SPONDYLOSIS, CORONARY ARTERY \nDISEASE  \nHEADACHE, HIP REPLACEMENT, HYPERLIPIDEMIA, HYPERTENSION, \nOSTEOARTHRITIS, HERPES ZOSTER, TOBACCO ABUSE, ATRIAL \nFIBRILLATION  \nANXIETY,GASTROINTESTINAL BLEEDING, OSTEOARTHRITIS, \nATHEROSCLEROTIC CARDIOVASCULAR DISEASE, PERIPHERAL VASCULAR \nDISEASE, CATARACT SURGERY ___  \nSurgery:  \nBILATERAL COMMON ILIAC ARTERY STENTING ___  \nBUNIONECTOMY  \nHIP REPLACEMENT  \nPRIOR CESAREAN SECTION  \nGANGLION CYST\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n \nPhysical ___:\n===================\nADMISSION PHYSICAL\n===================\nVitals: 98.9 ___ 74 18 96% RA  \nGeneral: Alert, oriented, no acute distress, breathing \ncomfortably  \nHEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  \nNeck: Supple, JVP not elevated, no LAD  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nLungs: Scattered wheezes throughout, bibasilar crackles, \nmoderate air movement.  \nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \nno organomegaly, no rebound or guarding  \nGU: No foley  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNeuro: Moves all extremities well  \n\n==================\nDISCHARGE PHYSICAL\n==================\nVitals: T: 98.3 BP: 149/87 P: 83 R:18 O2: 98% ra\nGeneral: NAD\nLungs: Diffuse end expiratory wheezing. No crackles or rhonchi\nCV: RRR. no M/R/G\nAbdomen: NTND \nExt: No edema \n \nPertinent Results:\n=====================\nADMISSION LABS\n=====================\n___ 06:15PM BLOOD WBC-5.7 RBC-4.46 Hgb-12.9 Hct-40.2 MCV-90 \nMCH-28.9 MCHC-32.1 RDW-14.6 RDWSD-48.5* Plt ___\n___ 06:15PM BLOOD Neuts-62.1 ___ Monos-9.4 Eos-0.3* \nBaso-0.3 Im ___ AbsNeut-3.55 AbsLymp-1.59 AbsMono-0.54 \nAbsEos-0.02* AbsBaso-0.02\n___ 06:15PM BLOOD Glucose-96 UreaN-15 Creat-0.9 Na-138 \nK-3.8 Cl-96 HCO3-32 AnGap-14\n\n====================\nPERTINENT LABS\n====================\n___ 05:55AM BLOOD cTropnT-<0.01\n___ 12:16AM BLOOD cTropnT-<0.01\n___ 06:15PM BLOOD cTropnT-<0.01\n\n====================\nDISCHARGE LABS\n====================\n___ 05:55AM BLOOD WBC-4.8 RBC-4.13 Hgb-11.9 Hct-37.2 MCV-90 \nMCH-28.8 MCHC-32.0 RDW-14.6 RDWSD-47.8* Plt ___\n___ 05:55AM BLOOD ___ PTT-29.0 ___\n___ 05:55AM BLOOD Glucose-149* UreaN-17 Creat-0.8 Na-137 \nK-4.5 Cl-99 HCO3-29 AnGap-14\n___ 05:55AM BLOOD Calcium-9.6 Phos-2.9 Mg-2.0\n\n====================\nEKG\n====================\n___ \nBaseline artifact. Probable ectopic atrial rhythm with frequent \npremature \natrial contractions. Left bundle-branch block. Compared to the \nprevious \ntracing of ___ ectopic atrial rhythm is new. \n\n====================\nCXR\n====================\n___\nIMPRESSION:\nNo acute cardiopulmonary process.\n \nBrief Hospital Course:\n___ y/o F with asthma, CAD s/p stents (reported by patient), \nCOPD, PAD, HTN, who presents with shortness of breath and \nintermittent episode of chest pain. \n\n# Mild COPD exacerbation: Patient with shortness of breath at \nrest, no cough or increased sputum production. Exam with wheezes \non examination and some improvement with nebs/pred. Lower \nsuspicion for PNA given normal WBC and lack of fevers. Also no \nevidence of volume overload on examination. Since patient only \nhas a mild exacerbation she will not require antibiotics. \nPaitent will recieve 5 days of predinose (last day ___ in \naddition to taking her home albuterol, fluticasone and \ntiotropoium inhalers.\n\n# Episode of chest pain: There was a concern for ACS given \ncardiac history but trops x 2 negative. EKG with no significant \nchanges from prior. The chest pain was non-exertional, resolved \nwithout intervention prior to arriving at the hospital, likely \nrelated to her COPD exacerbation.\n\nTRANSITIONAL ISSUES:\n[ ] Please confirm patient completed course of prednisone (last \nday ___ with resolution of symptoms\n[ ] Consider outpatient stress testing if chest pain returns\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 325 mg PO Q4H:PRN pain \n2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of \nbreath \n3. Aspirin 81 mg PO DAILY \n4. Clopidogrel 75 mg PO DAILY \n5. Diltiazem Extended-Release 180 mg PO DAILY \n6. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal \ncongestion \n7. Hydrochlorothiazide 50 mg PO DAILY \n8. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY \n9. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS \n10. Multivitamins W/minerals 1 TAB PO DAILY \n11. Theophylline ER 300 mg PO BID \n12. Tiotropium Bromide 1 CAP IH DAILY \n13. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n14. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) \n315/200 mg oral daily \n15. cod liver oil 1,250-135 unit oral BID \n16. Atorvastatin 10 mg PO QPM \n17. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n18. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H:PRN cough \n19. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n20. Ranitidine 150 mg PO BID \n21. Lorazepam 0.5 mg PO QHS:PRN insomnia \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q4H:PRN pain \n2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of \nbreath \n3. Aspirin 81 mg PO DAILY \n4. Atorvastatin 10 mg PO QPM \n5. Clopidogrel 75 mg PO DAILY \n6. Diltiazem Extended-Release 180 mg PO DAILY \n7. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal \ncongestion \n8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n9. Hydrochlorothiazide 50 mg PO DAILY \n10. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY \n11. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS \n12. Lorazepam 0.5 mg PO QHS:PRN insomnia \n13. Multivitamins W/minerals 1 TAB PO DAILY \n14. Ranitidine 150 mg PO BID \n15. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n16. PredniSONE 40 mg PO DAILY Duration: 4 Days \nRX *prednisone 20 mg 2 tablet(s) by mouth once a day Disp #*6 \nTablet Refills:*0\n17. Theophylline ER 300 mg PO BID \n18. Tiotropium Bromide 1 CAP IH DAILY \n19. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H:PRN cough \n20. cod liver oil 1,250-135 unit oral BID \n21. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) \n315/200 mg oral daily \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis:\nCOPD exacerbation\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital for shortness of breath and \nmild chest pain. While in the hospital we received an EKG and \nblood work which suggested that your pain was not coming from \nyour heart. Your shortness of breath is likely from a COPD \nattack and we gave you steroids and breathing treatments for \nyour symptoms. \n\nYou have a follow up appointment with Dr. ___ as detailed \nbelow. We are also sending you home with a short course of \nsteroids for your COPD. Your other medications are detailed in \nyour discharge medication list.\n\nIt was a pleasure taking care of you at ___.\n\nSincerely,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "52",
         "10001884-DS-30",
         "10001884",
         "26170293",
         "2130-04-19 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nNonexertional Chest pain\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nThis is a ___ year old female with PMHx CAD, PVD and COPD \npresenting with chest pain. She reports that she woke up at 3 am \nwith substernal pressure like pain which was associated with \nshortness of breath. She rated the pain a ___ and reports that \nit lasted for about 5 minutes and resolved spontaneously. She \nhad several more episodes of the same pain lasting about 5 \nminutes at a time throughout the morning but which were much \nless severe. She hasn't had an episode of pain since 1 pm. She \ndenies palpitations, lightheadedness, dizziness, nausea, \nvomiting, diaphoresis.  \nIn the ED, initial vitals were: 98.0 50 156/73 20 99%  \n- Labs were significant for:  \n- Na 137 K 3.0 Cl 94 CO2 32 BUN 16 Cr 0.8  \n- Ca: 10.6 Mg: 1.9 P: 2.9  \n- WBC 5.9 Hgb 13.6 Hct 41.1 Plt 238  \n- ___: 10.7 PTT: 28.7 INR: 1.0  \n- Lactate:2.0  \n- Trop-T: <0.01  \n- Imaging revealed:  \n- CXR: No acute cardiopulmonary process  \n- The patient was given: PO Aspirin 243, IH Albuterol 0.083% \nNeb, IH Ipratropium Bromide Neb, PO Potassium Chloride 40 mEq, \n40 mEq Potassium Chloride / 1000 mL NS  \n- Vitals prior to transfer were: 98.1 84 163/118 17 100% RA  \nUpon arrival to the floor, patient denies chest pain, shortness \nof breath, palpitations, lightheadedness, dizziness.  \nREVIEW OF SYSTEMS:  \n(+) Per HPI  \n\n \nPast Medical History:\nASTHMA/COPD/Tobacco use, Peripheral Arterial disease s/p recent \ncommon iliac stenting, ATRIAL TACHYCARDIA, ATYPICAL CHEST PAIN, \nCERVICAL RADICULITIS, CERVICAL SPONDYLOSIS, CORONARY ARTERY \nDISEASE  \nHEADACHE, HIP REPLACEMENT, HYPERLIPIDEMIA, HYPERTENSION, \nOSTEOARTHRITIS, HERPES ZOSTER, TOBACCO ABUSE, ATRIAL \nFIBRILLATION  \nANXIETY,GASTROINTESTINAL BLEEDING, OSTEOARTHRITIS, \nATHEROSCLEROTIC CARDIOVASCULAR DISEASE, PERIPHERAL VASCULAR \nDISEASE, CATARACT SURGERY ___  \nSurgery:  \nBILATERAL COMMON ILIAC ARTERY STENTING ___  \nBUNIONECTOMY  \nHIP REPLACEMENT  \nPRIOR CESAREAN SECTION  \nGANGLION CYST\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n \nPhysical ___:\nAdmission PE:\nVitals: 98.4 159/66 91 16 93% RA   Wt: 66.2\nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  \nNeck: Supple, JVP not elevated, no LAD  \nCV: Regular rate and rhythm, normal S1 + S2, ___ systolic murmur \nheard best at RUSB, no rubs or gallops  \nLungs: inspiratory and expiratory wheezes, no rales or rhonchi  \nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \nno organomegaly, no rebound or guarding  \nGU: No foley  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema\n\nDischarge PE:\nVitals: 98.5 ___ 20 ___ 98%RA \nWeight: 64.5\nWeight on admission: 66.2\nGeneral: NAD \nHEENT: Sclera anicteric \nNeck: JVP not elevated  \nCV: Regular rhythm with frequent skipped beats, normal S1 + S2, \n___ systolic murmur heard best at RUSB, no rubs or gallops  \nLungs: mild expiratory wheezes, diffuse mild rhonchi \n(pre-nebulizer) \nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \nno organomegaly, no rebound or guarding   \nExt: Warm, well perfused, no edema \n\n \nPertinent Results:\nAdmission Labs: \n\n___ 07:49PM   ___ PTT-28.7 ___\n___ 07:05PM   LACTATE-2.0\n___ 05:58PM   GLUCOSE-103* UREA N-16 CREAT-0.8 SODIUM-137 \nPOTASSIUM-3.0* CHLORIDE-94* TOTAL CO2-32 ANION GAP-14\n___ 05:58PM   estGFR-Using this\n___ 05:58PM   cTropnT-<0.01\n___ 05:58PM   CALCIUM-10.6* PHOSPHATE-2.9 MAGNESIUM-1.9\n___ 05:58PM   WBC-5.9 RBC-4.62 HGB-13.6 HCT-41.1 MCV-89 \nMCH-29.4 MCHC-33.1 RDW-14.7 RDWSD-47.1*\n___ 05:58PM   NEUTS-57.8 ___ MONOS-9.3 EOS-0.3* \nBASOS-0.2 IM ___ AbsNeut-3.41 AbsLymp-1.88 AbsMono-0.55 \nAbsEos-0.02* AbsBaso-0.01\n___ 05:58PM   PLT COUNT-238\n\nDischarge Labs:\n\n___ 06:20AM BLOOD WBC-6.1 RBC-4.60 Hgb-13.4 Hct-41.2 MCV-90 \nMCH-29.1 MCHC-32.5 RDW-14.9 RDWSD-47.8* Plt ___\n___ 06:20AM BLOOD Plt ___\n___ 06:20AM BLOOD Glucose-97 UreaN-17 Creat-1.0 Na-134 \nK-4.2 Cl-96 HCO3-24 AnGap-18\n___ 06:25AM BLOOD ALT-19 AST-22 LD(LDH)-260* AlkPhos-81 \nTotBili-0.4\n___ 06:20AM BLOOD Calcium-9.7 Phos-3.7 Mg-1.9\n\nStudies:\n1. CXR ___: No acute cardiopulmonary process  \n2. ___: Exercise stress test  \nINTERPRETATION: This ___ year old woman with a history of PAD and \n \nLBBB was referred to the lab from the ER following negative \nserial  \ncardiac markers for evaluation of chest discomfort. The patient \nwas  \nreferred for a dipyridamole stress test but due to her \ntheophylline  \ntherapy we were not able to proceed. Due to her frequent atrial \nectopy we chose not to give her dobutamine but had her walk on \nthe treadmill instead. She exercised for 3 minutes of a modified \n___ protocol and stopped due to leg claudication. The \nestimated peak MET capacity was 2.5 which represents a poor \nfunctional capacity for her age. No arm, neck, back or chest \ndiscomfort was reported by the patient throughout the study. The \nST segments are uninterpretable for ischemia in the setting of \nthe baseline LBBB. The rhythm was sinus with frequent isolated \napbs, occasional atrial couplets and a 6 beat run of PSVT. Rare \nisolated vpbs were also noted. Resting mild systolic \nhypertension with a pprorpriate increase in BP with exercise and \nrecovery.  \nIMPRESSION: No anginal type symptoms or interpretable ST \nsegments at a high cardiac demand and poor functional capacity. \nNuclear report sent separately.  \n3. ___ CATH:  \nLMCA: short, no CAD. LAD: mild  \nfocal origin disease (20%) and mild proximal disease (30%). LCX: \n \nminimal luminal irregularities. RCA: 30%.  \n4. ECG ___: sinus rhythm with multiple PACs, left axis \ndeviation, old LBBB \n5. ECG ___: Likely atrial tachycardia. Left bundle-branch \nblock. Compared to the previous tracing atrial tachycardia has \nreplaced sinus rhythm with premature atrial contractions. Left \nbundle-branch block was previously noted. \n6. ECHO ___: Conclusions  \nThe left atrium is normal in size. No atrial septal defect is \nseen by 2D or color Doppler. The estimated right atrial pressure \nis ___ mmHg. Left ventricular wall thickness, cavity size and \nregional/global systolic function are normal (LVEF >55%). There \nis considerable beat-to-beat variability of the left ventricular \nejection fraction due to an irregular rhythm/premature beats. \nTissue Doppler imaging suggests a normal left ventricular \nfilling pressure (PCWP<12mmHg). Right ventricular chamber size \nand free wall motion are normal. The aortic valve leaflets are \nmildly thickened (?#). There is no aortic valve stenosis. No \naortic regurgitation is seen. The mitral valve leaflets are \nmildly thickened. There is no mitral valve prolapse. Physiologic \nmitral regurgitation is seen (within normal limits). The left \nventricular inflow pattern suggests impaired relaxation. The \nestimated pulmonary artery systolic pressure is normal. There is \nno pericardial effusion. \nCompared with the prior study (images reviewed) of ___, \nfrequent atrial ectopy is seen; biventricular function appears \nsimilar.   \n\nMicro: ___: Bcx pending\n \nBrief Hospital Course:\nBrief Hospital Course\n===========================================================\n___ PMH of CAD, PVD, and COPD presenting with recurrent \nnon-exertional substernal chest pain. The patient has a history \nof mild CAD but labs were significant for negative troponins and \nEKG was without ischemic changes. During her admission, she also \ndeveloped multiple episodes of atrial tachycardia (AFib vs. \nAflutter) and was started on Amiodarone for rate/rhythm control \nand Rivaroxaban for anticoagulation, and kept on home dose of \nDiltiazem also for rate control. She did not have any episodes \nof chest pain during hospitalization, so was discharged once \natrial fibrillation/flutter was controlled. She will need to \nfollow up with her primary care doctor regarding vague chest \npain which led to admission.\n\nAcute Issues:\n========================================================\n#Atrial Tachycardia: During admission pt had runs of wide \ncomplex tachyarrythmia, thought likely supraventricular in \norigin: rapid Atrial Fibrillation/ Flutter vs. atrial \ntachycardia, with abberancy (complexes with similar morphology \nto native LBBB). She was treated with Diltiazem and Amiodarone \nand had fewer episodes of tachycardia. EP team evaluated patient \nand recommended anticoagulation and outpatient follow up to \nconsider EP study and possible ablation of Atrial Flutter. \nPatient was discharged with ___ of Hearts monitor, Amiodarone \n200mg twice daily x 1 week followed by 200 mg daily thereafter. \nDiltiazem continued at home dose. Rivaroxaban added for \nanticoagulation. As per outpatient cardiologist (Dr. ___, \nplavix was discontinued in light of addition of Rivaroxaban and \ninterest in avoiding triple therapy in this patient. Pt was \ngiven follow up appointments with Drs. ___. She was \nscheduled to see Dr. ___ EP evaluation in 2 months.\n\n#Chest pain: Pt presented with substernal chest pain that \noccurred at rest and was ruled out for MI with no troponin \nelevation or significant new ECG changes. Likely her chest pain \nwas related to periods of tachycardia, although while in the \nhospital the runs of atrial tachycardia did not reproduce chest \npain. She did not have any episodes of chest pain during \nhospitalization, so was discharged once atrial \nfibrillation/flutter was controlled. She will need to follow up \nwith her primary care doctor regarding vague chest pain which \nled to admission.\n\n#Dry eyes: pt had erythema and pain of R eye, found to have dry \neyes per optholmology. Sent out with Artificial tears and \nerythromycin eye drops. Patient had follow up appointment \nalready scheduled with optholmology and was instructed to attend \nappointment.\n\nChronic Issues:\n=============================================================\n# COPD  Pt appeared to be at baseline respiratory status. She \nwas sent home with her home albuterol neb, albuterol inhaler, \nFluticasone nasal spray, fluticasone-salmeterol diskus, \ntiotropium bromide nebs, and theophylline\n\n# PAD: \nAs above, we stopped Clopidogrel as patient is now on \nRivaroxaban and wanted to avoid triple therapy as per her \ncardiologist Dr. ___.\n\nTransitional Issues:\n==============================================================\n1. Patient was discharged on Amiodarone 200 mg po twice daily \nfor one week until ___ and then 200mg po daily thereafter \nuntil her EP appointment with Dr. ___ in approximately 2 months.\n2. Pt was discharged on Rivaroxaban 20 mg qpm with dinner\n3. Pt discharged with outpatient ___ of Hearts monitor with \nresults to be interpreted by Cardiologist.\n4. She presented with chest pain but did not have elevated \nbiomarkers or EKG changes concerning for myocardial damage. \nMoreover, pt remained asymptomatic during periods of \nsupraventricular tachycardia while she was hospitalized. Patient \nmay benefit from outpatient stress test if such symptoms return.\n5. On day of discharge, pt had significant R eye pain and \nredness, was evaluated by Optholmology, who felt that it was \njust dry eyes, treated with erythromycin drops and artifiical \ntears. Patient already has appt w/ Opthamology in 5 days which \nshe will need to attend.\n\nFull Code\nContact: CONTACT: ___ (husband) ___ ___ \n(daughter) ___ \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 325 mg PO Q4H:PRN pain \n2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of \nbreath \n3. Aspirin 81 mg PO DAILY \n4. Atorvastatin 10 mg PO QPM \n5. Clopidogrel 75 mg PO DAILY \n6. Diltiazem Extended-Release 180 mg PO DAILY \n7. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal \ncongestion \n8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n9. Hydrochlorothiazide 50 mg PO DAILY \n10. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY \n11. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS \n12. Lorazepam 0.5 mg PO QHS:PRN insomnia \n13. Multivitamins W/minerals 1 TAB PO DAILY \n14. Ranitidine 150 mg PO BID \n15. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n16. Theophylline ER 300 mg PO BID \n17. Tiotropium Bromide 1 CAP IH DAILY \n18. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H:PRN cough \n19. cod liver oil 1,250-135 unit oral BID \n20. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) \n315/200 mg oral daily \n\n \nDischarge Medications:\n1. Amiodarone 200 mg PO BID \nRX *amiodarone 200 mg 1 tablet(s) by mouth twice a day Disp #*60 \nTablet Refills:*1\n2. Rivaroxaban 20 mg PO DINNER \nRX *rivaroxaban [Xarelto] 20 mg 1 tablet(s) by mouth qpm Disp \n#*30 Tablet Refills:*1\n3. Acetaminophen 325 mg PO Q4H:PRN pain \n4. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of \nbreath \n5. Aspirin 81 mg PO DAILY \n6. Atorvastatin 10 mg PO QPM \n7. Diltiazem Extended-Release 180 mg PO DAILY \n8. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN nasal \ncongestion \n9. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n10. Guaifenesin-CODEINE Phosphate 5 mL PO Q6H:PRN cough \n11. Hydrochlorothiazide 50 mg PO DAILY \n12. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY \n13. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS \n14. Lorazepam 0.5 mg PO QHS:PRN insomnia \n15. Multivitamins W/minerals 1 TAB PO DAILY \n16. Ranitidine 150 mg PO BID \n17. Theophylline ER 300 mg PO BID \n18. Tiotropium Bromide 1 CAP IH DAILY \n19. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n20. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN eye \nirritation \nRX *dextran 70-hypromellose [Artificial Tears]  1 drop OPTH \nQID:prn Refills:*0\nRX *dextran 70-hypromellose [Artificial Tears (PF)]  ___ drops \neye as needed Disp #*1 Package Refills:*1\n21. Erythromycin 0.5% Ophth Oint 0.5 in RIGHT EYE TID \nRX *erythromycin 5 mg/gram (0.5 %) 0.5 (One half) inch OPTH \nTID:prn Refills:*0\n22. Calcarb 600 With Vitamin D (calcium carbonate-vitamin D3) \n315/200 mg oral daily \n23. cod liver oil 1,250-135 unit oral BID \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nRapid Atrial Fibrillation/Flutter\nCOPD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ due to concerning chest pain symptoms \nwhich we think are due to infrequent bursts of a rapid heart \nrate. Since the rapid rate makes you at increased risk for \nstroke, you were started on a blood thinning medication called \nRivaroxaban which you will need to take every day. Our \nspecialized cardiologists who deal specifically with the \nelectrical rhythm of the heart evaluated you and felt that you \nwould benefit from a medication called amiodarone which was also \nstarted. You will need to follow up with them in their clinic \nregarding this abnormal rhythm. In the meantime, you were \noutfitted with a Holter monitor to record your heart rate at \nhome. It is very important that you follow up with Dr. ___ \nyour cardiologist.\n\nWe wish you all the best,\n\nSincerely,\nYour care team at ___\n \nFollowup Instructions:\n___\n"
        ],
        [
         "53",
         "10001884-DS-31",
         "10001884",
         "26202981",
         "2130-08-23 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nAnemia, Melena, SOB\n \nMajor Surgical or Invasive Procedure:\nUpper endoscopy ___\n\n \nHistory of Present Illness:\n___ yo female with history of Afib on Xarelto, COPD, HTN, PAD who \npresents for abnormal labs. She noted dark, tarry, stool on \n___ and presented to PCP ___ ___, where H/H was noted \nto be 8.8/28.6 from prior 11.___.6 (baseline Hct about 38). She \nhas also been experiencing bright red blood with wiping, she \nbelieves from her hemorrhoids. PCP called pt who agreed to come \nto ED. She had colonoscopy in ___ with showed a benign polyp, \ninternal hemorrhoids, and diverticulosis. Her last BM was ___, \nwas reportedly \"regular.\" She currently complains of increased \nexertional fatigue and has been feeling more SOB than her \nbaseline.  Over the last 6 months she has noticed she becomes \nincreasingly out of breath, walking or climbing stairs.  She \nbecomes SOB after 6 stairs or less than 1 block, requiring her \nto stop, and at times use albuterol inhaler. She used to use her \nonly use her inhaler ___ times per day, now she uses it over \nfour times a day and nebulizers twice a day. \n\nShe denies any fevers, chills, nausea/vomit, diarrhea, dysuria, \nrash, unintentional weight loss.  \n \n \nIn the ED, initial vitals: 0 98 64 149/85 20 98% RA \nLabs significant for:\nWBC 5.0 HGB 8.8 HCT 28.4( Last baseline of 11.___/34.6 in \n___ MCV PLT 240 \n___ 16.7 INR 1.5 PTT 38.8\nChem 7 was normal\n\nShe was given albuterol nebs and started on IV normal saline\n \nOn transfer, vitals were:  T:98.4  BP: 152/60 P:68 R:18 18 \nO2:97%RA  \nOn arrival to the floor patient was stable and in good spirits. \nShe notes that she had some blood per rectum on her underwear.  \n\n \nPast Medical History:\nASTHMA/COPD/Tobacco use, Peripheral Arterial disease s/p recent \ncommon iliac stenting, ATRIAL TACHYCARDIA, ATYPICAL CHEST PAIN, \nCERVICAL RADICULITIS, CERVICAL SPONDYLOSIS, CORONARY ARTERY \nDISEASE  \nHEADACHE, HIP REPLACEMENT, HYPERLIPIDEMIA, HYPERTENSION, \nOSTEOARTHRITIS, HERPES ZOSTER, TOBACCO ABUSE, ATRIAL \nFIBRILLATION  \nANXIETY,GASTROINTESTINAL BLEEDING, OSTEOARTHRITIS, \nATHEROSCLEROTIC CARDIOVASCULAR DISEASE, PERIPHERAL VASCULAR \nDISEASE, CATARACT SURGERY ___  \nSurgery:  \nBILATERAL COMMON ILIAC ARTERY STENTING ___  \nBUNIONECTOMY  \nHIP REPLACEMENT  \nPRIOR CESAREAN SECTION  \nGANGLION CYST\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n \nPhysical ___:\nADMISSION PHYSICAL EXAM:\nVitals: T:98.4  BP: 152/60 P:68 R:18 18 O2:97%RA  \nGENERAL: Well nourished, well appearing AA female, sitting up in \nbed Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNECK: supple, JVP not elevated, no LAD  \nLUNGS: Clear to auscultation bilaterally though decreased air \nmovement. No no wheezes, rales, rhonchi  \nCV: Irregularly irregular rate and rhythm, normal S1 S2, ___ \nsystolic murmur heard best at RUSB, no rubs or gallops  \nABD: soft, non-tender, non-distended, bowel sounds present, no \nrebound tenderness or guarding, no organomegaly \nRectum: No obvious hemorrhoids  \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nSKIN: clear\nNEURO: No gross deficits.\n\nDISCHARGE PHYSICAL EXAM:\nVitals: T: 98.2, BP: 146-152/67-78, P:57-60, ___, O2:97%RA  \nGENERAL: Well nourished, well appearing, sitting up in bed, NAD\nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNECK: supple, JVP not elevated, no LAD  \nLUNGS: Scattered wheezes bilaterally but no resp distress \nCV: Irregularly irregular rate and rhythm, normal S1 S2, ___ \nsystolic murmur heard best at RUSB, no rubs or gallops\nABD: soft, non-tender, non-distended, bowel sounds present, no \nrebound tenderness or guarding, no organomegaly\nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nSKIN: clear\nNEURO: No gross deficits. \n \nPertinent Results:\nADMISSION LABS:\n================\n___ 12:28PM BLOOD WBC-5.0 RBC-3.28* Hgb-8.8* Hct-28.4* \nMCV-87 MCH-26.8 MCHC-31.0* RDW-16.1* RDWSD-50.4* Plt ___\n___ 02:28PM BLOOD ___ PTT-38.8* ___\n___ 12:28PM BLOOD Glucose-96 UreaN-18 Creat-1.0 Na-137 \nK-3.6 Cl-98 HCO3-28 AnGap-15\n\nPERTINENT FINDINGS:\n====================\nEGD negative for evidence of bleeding\n\nDISCHARGE LABS:\n================\n___ 06:35AM BLOOD WBC-4.7 RBC-3.38* Hgb-9.1* Hct-29.1* \nMCV-86 MCH-26.9 MCHC-31.3* RDW-16.1* RDWSD-50.5* Plt ___\n___ 06:35AM BLOOD ___ PTT-37.1* ___\n___ 06:35AM BLOOD Glucose-99 UreaN-8 Creat-0.9 Na-137 \nK-3.2* Cl-98 HCO3-30 AnGap-12\n___ 06:35AM BLOOD Calcium-9.5 Phos-3.3 Mg-2.___ PMH of CAD, PVD, and COPD and history of recurrent chest \npain present with drop in HCT and progressive SOB. \n\nACTIVE PROBLEMS\n#GI Bleed: Presented to PCP with melena and wiping BRBPR. CBC \nwas taken and Hgb found to drop from 11.3->8.8. Two large bore \nIVs were placed, started on IV PPI, and she was type and \nscreened. Vitals remained stable, so patient was continued on \nhome rivaroxaban. She was evaluated by GI who recommended upper \nGI endoscopy, which showed no evidence of bleeding. She remained \nhemodynamically stable throughout the admission. Hgb 9.1 on day \nof discharge. She was discharged home on both her Xarelto and \nASA.\n\n#SOB: Long standing history of smoking and COPD. Progressive \nexertional dyspnea despite use of Spiriva, advair, fluticasone \nnasal spray, theophylline, and albuterol nebulizers. Has \nincreased rescue inhaler use.  Etiology unclear, does not appear \nto be infectious given chronicity. Most likely is progression of \nunderlying COPD. PFT's were obtained while in-house. Smoking \ncessation was also discussed. Will need continued outpatient f/u \nre: her COPD.\n\nCHRONIC PROBLEMS\n#Afib: Continued home amiodarone and diltiazem. Continued \nrivaroxaban for anticoagulation, as discussed above.\n\n#HTN: Stable, continued on home diltiazem, Imdur, HCTZ\n\n#Anxiety/insomnia: stable, continued home lorazepam QHS PRN for \ninsomnia/anxiety.\n\n#Dry eyes: History of glaucoma. Continued home latanoprost \nophthalmic drops.\n\n#PAD: Stable, continued on home atorvastatin, s/p iliac stent. \nOK to continue aspirin as well.\n\nTRANSITIONAL ISSUES:\n- Should consider outpatient colonoscopy to potentially identify \nany source of lower GI Bleed.\n- Given stable hemoglobin/hematocrit while inpatient as well as \nno evidence of bleeding on EGD, her Xarelto and Aspirin were \ncontinued on discharge\n- Was treated with IV PPI while inpatient, but given no evidence \nof active bleeding, was discharged on home Ranitidine 300mg PO \ndaily\n- Continue to encourage smoking cessation\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Rivaroxaban 20 mg PO QPM \n2. Acetaminophen 325 mg PO Q6H:PRN pain \n3. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB \n4. Aspirin 81 mg PO DAILY \n5. Atorvastatin 10 mg PO QPM \n6. Diltiazem Extended-Release 180 mg PO BID \n7. Fluticasone Propionate NASAL 2 SPRY NU BID nasal congestion \n8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n9. Hydrochlorothiazide 50 mg PO DAILY \n10. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n11. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n12. Lorazepam 0.5 mg PO QHS:PRN insomnia \n13. Multivitamins W/minerals 1 TAB PO DAILY \n14. Ranitidine 300 mg PO DAILY \n15. Theophylline ER 300 mg PO BID \n16. Tiotropium Bromide 1 CAP IH BID \n17. TraMADOL (Ultram) 50 mg PO BID pain \n18. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN \nirritation \n19. Amiodarone 200 mg PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q6H:PRN pain \n2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB \n3. Amiodarone 200 mg PO DAILY \n4. Atorvastatin 10 mg PO QPM \n5. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN \nirritation \n6. Diltiazem Extended-Release 180 mg PO BID \n7. Fluticasone Propionate NASAL 2 SPRY NU BID nasal congestion \n8. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n9. Hydrochlorothiazide 50 mg PO DAILY \n10. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n11. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n12. Lorazepam 0.5 mg PO QHS:PRN insomnia \n13. Rivaroxaban 20 mg PO QPM \n14. Theophylline ER 300 mg PO BID \n15. Ranitidine 300 mg PO DAILY \n16. TraMADOL (Ultram) 50 mg PO BID pain \n17. Tiotropium Bromide 1 CAP IH BID \n18. Multivitamins W/minerals 1 TAB PO DAILY \n19. Aspirin 81 mg PO DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\n- Anemia\n\nSecondary:\n- Afib\n- CAD\n- HTN\n- COPD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs. ___,\n\nYou were admitted to ___ due to \na decrease in blood count on laboratory testing. Because we were \nconcerned for a bleed in your GI tract, you underwent an upper \nendoscopy. Fortunately, this did not show any evidence of \nbleeding. Your blood counts remained stable while in the \nhospital. You were discharged with plan for outpatient follow up \nwith GI for colonoscopy in the future. Pulmonary function \ntesting was done as well while you were here. You will also \nfollow up with Dr. ___ in his clinic.\n\nIt was a pleasure taking care of your at ___. If you have any \nquestions about the care you received, please do not hesitate to \nask.\n\nSincerely,\nYour Inpatient ___ Care Team\n\n \nFollowup Instructions:\n___\n"
        ],
        [
         "54",
         "10001884-DS-32",
         "10001884",
         "29678536",
         "2130-10-12 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___\n \nChief Complaint:\nDyspnea, Atrial Fibrillation\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ F with pmhx of COPD (nighttime O2), htn, afib who presents \nwith dyspnea, currently being treated for COPD and admitted for \nAfib with RVR.  \n The patient went to the ED on ___ and was diagnosed with a \nCOPD flare. She was discharged with a prednisone taper \n(currently on 60mg) and azithromycin. This AM she initially felt \nwell, then developed dyspnea at rest, worsening with exertion. \nHer inhalers improved her SOB. She felt that these symptoms were \nconsistent with her COPD. She saw her PCP ___ today in \nclinic where she was found to be in Afib w/ RVR, rate around \n110-120. She has a history of afib. He referred her to the ED \nfor persistent SOB and afib with RVR. She states she been \ncompliant with nebs and steroid/azithro regimen. She denies any \n___ edema, orthopnea. She denies recent travel, surgeries. She \nhad an episode of chest tightness this AM that felt like her \nCOPD flares. Denies fevers or coughing or production of sputum, \nhemomptysis.  \n \nPast Medical History:\nASTHMA/COPD  \n ATYPICAL CHEST PAIN  \n CERVICAL RADICULITIS  \n CERVICAL SPONDYLOSIS  \n CORONARY ARTERY DISEASE  \n HEADACHE  \n HIP REPLACEMENT  \n HYPERLIPIDEMIA  \n HYPERTENSION  \n OSTEOARTHRITIS  \n HERPES ZOSTER  \n ATRIAL FIBRILLATION  \n ANXIETY  \n GASTROINTESTINAL BLEEDING  \n OSTEOARTHRITIS  \n ATHEROSCLEROTIC CARDIOVASCULAR DISEASE  \n PERIPHERAL VASCULAR DISEASE\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n \nPhysical ___:\nADMISSION PHYSICAL EXAM:\nVS: 98.14 154/74 71 24 98% 2L  \n GENERAL: Well appearing, NAD, no accessory muscle use.  \n HEENT: NCAT. Sclera anicteric. PERRL, EOMI.  \n NECK: No JVD  \n CARDIAC: Irregular rhythm, normal rate. Normal S1, S2. No \nmurmurs/rubs/gallops.  \n LUNGS: Moving air well bilaterally. Trace inspiratory wheezing \nand louder expiratory wheezing in all lung fields. No \ncrackles/rhonchi.  \n ABDOMEN: Soft, NTND. No HSM or tenderness.  \n EXTREMITIES: No c/c/e. No femoral bruits.  \n\nDISCHARGE PHYSICAL EXAM:\nVS: Tm 98.8 Tc 98.4 ___ RA\nGENERAL: NAD\nHEENT: NCAT. Sclera anicteric. Conjunctivae noninjected. OM \nclear.\nNECK: No JVD  \nCARDIAC: RRR. Normal S1, S2. No murmurs/rubs/gallops.  \nLUNGS: Mildly reduced air movement, significant wheezing \nbilaterally, +rhonchi, no crackles  \nABDOMEN: Soft, NTND. No HSM or tenderness.  \nEXTREMITIES: No c/c/e. \n \nPertinent Results:\nADMISSION LABS:\n___ 03:38PM BLOOD WBC-7.2 RBC-4.06 Hgb-9.4* Hct-31.4* \nMCV-77* MCH-23.2* MCHC-29.9* RDW-16.9* RDWSD-47.2* Plt ___\n___ 03:38PM BLOOD Neuts-93.8* Lymphs-4.2* Monos-1.3* \nEos-0.0* Baso-0.0 Im ___ AbsNeut-6.74*# AbsLymp-0.30* \nAbsMono-0.09* AbsEos-0.00* AbsBaso-0.00*\n___ 03:38PM BLOOD ___ PTT-30.3 ___\n___ 03:38PM BLOOD Glucose-141* UreaN-20 Creat-1.0 Na-133 \nK-3.8 Cl-93* HCO3-30 AnGap-14\n___ 03:38PM BLOOD Calcium-9.9 Phos-2.8 Mg-2.1\n\nPERTINENT LABS:\n___ 03:58PM BLOOD cTropnT-<0.01\n___ 06:50AM BLOOD CK-MB-4 cTropnT-<0.01\n___ 06:50AM BLOOD calTIBC-398 Ferritn-16 TRF-306\n___ 06:50AM BLOOD TSH-4.5*\n___ 09:31AM BLOOD ___ pO2-73* pCO2-58* pH-7.35 \ncalTCO2-33* Base XS-3     \n___ 07:15AM BLOOD T4, FREE, DIRECT DIALYSIS-Test  \n\nDISCHARGE LABS:    \n___ 05:30AM BLOOD WBC-13.2* RBC-3.97 Hgb-9.0* Hct-31.1* \nMCV-78* MCH-22.7* MCHC-28.9* RDW-17.4* RDWSD-48.7* Plt ___\n___ 05:30AM BLOOD Glucose-85 UreaN-23* Creat-0.9 Na-136 \nK-3.9 Cl-95* HCO3-30 AnGap-15\n___ 06:30AM BLOOD Calcium-9.7 Phos-3.0 Mg-2.0\n\nIMAGING:\n___ Chest X ray: Relative increase in opacity over the lung \nbases bilaterally felt due to overlying soft tissue rather than \nconsolidation.  Lateral view may be helpful for confirmation.\n\n___ Chest X ray: There is hyperinflation.  There is no \npneumothorax, effusion, consolidation or CHF.  There is probable \nosteopenia.\n \nBrief Hospital Course:\n___ is a ___ with a history of CAD, PVD, and \nCOPD and history of recurrent chest pain who presented with afib \nwith RVR and COPD exacerbation. \n  \nACUTE PROBLEMS:\n\n#COPD exacerbation: Ms. ___ had had two recent ED visits \nfor COPD exacerbation, most recently ___ when she was started \non prednisone 60 mg. She presented to her PCP's office with \nworsening dyspnea despite this therapy and was also complaining \nof nasal congestion, suggesting a viral URI trigger. In clinic \nshe was also noted to be in afib with RVR so was referred to the \nED where she was admitted after control of her heart rate (see \nbelow). On admission to the floor, she was noted to have \nwheezing, increased work of breathing, and poor air movement. \nShe was treated with 125 mg solumedrol and maintained on 60 mg \nPO prednisone daily. Her home theophylline was decreased from \n400 mg BID to ___ mg BID due to concerns it was contributing to \nher tachyarrhythmia. She was placed on ipratropium nebs q6h, \nalbuterol nebs q2h, and fluticasone-salmeterol. Pulmonary was \nconsulted and recommended a trial of diuresis so she received 10 \nmg IV Lasix as well. Azithromycin was not given due to concerns \nfor QT prolongation with theophylline and amiodarone (QTc was \n460). She was started on a 5 day course of ceftriaxone instead, \nand discharged to finish the course with cefpodoxime. She was \ndischarged with a prednisone taper (10 mg decrease q3d until at \n10 mg, then stay at 10 mg until pulm follow up) as well as \nfollow up with pulmonary rehab and a pulmonologist she \npreviously followed with, Dr. ___. She was also discharged on \n2L supplemental O2 to be worn at all times. \n\n#Atrial fibrillation: Ms. ___ has known atrial \nfibrillation for which she was on amiodarone and apixaban but \nwas found to have HR in the 120s in her PCP's office, prompting \nher referral to the ED. Her COPD exacerbation was the likely \nprecipitant, with medications also possibly contributing, \nparticularly theophylline. She was started on a diltiazem gtt in \nthe ED to control her rates than transitioned to diltiazem 90 mg \nq6h. After arrival to the floor, her rates remained controlled. \nHer amiodarone and apixaban were continued. Her theophylline was \ndecreased to 200 mg BID from 400 mg BID.\n\n#Iron deficiency anemia. Patient was found to have microcytic \nanemia with low iron and ferritin. She was started on IV iron \n125 mg ferric gluconate x4 doses and wasdischarged on PO iron \nwith a bowel regimen. Her H/H was stable throughout the \nhospitalized; there was no evidence of bleeding.\n\nTransitional issues:\n- patient discharged on prednisone taper: decrease by 10 mg \nevery 3 days until at 10 mg, then keep at 10 mg until seen by \npulmonology\n- patient discharged with plan to follow up with pulmonology and \npulmonary rehab. Can call ___ to schedule appointment \nwith pulmonary rehab.\n- patient discharged on with 2 days of cefpodoxime to complete 5 \nday course of antibiotics for severe COPD exacerbation\n- patient discharged with O2 concentrator for continuous home O2\n- patient's theophylline decreased from 300 mg BID to ___ mg BID \ndue to her afib with RVR; may want to consider further \ntheophylline wean, and addition of azithromycin (if QTc is \ndecreased as patient also on amiodarone), and/or roflumilast \ntherapy\n- patient found to be iron deficient, started on IV iron \nrepletion, discharged on PO iron\n- patient found to have elevated TSH, please follow up free T4 \nwhich was pending on discharge\n- Code: full\n- Emergency Contact ___ (Husband) ___ \nDaughter ___: ___ \n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q6H:PRN pain \n2. Apixaban 5 mg PO BID \n3. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of \nbreath \n4. Amiodarone 200 mg PO DAILY \n5. Atorvastatin 10 mg PO QPM \n6. Artificial Tears ___ DROP BOTH EYES PRN irritation \n7. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n8. Diltiazem Extended-Release 180 mg PO BID \n9. Fluticasone Propionate NASAL 1 SPRY NU BID \n10. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n11. Hydrochlorothiazide 50 mg PO DAILY \n12. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n13. Lorazepam 0.5 mg PO QHS:PRN insomnia \n14. Theophylline ER 300 mg PO BID \n15. Ranitidine 300 mg PO DAILY \n16. Tiotropium Bromide 1 CAP IH DAILY \n17. Multivitamins W/minerals 1 TAB PO DAILY \n18. Aspirin 81 mg PO DAILY \n19. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n\n \nDischarge Medications:\n1. Home O2\n2 Liters continuous nasal cannula with exertion\nDiagnosis: chronic obstructive pulmonary disease (J44.9)\nLength of Needs: ongoing (years)\n2. Acetaminophen 650 mg PO Q6H:PRN pain \n3. Amiodarone 200 mg PO DAILY \n4. Apixaban 5 mg PO BID \n5. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN shortness of \nbreath \n6. Artificial Tears ___ DROP BOTH EYES PRN irritation \n7. Aspirin 81 mg PO DAILY \n8. Atorvastatin 10 mg PO QPM \n9. Diltiazem Extended-Release 180 mg PO BID \n10. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n11. Fluticasone Propionate NASAL 1 SPRY NU BID \n12. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n13. Hydrochlorothiazide 50 mg PO DAILY \n14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n15. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n16. Lorazepam 0.5 mg PO QHS:PRN insomnia \n17. Multivitamins W/minerals 1 TAB PO DAILY \n18. Ranitidine 300 mg PO DAILY \n19. Tiotropium Bromide 1 CAP IH DAILY \n20. Theophylline SR 200 mg PO BID \nRX *theophylline 200 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0\n21. Cefpodoxime Proxetil 200 mg PO Q12H Duration: 2 Days \nRX *cefpodoxime 200 mg 1 tablet(s) by mouth twice a day Disp #*4 \nTablet Refills:*0\n22. Ferrous Sulfate 325 mg PO DAILY \nRX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth \ndaily Disp #*30 Tablet Refills:*0\n23. Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*0\n24. Polyethylene Glycol 17 g PO DAILY \nRX *polyethylene glycol 3350 17 gram/dose 1 powder(s) by mouth \ndaily Refills:*0\n25. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN dyspnea, wheezing \nRX *ipratropium bromide 0.2 mg/mL  (0.02 %) 1 neb INH Every six \nhours Disp #*30 Nebule Refills:*0\n26. PredniSONE 10 mg PO ASDIR \n50 mg ___, then \n40 mg ___, then\n30 mg ___, then\n20 mg ___, then\n10 mg ongoing \nTapered dose - DOWN \nRX *prednisone 10 mg 1 to 5 tablet(s) by mouth As directed Disp \n#*50 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnoses:\nChronic obstructive pulmonary disease\nAtrial fibrillation with rapid ventricular response\n\nSecondary diagnoses:\nHypertension\nCoronary artery disease\nPeripheral vascular disease\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were hospitalized at ___ \nbecause you were having difficulty breathing and were found in \nclinic to have a fast heart rate. Your difficulty breathing was \ndue to your COPD flaring. Your fast heart rate was due to your \natrial fibrillation, which is an irregular heart rate that can \nsometimes cause the heart to beat very quickly. Medications that \nyou were taking, such as theophylline, were likely contributing. \nYour heart rate was lowered using the same medication that you \ntake at home, diltiazem, given through your IV. \n\nYour COPD was likely worsened because of a cold. However, your \nflare was very serious requiring IV steroids and many inhaled \ntreatments. You should follow up with the lung doctors as ___ \nas with pulmonary rehab to make sure your lung disease is being \ntreated as well as possible to prevent you from coming into the \nhospital as often. Please call ___ to schedule an \nappointment with them.\n\nIt was a pleasure participating in your care. We wish you all \nthe best in the future.\n\nSincerely,\n\nYour ___ team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "55",
         "10001884-DS-33",
         "10001884",
         "28475784",
         "2130-10-22 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\ncough, dyspnea\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nHPI: ___ year old female with history of COPD (on home O2), HTN, \nAfib admitted with dyspnea and cough.  \n Pt states inc dyspnea since this am, also one episode of \nretrosternal chest pressure lasting 2minuts on way to ED. No cp \ncurrently. on home O2. no fevers/chills or abd sx.  \n Patient was recently admitted from ___ with COPD flare \nand afib with RVR. She could not receive azithromycin due to \nconcern for QTc prolongation and so was treated with \nceftriaxone/cefpodoxime. She was treated with 60mg PO prednisone \nand discharged with a prednisone taper of 10 mg decrease q3d \nuntil at 10 mg, then stay at 10 mg until pulm follow up. She was \nalso counseled to do pulmonary rehab and follow up with Dr. \n___. She was discharged on 2L supplemental O2 to be worn at \nall times. He theophylline was decreased from 300 mg BID to ___ \nmg BID due to her afib with RVR.  \n She was also seen in the ED on ___ and ___ due to dyspnea \nwhich was felt to be a continuation of her COPD flare in the \nsetting of patient not taking her home medications. She was \ngiven nebulizers and improved. She was DCed home with ___ for \nassistance with medications. She declined pulmonary rehab \nfacility disposition.  \n\nIn the ED, initial vitals:  \n- Exam notable for: diffuse insp/esp wheezing, dry oropharynx  \n- Labs notable for: nl WBC. Trop X1 neg. EKG in sinus.\n- Imaging notable for: CXR no acute process. \n- Pt given: duoneb X 3. methylpred 125mg. Aspirin 325mg, 1L NS, \nand azithromycin 500mg. Peak flow 150, baseline per pt. Symptoms \noverall improved after nebs. \n- Vitals prior to transfer: 98.2 76 138/72 20 97NC.  \n\nOn arrival to the floor, pt reports feeling much improved and \nminimal wheezing.\n\nROS:  \nNo fevers, chills, night sweats, or weight changes. No changes \nin vision or hearing, no changes in balance. No cough, no \nshortness of breath, no dyspnea on exertion. No chest pain or \npalpitations. No nausea or vomiting. No diarrhea or \nconstipation. No dysuria or hematuria. No hematochezia, no \nmelena. No numbness or weakness, no focal deficits.  \n\n \nPast Medical History:\nASTHMA/COPD  \n ATYPICAL CHEST PAIN  \n CERVICAL RADICULITIS  \n CERVICAL SPONDYLOSIS  \n CORONARY ARTERY DISEASE  \n HEADACHE  \n HIP REPLACEMENT  \n HYPERLIPIDEMIA  \n HYPERTENSION  \n OSTEOARTHRITIS  \n HERPES ZOSTER  \n ATRIAL FIBRILLATION  \n ANXIETY  \n GASTROINTESTINAL BLEEDING  \n OSTEOARTHRITIS  \n ATHEROSCLEROTIC CARDIOVASCULAR DISEASE  \n PERIPHERAL VASCULAR DISEASE\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n \nPhysical ___:\nAdmission\n\nVitals: 99 142/80 77 20 95/2L \nGeneral: Alert, oriented, no acute distress, appears very calm \nand can talk in full sentences \nHEENT: Sclerae anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: scattered wheezing  \nCV: II/VI RUSB systolic murmur, Nl S1, S2, No MRG  \nAbdomen: soft, NT/ND bowel sounds present, no rebound tenderness \nor guarding, no organomegaly  \nGU: no foley  \nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ \nedema b/l\nNeuro: CN2-12 intact, no focal deficits \n\nVitals: 98.5 122/69(130-150) 76(70s) 18 100/2L \nGeneral: Alert, oriented, no acute distress, appears very calm \nand can talk in full sentences \nHEENT: Sclerae anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: scattered wheezing  \nCV: II/VI RUSB systolic murmur, Nl S1, S2, No MRG  \nAbdomen: soft, NT/ND bowel sounds present, no rebound tenderness \nor guarding, no organomegaly  \nGU: no foley  \nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ \nedema b/l\nNeuro: CN2-12 intact, no focal deficits\n \nPertinent Results:\nAdmission\n\n___ 01:46PM BLOOD WBC-8.3 RBC-4.52 Hgb-10.8* Hct-36.2 \nMCV-80* MCH-23.9* MCHC-29.8* RDW-21.6* RDWSD-52.4* Plt ___\n___ 01:46PM BLOOD Neuts-93.4* Lymphs-4.0* Monos-1.8* \nEos-0.1* Baso-0.1 Im ___ AbsNeut-7.77* AbsLymp-0.33* \nAbsMono-0.15* AbsEos-0.01* AbsBaso-0.01\n___ 01:46PM BLOOD ___ PTT-31.9 ___\n___ 01:46PM BLOOD Glucose-121* UreaN-19 Creat-1.1 Na-134 \nK-3.7 Cl-91* HCO3-31 AnGap-16\n___ 01:46PM BLOOD cTropnT-<0.01\n___ 01:46PM BLOOD Calcium-10.1 Phos-2.7 Mg-2.1\n___ 01:58PM BLOOD Lactate-1.6\n\nDISCHARGE\n\n___ 05:52AM BLOOD WBC-14.1*# RBC-3.81* Hgb-9.4* Hct-30.8* \nMCV-81* MCH-24.7* MCHC-30.5* RDW-22.5* RDWSD-58.1* Plt ___\n___ 05:52AM BLOOD Glucose-107* UreaN-26* Creat-0.9 Na-136 \nK-3.5 Cl-94* HCO3-35* AnGap-11\n\nCXR ___\n\nIMPRESSION:  \n  \nNo acute cardiopulmonary process. \n\n \nBrief Hospital Course:\n___ year old female with history of COPD (on home O2), HTN, Afib \nadmitted with dyspnea and cough.  \n\n#  COPD exacerbation: Presenting with cough, significant \nwheezing and poor air movement initially consistent with COPD \nexacerbation. No PNA on CXR. No ischemic EKG changes. Symptoms \nimproved with duonebs, prednisone and doxycycline. Evaluated by \n___ and discharged to rehab facility for physical strengthening \nand respiratory rehab. Discharged on home COPD meds and steroid \ntaper and abx course.\n\n# pAfib: currently rate well controlled. on apixaban\n\n- continued diltiazam\n- continued apixaban\n- continued amiodarone\n\n# Anemia: Fe def anemia on recent admission, discharged on Fe, \ncontinued iron supplement\n\n# CAD: continue aspirin, atorvastatin\n# Constipation: continue home bowel reg\n# Anxiety: continued home meds\n\nTRANSITIONAL \n\n- Discharged on steroid taper with maintenance dose of 10mg \ndaily until she sees PCP\n* Take ___-\n\n- Doxycycline 100mg BID to ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q6H:PRN pain \n2. Amiodarone 200 mg PO DAILY \n3. Apixaban 5 mg PO BID \n4. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN SOB \n5. Artificial Tears ___ DROP BOTH EYES PRN irritation \n6. Aspirin 81 mg PO DAILY \n7. Atorvastatin 10 mg PO QPM \n8. Diltiazem Extended-Release 180 mg PO BID \n9. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n10. Fluticasone Propionate NASAL 1 SPRY NU BID \n11. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n12. Hydrochlorothiazide 50 mg PO DAILY \n13. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n14. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n15. Lorazepam 0.5 mg PO QHS:PRN insomnia \n16. Multivitamins W/minerals 1 TAB PO DAILY \n17. Ranitidine 300 mg PO DAILY \n18. Tiotropium Bromide 1 CAP IH DAILY \n19. Theophylline SR 200 mg PO BID \n20. Ferrous Sulfate 325 mg PO DAILY \n21. Docusate Sodium 100 mg PO BID \n22. Polyethylene Glycol 17 g PO DAILY \n23. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB \n24. PredniSONE 30 mg PO DAILY \nStart: ___, First Dose: Next Routine Administration Time \nThis is dose # 1 of 2 tapered doses\n25. PredniSONE 20 mg PO DAILY \nStart: After 30 mg DAILY tapered dose \nThis is dose # 2 of 2 tapered doses\n26. PredniSONE 10 mg PO DAILY \nStart: After last tapered dose completes \nThis is the maintenance dose to follow the last tapered dose\n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q6H:PRN pain \n2. Amiodarone 200 mg PO DAILY \n3. Apixaban 5 mg PO BID \n4. Artificial Tears ___ DROP BOTH EYES PRN irritation \n5. Aspirin 81 mg PO DAILY \n6. Atorvastatin 10 mg PO QPM \n7. Diltiazem Extended-Release 180 mg PO BID \n8. Docusate Sodium 100 mg PO BID \n9. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n10. Ferrous Sulfate 325 mg PO DAILY \n11. Fluticasone Propionate NASAL 1 SPRY NU BID \n12. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n13. Hydrochlorothiazide 50 mg PO DAILY \n14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n15. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n16. Lorazepam 0.5 mg PO QHS:PRN insomnia \n17. Multivitamins W/minerals 1 TAB PO DAILY \n18. Polyethylene Glycol 17 g PO DAILY \n19. Ranitidine 300 mg PO DAILY \n20. Theophylline SR 200 mg PO BID \n21. Tiotropium Bromide 1 CAP IH DAILY \n22. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n23. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB \n24. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN SOB \n25. Doxycycline Hyclate 100 mg PO Q12H Duration: 2 Days \nto end ___ \n26. PredniSONE 10 mg PO ASDIR \nTake ___- \nTapered dose - DOWN \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary\n\nCOPD exacerbation\n\nSecondary\n\n CORONARY ARTERY DISEASE  \n HYPERLIPIDEMIA  \n HYPERTENSION  \n OSTEOARTHRITIS  \n ATRIAL FIBRILLATION  \n ANXIETY  \n GASTROINTESTINAL BLEEDING  \n OSTEOARTHRITIS  \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear ___,\n\n    ___ were admitted with exacerbation of your COPD. We gave \n___ some treatments and ___ improved. ___ were evaluated by the \nphysical therapy team who recommended a rehab stay for \nstrengthening and improve your breathing. Please take your \nmedications as prescribed and follow up with your providers.\n\nSincerely,\n___ medical team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "56",
         "10001884-DS-34",
         "10001884",
         "28664981",
         "2130-11-30 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ yo woman with a PMH notable for COPD on \nhome O2(hospitalized ___, multiple recent ED visits), Afib on \napixaban, HTN, CAD, and HLD who presents with several days of \nworsening dyspnea.\n\nPatient has had several ED visits for dyspnea and a recent \nhospitalization for a COPD exacerbation in ___. She has \nbeen on steroid therapy with several attempts to taper over the \nlast several months. After her most recent ED visit on ___ \nshe was on placed on 60 mg PO prednisone with a taper down by 10 \nmg each day. Her SOB worsened with the taper and she was seen on \n___ by her PCP who started her on a course of prednisone 30 mg \nPO to be tapered down by 5 mg every 3 days. With the taper she \nis currently on prednisone 25 mg QD.\n\nShe reports that her SOB improved slightly after starting the \nsteroids on ___. However, last night it acutely worsened and she \nwas unable to sleep. She usually uses 3 pillows to sleep but was \nonly comfortable seated upright last night. This morning she \nincreased her oxygen to 3L and felt better. She is usually on 2L \nNC at home. She reports that for the last several months she has \nbeen using two different albuterol inhalers each every ___ \nhours. She knows that this is more than they are prescribed for \nbut it makes her comfortable. She mostly stays put on the second \nfloor of her home. She states that she can walk to the bathroom \nwithout being short of breath, but does not use the stairs \nunless she has to leave the house because it worsens her \nbreathing. She endorses a cough occasionally productive of ___ \nsputum. This is consistent with her baseline. She endorses one \nepisode of non-exertional chest pain today that spontaneously \nresolved. She denies fever, chills, recent sick contacts, and \nlower extremity edema.\n\nIn the ED, initial vital signs were: T 98.5 P 80 BP 154/97 R 20 \nO2 sat 97% NC.  \n- Exam notable for: Diffuse expiratory wheezing, prolonged \nexpiratory phase, left inspiratory crackles, irregularly \nirregular rhthym, minimal pedal edema  \n- Labs were notable for CBC wnl, proBNP 235, Trop 0.02, chem \nnotable for bicarb 31, AG 13, UA notable for 40 RBCs  \n- Studies performed include CXR with stable mild/moderate \ncardiomegaly, atelectasis at bases, otherwise clear lung fields\n- Patient was given Albuterol neb x 1, ipratropium neb x 1, \nAzithromycin 500 mg PO, Prednisone 25 mg PO\n\nUpon arrival to the floor, the patient states that she is doing \nwell. She says that her SOB has improved since this morning and \nis better than last night when she could not sleep.  \n \nReview of Systems:  \n (+) per HPI  \n (-) fever, chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, abdominal pain, nausea, \nvomiting, diarrhea, constipation, BRBPR, melena, hematochezia, \ndysuria, hematuria.  \n \nPast Medical History:\nASTHMA/COPD  \nATYPICAL CHEST PAIN  \nCERVICAL RADICULITIS  \nCERVICAL SPONDYLOSIS  \nCORONARY ARTERY DISEASE  \nHEADACHE  \nHIP REPLACEMENT  \nHYPERLIPIDEMIA  \nHYPERTENSION  \nOSTEOARTHRITIS  \nHERPES ZOSTER  \nATRIAL FIBRILLATION  \nANXIETY  \nGASTROINTESTINAL BLEEDING  \nOSTEOARTHRITIS    \nPERIPHERAL VASCULAR DISEASE (s/p bilateral iliac stents)\n \nSocial History:\n___\nFamily History:\nMother: ___, HTN  \nFather: ___ CA  \nBrother: CA?  \nBrother: ___ \n \nPhysical ___:\n=================\nADMISSION EXAM:\n=================\nVitals- T 98.0 BP 148/70 HR 70 RR 24 O2Sat 96% on 2L NC  \nGENERAL: AOx3, NAD, sitting up in bed\nHEENT: Normocephalic, atraumatic.  Pupils equal, round, and \nreactive bilaterally, extraocular muscles intact.  No \nconjunctival pallor or injection, sclera anicteric and without \ninjection. Moist mucous membranes, good dentition.  Oropharynx \nis clear.\nNECK: Supple. JVD not visualized.\nCARDIAC: Irregularly irregular, ___ systolic murmur best at the \nLSB, no rubs or gallops.\nLUNGS: Poor air movement throughout. Mild diffuse inspiratory \nand expiratory wheezes. No use of accessory muscles of \nbreathing. No rhonchi or rales.\nBACK: No CVA tenderness \nABDOMEN:  Normal bowels sounds, non distended, non-tender to \ndeep palpation in all four quadrants. No organomegaly.\nEXTREMITIES: No clubbing or cyanosis. Bilateral pitting edema to \nthe mid shin. Pulses DP/Radial 2+ bilaterally.\nSKIN: No rash or ulcers\nNEUROLOGIC: CN2-12 intact.  Moves all extremities spontaneously. \n Normal sensation. \n=================\nDISCHARGE EXAM:\n=================\nVitals- T 98.7 BP 154/85 HR 77 RR 18 O2Sat 99% on 3L NC  \nGENERAL: AOx3, NAD, sitting up in bed\nHEENT: NCAT.  PERRL. EOMI. Sclera anicteric and not injected. \nMMM.   Oropharynx is clear.\nNECK: Supple. No LAD. JVP not appreciated at 45 degrees.\nCARDIAC: Irregularly irregular, normal rate. ___ systolic murmur \nat the RUSB. No rubs or gallops.\nLUNGS: Poor air movement throughout all zones of the lungs. No \nwheezes. No prolonged expiratory phase. No rhonchi or rales. \nDoes typically sit cross legged in the bed with forearms on her \nlegs in a tripod position.\nBACK: No CVA tenderness. \nABDOMEN:  +BS, soft, nontender, nondistended\nEXTREMITIES: Trace pitting edema to the mid shin. 2+ DP pulses \nbilaterally. No TTP.\nSKIN: No rash or ulcers.\nNEUROLOGIC: CN2-12 intact.  Moves all extremities spontaneously. \n Normal sensation. \n \nPertinent Results:\n==================\nADMISSION LABS:\n==================\n___ 02:27PM BLOOD WBC-7.4 RBC-4.57 Hgb-12.3 Hct-39.3 MCV-86 \nMCH-26.9 MCHC-31.3* RDW-23.6* RDWSD-70.9* Plt ___\n___ 02:27PM BLOOD Neuts-86.5* Lymphs-6.1* Monos-6.6 \nEos-0.0* Baso-0.0 Im ___ AbsNeut-6.38* AbsLymp-0.45* \nAbsMono-0.49 AbsEos-0.00* AbsBaso-0.00*\n___ 02:27PM BLOOD Glucose-132* UreaN-17 Creat-1.0 Na-137 \nK-3.7 Cl-93* HCO3-31 AnGap-17\n==================\nPERTINENT RESULTS:\n==================\nLABS:\n==================\n___ 12:15AM BLOOD ___ pO2-103 pCO2-49* pH-7.42 \ncalTCO2-33* Base XS-5\n===\n___ 02:27PM BLOOD cTropnT-0.02* proBNP-235\n___ 09:05PM BLOOD CK-MB-6 cTropnT-<0.01\n___ 07:45AM BLOOD CK-MB-6 cTropnT-0.02*\n===\n___ 07:45AM BLOOD THEOPHYLLINE-17.3 (10.0-20.0)\n==================\nIMAGING:\n==================\nCXR (___): PA and lateral views the chest provided. Biapical \npleural parenchymal scarring noted.  No focal consolidation \nconcerning for pneumonia. No effusion or pneumothorax.  No signs \nof congestion or edema. Cardiomediastinal silhouette is stable \nwith an unfolded thoracic aorta and top-normal heart size. Bony \nstructures are intact.\n===\nCT Chest (___):\n1.  Moderate upper lobe predominant centrilobular and paraseptal \nemphysema.\n2.  New left lower lobe nodule, potentially measuring as large \nas 6 x 8 mm, warrants close follow-up.  Stable to slightly \nsmaller 4 mm right middle lobe nodule.\n3.  Severe coronary artery calcifications.  Aortic valve \ncalcifications. \n4.  Enlargement of the main and right pulmonary arteries is \nsuggestive of chronic pulmonary arterial hypertension. \n5.  Fusiform aneurysmal dilatation of the abdominal aorta \nmeasuring up to 3.7 cm has progressed compared to prior \nexamination.\n==================\nDISCHARGE LABS:\n==================\n___ 07:45AM BLOOD WBC-7.8 RBC-4.74 Hgb-12.7 Hct-41.0 MCV-87 \nMCH-26.8 MCHC-31.0* RDW-23.7* RDWSD-71.7* Plt ___\n___ 07:45AM BLOOD Glucose-94 UreaN-18 Creat-1.0 Na-135 \nK-3.3 Cl-93* HCO3-31 AnGap-14\n___ 07:45AM BLOOD Calcium-9.8 Phos-2.8 Mg-2.0\n \nBrief Hospital Course:\nMs. ___ is a ___ y/o woman with a PMH notable for COPD on \nhome O2 (hospitalized ___, multiple recent ED visits), Afib \non apixaban, HTN, CAD, and HLD who presented with dyspnea and \northopnea in the setting of a steroid taper for recent COPD \nexacerbation. Her dyspnea was thought to be multifactorial due \nto her severe COPD and with a component of anxiety. The patient \nwas not thought to be having an acute COPD exacerbation.\n\n================\nACTIVE ISSUES:\n================\n\n# Dyspnea: Patient was admitted after one night of worsened \northopnea and dyspnea in the setting of a steroid taper from 30 \nmg to 25 mg. Her dyspnea was thought to be multifactorial due to \nher severe COPD and with a component of anxiety. The patient was \nnot thought to be having an acute COPD exacerbation. The patient \nwas treated with occasional duonebs and lorazepam 0.5 mg PRN \nthat helped relieve her dyspnea. Pulmonology was consulted. The \npatient underwent CT that showed emphysema but no evidence of \ninfection such as ___. The patient was initiated on a steroid \ntaper on ___ of prednisone 30 mg for 3 days, then 20 mg for 3 \ndays, then 10 mg until outpatient follow-up. Pulmonology \nrecommended increasing her Advair dose to 500/50, which was \ndone. They also recommended switching from theophylline to \nroflumilast and initiation of long-term azithromycin therapy \nprovided the patient's QTc was not prolonged; this was deferred \nto the outpatient setting. Throughout her admission she had O2 \nsats greater than 95% on 2L NC. She did not desaturate on \nambulation. \n\n# Anxiety/Insomnia: Patient with a history of anxiety and \ninsomnia, thought to be contributing to her experience of \ndyspnea. The patient was discharged with lorazepam Q8H as needed \nfor anxiety. The patient would likely benefit from therapy with \nan SSRI.\n\n# Demand Ischemia: Patient with troponin 0.02, <0.01, then 0.02. \nECG without acute ischemic changes.\n\n# Microscopic hematuria: On admission the patient had a UA with \n40 RBCs. Occasional UAs over the last year in OMR with \nmicroscopic hematuria. Would recommend repeat UA as an \noutpatient or work-up for microscopic hematuria.\n\n================\nCHRONIC ISSUES:\n================\n\n# Smoking: Patient recently quit smoking one month ago. Patient \nwas provided with a nicotine patch 7 mg while in house; could \nconsider continuing as an outpatient if patient endorses \ncravings.\n\n# Atrial fibrillation: Patient continued on diltiazem 240 mg PO \nBID and apixaban 5 mg BID.\n\n# HTN: Patient with a history of hypertension. Blood pressure \nwell-controlled. Continued on isosorbide mononitrate ER 240 mg \nPO daily and hydrochlorothiazide 50 mg PO daily.\n\n# CAD: Cardiac catheterization in ___ without evidence of \nsignificant stenosis of coronaries. ECHO on ___ with EF>55% \nand no regional or global wall motion abnormalities. The patient \nwas continued on aspirin 81 mg daily and atorvastatin 10 mg QPM.\n\n===================\nTRANSITIONAL ISSUES:\n===================\n#New Medications:\n-Prednisone 30 mg PO QD through ___, then on ___ mg for 3 \ndays, then on ___ mg until outpatient follow-up\n-Increased Advair (Fluticasone-Salmeterol) to 500/50 dose\n-Lorazepam 0.5 mg PO Q8H PRN for anxiety\n\n#Follow-up:\n-Appointment arranged with PCP, ___ ___\n-Appointment arranged with Pulmonologist, Dr. ___, ___\n\n#COPD: Patient was seen by pulmonology during admission who had \nthe following recommendations to consider as an outpatient.\n-Switch to roflumilast from theophylline\n-Daily azithromycin for treatment of chronic inflammation \nprovided QTc within normal limits.\n-Patient may benefit from treatment of anxiety with an SSRI, as \nher anxiety is likely contributing to her experience of dyspnea.\n-In the future, palliative care consult for consideration of \nopioid treatment of dyspnea\n\n#Microscopic hematuria: Patient had a UA with 40 RBCs on \nadmission \n-Recommend repeat UA as an outpatient or work-up for microscopic \nhematuria\n\n#Lung nodule: New left lower lobe nodule, potentially measuring \nas large as 6 x 8 mm, warrants close follow-up.  Stable to \nslightly smaller 4 mm right middle lobe nodule. Follow-up CT in \n___ months as per ___ guidelines for evaluation \nof new left lower lobe pulmonary nodule.\n\n#Code Status: Full code\n#Emergency Contact/HCP: ___ (HUSBAND) ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. PredniSONE 5 mg PO DAILY \nTapered dose - DOWN \n2. Acetaminophen 325 mg PO Q4H:PRN Pain \n3. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing \n4. Tiotropium Bromide 1 CAP IH DAILY \n5. Guaifenesin 1 teaspoon PO Q3H:PRN cough \n6. Lorazepam 0.5 mg PO QHS vertigo/insomnia \n7. Diltiazem Extended-Release 240 mg PO BID \n8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n9. Docusate Sodium 100 mg PO BID \n10. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n11. Apixaban 5 mg PO BID \n12. Ranitidine 300 mg PO DAILY \n13. Atorvastatin 10 mg PO QPM \n14. Ferrous Sulfate 325 mg PO DAILY \n15. Multivitamins 1 TAB PO DAILY \n16. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n17. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n18. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n19. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n20. Theophylline SR 300 mg PO BID \n21. Aspirin 81 mg PO DAILY \n22. albuterol sulfate 90 mcg/actuation inhalation Q4H \n23. Hydrochlorothiazide 50 mg PO DAILY \n24. cod liver oil 1 capsule  oral BID \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. Apixaban 5 mg PO BID \n3. Aspirin 81 mg PO DAILY \n4. Atorvastatin 10 mg PO QPM \n5. Diltiazem Extended-Release 240 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n8. Ferrous Sulfate 325 mg PO DAILY \n9. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n10. Hydrochlorothiazide 50 mg PO DAILY \n11. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n12. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n13. Multivitamins 1 TAB PO DAILY \n14. PredniSONE 30 mg PO DAILY \nRX *prednisone 10 mg 3 tablet(s) by mouth Daily Disp #*30 Tablet \nRefills:*0\n15. Ranitidine 300 mg PO DAILY \n16. Theophylline SR 300 mg PO BID \n17. Tiotropium Bromide 1 CAP IH DAILY \n18. Guaifenesin 1 teaspoon PO Q3H:PRN cough \n19. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing \n20. cod liver oil 1 capsule  oral BID \n21. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n22. albuterol sulfate 90 mcg/actuation inhalation Q4H \n23. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \nRX *fluticasone-salmeterol [Advair Diskus] 500 mcg-50 mcg/dose 1 \ndose Inhaled Twice a day Disp #*1 Disk Refills:*1\n24. Lorazepam 0.5 mg PO Q8H:PRN Anxiety \nRX *lorazepam [Ativan] 0.5 mg 0.5 (One half) mg by mouth Every 8 \nhours Disp #*30 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\nChronic obstruction pulmonary disease exacerbation\n\nSecondary Diagnoses:\nTobacco use disorder\nAtrial fibrillation\nHypertension\nAnxiety\nCoronary Artery Disease\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a privilege taking care of you during your admission to \n___. You were admitted to the hospital for \nshortness of breath and concern that you were having a flare of \nyour COPD.\n\nWhile in the hospital we increased your dose of steroids to help \nyour breathing. You also received several nebulizer treatments \nthat helped your breathing. You were also expressing some \nanxiety that may have been contributing to your shortness of \nbreath. You were given a medication called Ativan for your \nanxiety that also seemed to help your breathing.\n\nDuring your admission you were seen by the pulmonary \nspecialists. They recommended a CT scan that showed that you \nhave extensive COPD but did not show any infection. They also \nsuggested increasing the dose of your Advair inhaler, which we \ndid.\n\nIf you feel short of breath, first please check your oxygen \nlevel. If it is less than 90, you can use oxygen and your \ninhaler. If not, try to wait a few minutes, take a few deep \nbreaths and see if your shortness of breath improves. You can \nuse the medication called Ativan(lorazepam) to help with the \nshortness of breath(no more than three times a day). If still \nnot improved, you can use one of the inhalers/oxygen. \n\nPlease follow-up with all your appointments as listed below and \ncontinue to take all of your medications as prescribed. If you \nexperience any of the danger signs listed you should call your \ndoctor immediately or go to the Emergency Room.\n\nWe wish you the best!\n\nSincerely,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "57",
         "10001884-DS-35",
         "10001884",
         "24962904",
         "2130-12-08 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nShortness of Breath\n\n \nMajor Surgical or Invasive Procedure:\nN/A\n\n \nHistory of Present Illness:\nMs. ___ is a ___ female with history of \nCOPD on home O2, atrial fibrillation on apixaban, hypertension, \nCAD, and hyperlipidemia who presents with shortness of breath, \ncough, and wheezing for one day.\n\nThe patient reports shortness of breath, increased cough \nproductive of ___ red-flected sputum, and wheezing since \nyesterday evening.  She has been using albuterol IH more \nfrequently (___) with ipratropium nebs every 4 hours with \nminimal relief. She had to increase her O2 flow up to 4L without \nsignificant improvement. She was currently taking 10mg of \nprednisone. She has also been taking tiotropium IH, \ntheophylline, advair IH at home as prescribed. She denies sick \ncontacts. She quit smoking approximately 1 month ago.\n\nShe reports an episode of chest pain in waiting room while \nsitting down, non-exertional, resolved after 2 minutes. She \ndenies fever/chills, abdominal pain, nausea/vomiting, \npalpitations, and diaphoresis.  \n\nShe was recently admitted from ___ to ___ for dyspnea that \nwas thought to be secondary to steroid taper for recent COPD \nexacerbation with a component of anxiety (not an acute COPD \nexacerbation) and was treated with steroids and duonebs but no \nantibiotics. She had a CT that showed emphysema but no evidence \nof infection such as ___. Pulmonary was consulted and \nrecommended increasing her Advair dose to 500/50 (which was \ndone) and switching from theophylline to \nroflumilast and initiation of long-term azithromycin therapy \n(which was deferred for outpatient follow-up) She was initiated \non a steroid \ntaper on ___ of prednisone 30 mg for 3 days, then 20 mg for 3 \ndays, then 10 mg until outpatient follow-up.\n\nIn the ED, initial vital signs were: 97.6 67 132/82 22 97% 4L. \nExam was notable for limited air movement with wheezing \nbilaterally. Labs were notable for WBC 7.1, H/H 12.8/41.1, Plt \n233, Na 133, K 3.6, BUN/Cr ___, trop < 0.01, BNP 181, lactate \n1.5, VBG 7.43/___. Imaging with CXR showed mild basilar \natelectasis without definite focal consolidation. The patient \nwas given Duonebs and solumedrol 125mg IV. Vitals prior to \ntransfer were:\n\nUpon arrival to the floor, she reports her breathing is \nimproved.\n\nREVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, \npharyngitis, rhinorrhea, nasal congestion, fevers, chills, \nsweats, weight loss, abdominal pain, nausea, vomiting, diarrhea, \nconstipation, hematochezia, dysuria, rash, paresthesias, and \nweakness.\n \nPast Medical History:\n- COPD/Asthma on home 2L O2\n- Atypical Chest Pain\n- Hypertension\n- Hyperlipidemia\n- Osteroarthritis\n- Atrial Fibrillation on Apixaban\n- Anxiety\n- Cervical Radiculitis\n- Cervical Spondylosis\n- Coronary Artery Disease\n- Headache\n- Herpes Zoster\n- GI Bleeding\n- Peripheral Vascular Disease s/p bilateral iliac stents\n- s/p hip replacement\n \nSocial History:\n___\nFamily History:\nMother with asthma and hypertension. Father with colon cancer. \nBrother with leukemia.\n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n==========================\nVITALS: Temp 97.3, HR 76, O2 sat 160/80, RR 20, O2 sat 94% 4L\nGENERAL: AOx3, speaking in full sentences, NAD, resting in bed \ncomfortably.\nHEENT: NCAT. PERRL. EOMI. Sclera anicteric and not injected. \nMMM. Oropharynx is clear.\nNECK: Supple. No LAD. JVP not appreciated at 45 degrees.\nCARDIAC: Irregularly irregular, normal rate. ___ systolic murmur \n\nat the RUSB. No rubs or gallops.\nLUNGS: Expiratory wheezes throughout with poor air movement.\nABDOMEN: +BS, soft, nontender, and nondistended.\nEXTREMITIES: Warm and well-perfused. No edema. 2+ DP pulses \nbilaterally. \nNEUROLOGIC: A&Ox3, CNII-XII intact, strength and sensation \ngrossly intact bilaterally.\n\nDISCHARGE PHYSICAL EXAM:\n===========================\nVITALS: Tm 99.1, 146/69 (143-159/69-77), 94, 22, 94-95%% 2L\nGENERAL: speaking in full sentences, NAD, resting in bed \ncomfortably.\nCARDIAC: rrr, normal rate. ___ systolic murmur at the RUSB\nLUNGS: +mild wheezes throughout\nABDOMEN: +BS, soft, nontender, and nondistended.\nEXTREMITIES: Warm and well-perfused. 1+ b/l ___ edema. \nNEUROLOGIC: grossly nonfocal, aaox3\n \nPertinent Results:\nADMISSION LABS: \n=========================\n___ 05:54PM BLOOD WBC-7.1 RBC-4.74 Hgb-12.8 Hct-41.1 MCV-87 \nMCH-27.0 MCHC-31.1* RDW-22.6* RDWSD-69.0* Plt ___\n___ 05:54PM BLOOD Neuts-81.8* Lymphs-9.6* Monos-7.6 \nEos-0.3* Baso-0.1 Im ___ AbsNeut-5.82 AbsLymp-0.68* \nAbsMono-0.54 AbsEos-0.02* AbsBaso-0.01\n___ 06:35AM BLOOD Calcium-9.9 Phos-4.1 Mg-2.0\n___ 05:54PM BLOOD ___ pO2-52* pCO2-49* pH-7.43 \ncalTCO2-34* Base XS-6\n___ 05:54PM BLOOD Lactate-1.5\n___ 05:54PM BLOOD proBNP-181\n___ 05:54PM BLOOD cTropnT-<0.01\n\nSTUDIES: \n=========================\n+ CXR (___): Mild basilar atelectasis without definite focal \nconsolidation.\n+ EKG: Sinus rhythm at 69, left bundle branch block, no acute ST \nor T wave changes.\n\nDISCHARGE LABS: \n=========================\n___ 06:38AM BLOOD WBC-14.4*# RBC-4.34 Hgb-11.8 Hct-37.6 \nMCV-87 MCH-27.2 MCHC-31.4* RDW-22.5* RDWSD-69.4* Plt ___\n___ 06:38AM BLOOD Glucose-113* UreaN-18 Creat-0.8 Na-137 \nK-3.1(repleted)* Cl-94* HCO3-31 AnGap-15\n\n \nBrief Hospital Course:\nMs. ___ is a ___ female with history of \nCOPD on home O2, atrial fibrillation on apixaban, hypertension, \nCAD, and hyperlipidemia who presents with shortness of breath, \ncough, and wheezing for one day. Pt recently DC'd from hospital \nfor dyspnea, treated only w/nebs and steroids as not thought ___ \ntrue COPD exacerbation, c/f anxiety component. Pt re-admitted \nw/similar Sx, thought ___ COPD exacerbation, received nebs, \nsteroids, azithromycin. Pt's wheezing, cough, SOB improved \nshortly after admission, O2 titrated down & satting well on 2L \nin mid-90s which is baseline. Evaluated by ___, recommended DC to \npulmonary rehab, pt was agreeable. \n\nACTIVE ISSUES\n=================\n# Shortness of Breath: Patient with history of COPD and recent \nadmission for dyspnea in the setting of steroid taper. Her \nsymptoms on presentation were consistent with severe COPD given \ndiffuse wheezing and poor air movement. She likely had an \nexacerbation in the setting of a decrease in her steroids. There \nmay also be a component of anxiety. She underwent CT last \nadmission that was negative for infections such as ___. She was \ncontinued on home spiriva, theophylline, advair. She was started \non standing duonebs q6h and albuterol q2h prn and prednisone was \nstarted at 40mg daily with slow taper. She was also given \nazithromycin to complete 5 day course. She had improvement in \nher wheezing and returned to baseline O2 requirement after 48 \nhours. She was seen by ___ who felt that she would benefit from \ndischarge to inpatient pulmonary rehabilitation program. On DC \nto ___ rehab, recommended continued Prendisone 40mg \ndaily for 1x week with slow taper by 5mg every 5 days. ___ also \nconsider starting bactrim ppx with extended duration of steroids \nif unable to wean less than 20mg qd. Will also f/u as outpatient \nwith pulm.\n\nCHRONIC ISSUES: \n==================\n# Anxiety/Insomnia: Continued home lorazepam. Consider starting \nSRRI as an outpatient. \n# Atrial Fibrillation: Continued dilt for rate control and \napixaban for anticoagulation.\n# Hypertension: Continued home imdur, hydrochlorothiazide, and \ndiltiazem.\n# CAD: Cardiac catheterization in ___ without evidence of \nsignificant stenosis of coronaries. ECHO on ___ with EF > \n55% and no regional or global wall motion abnormalities. \nContinued home aspirin and atorvastatin.\n# Anemia: Continued home iron supplements.\n\nTRANSITIONAL ISSUES:\n==========================\n[] For pt's continued COPD exacerbations, recommend finishing 5d \ncourse of Azithromycin, 250mg qd until ___\n[] Recommend extended prednisone taper for pt, 5d 40mg \nPrednisone (to finish ___ followed by 10mg taper every 5 days \n(35mg from ___, 30mg ___, etc...). \n[] Would consider PCP prophylaxis with ___ if unable to wean \nprednisone to less than 20mg daily. \n[] Pt's SOB may have an anxiety component, may benefit from \nstarting SSRI in addition to home benzos already prescribed\n\n# CONTACT: Full Code\n# CODE STATUS: ___ (husband/HCP) ___\n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. Apixaban 5 mg PO BID \n3. Aspirin 81 mg PO DAILY \n4. Atorvastatin 10 mg PO QPM \n5. Diltiazem Extended-Release 240 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n8. Ferrous Sulfate 325 mg PO DAILY \n9. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n10. Hydrochlorothiazide 50 mg PO DAILY \n11. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n12. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n13. Multivitamins 1 TAB PO DAILY \n14. PredniSONE 10 mg PO DAILY \n15. Ranitidine 300 mg PO DAILY \n16. Theophylline SR 300 mg PO BID \n17. Tiotropium Bromide 1 CAP IH DAILY \n18. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing \n19. cod liver oil 1 capsule  oral BID \n20. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n21. albuterol sulfate 90 mcg/actuation inhalation Q4H \n22. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n23. Lorazepam 0.5 mg PO Q8H:PRN Anxiety \n24. Guaifenesin ___ mL PO Q4H:PRN cough \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. albuterol sulfate 90 mcg/actuation inhalation Q4H \n3. Apixaban 5 mg PO BID \n4. Aspirin 81 mg PO DAILY \n5. Atorvastatin 10 mg PO QPM \n6. Diltiazem Extended-Release 240 mg PO BID \n7. Docusate Sodium 100 mg PO BID \n8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n9. Ferrous Sulfate 325 mg PO DAILY \n10. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n11. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n12. Guaifenesin ___ mL PO Q4H:PRN cough \n13. Hydrochlorothiazide 50 mg PO DAILY \n14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n16. Lorazepam 0.5 mg PO Q8H:PRN Anxiety \n17. Multivitamins 1 TAB PO DAILY \n18. Ranitidine 300 mg PO DAILY \n19. Theophylline SR 300 mg PO BID \n20. Tiotropium Bromide 1 CAP IH DAILY \n21. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n22. cod liver oil 1 capsule  oral BID \n23. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing \n24. Nicotine Patch 7 mg TD DAILY \n25. Azithromycin 250 mg PO Q24H Duration: 4 Doses \nplease take until ___. PredniSONE 40 mg PO DAILY Duration: 5 Days \n40mg until ___ \nTapered dose - DOWN \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \n___ Diagnosis:\nPRIMARY:\nCOPD Exacerbation\n\nSECONDARY:\nAfib\nAnxiety\nHTN\nCAD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ after you developed \nshortness of breath and wheezing at home shortly after your last \ndischarge. You were treated for a COPD exacerbation and your \nbreathing quickly got better. Our physical therapists evaluated \nyou and recommended that you have a short stay at Pulmonary \n___ before going home to improve your breathing. \n\nWe wish you all the best at rehab and send our condolences to \nyour family on your recent loss.\n\nIt was truly a pleasure taking care of you.\n\nYour ___ Team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "58",
         "10001884-DS-36",
         "10001884",
         "27507515",
         "2130-12-24 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMs. ___ is a ___ with hx COPD on home O2, atrial \nfibrillation on apixaban, hypertension, CAD, and hyperlipidemia \nwho presented with dyspnea.  \nShe has had multiple prior admissions for dyspnea. She was \nrecently discharged on ___ after 3 day inpatient admission for \nCOPD exacerbation. She was discharged on extended prednisone \ntaper with plan for 5d 40mg Prednisone (to finish ___ followed \nby 10mg taper every 5 days (35mg from ___, 30mg ___, \netc...). She initially went to rehab and subsequently went home \n2 days prior to admission.  \nUpon arrival at home she subsequently had recrudescence of \nfatigue, wheezing, dyspnea. She also had increased O2 \nrequirements (up to 3L, using oxygen 24hr instead of during day \nonly). Also with new cough, non-productive. Denies f/c, CP. No \nn/v, no myalgias. Decreased hearing in right ear with fullness \nfor past 4 days. She was seen by PCP ___ noted to have \ninspiratory/expiratory wheezes, as well as decreased hearing and \nbulging TM right ear. She was referred to the ___ ED for \nfurther management.  \nIn the ED, initial vital signs were: 98.4 74 142/69 16 100%(2L \nNC)  \n- Labs were notable for:  \n 136 95 17 140  \n 3.5 29 1.0  \n BNP 254  \n CBC within normal limits, but with neutrophil predominance  \n UA with 30 protein  \n VBG: pH 7.45, pCO2 43, pO2 59, HCO3 31  \n Flu PCR negative  \n- Imaging:  \n CXR notable for no acute cardiopulmonary process.  \n- The patient was given:  \n ___ 16:03 IH Albuterol 0.083% Neb Soln 1 NEB  \n ___ 16:03 IH Ipratropium Bromide Neb 1 NEB  \n ___ 17:12 IH Albuterol 0.083% Neb Soln 1 NEB  \n ___ 17:12 IH Ipratropium Bromide Neb 1 NEB  \n ___ 18:12 IH Albuterol 0.083% Neb Soln 1 NEB  \n ___ 18:12 IH Ipratropium Bromide Neb 1 NEB  \n ___ 21:05 IH Albuterol 0.083% Neb Soln 1 NEB  \n ___ 21:05 PO PredniSONE 60 mg  \n ___ 21:05 IV Magnesium Sulfate 2 gm  \n ___ 21:33 IH Albuterol 0.083% Neb Soln 1 NEB  \n Vitals prior to transfer were:  \n 98.8 87 131/83 16 97% (2L)  \nUpon arrival to the floor, she complained of wheezing and SOB, \nand persistent decreased hearing with fullness in right ear.  \n \nREVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, \npharyngitis, rhinorrhea, nasal congestion, cough, fevers, \nchills, sweats, weight loss, dyspnea, chest pain, abdominal \npain, nausea, vomiting, diarrhea, constipation, hematochezia, \ndysuria, rash, paresthesias, and weakness.\n \nPast Medical History:\n- COPD/Asthma on home 2L O2\n- Atypical Chest Pain\n- Hypertension\n- Hyperlipidemia\n- Osteroarthritis\n- Atrial Fibrillation on Apixaban\n- Anxiety\n- Cervical Radiculitis\n- Cervical Spondylosis\n- Coronary Artery Disease\n- Headache\n- Herpes Zoster\n- GI Bleeding\n- Peripheral Vascular Disease s/p bilateral iliac stents\n- s/p hip replacement\n \nSocial History:\n___\nFamily History:\nMother with asthma and hypertension. Father with colon cancer. \nBrother with leukemia.\n\n \nPhysical Exam:\nPHYSICAL EXAMINATION ON ADMISSION:\n==================================\nVITALS: 98.1 139/79 78 22 98RA  \nGENERAL: Pleasant, well-appearing, in no apparent distress.  \nHEENT - normocephalic, atraumatic, no conjunctival pallor or \nscleral icterus, PERRLA, EOMI, OP clear.  \nNECK: Supple, no LAD, no thyromegaly, JVP flat.  \nCARDIAC: Normal S1/S2, no murmurs rubs or gallops.  \nPULMONARY: Inspiratory and expiratory wheezes in all lung fields \n \nABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, \nno organomegaly.  \nEXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or \nedema.  \nSKIN: Without rash.  \nNEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, \nwith strength ___ throughout.  \n\nPHYSICAL EXAMINATION ON DISCHARGE:\n==================================\nVITALS: 98.2 130-140/70'S 70-80's 20  98RA  \nGENERAL: Pleasant, well-appearing, in no apparent distress.  \nHEENT - normocephalic, atraumatic, no conjunctival pallor or \nscleral icterus, PERRLA, EOMI, OP clear.  \nNECK: Supple, no LAD, no thyromegaly, JVP flat.  \nCARDIAC: Normal S1/S2, no murmurs rubs or gallops.  \nPULMONARY: Decreased inspiratory and expiratory wheezes in all \nlung fields  \nABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, \nno organomegaly.  \nEXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or \nedema.  \nSKIN: Without rash.  \nNEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, \nwith strength ___ throughout.  \n\n \nPertinent Results:\nLABS ON ADMISSION:\n==================\n___ 04:00PM BLOOD Neuts-92.1* Lymphs-4.5* Monos-2.7* \nEos-0.0* Baso-0.0 Im ___ AbsNeut-5.51 AbsLymp-0.27* \nAbsMono-0.16* AbsEos-0.00* AbsBaso-0.00*\n___ 04:00PM BLOOD Plt ___\n___ 04:00PM BLOOD Glucose-140* UreaN-17 Creat-1.0 Na-136 \nK-3.5 Cl-95* HCO3-29 AnGap-16\n___ 04:00PM BLOOD proBNP-254\n___ 03:58PM BLOOD ___ pO2-59* pCO2-43 pH-7.45 \ncalTCO2-31* Base XS-4\n\nLABS ON DISCHARGE:\n==================\n___ 08:00AM BLOOD WBC-5.8 RBC-4.37 Hgb-11.9 Hct-38.2 MCV-87 \nMCH-27.2 MCHC-31.2* RDW-20.4* RDWSD-65.6* Plt ___\n___ 08:00AM BLOOD Plt ___\n___ 08:00AM BLOOD Glucose-156* UreaN-21* Creat-0.9 Na-134 \nK-3.4 Cl-92* HCO3-30 AnGap-15\n___ 08:00AM BLOOD Calcium-9.7 Phos-3.6 Mg-2.0\n\nSTUDIES:\n========\nCXR ___: No acute cardiopulmonary process  \nEKG: NSR rate 72, QTC 469, LBBB\n \nBrief Hospital Course:\n___ yo F with history of COPD on home O2, atrial fibrillation on \napixaban, hypertension, CAD, hyperlipidemia, and recurrent \nhospitalization for COPD exacerbation over the last 4 months, \nwho presented with dyspnea consistent with COPD exacerbation, \npossibly secondary to acute viral URI with concurrent sinusitis \n/ Eustachian tube dysfunction\n\n# COPD exacerbation:  \nPatient has been experiencing recurrent COPD exacerbations over \nthe last 4 months. She presented with dyspnea consistent with \nCOPD exacerbation, possibly secondary to acute viral URI with \nconcurrent sinusitis / Eustachian tube dysfunction. We continued \nhome spiriva, theophylline, and advair. We continued her steroid \ntherapy at 30mg prednisone daily with a slow taper (5mg every 2 \nweeks). We also treated her with levofloxacin (Day ___ \nwith plan for 5-day course given COPD exacerbation with \nconcurrent concern for sinusitis / bulging right tympanic \nmembrane.\n\nCHRONIC ISSUES:  \n==================  \n# Anxiety/Insomnia: We continued home lorazepam.  \n\n# Atrial Fibrillation: We continued diltiazem for rate control \nand apixaban for anticoagulation.\n \n# Hypertension: We continued home imdur, hydrochlorothiazide, \nand diltiazem.  \n \n# CAD: Cardiac catheterization in ___ without evidence of \nsignificant stenosis of coronaries. ECHO on ___ with EF > \n55% and no regional or global wall motion abnormalities. We \ncontinued home aspirin and atorvastatin.  \n \n# Anemia: We continued home iron supplements.\n\n***TRANSITIONAL ISSUES:*** \n- Continue levofloxacin with plan for 5-day course (Day \n___ end ___\n- Patient was started Bactrim PPX (1 tab SS daily) given \nextended courses of steroids, stop after discontinuation of \nsteroids\n- Patient was discharged on prednisone 30 mg with plan for taper \nby 5mg every 2 weeks:\n Prednisone 30 mg for two weeks (Day 1= ___ end \n___\n Prednisone 25 mg for two weeks (Day 1= ___ end \n___\n Prednisone 20 mg for two weeks (Day 1= ___ end \n___\n etc...\n# CONTACT: ___ (husband/HCP) ___ \n# CODE STATUS: Full confirmed \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. albuterol sulfate 90 mcg/actuation inhalation Q4H \n3. Apixaban 5 mg PO BID \n4. Aspirin 81 mg PO DAILY \n5. Atorvastatin 10 mg PO QPM \n6. Diltiazem Extended-Release 240 mg PO BID \n7. Docusate Sodium 100 mg PO BID \n8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n9. Ferrous Sulfate 325 mg PO DAILY \n10. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n11. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n12. Guaifenesin ___ mL PO Q4H:PRN cough \n13. Hydrochlorothiazide 50 mg PO DAILY \n14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n16. Lorazepam 0.5 mg PO Q8H:PRN Insomnia, anxiety, vertigo \n17. Multivitamins 1 TAB PO DAILY \n18. Ranitidine 300 mg PO DAILY \n19. Theophylline SR 300 mg PO BID \n20. Tiotropium Bromide 1 CAP IH DAILY \n21. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n22. cod liver oil 1 capsule  oral BID \n23. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing \n24. PredniSONE 30 mg PO DAILY \nTapered dose - DOWN \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. albuterol sulfate 90 mcg/actuation inhalation Q4H \n3. Apixaban 5 mg PO BID \n4. Aspirin 81 mg PO DAILY \n5. Atorvastatin 10 mg PO QPM \n6. Diltiazem Extended-Release 240 mg PO BID \n7. Docusate Sodium 100 mg PO BID \n8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n9. Ferrous Sulfate 325 mg PO DAILY \n10. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n11. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n12. Guaifenesin ___ mL PO Q4H:PRN cough \n13. Hydrochlorothiazide 50 mg PO DAILY \n14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n16. Lorazepam 0.5 mg PO Q8H:PRN Insomnia, anxiety, vertigo \n17. Multivitamins 1 TAB PO DAILY \n18. PredniSONE 30 mg PO DAILY \nPlease decrease dose by 5mg every 2 weeks \nTapered dose - DOWN \nRX *prednisone 10 mg 3 tablets(s) by mouth once a day Disp #*45 \nDose Pack Refills:*0\n19. Ranitidine 300 mg PO DAILY \n20. Theophylline SR 300 mg PO BID \n21. Tiotropium Bromide 1 CAP IH DAILY \n22. Levofloxacin 750 mg PO DAILY Duration: 5 Days \nRX *levofloxacin 750 mg 1 tablet(s) by mouth once a day Disp #*4 \nTablet Refills:*0\n23. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for \nlong term steroid use \nRX *sulfamethoxazole-trimethoprim 400 mg-80 mg 1 tablet(s) by \nmouth once a day Disp #*30 Tablet Refills:*0\n24. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n25. cod liver oil 1 capsule  oral BID \n26. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\nCOPD exacerbation\n\nSECONDARY DIAGNOSES:\nCAD\nHypertension anxiety\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear ___,\n\n___ was a great pleasure taking care of you at ___ \n___. You came here because you were \nexperiencing worsening shortness of breath as well as nasal \ncongestion and decreased hearing. Your symptoms are likely \nrelated to an upper respiratory tract infection and exacerbation \nof your COPD. We started you on antibiotics and continued your \nprednisone.\n\nThe dose of prednisone will be decreased by 5 mg every two \nweeks; please take your prednisone as follows:\n- Prednisone 30 mg for two weeks (Day 1= ___ end \n___\n- Prednisone 25 mg for two weeks (Day 1= ___ end \n___\n- Prednisone 20 mg for two weeks (Day 1= ___ end \n___\n- Discuss with Dr. ___ further taper at f/u \n\nPlease take all your medications on time and follow up with your \ndoctors as ___.\n\nBest regards,\nYour ___ team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "59",
         "10001884-DS-37",
         "10001884",
         "24746267",
         "2130-12-30 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ with hx COPD on home O2, atrial \nfibrillation on apixaban, hypertension, CAD, and hyperlipidemia, \nwith recurrent hospitalizations for COPD exacerbations, who \npresented with dyspnea.\n  \nShe has had multiple prior admissions for dyspnea. She was \nrecently discharged on ___ after 3 day inpatient admission for \nCOPD exacerbation. She was discharged on extended prednisone \ntaper with plan for 5d 40mg Prednisone (to finish ___ followed \nby 10mg taper every 5 days (35mg from ___, 30mg ___, \netc...). \n\nOn the evening prior to presentation, patient experienced \nworsening shortness of breath, nonproductive cough and wheezing \nc/w prior COPD exacerbations. She reported taking inhalers as \ndirected, without relief. The patient reported that this is \nalmost identical to her last presentation. She also felt that \nshe was taking too many medications and does not wish to \ncontinue to take prednisone. The patient was also noted to have \nincreased O2 requirement and she was referred to the ___ ED \nfor further management. Of note, please see prior admission note \nfor details regarding prior admission.  \n \nIn the ED, initial vital signs were: 88 143/105 26 94% RA. Labs \nwere notable for normal BNP and a creatinine of 1.2. Patient was \ngiven azithromycin and duoneb. Patient was scheduled to have \nmethylpred but did not have it administered until arrival to the \nfloor.  \n Upon arrival to the floor, she complained of wheezing and SOB. \nShe otherwise felt well. She agreed to take the methyprednisone \nbut does not wish to take prednisone any more.  \n \nREVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, \npharyngitis, fevers, chills, sweats, weight loss, chest pain, \nabdominal pain, nausea, vomiting, diarrhea, constipation, \nhematochezia, dysuria, rash, paresthesias, and weakness.\n \nPast Medical History:\n- COPD/Asthma on home 2L O2\n- Atypical Chest Pain\n- Hypertension\n- Hyperlipidemia\n- Osteroarthritis\n- Atrial Fibrillation on Apixaban\n- Anxiety\n- Cervical Radiculitis\n- Cervical Spondylosis\n- Coronary Artery Disease\n- Headache\n- Herpes Zoster\n- GI Bleeding\n- Peripheral Vascular Disease s/p bilateral iliac stents\n- s/p hip replacement\n \nSocial History:\n___\nFamily History:\nMother with asthma and hypertension. Father with colon cancer. \nBrother with leukemia.\n\n \nPhysical Exam:\nPHYSICAL EXAMINATION ON ADMISSION:\n==================================\n VITALS: 97.3 159/91 75  16  94% on 2L  \n GENERAL: Pleasant, well-appearing, in no apparent distress.  \n HEENT: Normocephalic, atraumatic, no conjunctival pallor or \nscleral icterus, PERRLA, EOMI, OP clear.  \n NECK: Supple, no LAD, no thyromegaly, JVP flat.  \n CARDIAC: Normal S1/S2, no murmurs rubs or gallops.  \n PULMONARY: Mild expiratory wheezes in all lung fields  \n ABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, \nno organomegaly.  \n EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or \nedema.  \n SKIN: Without rash.  \n NEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, \nwith strength ___ throughout.   \n\nPHYSICAL EXAMINATION ON DISCHARGE:\n==================================\n VITALS: 98.6 127-150/50-60  70-90'S 16  98% on 3L  \n GENERAL: Pleasant, well-appearing, in no apparent distress.  \n HEENT: Normocephalic, atraumatic, no conjunctival pallor or \nscleral icterus, PERRLA, EOMI, OP clear.  \n NECK: Supple, no LAD, no thyromegaly, JVP flat.  \n CARDIAC: Normal S1/S2, no murmurs rubs or gallops.  \n PULMONARY: Minimally decreased bilateral air entry, no wheezes \nin all lung fields  \n ABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, \nno organomegaly.  \n EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or \nedema.  \n SKIN: Without rash.  \n NEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, \nwith strength ___ throughout.  \n \nPertinent Results:\nLABS ON ADMISSION:\n==================\n___ 06:15PM BLOOD WBC-7.7 RBC-4.92 Hgb-13.5 Hct-42.4 MCV-86 \nMCH-27.4 MCHC-31.8* RDW-19.6* RDWSD-61.2* Plt ___\n___ 06:15PM BLOOD Neuts-87.4* Lymphs-5.7* Monos-6.1 \nEos-0.0* Baso-0.1 Im ___ AbsNeut-6.72* AbsLymp-0.44* \nAbsMono-0.47 AbsEos-0.00* AbsBaso-0.01\n___ 06:15PM BLOOD ___ PTT-29.6 ___\n___ 06:15PM BLOOD Plt ___\n___ 06:15PM BLOOD Glucose-122* UreaN-21* Creat-1.2* Na-136 \nK-3.4 Cl-92* HCO3-31 AnGap-16\n___ 06:15PM BLOOD ALT-52* AST-34 AlkPhos-69 TotBili-0.3\n___ 06:15PM BLOOD Lipase-28\n___ 06:15PM BLOOD cTropnT-<0.01 proBNP-325\n___ 06:15PM BLOOD Albumin-4.2\n\nLABS ON DISHCHARGE:\n===================\n___ 06:40AM BLOOD WBC-10.3* RBC-4.20 Hgb-11.8 Hct-37.0 \nMCV-88 MCH-28.1 MCHC-31.9* RDW-19.9* RDWSD-65.1* Plt ___\n___ 06:40AM BLOOD Plt ___\n___ 06:40AM BLOOD Glucose-112* UreaN-18 Creat-0.9 Na-137 \nK-3.6 Cl-96 HCO3-28 AnGap-17\n___ 06:40AM BLOOD Calcium-9.5 Phos-2.6* Mg-2.1\n\nIMAGING:\n========\n___ CXR:\nNo acute cardiopulmonary process.\n\n \nBrief Hospital Course:\n___ yo F with history of COPD on home O2, atrial fibrillation on \napixaban, hypertension, CAD, hyperlipidemia, and recurrent \nhospitalization for COPD exacerbation over the last 4 months, \nwho presented with dyspnea and increased wheezing secondary to \nsevere COPD.\n \n#Recurrent COPD exacerbation: Patient presented with increased \ndyspnea and diffuse wheezing, likely secondary to COPD \nexacerbation. She has a history of multiple recurrent COPD \nhospitalizations. According to Pulmonary, patient has severe \nCOPD based on her obstructive deficits on PFTs as well as her \nsevere symptoms even at rest, as well as her more frequent \nexacerbations and is likely approaching end-stage disease. We \ncontinued Advair 500/50 BID, Spiriva, standing nebulizers, and \ntheophylline. Pulmonary recommended additional budesonide \ninhalers to allow reduction of PO prednisone dose. Prednisone \ndose was increased back to 40mg (where patient was better) with \na plan for slow wean by 5mg every 2 weeks. Also, patient was \nstarted on chronic azithromycin for chronic anti-inflammation; \nafter discussion with Dr. ___ was agreed to stop \nazithromycin on discharge due to inability to monitor QT the \nweek after discharge, with plan to restart azithromycin once Dr. \n___ is able to see the patient. Patient did not want to go to \npulmonary rehab. She was seen by Palliative Care who recommended \ninitiation of morphine liquid suspension as needed for shortness \nof breath.\n\n# Acute kidney injury: Creatinine was slightly elevated to 1.2 \nfrom a baseline of 1.0. She likely had poor PO intake. \nCreatinine on discharge was 0.9.\n \nCHRONIC ISSUES:  \n==================  \n# Anxiety/Insomnia: We continued home lorazepam.\n \n# Atrial fibrillation: We continued diltiazem for rate control \nand apixaban for anticoagulation.  \n \n# Hypertension: We continued home imdur, hydrochlorothiazide, \nand diltiazem.  \n \n# CAD: Cardiac catheterization in ___ showed no evidence of \nsignificant stenosis of coronaries. ECHO on ___ showed EF > \n55% and no regional or global wall motion abnormalities. We \ncontinued home aspirin and atorvastatin.\n \n# Anemia: We continued home iron supplements. \n\n***TRANSITIONAL ISSUES:*** \n- Continue Advair 500/50 BID, Spiriva, and theophylline \n- Make sure patient receives standing nebulizers \n- Added additional budesonide inhalers to allow reduction of PO \nprednisone dose \n- Start chronic azithromycin for chronic anti-inflammation. \n(Patient was started on azithromycin in the hospital and QTc on \n___ was 472 ms. ___ discussion with Dr. ___ was agreed \nto stop azithromycin on discharge due to inability to monitor QT \nthe week after discharge, with the plan to restart azithromycin \nonce Dr. ___ is able to see the patient.)\n- Would recommend audiology testing at some point while patient \nis on chronic azithromycin\n- Continue supplemental oxygen for comfort\n- Follow up with Dr. ___ discharge \n- Continue Bactrim PPX (1 tab SS daily) given extended courses \nof steroids \n- Patient was discharged on prednisone 40 mg with plan for taper \nby 5mg every 2 weeks:\n Prednisone 40 mg for two weeks (Day 1= ___ end \n___\n Prednisone 35 mg for two weeks (Day 1= ___ end \n___\n Prednisone 30 mg for two weeks (Day 1= ___ end \n___\n etc...\n# CONTACT: ___ (husband/HCP) ___ \n# CODE STATUS: Full confirmed \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. albuterol sulfate 90 mcg/actuation inhalation Q4H \n3. Apixaban 5 mg PO BID \n4. Aspirin 81 mg PO DAILY \n5. Atorvastatin 10 mg PO QPM \n6. Diltiazem Extended-Release 240 mg PO BID \n7. Docusate Sodium 100 mg PO BID \n8. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n9. Ferrous Sulfate 325 mg PO DAILY \n10. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n11. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n12. Guaifenesin ___ mL PO Q4H:PRN cough \n13. Hydrochlorothiazide 50 mg PO DAILY \n14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n15. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n16. Lorazepam 0.5 mg PO Q8H:PRN Insomnia, anxiety, vertigo \n17. Multivitamins 1 TAB PO DAILY \n18. PredniSONE 30 mg PO DAILY \nTapered dose - DOWN \n19. Ranitidine 300 mg PO DAILY \n20. Theophylline SR 300 mg PO BID \n21. Tiotropium Bromide 1 CAP IH DAILY \n22. Levofloxacin 750 mg PO DAILY \n23. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for \nlong term steroid use \n24. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n25. cod liver oil 1 capsule  oral BID \n26. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN Wheezing \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n3. Tiotropium Bromide 1 CAP IH DAILY \n4. Theophylline SR 300 mg PO BID \n5. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for long \nterm steroid use \n6. Ranitidine 300 mg PO DAILY \n7. PredniSONE 40 mg PO DAILY \n8. Lorazepam 0.5 mg PO Q8H:PRN Insomnia, anxiety, vertigo \n9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n10. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n11. Ipratropium Bromide Neb 1 NEB IH Q6H Wheezing \n12. Hydrochlorothiazide 50 mg PO DAILY \n13. Guaifenesin ___ mL PO Q4H:PRN cough \n14. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n15. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n16. Ferrous Sulfate 325 mg PO DAILY \n17. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n18. albuterol sulfate 90 mcg/actuation inhalation Q4H \n19. Apixaban 5 mg PO BID \n20. Aspirin 81 mg PO DAILY \n21. Atorvastatin 10 mg PO QPM \n22. Diltiazem Extended-Release 240 mg PO BID \n23. Docusate Sodium 100 mg PO BID \n24. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal discomfort \nRX *sodium chloride 0.65 % ___ spray QID nasal congestion Disp \n#*1 Spray Refills:*0\n25. Morphine Sulfate (Oral Solution) 2 mg/mL 5 mg PO Q4H:PRN \nshortness of breath \nRX *morphine 10 mg/5 mL 2.5 mL by mouth every four (4) hours \nDisp ___ Milliliter Milliliter Refills:*0\n26. Budesonide Nasal Inhaler 180 mcg Other DAILY \nRX *budesonide [Pulmicort Flexhaler] 180 mcg/actuation (160 mcg \ndelivered) 1 puff INH DAILY Disp #*1 Inhaler Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\nSevere COPD\n\nSECONDARY DIAGNOSES:\nCAD\nHypertension\nAtrial fibrillation\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\n___ was a great pleasure taking care of you at ___ \n___. You came to the hospital because you \nwere experiencing worsening shortness of breath. Pulmonary team \nsaw you and reviewed your condition, and your symptoms are \nthought to be related to severe COPD. We did some changes in \nyour medications and increased the dose of prednisone. The \nPalliative Care team was consulted and started you on morphine \nliquid suspension to help with your breathing symptoms.\n\nPlease take all your medications on time and follow up with your \ndoctors as ___.\n\nBest regards,\nYour ___ team\n \nFollowup Instructions:\n___\n"
        ],
        [
         "60",
         "10001884-DS-38",
         "10001884",
         "26184834",
         "2131-01-20 00:00:00",
         " \nName:  ___             Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: CARDIOTHORACIC\n \nAllergies: \nIV Dye, Iodine Containing Contrast Media / Oxycodone / \ncilostazol / Varenicline\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nIntubation & Mechanical Ventilation (Extubated)\nTemporary Pacer Placement\nCVL Insertion\n\n \nHistory of Present Illness:\n___ with COPD who has been admitted 9 times since ___ for \ndyspnea, CAD, atrial fibrillation on apixaban who presented with \nshortness of breath since being discharged on ___. She was \ndischarged home with services.  \n \nMrs. ___ has significant COPD, with recent PFTs on ___ \nshowing severely reduced FEV1 and moderately reduced FEV1/FVC. \nShe was generally feeling better since discharged on ___, \ncontinuing her prednisone (at 40mg today) until the day prior to \npresentation. She subsequently began to become short of breath, \nespecially with exertion, and developed a cough productive of \nbrown sputum. No fever, chills, nausea, vomiting, diarrhea. She \nsleeps with three pillows laying on her side, which is stable. \nHer secondary concern is that she is having trouble walking due \nto pain in her R-hip to R-thigh with weight bearing. This was \nnew. No falls or trauma. No loss of sensation, numbness, \nweakness, urinary or fecal incontinence or difficulty urinating. \n \n \nIn the ED, initial vital signs were: 99.0 80 116/66 24 98% Nasal \nCannula  \n - Exam was notable for: diffuse ronchi worst in the RLL, \ntripoding  \n - Labs were notable for: flu swab negative, WBC 7.5 with left \nshift, CBC otherwise WNL, BNP 425, lactate 3.0, U/A cloudy with \n30 protein but otherwise negative, BUN/Cr ___  \n - Imaging: CXR with mild bibasilar atelectasis, though ED \nphysicians concerned for pneumonia on lateral view  \n - The patient was given: 1g Vancomycin, 2g cefepime, 500 mg PO \nazithromycin, 1 duoneb, 20 mg prednisone (total 60 mg that day)  \n\n - Consults: none  \n Vitals prior to transfer were: 98.2 87 148/76 18 92% RA  \n \nUpon arrival to the floor, Mrs. ___ stated her breathing \nwas slightly better, but she continued to have shortness of \nbreath. She felt as though her ears are clogged up, and this was \nher as well. She stated she has been taking all her medications \nas prescribed.  \n \nPast Medical History:\n- COPD/Asthma on home 2L O2\n- Atypical Chest Pain\n- Hypertension\n- Hyperlipidemia\n- Osteroarthritis\n- Atrial Fibrillation on Apixaban\n- Anxiety\n- Cervical Radiculitis\n- Cervical Spondylosis\n- Coronary Artery Disease\n- Headache\n- Herpes Zoster\n- GI Bleeding\n- Peripheral Vascular Disease s/p bilateral iliac stents\n- s/p hip replacement\n \nSocial History:\n___\nFamily History:\nMother with asthma and hypertension. Father with colon cancer. \nBrother with leukemia.\n\n \nPhysical Exam:\nPHYSICAL EXAMINATION ON ADMISSION:\n==================================\n VITALS: 98.4 140/83 77 22 94% RA  \n GENERAL: breathing somewhat heavily with audible wheeze  \n HEENT - no pallor or icterus, no oropharyngeal lesion, no sinus \ntenderness  \n NECK: Supple, JVP flat  \n CARDIAC: RRR, unable to appreciate any m/r/g due to breathing  \n PULMONARY: diffuse wheezes and ronchi  \n ABDOMEN: NT/ND, +BS  \n EXTREMITIES: 1+ lower extremity edema up shins, patient is \nsitting ___ style and I do not appreciate tenderness at the R \nhip  \n SKIN: Without rash.  \n NEUROLOGIC: A&Ox3, moving all extremities with purpose  \n \nPHYSICAL EXAMINATION ON DISCHARGE:\n==================================\n HR and RR went to zero on continuous telemetry. Patient did not \nrespond to vocal or tactile stimuli. Pupils were non-reactive to \nlight. She had no heart or lung sounds for > 1 minute on \nauscultation. She was pronounced dead at 0515. Family was \nnotified, they had previously declined an autopsy. \n \nPertinent Results:\nLABS ON ADMISSION:\n==================\n___ 04:38PM BLOOD WBC-7.5 RBC-4.39 Hgb-12.3 Hct-38.6 MCV-88 \nMCH-28.0 MCHC-31.9* RDW-18.0* RDWSD-56.9* Plt ___\n___ 04:38PM BLOOD Neuts-92.1* Lymphs-3.9* Monos-3.5* \nEos-0.0* Baso-0.0 Im ___ AbsNeut-6.91* AbsLymp-0.29* \nAbsMono-0.26 AbsEos-0.00* AbsBaso-0.00*\n___ 04:38PM BLOOD Plt ___\n___ 04:38PM BLOOD Glucose-143* UreaN-20 Creat-1.1 Na-135 \nK-3.5 Cl-91* HCO3-29 AnGap-19\n___ 04:38PM BLOOD ALT-50* AST-41* AlkPhos-73 TotBili-0.3\n___ 04:38PM BLOOD proBNP-425\n___ 04:38PM BLOOD Albumin-4.4 Calcium-10.3 Phos-3.6 Mg-2.0\n___ 10:40AM BLOOD ___ pO2-130* pCO2-41 pH-7.42 \ncalTCO2-28 Base XS-2 Comment-GREEN TOP\n___ 04:44PM BLOOD Lactate-3.0*\n\nLABS ON DISCHARGE:\n==================\n___ 04:15AM BLOOD WBC-13.4* RBC-2.42* Hgb-7.0* Hct-22.9* \nMCV-95 MCH-28.9 MCHC-30.6* RDW-17.5* RDWSD-56.8* Plt ___\n___ 04:15AM BLOOD Glucose-94 UreaN-15 Creat-0.6 Na-138 \nK-4.2 Cl-97 HCO3-37* AnGap-8\n___ 04:15AM BLOOD Calcium-8.3* Phos-3.0 Mg-2.0\n\nSELECT IMAGING:\n===============\n___ CXR:  \nCOMPARISON: ___  \nFINDINGS:  \n Heart size is mildly enlarged. There is mild unfolding of the \nthoracic aorta. Cardiomediastinal silhouette and hilar contours \nare otherwise unremarkable. There is mild bibasilar atelectasis. \nLungs are otherwise clear. Pleural surfaces are clear without \neffusion or pneumothorax. Focus of air seen under the right \nhemidiaphragm, likely represents colonic interposition.  \nIMPRESSION:No acute cardiopulmonary abnormality.  \n\n___ RUE U/S:\n IMPRESSION: 4 cm acute deep vein thrombosis noted within the \nmid right brachial vein as detailed above. \n\n___ CXR:\n IMPRESSION: The endotracheal tube tip is 6 cm above the carina. \n Nasogastric tube tip is beyond the GE junction and off the edge \nof the film.  A left central line is present in the tip is in \nthe mid SVC.  A pacemaker is noted on the right in the lead \nprojects over the right ventricle.  There is probable scarring \nin both lung apices.  There are no new areas of consolidation.  \nThere is upper zone redistribution and cardiomegaly suggesting \npulmonary venous hypertension. There is no pneumothorax. \n \nBrief Hospital Course:\n___ hx severe COPD, AFib, CAD, HTN, HLD, recent hospitalizations \nfor recurrent COPD exacerbations over the last several months, \nwho presented with dyspnea and increased wheezing secondary to \nsevere COPD. \n\nShe was treated for her COPD with nebulizers and steroids, but \ncontinued to decline eventually suffering a PEA arrest thought \ndue to hypoxemia requiring endotracheal intubation and \nmechanical ventilation. A temporary pacemaker was placed for \nperiods of bradycardia that may also have contributed to her PEA \narrest (versus being a manifestation of severe hypoxemia/severe \nhypercarbia preceding her arrest). She made a cognitive recovery \nbut was unable to be successfully weaned from her ventilator. \nShe had capacity and was able to make it understand that she did \nnot wish: continued intubation & mechanical ventilation; \nre-intubation and mechanical ventilation once extubated; or, \npositive non-invasive pressure ventilation. After extensive \ndiscussions with her and her family, she was transitioned to \nDNR/DNI and comfort-oriented care. She was extubated to spend \nquality time with her family before passing from respiratory \nfailure on the morning of ___ at 0515. Autopsy was declined \nby family.\n\nShe was incidentally found to have a RUE DVT that was treated \nwith heparin gtt (which was also used for anticoagulation for \nher atrial fibrillation; she was temporarily transitioned to \nargatroban for concern of HIT, but PF4 antibodies returned at \nvery low OD, making this diagnosis unlikely). She was also \ntreated for an acute sinusitis with Augmentin during her \nhospital stay. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 325 mg PO Q4H:PRN Pain \n2. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315 mg - \n200 units  oral DAILY \n3. Tiotropium Bromide 1 CAP IH DAILY \n4. Theophylline SR 300 mg PO BID \n5. Sulfameth/Trimethoprim SS 1 TAB PO DAILY prophylaxis for long \nterm steroid use \n6. Ranitidine 300 mg PO DAILY \n7. PredniSONE 40 mg PO DAILY \n8. Lorazepam 0.5 mg PO Q8H:PRN Insomnia, anxiety, vertigo \n9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n10. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n11. Ipratropium Bromide Neb 1 NEB IH Q6H Wheezing \n12. Hydrochlorothiazide 50 mg PO DAILY \n13. Guaifenesin ___ mL PO Q4H:PRN cough \n14. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n15. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n16. Ferrous Sulfate 325 mg PO DAILY \n17. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n18. albuterol sulfate 90 mcg/actuation inhalation Q4H \n19. Apixaban 5 mg PO BID \n20. Aspirin 81 mg PO DAILY \n21. Atorvastatin 10 mg PO QPM \n22. Diltiazem Extended-Release 240 mg PO BID \n23. Docusate Sodium 100 mg PO BID \n24. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal discomfort \n25. Morphine Sulfate (Oral Solution) 2 mg/mL 5 mg PO Q4H:PRN \nshortness of breath \n26. Budesonide Nasal Inhaler 180 mcg Other DAILY \n\n \nDischarge Medications:\nNone.\n \nDischarge Disposition:\nExpired\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES:\ns/p PEA Arrest \nRespiratory Failure\nCOPD\nSinusitis\nRUE DVT\n\nSECONDARY DIAGNOSES:\nAtrial fibrillation\nHypertension\nCAD\n \nDischarge Condition:\nDeceased. \n \nDischarge Instructions:\nN/A\n \nFollowup Instructions:\n___\n"
        ]
       ],
       "shape": {
        "columns": 5,
        "rows": 23
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>note_id</th>\n",
       "      <th>subject_id</th>\n",
       "      <th>hadm_id</th>\n",
       "      <th>charttime</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10000032-DS-21</td>\n",
       "      <td>10000032</td>\n",
       "      <td>22595853</td>\n",
       "      <td>2180-05-07 00:00:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10000032-DS-22</td>\n",
       "      <td>10000032</td>\n",
       "      <td>22841357</td>\n",
       "      <td>2180-06-27 00:00:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10000032-DS-23</td>\n",
       "      <td>10000032</td>\n",
       "      <td>29079034</td>\n",
       "      <td>2180-07-25 00:00:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10000032-DS-24</td>\n",
       "      <td>10000032</td>\n",
       "      <td>25742920</td>\n",
       "      <td>2180-08-07 00:00:00</td>\n",
       "      <td>\\nName:  ___                     Unit No:   _...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>10000935-DS-18</td>\n",
       "      <td>10000935</td>\n",
       "      <td>29541074</td>\n",
       "      <td>2183-11-04 00:00:00</td>\n",
       "      <td>\\nName:  ___                   Unit No:   ___...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>10000935-DS-19</td>\n",
       "      <td>10000935</td>\n",
       "      <td>21738619</td>\n",
       "      <td>2187-07-12 00:00:00</td>\n",
       "      <td>\\nName:  ___                   Unit No:   ___...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>10000935-DS-20</td>\n",
       "      <td>10000935</td>\n",
       "      <td>26381316</td>\n",
       "      <td>2187-08-27 00:00:00</td>\n",
       "      <td>\\nName:  ___                   Unit No:   ___...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>10000935-DS-21</td>\n",
       "      <td>10000935</td>\n",
       "      <td>25849114</td>\n",
       "      <td>2187-10-26 00:00:00</td>\n",
       "      <td>\\nName:  ___                   Unit No:   ___...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>10001884-DS-24</td>\n",
       "      <td>10001884</td>\n",
       "      <td>21268656</td>\n",
       "      <td>2125-10-20 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>10001884-DS-25</td>\n",
       "      <td>10001884</td>\n",
       "      <td>26679629</td>\n",
       "      <td>2125-10-27 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>10001884-DS-26</td>\n",
       "      <td>10001884</td>\n",
       "      <td>23594368</td>\n",
       "      <td>2125-12-03 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>10001884-DS-27</td>\n",
       "      <td>10001884</td>\n",
       "      <td>21577720</td>\n",
       "      <td>2125-12-27 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>10001884-DS-28</td>\n",
       "      <td>10001884</td>\n",
       "      <td>25758848</td>\n",
       "      <td>2128-07-17 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>10001884-DS-29</td>\n",
       "      <td>10001884</td>\n",
       "      <td>29675586</td>\n",
       "      <td>2130-04-09 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>10001884-DS-30</td>\n",
       "      <td>10001884</td>\n",
       "      <td>26170293</td>\n",
       "      <td>2130-04-19 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>10001884-DS-31</td>\n",
       "      <td>10001884</td>\n",
       "      <td>26202981</td>\n",
       "      <td>2130-08-23 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>10001884-DS-32</td>\n",
       "      <td>10001884</td>\n",
       "      <td>29678536</td>\n",
       "      <td>2130-10-12 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>10001884-DS-33</td>\n",
       "      <td>10001884</td>\n",
       "      <td>28475784</td>\n",
       "      <td>2130-10-22 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>10001884-DS-34</td>\n",
       "      <td>10001884</td>\n",
       "      <td>28664981</td>\n",
       "      <td>2130-11-30 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>10001884-DS-35</td>\n",
       "      <td>10001884</td>\n",
       "      <td>24962904</td>\n",
       "      <td>2130-12-08 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>10001884-DS-36</td>\n",
       "      <td>10001884</td>\n",
       "      <td>27507515</td>\n",
       "      <td>2130-12-24 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>10001884-DS-37</td>\n",
       "      <td>10001884</td>\n",
       "      <td>24746267</td>\n",
       "      <td>2130-12-30 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>10001884-DS-38</td>\n",
       "      <td>10001884</td>\n",
       "      <td>26184834</td>\n",
       "      <td>2131-01-20 00:00:00</td>\n",
       "      <td>\\nName:  ___             Unit No:   ___\\n \\nA...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           note_id  subject_id   hadm_id            charttime  \\\n",
       "0   10000032-DS-21    10000032  22595853  2180-05-07 00:00:00   \n",
       "1   10000032-DS-22    10000032  22841357  2180-06-27 00:00:00   \n",
       "2   10000032-DS-23    10000032  29079034  2180-07-25 00:00:00   \n",
       "3   10000032-DS-24    10000032  25742920  2180-08-07 00:00:00   \n",
       "14  10000935-DS-18    10000935  29541074  2183-11-04 00:00:00   \n",
       "15  10000935-DS-19    10000935  21738619  2187-07-12 00:00:00   \n",
       "16  10000935-DS-20    10000935  26381316  2187-08-27 00:00:00   \n",
       "17  10000935-DS-21    10000935  25849114  2187-10-26 00:00:00   \n",
       "46  10001884-DS-24    10001884  21268656  2125-10-20 00:00:00   \n",
       "47  10001884-DS-25    10001884  26679629  2125-10-27 00:00:00   \n",
       "48  10001884-DS-26    10001884  23594368  2125-12-03 00:00:00   \n",
       "49  10001884-DS-27    10001884  21577720  2125-12-27 00:00:00   \n",
       "50  10001884-DS-28    10001884  25758848  2128-07-17 00:00:00   \n",
       "51  10001884-DS-29    10001884  29675586  2130-04-09 00:00:00   \n",
       "52  10001884-DS-30    10001884  26170293  2130-04-19 00:00:00   \n",
       "53  10001884-DS-31    10001884  26202981  2130-08-23 00:00:00   \n",
       "54  10001884-DS-32    10001884  29678536  2130-10-12 00:00:00   \n",
       "55  10001884-DS-33    10001884  28475784  2130-10-22 00:00:00   \n",
       "56  10001884-DS-34    10001884  28664981  2130-11-30 00:00:00   \n",
       "57  10001884-DS-35    10001884  24962904  2130-12-08 00:00:00   \n",
       "58  10001884-DS-36    10001884  27507515  2130-12-24 00:00:00   \n",
       "59  10001884-DS-37    10001884  24746267  2130-12-30 00:00:00   \n",
       "60  10001884-DS-38    10001884  26184834  2131-01-20 00:00:00   \n",
       "\n",
       "                                                 text  \n",
       "0    \\nName:  ___                     Unit No:   _...  \n",
       "1    \\nName:  ___                     Unit No:   _...  \n",
       "2    \\nName:  ___                     Unit No:   _...  \n",
       "3    \\nName:  ___                     Unit No:   _...  \n",
       "14   \\nName:  ___                   Unit No:   ___...  \n",
       "15   \\nName:  ___                   Unit No:   ___...  \n",
       "16   \\nName:  ___                   Unit No:   ___...  \n",
       "17   \\nName:  ___                   Unit No:   ___...  \n",
       "46   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "47   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "48   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "49   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "50   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "51   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "52   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "53   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "54   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "55   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "56   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "57   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "58   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "59   \\nName:  ___             Unit No:   ___\\n \\nA...  \n",
       "60   \\nName:  ___             Unit No:   ___\\n \\nA...  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "patient_list = [10000032, 10000935, 10001884]\n",
    "\n",
    "patient_df = df[df['subject_id'].isin(patient_list)]\n",
    "patient_df = patient_df.drop(['note_type', 'note_seq', 'storetime'], axis=1)\n",
    "patient_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "800dacdc",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "17,  \n",
      "Name:  ___             Unit No:   ___\n",
      " \n",
      "Admission Date:  ___              Discharge Date:   ___\n",
      " \n",
      "Date of Birth:  ___             Sex:   F\n",
      " \n",
      "Service: MEDICINE\n",
      " \n",
      "Allergies: \n",
      "IV Dye, Iodine Containing Contrast Media / Oxycodone / \n",
      "cilostazol / Varenicline\n",
      " \n",
      "Attending: ___.\n",
      " \n",
      "Chief Complaint:\n",
      "cough, dyspnea\n",
      " \n",
      "Major Surgical or Invasive Procedure:\n",
      "None\n",
      "\n",
      " \n",
      "History of Present Illness:\n",
      "HPI: ___ year old female with history of COPD (on home O2), HTN, \n",
      "Afib admitted with dyspnea and cough.  \n",
      " Pt states inc dyspnea since this am, also one episode of \n",
      "retrosternal chest pressure lasting 2minuts on way to ED. No cp \n",
      "currently. on home O2. no fevers/chills or abd sx.  \n",
      " Patient was recently admitted from ___ with COPD flare \n",
      "and afib with RVR. She could not receive azithromycin due to \n",
      "concern for QTc prolongation and so was treated with \n",
      "ceftriaxone/cefpodoxime. She was treated with 60mg PO prednisone \n",
      "and discharged with a prednisone taper of 10 mg decrease q3d \n",
      "until at 10 mg, then stay at 10 mg until pulm follow up. She was \n",
      "also counseled to do pulmonary rehab and follow up with Dr. \n",
      "___. She was discharged on 2L supplemental O2 to be worn at \n",
      "all times. He theophylline was decreased from 300 mg BID to ___ \n",
      "mg BID due to her afib with RVR.  \n",
      " She was also seen in the ED on ___ and ___ due to dyspnea \n",
      "which was felt to be a continuation of her COPD flare in the \n",
      "setting of patient not taking her home medications. She was \n",
      "given nebulizers and improved. She was DCed home with ___ for \n",
      "assistance with medications. She declined pulmonary rehab \n",
      "facility disposition.  \n",
      "\n",
      "In the ED, initial vitals:  \n",
      "- Exam notable for: diffuse insp/esp wheezing, dry oropharynx  \n",
      "- Labs notable for: nl WBC. Trop X1 neg. EKG in sinus.\n",
      "- Imaging notable for: CXR no acute process. \n",
      "- Pt given: duoneb X 3. methylpred 125mg. Aspirin 325mg, 1L NS, \n",
      "and azithromycin 500mg. Peak flow 150, baseline per pt. Symptoms \n",
      "overall improved after nebs. \n",
      "- Vitals prior to transfer: 98.2 76 138/72 20 97NC.  \n",
      "\n",
      "On arrival to the floor, pt reports feeling much improved and \n",
      "minimal wheezing.\n",
      "\n",
      "ROS:  \n",
      "No fevers, chills, night sweats, or weight changes. No changes \n",
      "in vision or hearing, no changes in balance. No cough, no \n",
      "shortness of breath, no dyspnea on exertion. No chest pain or \n",
      "palpitations. No nausea or vomiting. No diarrhea or \n",
      "constipation. No dysuria or hematuria. No hematochezia, no \n",
      "melena. No numbness or weakness, no focal deficits.  \n",
      "\n",
      " \n",
      "Past Medical History:\n",
      "ASTHMA/COPD  \n",
      " ATYPICAL CHEST PAIN  \n",
      " CERVICAL RADICULITIS  \n",
      " CERVICAL SPONDYLOSIS  \n",
      " CORONARY ARTERY DISEASE  \n",
      " HEADACHE  \n",
      " HIP REPLACEMENT  \n",
      " HYPERLIPIDEMIA  \n",
      " HYPERTENSION  \n",
      " OSTEOARTHRITIS  \n",
      " HERPES ZOSTER  \n",
      " ATRIAL FIBRILLATION  \n",
      " ANXIETY  \n",
      " GASTROINTESTINAL BLEEDING  \n",
      " OSTEOARTHRITIS  \n",
      " ATHEROSCLEROTIC CARDIOVASCULAR DISEASE  \n",
      " PERIPHERAL VASCULAR DISEASE\n",
      " \n",
      "Social History:\n",
      "___\n",
      "Family History:\n",
      "Mother: ___, HTN  \n",
      "Father: ___ CA  \n",
      "Brother: CA?  \n",
      "Brother: ___ \n",
      " \n",
      "Physical ___:\n",
      "Admission\n",
      "\n",
      "Vitals: 99 142/80 77 20 95/2L \n",
      "General: Alert, oriented, no acute distress, appears very calm \n",
      "and can talk in full sentences \n",
      "HEENT: Sclerae anicteric, MMM, oropharynx clear  \n",
      "Neck: supple, JVP not elevated, no LAD  \n",
      "Lungs: scattered wheezing  \n",
      "CV: II/VI RUSB systolic murmur, Nl S1, S2, No MRG  \n",
      "Abdomen: soft, NT/ND bowel sounds present, no rebound tenderness \n",
      "or guarding, no organomegaly  \n",
      "GU: no foley  \n",
      "Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ \n",
      "edema b/l\n",
      "Neuro: CN2-12 intact, no focal deficits \n",
      "\n",
      "Vitals: 98.5 122/69(130-150) 76(70s) 18 100/2L \n",
      "General: Alert, oriented, no acute distress, appears very calm \n",
      "and can talk in full sentences \n",
      "HEENT: Sclerae anicteric, MMM, oropharynx clear  \n",
      "Neck: supple, JVP not elevated, no LAD  \n",
      "Lungs: scattered wheezing  \n",
      "CV: II/VI RUSB systolic murmur, Nl S1, S2, No MRG  \n",
      "Abdomen: soft, NT/ND bowel sounds present, no rebound tenderness \n",
      "or guarding, no organomegaly  \n",
      "GU: no foley  \n",
      "Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ \n",
      "edema b/l\n",
      "Neuro: CN2-12 intact, no focal deficits\n",
      " \n",
      "Pertinent Results:\n",
      "Admission\n",
      "\n",
      "___ 01:46PM BLOOD WBC-8.3 RBC-4.52 Hgb-10.8* Hct-36.2 \n",
      "MCV-80* MCH-23.9* MCHC-29.8* RDW-21.6* RDWSD-52.4* Plt ___\n",
      "___ 01:46PM BLOOD Neuts-93.4* Lymphs-4.0* Monos-1.8* \n",
      "Eos-0.1* Baso-0.1 Im ___ AbsNeut-7.77* AbsLymp-0.33* \n",
      "AbsMono-0.15* AbsEos-0.01* AbsBaso-0.01\n",
      "___ 01:46PM BLOOD ___ PTT-31.9 ___\n",
      "___ 01:46PM BLOOD Glucose-121* UreaN-19 Creat-1.1 Na-134 \n",
      "K-3.7 Cl-91* HCO3-31 AnGap-16\n",
      "___ 01:46PM BLOOD cTropnT-<0.01\n",
      "___ 01:46PM BLOOD Calcium-10.1 Phos-2.7 Mg-2.1\n",
      "___ 01:58PM BLOOD Lactate-1.6\n",
      "\n",
      "DISCHARGE\n",
      "\n",
      "___ 05:52AM BLOOD WBC-14.1*# RBC-3.81* Hgb-9.4* Hct-30.8* \n",
      "MCV-81* MCH-24.7* MCHC-30.5* RDW-22.5* RDWSD-58.1* Plt ___\n",
      "___ 05:52AM BLOOD Glucose-107* UreaN-26* Creat-0.9 Na-136 \n",
      "K-3.5 Cl-94* HCO3-35* AnGap-11\n",
      "\n",
      "CXR ___\n",
      "\n",
      "IMPRESSION:  \n",
      "  \n",
      "No acute cardiopulmonary process. \n",
      "\n",
      " \n",
      "Brief Hospital Course:\n",
      "___ year old female with history of COPD (on home O2), HTN, Afib \n",
      "admitted with dyspnea and cough.  \n",
      "\n",
      "#  COPD exacerbation: Presenting with cough, significant \n",
      "wheezing and poor air movement initially consistent with COPD \n",
      "exacerbation. No PNA on CXR. No ischemic EKG changes. Symptoms \n",
      "improved with duonebs, prednisone and doxycycline. Evaluated by \n",
      "___ and discharged to rehab facility for physical strengthening \n",
      "and respiratory rehab. Discharged on home COPD meds and steroid \n",
      "taper and abx course.\n",
      "\n",
      "# pAfib: currently rate well controlled. on apixaban\n",
      "\n",
      "- continued diltiazam\n",
      "- continued apixaban\n",
      "- continued amiodarone\n",
      "\n",
      "# Anemia: Fe def anemia on recent admission, discharged on Fe, \n",
      "continued iron supplement\n",
      "\n",
      "# CAD: continue aspirin, atorvastatin\n",
      "# Constipation: continue home bowel reg\n",
      "# Anxiety: continued home meds\n",
      "\n",
      "TRANSITIONAL \n",
      "\n",
      "- Discharged on steroid taper with maintenance dose of 10mg \n",
      "daily until she sees PCP\n",
      "* Take ___-\n",
      "\n",
      "- Doxycycline 100mg BID to ___\n",
      " \n",
      "Medications on Admission:\n",
      "The Preadmission Medication list is accurate and complete.\n",
      "1. Acetaminophen 650 mg PO Q6H:PRN pain \n",
      "2. Amiodarone 200 mg PO DAILY \n",
      "3. Apixaban 5 mg PO BID \n",
      "4. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN SOB \n",
      "5. Artificial Tears ___ DROP BOTH EYES PRN irritation \n",
      "6. Aspirin 81 mg PO DAILY \n",
      "7. Atorvastatin 10 mg PO QPM \n",
      "8. Diltiazem Extended-Release 180 mg PO BID \n",
      "9. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n",
      "10. Fluticasone Propionate NASAL 1 SPRY NU BID \n",
      "11. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n",
      "12. Hydrochlorothiazide 50 mg PO DAILY \n",
      "13. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n",
      "14. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n",
      "15. Lorazepam 0.5 mg PO QHS:PRN insomnia \n",
      "16. Multivitamins W/minerals 1 TAB PO DAILY \n",
      "17. Ranitidine 300 mg PO DAILY \n",
      "18. Tiotropium Bromide 1 CAP IH DAILY \n",
      "19. Theophylline SR 200 mg PO BID \n",
      "20. Ferrous Sulfate 325 mg PO DAILY \n",
      "21. Docusate Sodium 100 mg PO BID \n",
      "22. Polyethylene Glycol 17 g PO DAILY \n",
      "23. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB \n",
      "24. PredniSONE 30 mg PO DAILY \n",
      "Start: ___, First Dose: Next Routine Administration Time \n",
      "This is dose # 1 of 2 tapered doses\n",
      "25. PredniSONE 20 mg PO DAILY \n",
      "Start: After 30 mg DAILY tapered dose \n",
      "This is dose # 2 of 2 tapered doses\n",
      "26. PredniSONE 10 mg PO DAILY \n",
      "Start: After last tapered dose completes \n",
      "This is the maintenance dose to follow the last tapered dose\n",
      "\n",
      " \n",
      "Discharge Medications:\n",
      "1. Acetaminophen 650 mg PO Q6H:PRN pain \n",
      "2. Amiodarone 200 mg PO DAILY \n",
      "3. Apixaban 5 mg PO BID \n",
      "4. Artificial Tears ___ DROP BOTH EYES PRN irritation \n",
      "5. Aspirin 81 mg PO DAILY \n",
      "6. Atorvastatin 10 mg PO QPM \n",
      "7. Diltiazem Extended-Release 180 mg PO BID \n",
      "8. Docusate Sodium 100 mg PO BID \n",
      "9. Dorzolamide 2% Ophth. Soln. 1 DROP BOTH EYES BID \n",
      "10. Ferrous Sulfate 325 mg PO DAILY \n",
      "11. Fluticasone Propionate NASAL 1 SPRY NU BID \n",
      "12. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n",
      "13. Hydrochlorothiazide 50 mg PO DAILY \n",
      "14. Isosorbide Mononitrate (Extended Release) 240 mg PO DAILY \n",
      "15. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS \n",
      "16. Lorazepam 0.5 mg PO QHS:PRN insomnia \n",
      "17. Multivitamins W/minerals 1 TAB PO DAILY \n",
      "18. Polyethylene Glycol 17 g PO DAILY \n",
      "19. Ranitidine 300 mg PO DAILY \n",
      "20. Theophylline SR 200 mg PO BID \n",
      "21. Tiotropium Bromide 1 CAP IH DAILY \n",
      "22. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB \n",
      "23. Ipratropium Bromide Neb 1 NEB IH Q6H:PRN SOB \n",
      "24. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN SOB \n",
      "25. Doxycycline Hyclate 100 mg PO Q12H Duration: 2 Days \n",
      "to end ___ \n",
      "26. PredniSONE 10 mg PO ASDIR \n",
      "Take ___- \n",
      "Tapered dose - DOWN \n",
      "\n",
      " \n",
      "Discharge Disposition:\n",
      "Extended Care\n",
      " \n",
      "Facility:\n",
      "___\n",
      " \n",
      "Discharge Diagnosis:\n",
      "Primary\n",
      "\n",
      "COPD exacerbation\n",
      "\n",
      "Secondary\n",
      "\n",
      " CORONARY ARTERY DISEASE  \n",
      " HYPERLIPIDEMIA  \n",
      " HYPERTENSION  \n",
      " OSTEOARTHRITIS  \n",
      " ATRIAL FIBRILLATION  \n",
      " ANXIETY  \n",
      " GASTROINTESTINAL BLEEDING  \n",
      " OSTEOARTHRITIS  \n",
      "\n",
      " \n",
      "Discharge Condition:\n",
      "Mental Status: Clear and coherent.\n",
      "Level of Consciousness: Alert and interactive.\n",
      "Activity Status: Ambulatory - requires assistance or aid (walker \n",
      "or cane).\n",
      "\n",
      " \n",
      "Discharge Instructions:\n",
      "Dear ___,\n",
      "\n",
      "    ___ were admitted with exacerbation of your COPD. We gave \n",
      "___ some treatments and ___ improved. ___ were evaluated by the \n",
      "physical therapy team who recommended a rehab stay for \n",
      "strengthening and improve your breathing. Please take your \n",
      "medications as prescribed and follow up with your providers.\n",
      "\n",
      "Sincerely,\n",
      "___ medical team\n",
      " \n",
      "Followup Instructions:\n",
      "___\n",
      "\n"
     ]
    }
   ],
   "source": [
    "random = rnd.randint(1,len(patient_df))\n",
    "\n",
    "test_cell = patient_df.iloc[random, 4]    \n",
    "\n",
    "print(f\"{random}, {test_cell}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "6ddce947",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " Created 23 documents in /Users/maui/Developer/Developer Projects/Python/Text-Analytics-Final-Project/Documents\n"
     ]
    }
   ],
   "source": [
    "DATA = patient_df\n",
    "# Output folder\n",
    "out_dir = Path('../Documents')\n",
    "out_dir.mkdir(exist_ok=True)\n",
    "\n",
    "def safe_name(s):\n",
    "    return \"\".join(ch for ch in str(s) if ch not in r'\\/:*?\"<>|').strip() or \"unnamed\"\n",
    "\n",
    "created = 0\n",
    "for _, row in DATA.iterrows():\n",
    "    doc = Document()\n",
    "\n",
    "    # Header\n",
    "    doc.add_heading(f\"Note ID: {row['note_id']}\", level=1)\n",
    "\n",
    "    # Metadata\n",
    "    p = doc.add_paragraph()\n",
    "    p.add_run(\"Subject ID: \").bold = True\n",
    "    p.add_run(str(row['subject_id']))\n",
    "    p = doc.add_paragraph()\n",
    "    p.add_run(\"HADM ID: \").bold = True\n",
    "    p.add_run(str(row['hadm_id']))\n",
    "\n",
    "    doc.add_paragraph(\"\")  # spacer\n",
    "    doc.add_heading(\"Text\", level=2)\n",
    "    doc.add_paragraph(\"\" if pd.isna(row['text']) else str(row['text']))\n",
    "\n",
    "    # Filename from note_id\n",
    "    fname = out_dir / f\"note_{safe_name(row['note_id'])}.docx\"\n",
    "    doc.save(fname)\n",
    "    created += 1\n",
    "\n",
    "print(f\" Created {created} documents in {out_dir.resolve()}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
